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Abstract
Oral cancers, i.e. those which affect the mouth, possess a number of features which, despite the 
relative ease with which the mouth can be visually and palpably examined, add yet more layers of 
complexity to the detection, diagnosis and treatment of these cancers. One such factor is the 
tendency for benign, potentially malignant and cancerous lesions to be similar upon visual 
inspection. Another is the often asymptomatic development of oral cancers, which often go 
undetected by patients until the point of metastatic spread.
A number of factors contribute to the early diagnosis and successful treatment of oral cancers, 
however, in this thesis, the researcher focused on the following; detection of lesions as dysplastic or 
cancerous, potentially at an early stage of cancer development, by using minimally invasive sampling 
and testing methods. Samples of oral tissue were collected from patients with cancerous and 
potentially malignant lesions, and healthy participants, using brush biopsies. Cells collected from the 
mouths of patients and participants were then tested using a label-free technique employed to 
elucidate the electrophysiological properties of said cells by exposing them to alternating current 
electric fields, known as dielectrophoresis or DEP.
Dielectrophoresis was also used to characterise a sub-group of cells reported to drive tumour 
formation, metastasis and treatment evasion-cancer stem cells. Specifically, this thesis contains work 
on the use of collagen IV adherence as an oral cancer stem-ness biomarker, and the evaluation of 
oral cancer stem cells with epithelial and the more motile, mesenchymal phenotype.
In summary, the work presented here forms three, main studies in which dielectrophoresis was used 
to explore key factors involved in the potential for successful diagnosis of oral cancers-early 
detection leading to early diagnosis, and the characteristics of cancer stem cells.
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Chapter 1. Introduction to General 
Subject Areas
1.1 Cancer
The impact of cancer, worldwide, can be summarised by one statistic: in 2012, one of the leading 
causes of death globally, was cancer [1]. The deaths of 8.2 million people, in 2012, were attributed 
solely to cancer, and there were 14.1 million new cases of the disease in that year alone [1].
Cancer is defined as "an abnormal growth of cells caused by multiple changes in gene expression 
leading to dysregulated balance of cell proliferation and cell death and ultimately evolving into a 
population of cells that can evade tissues and metastasize to distant sites, causing significant 
morbidity and, if untreated, death of the host." [2]. It has been estimated that the number of cells 
which undergo changes in gene expression or mutations, daily is lO '^* [3]. Where these mutations 
give a selective advantage (i.e. the Darwinian principle of "survival of the fittest") over other normal 
cells, in terms of survival, leads to these mutant cells becoming the founding cell in a mutant clone. 
Over a period of years, this founding cell can then produce rounds of mutated progeny which retain 
the advantageous mutation. This is the basic process through which cancer develops [3]. In essence, 
cancer disobeys homoestasis (the governing principle of balance within the body)-to create positive 
feedback loops which allow cancer cells to have a ready supply of the signals, factors and nutrients 
they require within their environment, to proliferate (i.e. to allow rate of cell proliferation to be 
greater than the rate of cell attrition), evade their tissue of origin, and metastasise.
Hanahan and Weinberg produced a paper in 2000, which was and is to this day, a highly respected 
and highly cited work, called "The Hallmarks of Cancer" [4]. In this paper, the authors looked to 
reduce the complexity of cancer research by summarising common characteristics and traits of many, 
if not all human cancers, into a small number of governing principles required for malignant 
transformation of normal cells (a process called tumorigenesis), and they also hinted that the 
complexity of cancer is a bi-product of the vast scope of research conducted for the investigation of 
cancer and the heterogeneous nature of cancer manifestation [4]. For most types of cancer, the 
authors suggested that there are six essential physiological alterations which collectively, govern 
malignant transformation of cells: lack of sensitivity to growth inhibition signals, self-sufficiency in 
terms of growth signal production, the potential for limitless self-replication, the ability to evade
programmed cell death (apoptosis), sustained production of blood vessels (angiogenesis), and 
metastasis [4].
The authors state that of the six physiological alterations needed for cancer development, acquisition 
of autonomous growth signal production was the first to be discovered by cancer researchers, and 
that there are three main ways in which cancer cells achieve this autonomy [4]. They are alteration of 
the extracellular growth signals, alteration of the trans-cellular mechanisms for transmission of these 
signals to the cell interior, and alteration of how these signals are translated by intracellular 
components, and the authors suggest that in all human tumours, the growth signalling pathways are 
deregulated, but can concede that whilst there are suggestions of this in the literature, it is very 
difficult to prove [4]. In healthy, normal tissue, normal cells are required to be in the active state in 
order to proliferate, and transition into this active state is achieved by mitogenic growth signals, 
which are transmitted to the cell interior by transmembrane receptors [4]. The transmembrane 
receptors respond to specific signalling molecules: growth factors, components of the extracellular 
matrix (which acts as the scaffold for tissue architecture) and connective tissue, such as collagen, 
fibrinogen, fibroblasts etc [3] and molecules which permit cell-to-cell adhesion and interaction [4]. It 
has been suggested that the lack of reliance that cancer cells show for growth factors, supplied by 
components of the cells' environment, is due to cancer cells possessing the ability to manufacture 
their own growth factors, therefore "side-stepping" this method of normal cell governance [4]. As 
well as being able to manufacture their own growth signals, the authors stated that cancer cells must 
be able to avoid anti-growth signals which would act to force them from a proliferative state to a 
quiescent state in their cell cycle, or force them into a permanent state of being unable to proliferate 
by forcing them to differentiate (i.e. senescence), although it has been suggested that senescent cells 
may be able to contribute to tissue structure and function changes associated with age, and 
therefore age-related pathologies (which many types of cancer qualify as) [5], which can be avoided 
if cancer cells overexpress the oncoprotein c-myc [4]. At the molecular level, anti-proliferative 
signalling (in many, if not all cases) encounters the retinoblastoma protein (pRb) or its associated 
proteins p l07  and p l30, and disruption of the pRb pathway (by molecules such as TGF-P) renders 
cells insensitive to anti-growth signals [4]. Also, other cell types found within the cancer cell's 
environment play a role in deregulation of growth signalling, such as fibroblasts and endothelial cells, 
and cell-to-cell signalling, be it from neighbouring cells (paracrine signals) or from systems (endocrine 
signals), almost certainly influences human tumour development [4]. Cancer cells also appear to be 
able to select which type of integrins (a group of extracellular matrix signal receptors) they express
[4]. This is important for cancer development, as successful binding of integrins to specific
extracellular matrix components transmits signals to the cell interior which in turn then influence cell 
behaviour, such as allowing the cell to evade apoptosis and to enter into an active state within the 
cell cycle in order to proliferate [4].
The avoidance of cell death is another trait of cancer cells, listed by the authors [4]. The multi-step 
process of cell death termed "apoptosis" occurs over a period of 30-120 minutes, in which time the 
cell membrane is disrupted (e.g. blebbing) and breached, the cytoplasmic and nuclear scaffolds are 
destroyed and chromosomes are degraded and the nucleus destroyed [4]. Within 24 hours, the cell is 
no longer even apparent, as it is consumed by other cells [4]. It is therefore no surprise that 
inactivation of the protein p53, which acts by signalling for apoptosis to begin upon sensing DNA 
damage thus suppressing tumour development, is evident in more than 50% of human cancers [4].
However, research has shown that expansive tumour growth does not occur due to lack of sensitivity 
to growth inhibition signals, self-sufficiency in terms of growth signal production and the ability to 
evade apoptosis, alone, but also requires limitless replicative potential [4]. The number of 
generations normal cells can produce is a barrier to cancer formation, as research has shown that the 
number of cells which constitute a tumour is a small percentage of the number of cells required to 
produce the tumour [4]. The cell mechanism for "counting" the number of times a cell reproduces is 
telomere shortening [4]. Telomeres are found at the end of chromosomes, and shorten during each 
cell cycle. Without telomeres to protect the ends of chromosomal DNA, the cell enters a crisis state, 
which almost inevitably ends in cell death. Maintenance of telomeres allows cancer cells to avoid this 
crisis state, and therefore death, and hence is implicated in almost all malignant cancer cells. Cancer 
cells (85-90%) avoid this telomere-associated death by up-regulating the telomerase enzyme which 
acts in turn to lengthen the telomere ends [4].
Angiogenesis was another key factor for tumour development outlined by the authors [4]. Vascular 
endothelial growth factor (VEGF) and fibroblast growth factor (FGF) play a role in angiogenesis 
initiation and many tumours display increased expression of one or both [4].
However, of the six common traits outlined by the authors, the ability to metastasise or spread is a 
key factor in cancer mortality, as métastasés are the cause of 90% of cancer deaths [6]. The process 
of metastasis requires alteration of tethering abilities, with regards to tethering between cells and 
tethering between cells and the extracellular matrix [4]. The former is achieved by cell-to-cell 
adhesion molecules (CAMs) such as immunoglobulins and calcium-dependent cadherins, and the 
latter is achieved by integrins, with E-cadherins (which act to link cells to allow for passage of signals 
such as anti-growth signals) being lost in most epithelial cancers [4].
The authors did not include genomic instability among the six characteristics of cancer [4]. Rather, 
they considered it to be what drives pre- or potentially malignant cells to acquire these six 
characteristics [4]. The authors concluded by suggesting that the studying of cancer in vitro has lead 
to the collection of much of the information gained in cancer research, but this approach is in danger 
of simplifying our understanding of cancer by failing to consider the complex mixture of other cell 
types found in vivo [4].
In 2011 Hanahan and Weinberg produced a paper reviewing the theories postulated in their 
"Hallmarks of Cancer" paper, and updated and expanded upon them, in view of a decade more 
cancer research [7]. In this updated work, they state that tumour biology cannot be fully understood 
by considering the traits of the cancer cells alone, but must also take account of the tumour 
microenvironment, and emphasise that the destruction of negative feedback signalling pathways is 
common in human cancer cells, and is of great importance for these cells if they are to develop 
proliferative independence [7]. The authors also add that cellular necrosis could aid cancer 
development rather than hindering it by destroying cells with genetic mutations, given it involves the 
release of factors which encourage neighbouring cells to proliferate, and releases inflammatory 
signals which in turn, recruit inflammatory cells which can in turn be tumour-promoting [7]. They 
state that the vast majority of cancerous lesions contain immune cell populations, varying from 
subtle to extremely large, and that inflammation can contribute growth factors, pro-angiogenic 
factors and survival factors by supplying molecules to the tumour microenvironment which 
accomplish these ends [7]. The authors also add that two more attributes could possibly be added to 
the six traits of cancer cells presented by the authors in their previous paper [4]: reprogramming of 
cellular metabolism to provide energy for growth and proliferation, and evasion of immune system 
attacks [7].
There are a number of risk factors associated with cancer development, and in a paper by Parkin and 
colleagues [8], 14 such risk factors associated with and attributed to behaviour and lifestyle choices 
were identified: tobacco smoke, alcohol consumption, infections, ionising radiation, UV radiation, 
occupational exposures, overweight and obesity, lack of physical exercise, exogeneous hormones, 
reproduction (breast feeding), deficient intake of fruit and vegetables, red and preserved meat, 
deficient intake of dietary fibre and excess intake of salt. Within this work, risk factors that act on 
different carcinogenic pathways were considered independent and the effects on relative risks were 
considered multiplicative, e.g. the joint effects of smoking and alcohol. Of these, tobacco smoke was 
found to be the most important risk factor for cancer in the UK in 2010, as it was thought to be 
responsible for 19.4% of new cancer cases [8]. In men 6.1% of cancer cases occurred in individuals
with a diet deficient in fruits and vegetables, 4.9% were linked to occupational exposures and 4.6% 
were linked to alcohol consumption [8]. In women, obesity was thought to play a significant role in 
6.9% of cancer cases (thought to be due to the effect of obesity on breast cancer), and 3.7% were 
due to infectious agents [8]. Between them, tobacco smoking, dietary factors, alcohol intake and 
body weight accounted for 34% of cancers in the UK in 2010, and accounted for almost 80% of the 
total cases from the 14 risk factors outlined [8]. Also of note was that deviation from recommended 
intake levels for fruits, vegetables, meat and salt accounted for 9.2% of cancers in 2010 in the UK, 
and excess body weight accounted for 5.5% of cancers in the UK in 2010, though the authors state 
that given the trends observed for children and young people, the full impact of increasing rates of 
obesity has yet to be experienced [8].
Bray and colleagues examined global cancer prevalence, for 27 cancer sites [9] and found that the 
most prevalent (in terms of 5 year prevalence) cancer, worldwide, was breast cancer, with 5.2 million 
cases. Prostate and colorectal cancers were the 2"  ^and 3^  ^most prevalent, with approximately 3.2 
million cases each and when considered together, these three types of cancer are responsible for 
40% of the prevalence burden [9]. The 4^ ,^ 5^  ^and 6‘  ^most prevalent types of cancer were lung, 
stomach and cervix, respectively [9].
Considering the male population only, prostate cancer was the most prevalent cancer for men in 111 
countries, including all of the countries comprising the Americas, most European countries and 67.4% 
of Sub-Saharan countries [9]. Colorectal cancers were most prevalent for men in 25 countries (13 of 
which were Asian countries), and oral cancer was the most prevalent cancer in Indian men [9].
When only the female population was considered, breast cancer was the most prevalent cancer in 
women, in 145 of 184 (78.8%) countries. In 37 countries, including Sub-Saharan Africa and parts of 
Asia (including India), cervical cancer was the most prevalent. In fact, female-specific cancers were 
the most prevalent cancers in 75% of the countries in the world, when considering cancers in both 
sexes, with breast cancers and cervical cancers the 1^  ^and 2"  ^most prevalent cancers worldwide [9]. 
The most prevalent cancer in 95% of the 184 countries of the world, was one of the following: breast, 
cervical or prostate cancer, however, the majority of cancers associated with higher fatality rates 
(including liver, oesophagus and stomach) occurred in men [9].
Of note were the statistics stating that 62.2% of cancer cases occur in countries which score high to 
very high on the Human Development Index (HDI), and that 47.2% of cases came from countries 
which scored very high on the HDI, despite these countries containing only 17% of the world's 
population [9]. In contrast, medium HDI countries, which house 64.3% of the world's population
accounted for only 35.8% of cancer prevalence, and low HDI countries accounted for 4.5% of the 
world's population and 1.7% of cancer cases [9].
In summary, there is a degree of inevitability regarding the risk of developing cancer. Given a long 
enough lifespan, the chance that an error will be encountered during one of several million cell 
replications humans undergo per day [3], is almost a certainty [2]. This, combined with daily 
exposure to various forms of carcinogenic toxins in our environment, such as radiation, bacteria and 
viruses [1], goes some way to explaining why cancer occurrence is so high worldwide. However, the 
World Health Organisation (WHO) estimated that of these 8.2 million cancer deaths, 2.5 million 
(30%) were preventable [1]. These 2.5 million cancer deaths arose due to any or a combination of, 
five dietary and behavioural factors considered to present a high risk for cancer development: low 
intake of fruits and vegetables, alcohol consumption, tobacco intake, high body mass index (BMI) and 
low levels of physical exercise [1]. Cancers of the oral cavity and pharynx are estimated to be 
preventable in 91% of cases, in the UK [8]. In the next section of this review, the researcher will 
provide background information on the oral mucosa, and the section following that will focus 
specifically upon oral cancer and its associated risk factors, diagnosis and treatments etc.
1.2 The Oral Mucosa and the Oral Cavity
The oral cavity (Figure 1.1), commonly known as the mouth, is comprised of the lips, hard and soft 
palates, buccal mucosa (cheek lining), floor of the mouth, the alveolus and the anterior two-thirds of 
the tongue [10]. The lining of the oral cavity is referred to as the oral mucous membrane or oral 
mucosa [11], and could be considered an organ, as the two tissue components it is composed of, 
covering epithelium and connective tissue, perform a common function [11]. At the lip region, the 
oral mucosa is continuous with the facial skin, and at the pharynx the oral mucosa is continuous with 
the gut [11]. Therefore, anatomically, the oral mucosa is located between the facial skin and the 
gastrointestinal mucosa and therefore unsurprisingly, shares properties in common with each of 
these tissues [11].
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Figure 1.1: Anatomical layout of the oral cavity, detailing the main areas and structures, and the types of tissue they are
composed of (courtesy of [12]).
The main function of the oral mucosa is to provide protection for underlying tissues of the oral cavity 
[13], and it is also a site for glandular activity and secretion [11]. Specifically, this tissue provides 
protection from the actions of seizing, biting, mastication and swallowing food, which exposes it to 
tension, compression, shearing and abrasions [11]. It also provides a protective barrier for deeper 
tissues against micro-organisms which could cause infection [11].
Another role of the oral mucosa is as a sensory organ. Within the mouth, there are receptors which 
respond to temperature, pain, touch and taste (taste buds on the tongue) [11]. Vital reflexes like 
retching, gagging, salivating and swallowing are also initiated by receptors located in the oral cavity 
[11].
Mucosa of the oral cavity which is exposed to high friction, through mastication, is keratinised (or 
cornified), for example the gingiva, hard palate and parts of the dorsum of the tongue, and therefore 
is often referred to as masticatory mucosa or epithelium [12 ,14 ,15]. Oral mucosa which is not, or is 
less, exposed to the high friction of mastication, such as that comprising the floor of the mouth, 
buccal region (cheek lining) and inferior aspect of the tongue, is non-keratinised [14], and often 
referred to as lining mucosa (which is similar to the lining mucosa of the oesophagus and the cervix 
[16]. Figure 1.2 shows the cell layers which constitute keratinised and non-keratinised mucosa. 
Essentially, the keratin layer (stratum corneum) acts as a protective layer to tissue frequently 
subjected to the potentially damaging abrasive forces encountered during mastication. The tongue is 
a site of a third type of mucosa-specialised mucosa, which has characteristics of both lining and 
masticatory mucosa [16].
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Figure 1.2: Architecture of cell layers comprising (a) keratinised and (b) non-keratinised oral epithelium (courtesy of [12]).
Both keratinised and non-keratinised areas of the oral mucosa can be arranged into two general 
structural layers: the superficial stratified squamous epithelium and the deeper lamina propria, 
which are separated by the intermediary layer, the basal lamina [14]. The lamina propria consists of 
collagen fibres, non- epithelial cells (fibroblasts, mast cells, macrophages, neutrophils, lymphocytes, 
plasma cells, endothelial cells and inflammatory cells) and blood vessels [11]. However, in lining
mucosa, the lamina propria contains fewer collagen fibres than the masticatory mucosa [11].
Upward projections of the lamina propria are called connective tissue papillae and these interlock 
with epithelial ridges called pegs or rete ridges [11]. The basal layer (the deepest layer of the 
epithelium) can itself be sub-divided into three areas, the lamina lucida, lamina densa and lamina 
fibroreticularis [11]. The lamina densa is composed of collagen IV and laminins, and the lamina lucida 
contains proteins allowing cells to connect to the basal lamina, and is composed of collagen XVII, 
integrins and laminin-5 [11].
The oral epithelium consists of two populations of cells, progenitor cells and mature cells [11]. 
Progenitor cells can be found in the basal layer or the lower two or three layers, depending upon the 
thickness of the epithelia, and mitotic cells tend to be found at the bottom rather than the top of 
epithelial ridges [12]. Within the progenitor populations there are two sub-populations: stem cells 
and amplifying cells (which increase the number of cells to mature) [11]. Maturation of cells from the 
oral epithelium results in either kératinisation or non-keratinisation.
There are a number of distinct layers in keratinised epithelium (which contains keratins 1, 6 ,10  and 
16) [11]. The basal layer is formed of the least differentiated cells, which are cuboidal or columnar in 
shape and contain nuclei, mitochondria, ribosomes, Golgi complexes, endoplasmic reticula, 
tonofilaments (fibrous proteins) and desmosomes [11]. Located above this layer are several rows of 
elliptical or spherical prickle cells (stratum spinosum), named due to the appearance of desmosomes 
(intercellular connectors) [11]. These two layers (basal and prickle) constitute 50-67% of the 
epithelial thickness [11]. The layer above the prickle cell layer is called the granular layer, and 
consists of large, flat cells containing small keratohyalin granules (which stain when exposed to acidic 
dyes e.g. hematotoxylin) [11]. The surface or superficial layer is composed of flat cells (squames) that 
do not contain nuclei, and this is called the keratinised layer, stratum corneum or cornified layer [11]. 
The term associated with the maturation of cells in the keratinised layer is orthokeratinisation [11]. 
Some masticatory mucosa however, undergoes parakeratinisation instead, whereby pyknotic 
(shrunken) nuclei can be found in some if not all of the squames, however, parakeratinasation is a 
normal process in oral epithelium [11].
With regards to the structure of non-keratinised epithelium, there is a prickle layer present, though 
this is often not referred to as a "prickle layer", as the desmosomes are less apparent than in 
keratinised tissue [11]. There is no granular layer in non-keratinised epithelium. Just an intermediate 
layer and unlike in keratinised epithelium, cells in the most superficial layer contain nuclei [11].
As mentioned previously, the dorsum of the tongue is considered to be specialised mucosa [11]. The 
body of the tongue consists of the anterior two thirds and the base of the tongue consists of the 
posterior third, and the anterior region of the tongue plays host to fungiform, filiform and vallate 
papillae [11,17]. Fungiform papillae are mushroom-shaped, smooth, round structures with taste 
buds on their superior surface [11], but by far the most abundant papillae are the filiform papillae, 
whose surface is cornified [14]. As a whole, the dorsum of the tongue is composed of a "patchwork" 
of keratinised and non-keratinised epithelium, due to the cornified évaginations (filiform and 
fungiform papillae) and non-cornified invaginations (vallate papillae) [12 ,14 ,16].
In order to fulfil its role of protecting underlying structures and tissues, the oral mucosa possesses 
some natural defences. Superficial cells in the granular layer in keratinised tissue have a thickening of 
the inner aspect of their membranes [11]. This helps the keratinised layer (which contains cells 
which are dehydrated and form flattened hexagonal disks) to resist chemical solvents [11]. Lack of 
permeability also helps protect underlying structures from toxins. In keratinised oral epithelium, a 
lipid-rich discharge forms a permeability barrier, limiting the ability of aqueous solutions to fill 
intercellular spaces [11]. As a result, keratinised areas are least permeable and lining mucosa (non- 
keratinised) areas most permeable [16], with the floor of the mouth being most permeable area in 
the mouth, hence why some medications are placed under the tongue for absorption [11]. Lack of 
permeability of the oral mucosa is evident due to infrequent occurrence of lesions in an area 
abundant in flora and bacteria, and because xerostomia (dry mouth) can occur [16]. The floor of the 
mouth and lateral border of the tongue are considered high risk for squamous cell carcinoma 
development, possibly due to proximity to pooling saliva which contains toxins, and there is 
considerable evidence supporting the theory that alcohol and tobacco consumption have a 
synergistic effect in permeating through the tissue barrier [16].
The turnover times (time taken for a cell to divide and pass through all the layers of the epithelium) 
for the gut is 4-14 days, 25 days for the cheek, 41-57 days for the gingiva and 75 days for skin, and 
non-keratinised tissue has a faster turnover rate than keratinised tissue [11]. These times have 
implications for cancer therapy [11]. Chemotherapeutic drugs target cells undergoing mitotic 
division, be they normal or abnormal, and cells with a short turnover rate, such as those of the 
intestinal and oral epithelium are therefore damaged [11].
Having now established the structure and function of normal oral mucosa within the oral cavity, 
attention will now soon be turned to the abnormal structure and function encountered when cancer 
develops within the oral cavity. Prior to that, the phenomenon observed and used for the purposes
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of cellular characterisation in all research chapters in thisthesis-the phenomenon known as 
"dielectrophoresis", is examined. In the following section, dielectrophoresis is defined, and the 
theory underpinning the phenomenon and its biomedical applications to date are discussed.
1.3 Dielectrophoresis and Electrokinetics
Electrokinetics is the study of the motion of charged particles. Large-scale motion of charged 
particles is achieved through exposure to force resulting from an electric field produced by 
electrodes. Charged particles can be in the form of particles such as complex compounds which 
possess an intrinsic charge (e.g. certain proteins and DNA), or particles which are intrinsically neutral 
but for whom motion is induced by net forces acting on the particle, resulting from the induction of 
electric pole formation within the particle itself. The phenomenon whereby particles which possess 
an intrinsic charge undergo motion is termed electrophoresis, whilst the phenomenon whereby 
particles which do not possess an intrinsic charge undergo motion in an electric field is termed 
dielectrophoresis. One obvious advantage of using dielectrophoresis rather than electrophoresis to 
study particles is that the particles themselves do not require an intrinsic charge in order for their 
bioelectrical properties to be deduced from their motion in an electric field, and therefore there is a 
vast array of particle types, which can be studied using the former but not the latter phenomenon. 
On this basis, dielectrophoretic testing was selected for the study of oral cancer at a cellular level.
This section of the Background chapter will provide details on the theory underpinning 
dielectrophoresis, followed by details of applications of dielectrophoresis within the field of 
biomedicine.
1,3.1 Dielectrophoretic Theory
The term "dielectrophoresis" is attributed to Professor Herbert A. Pohl, who defined the 
phenomenon as "the motion of suspensoid particles relative to that of the solvent resulting from  
polarization forces produced by an inhomogeneous electric field..." in 1951 [18]. Pohl stated that 
dielectrophoresis (DEP) does not require charged or ionized particles in order for motion to be 
produced, but does require that the charges which act to displace the particles be induced or 
attracted in an asymmetrical manner [18]. The reason DEP does not require particles to carry or
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possess intrinsic charge (positive or negative) is because upon application of an electric field to the 
particles suspended in a solvent or medium, dipoles can be induced within the particles.
A dipole is a pair of charges equal in magnitude and of opposite charge signs (i.e. one of positive 
charge and one of negative charge), separated by a finite distance [19]. Upon application of an 
electric field, for example by exposing a neutral particle suspended in a solvent to an electrode 
system, the equal amounts of positive and negative charges which compose the neutral particle will 
group together with charges of the same sign (positive charges with positive charges and negative 
charges with negative charges), to form two poles (hence the term dipole) within the particle. The 
particle will then orientate itself such that its dipole is aligned with the applied external electric field 
(i.e. the electric field produced by the electrode system). This process of charge alignment is termed 
"polarisation", which is depicted in Figure 1.3.
Suspending Medium
A
Polarisation
Negative
Pole
Positive
Pole
©/O
Suspending Mediurh
B
Figure 1.3: Illustration of polarisation of a spherical particle, suspended in a conductive medium. A shows the particle prior 
to application of the electric field E, where charges contained within the particle are randomly distributed. B shows the 
charge distribution inside and around (i.e. in the suspending medium) the particle upon application of the electric field E 
(whose direction is indicated by the navy-coloured arrow), i.e. upon the formation of the dipole within the particle. The 
pole regions in B are defined by the red dashed line. As the charges inside the particle are exactly balanced with the charges 
around the particle, no net force is exerted on the particle, i.e. no dielectrophoresis occurs. The type of polarisation 
demonstrated in B is interfacial polarisation, i.e. polarisation that occurs at the border of the cell and the suspending 
medium.
Polarisation of the dipole particle can be likened to how a simple compass functions-just as the 
compass needle (which is itself a dipole, with a positively charged end and a negatively charged end) 
aligns itself with Earth's magnetic field lines, the particle (which is either a permanent or an induced 
dipole) aligns itself with the electric field lines supplied by the electrode system. If the electric field is 
inhomogeneous, i.e. it is non-uniform, one hemisphere of the particle, containing one of the two
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poles, will be subject to lesser electric field strength and the second hemisphere will be subject to 
greater electric field strength [20]. This imbalance of electric field strength will result in a net force 
iPdipole ) acting on the particle, [21]:
F  dipole =  P • V l  (1)
Where p is the dipole moment, defined as the net charge of the dipole (i.e. the sum of the positive 
charge and the negative charge) multiplied by the distance separating the charges of the dipoles, and 
VË is gradient of the electric field strength [22]. The effective dipole moment of a spherical particle 
can be defined using equation (2) [23]:
Peff =  A^nsoSrKr^E (2)
Where Eq is the permittivity of free space (8.854187817 x 10'^  ^F/ m), Ej. is the relative permittivity of
the particle, K is the Clausius-Mossotti factor, r is the radius of the spherical particle and Ë is the
electric field vector. The dielectrophoretic force acting on the spherical particle can then be found by 
combining equations (1) and (2), to produce the well-established equation labelled as equation (3) 
[21]:
F  DEP =  2iTEo£rr^Re[K(^ù))]VE^ (3)
Where Re[K{o))] represents the real part of the Clausius-Mossotti factor, which is a measure of 
frequency-dependent polarisability. According to the single-shell model, the magnitude and 
direction of the DEP force (Fj)ep ) is dependent upon the polarisability of the particle (Ep) relative to 
the polarisability of the medium in which it is suspended (Sg), as shown in equation (4) [21, 23]:
Where * denotes the particle and medium polarisability as possessing real and imaginary 
components (and e* = e -  j (a / w)). The single-shell model converts particles suspended in a medium 
and composed of a number of materials with differing dielectric properties (each considered to be a 
"shell") to particles composed of a homogeneous core, suspended in a medium. This conversion is 
shown for a biological cell in Figure 1.4 and the conversion of a biological cell enclosed by a plasma 
membrane, to a homogenous sphere is summarised in equation (5).
(5)
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Where the subscripts c, m and p denote the cell interior, cell membrane and particle respectively, 
and a = Ri/ R2 in Figure 1.4.
Figure 1.4: Diagram illustrating two possible interpretations of the single-shell model. For the picture on the left, Rj is the 
cell radius and R2 is the cell radius minus the plasma membrane thickness, while e and a represent the permittivity and 
conductivity, respectively and the subscripts c, m and s refer to the cell interior, membrane and suspending medium, 
respectively. In the picture on the right, R is the cell radius, £p* is the effective permittivity of the particle (i.e. cell) and 
is the effective permittivity of the suspending medium, and the membrane properties are ignored. The model on the left 
best represents how cells were modelled, using the single-shell model, in this thesis.
If the particle is suspended in a conducting medium (for example, an aqueous-based medium), the 
sign of the real part of the Clausius-Mossotti factor details whether the particle is more polarisable 
than the medium, or the medium is more polarisable than the particle [18]. In the case of former, the 
DEP force will act to draw the particle towards the region of high electric field strength (i.e. the 
electrodes). This is termed "positive DEP". In the case of the latter, the medium rather than the 
particle will be drawn to the region of highest electric field strength, giving the appearance that the 
particle is being repelled by the electrodes, and this is termed "negative DEP". Upon reversal of the 
direction of the electric field, the direction of the dipole is also reversed, but motion of the particle 
will still be towards the area witnessing greatest electric field strength, as the net force is still 
greatest here [20].
Whilst the passage above credits the development of many of the founding principles of DEP to Pohl, 
work had been undertaken prior to Pohl's 1951 paper, on the study of particle movement under the 
force of electric fields. In their 1987 review paper, Pethig and Kell [24] state that in 1910 Hobner 
found that the impedance of erythrocytes decreased when they were exposed to increasing 
frequency, and deduced that these were cells composed of a cytoplasm with low resistivity.
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surrounded by a poorly conducting membrane. In the same review paper, Pethig and Kell [24] refer 
to the work of Fricke in 1925, in which the author estimated the membrane capacitance of 
erythrocytes to be 0.81 pF/ cm^. Pohl himself also credits the work of Fricke, as well as works by 
Soyenoff in 1931 (on the dielectric considerations of separating coal dust from toluene) [25], and the 
studies of cells in electric fields, by Muth in 1927 and Liebesny (who observed dipole-dipole 
interactions of erythrocytes) in 1939 [26], as laying the foundations for his own work [21]. Flowever, 
Pohl was responsible for detailing many of the principles governing DEP and even assigning the term  
"dielectrophoresis" to the phenomenon, and he was also an integral member of a group of 
researchers who laid the foundations for defining the principles of DEP and applying them to 
biomedical research.
In his 1951 paper [18], Pohl stated that DEP was used in his laboratory for polymer analysis, where 
removal of particles from solutions using filters and centrifugation failed or was difficult. However, in 
their 1966 paper, Pohl and Hawk turned their attention to applying DEP to biological cells, by 
separating live and dead yeast cells using a pin-plate electrode setup [20]. The authors of the paper 
suggested that this study was conducted because the results of work by Schwan [27] suggested that 
DEP of living cells suspended in aqueous media would be successful. The conclusions of this work 
[20] were that DEP was successfully used to separate live and dead yeast cells, with the live yeast 
cells remaining viable post DEP separation, and that the high level of effective permittivity of living 
cells could be attributed to an electrical double layer formed across the plasma membrane of the 
cells. The authors also concluded that for successful separation of live and dead cells to be achieved 
using DEP, alternating, non-uniform fields of high frequency must be used to supply cells suspended 
in a medium of very low frequency, whereby there is a known difference in complex permittivities of 
the cells and their suspending medium [20].
In 1971, Pohl and Crane studied the dielectrophoretic collection rate (yield) of yeast cells, and the 
physical and biological factors affecting this collection rate, using a pin-pin electrode setup [28]. They 
found that at low to moderate voltages (not specifically defined), dielectrophoretic yield was seen to 
vary with voltage in a linear manner, and that this yield increased linearly with cell concentration and 
was proportional to the square root of elapsed time [28]. They also observed that living cells gave 
much more reproducible DEP results than dead cells (killed using heat), in terms of variation of yield 
with frequency and conductivity, and observed cell rotation, with cells rotating about an axis 
perpendicular to field lines [28]. The authors concluded that this could occur at any region of the 
electric field, at any frequency and that an increase in voltage increased the rate of revolution [28].
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Pohl and Crane also made the point that as rotation of cells distinguished young from old cells in this 
study, this could be used for diagnostic purposes in the future [28].
Whilst Pohl and colleagues charted dielectrophoretic yield as the outcome of their DEP tests on cells, 
other research groups attempted to deduce dielectric characteristics, such as conductivity, 
permittivity, conductance and capacitance, of the particles they were studying. In his 1955 paper, 
Fricke developed a shelled model in which particles were considered to be homogeneous spheres or 
cylinders surrounded by a poorly conducting, thin membrane [29]. Pauly, Packer and Schwan 
conducted a study on the dielectric properties of mitochondria membranes, in 1960 [30] and 
concluded that as the values they gained for membrane capacitance (the ability of the membrane to 
store electric charge) fell within the range of capacitances found for cellular plasma membranes (0.5-
1.5 pF/ cm^), the membrane surrounding mitochondria was similar to the structure and composition 
of the cellular membrane. In 1962, Schwan and Pauly, this time in collaboration with colleagues 
Schwarz and Maczuk [31], conducted a study in which they found that the conductance and 
capacitance on the surface of cell membranes varies with cell size and ionic strength of the 
suspending medium, and that the surface conductance has both a frequency-dependent and a 
frequency-independent component.
However, a paper in 1975 by Hanai, Koizumi and Irimajiri [32] proposed a new method for 
determining the dielectric characteristics of biological shells, by adapting a model proposed by Pauly 
and Schwan in 1959. This paper by Hanai and colleagues marked the introduction of the use of the 
single-shell model for deducing cellular dielectric characteristics, in which the cell interior and the 
plasma membrane are represented by a one homogeneous shell (Figure 1.4). In this work, Hanai and 
colleagues [32] simplified the model proposed by Pauly and Schwan, detailed how one would achieve 
a "best-fit" of experimentally-derived parameters with theoretical parameters, and suggested the 
following range of values for cellular dielectric properties which would render their model successful:
o Membrane thickness = 5 0 -1 0 0  Â (where 10 Â = 1 nm) 
o Membrane thickness/ cell interior diameter < 10'^ 
o Medium permittivity = 3 -100  
o Membrane permittivity = 3 -50 
o Cytoplasmic permittivity = 3 -1 0 0  
o Medium conductivity = 10'^ -10 '^  mS/ cm 
o Cytoplasmic conductivity = (10'^ -10^ ) x medium conductivity 
o Membrane conductivity < 10'^ x (cell interior conductivity and medium conductivity).
This model was then further developed four years later, by Irimajiri, Hanai and Inouye [33], to allow it 
to accommodate cells whose nuclei occupied a large percentage of intracellular space. This double­
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shell model not only took the cell membrane into account, but also accounted for the properties of a 
membrane surrounding the nucleus and the cell interior (cytosol) [33]. The theory underpinning the 
double-shell model also allowed cells considered to have one shell (i.e. n = 1) and cells with a cell wall 
surrounding the cell interior and membrane (n = 2) for example viruses and plant cells, to be 
modelled [33]. The authors concluded that the single-shell model was a poor approximation when 
nuclear volume comprised more than 6% of the total intracellular space, such as when studying 
lymphoma cells (which the authors estimated had nuclei occupying more than 33.3% of the 
intracellular space) and, as with their previous paper, presented a step-by-step curve-fitting 
procedure to obtain dielectric data from the multi-shell model, but stated that a computerised, non­
linear least-fit squares model would also be feasible [33].
It was in a paper by Jones and Kallio in 1979 [34] however, that equation (5) was presented and 
substituted into the equation numbered (4) in this passage, enabling biological cells, surrounded by a 
cell membrane, to be modelled using the single-shell m odel. In this paper, the authors also 
presented an equation for the cutoff frequency (also known as the low frequency crossover), which is 
the frequency where the cell polarisability is in the process of changing from negative to positive and 
the effective dipole moment equals zero, therefore no DEP occurs [34]. The equation for the low 
frequency crossover (fc) is shown in equation (6).
(_(Ts "h
"f" 2 Eg) (®)
In Table 1 of their paper [34], the authors listed the conditions for which a low frequency crossover 
can occur, which are:
•  When Om > Osand Cm < £s
•  When Om < Os and > £s
Subscripts s and m denote suspending medium and membrane respectively.
Benguigui and Lin also proposed equation (7) to determine the real part of the Clausius-Mossotti
factor in 1982 [35], based on a general formula, proposed by Molinari and Viviani [36] and applied it
to cases where AC fields were used:
En — f  c
Re[Ki(o)]  =  ^ - F
Tm w ((^p +  2o-g) (1  -f cüHijw )
Subscripts p and s denoted the particle and suspending medium, respectively and represents 
the Maxwell-Wagner relaxation time, defined as:
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The authors [35] discovered that their equation generated the same results as the equations from 
Jones and Kallio's paper [34], but using just equation (7). The authors then produced a second paper 
[37] in which they presented formulae for the calculation of the average DEP force acting on spheres 
for time-independent and time-dependent cases.
From the late 1980's onwards, the focus of DEP research seemed to shift, from developing the 
theories upon which dielectrophoresis is based, to applying those theories to biological cells for the 
purpose of gleaning information on the dielectric properties of said cells. In their 1987 review paper, 
Pethig and Kell [24] summarise some of the properties of cells which had by that point been 
estimated or deduced, including the membrane thickness, which the authors reported as 5 nm 
(though there are a variety of membrane thicknesses used currently, varying from 5 - 1 0  nm) and the 
membrane capacitance of a cell with a smooth membrane surface (= 6 mF/ m^). Work from a paper 
by Turcu and colleagues [38], published two years later also suggested that the main polarisation 
force up to 10 MHz was the Maxwell-Wagner interfacial polarisation, i.e. due to differences between 
the suspended particles and surrounding medium.
Two groups published papers in the early 1990's comparing the results of DEP with another 
electrokinetic technique (electrorotation). Gimsa and colleagues compared and contrasted DEP and 
electro rotation (ROT), by using both techniques to study neurospora slime and murine myeloma cells 
[39]. Whilst they only produced ROT spectra, the group concluded that ion leakage would act to 
increase membrane conductivity (i.e. the extent to which current was able to flow through the 
membrane), and suggested that myeloma cells deviated from the single-shell model due to the 
nucleus occupying approximately 80% of the cell interior (cytoplasmic region) [39]. This large nuclear 
area, according to the work of Irimajiri and colleagues [33], would seem to suggest that the multi­
shell model should have been used rather than the single-shell model. The second of the two groups, 
Huang and colleagues, used DEP and ROT to study yeast cells [40]. They found that the membrane 
conductivity of yeast cells increased with heat treatment, whilst the cytoplasmic conductivity (i.e. the 
extent to which current was able to flow through the cytoplasm) decreased [40]. In this paper, the 
authors used a variation of the single-shell approach and concluded that this functioned well unless 
the shell thickness was > 10% of the cell radius [40].
Work by Grosse and Schwan [41] suggested that both surface conductance and membrane 
conductance affected the membrane potential (which according to Weiss [42] is affected by
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intracellular and extracellular ion concentrations), where membrane conductance was related to 
currents flowing through the membrane and surface conductance was concerned with currents 
flowing oround the membrane [41]. The suggestion that membrane conductance was related to ionic 
current flowing through the membrane was seemingly confirmed by Grimes and Martinsen, who 
stated that net cell membrane conductance is governed by ion channels [43].
As a result, the authors then suggested use of a surface admittance variable, which would take into 
account the frequency dependent elements, surface conductance and surface capacitance [41]. They 
also suggest that when the medium outside of the cell (i.e. surrounding the cell) was of low 
conductivity, then membrane conductance, surface admittance and space charge effects should be 
considered [41].
Several groups then turned their attention to dispersion and low frequency crossovers in review 
papers. In his review paper, Asami [44] stated that the a  dispersion at frequencies of a few kHz or 
less could be due to counterion displacement and membrane bound charges, the p dispersion is due 
to interfacial polarisation (of the Maxwell-Wagner type) due to the plasma membrane, and occurs in 
the kHz- MHz range, and the y dispersion is due to re-orientation of water molecules at above 1 GHz. 
His statements on the a  and P dispersions are in agreement with the published work of Grimes and 
Martinsen [43]. Asami also cited the membrane thickness as approximately 10 nm (in disagreement 
with the value cited by Pethig and Kell [24]), and stated that membrane conductance for intact 
membranes was often found to be below 100 S/ m  ^[44]. Another review, produced by Gascoyne and 
Vykoukal [45] suggested that complex permittivity should take into account an additional layer in 
aqueous solutions (an additional shell) between the membrane and the suspending medium, 
composed of surface charge, bound ions (i.e. the Stern layer) and a double layer, but that the charge 
double-layer was more of a consideration for small cells surrounded by low conductivity medium, 
when low frequencies (low kHz range) were applied. The authors also postulated that differential 
DEP affinity separation was impractical for particle separation if there was less than 50% difference in 
crossover frequencies of said particles, and therefore concluded that it was inadequate for use on 
mixed samples of mammalian cells [45]. The authors also suggested that Brownian motion can be 
ignored for particles greater than 1pm in diameter [45].
Three groups, in the year 2002, then conducted studies focusing on applications of crossover 
frequencies and membrane capacitance, marking the transition from papers detailing DEP theory 
development to those detailing applications of such theories and models to biomedicine. Huang and 
colleagues [46] looked at the membrane properties determined by crossover frequencies of five cell
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lines and one mononuclear peripheral blood line, and successfully separated them using DEP, in 
order to produce gene profiles for the separated populations. Ratanachoo and colleagues [47] also 
used crossover frequencies, in order to determine membrane conductance and capacitance and 
found that DEP could detect changes in human myelogenous leukemia cells when they were exposed 
to toxicants. This group proposed that small changes in membrane capacitance would have been due 
to membrane composition, but that the large membrane changes they saw of 40% difference were 
due to morphology and hence total surface area changes, influenced by microvilli, blebs, folds, ruffles 
etc, which they confirmed using scanning electron microscopy [47]. Therefore, this result confirmed 
that membrane capacitance was due to large changes in surface area caused by protrusions ad 
membrane ruffling. Ratanachoo and colleagues also cited that a membrane capacitance value of 9 
mF/ m  ^denoted a cell with a perfectly flat (smooth) biological membrane [48,49], though this was a 
higher value than that quoted by Pethig and Kell of 6 mF/ m  ^ [24]. Wang and colleagues [50] also 
confirmed membrane capacitance varies very little with membrane composition, and in the course of 
their study determined that DEP could detect changes in membrane dielectric properties of cells 
after just one hour of exposure to apoptotic agents. These studies were just three of many to apply 
the theories of dielectrophoresis, to biomedicine.
1,3.2 Biomedical Applications of Dielectrophoresis
Summarised in this section are some of the numerous studies which have applied DEP testing to the 
field of biomedicine, for the purpose of providing examples of the variety of subject areas DEP 
research encompasses.
This aim of this section is to provide a brief summary and as such, some sub-sections are expanded 
upon more than others. This depends on the context they lend to the studies presented in this thesis 
and whether the subject areas they cover are explored in greater detail in the literature reviews 
found at the start of each research chapter.
1.3.2.1 Rare Cells
A review article by Hyun and colleagues detailed many studies which used DEP to separate cells 
deemed to be rare from a population mainly composed of another cell type [51]. The majority of 
these studies (80%) used DEP to separate cancer cells from another cell type, in most cases blood
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cells, but some instead separated foetal cells from blood [52] and stem cells from other cell types 
[53-57].
One such study, which used DEP to separate rare circulating tumour cells (CTCs) from peripheral 
blood, was that conducted by Gascoyne and colleagues [53]. This group studied the possibility of 
using dielectrophoretic field flow fractionation (i.e. separating particles of different types by applying 
frequencies to these particles in solution as they flowed through an electrode system and hereby 
attracting one particle type whilst repelling the other) to isolate circulating tumour cells from blood 
samples of cancer patients, by adding cultured in-vitro cells from three different lines to peripheral 
blood. The authors stated that other methods had been used to detect CTCs, including polymerase 
chain reaction (PCR), scanning fluorescence and magnetic-activated cell sorting (MACS), but that 
these methods tended to require some form of cell surface biomarkers and therefore altered the 
intrinsic properties of the cells, and their viability post-detection [53].
This work built on previous work by these authors in which they separated cancer cells from blood 
cells [54-56] and cancer cells from hemopoietic stem cells [57]. In this paper, the group found that 
whilst the recovery rate of rare tumour cells was independent of the tumour to blood cell ratio, 
which ranged from 1:10 to 1:1000, the rate varied greatly with the percentage of chamber length 
loaded and the total cell load [53]. The best recovery rates, of 92% and 70% were achieved when the 
percentage of the chamber length that was loaded was 10% or 50%, respectively, using total cell 
loads of 1 X 10^ and 5 x 10^ respectively [53].
The use of DEP-field flow fractionation relied upon the CTCs and blood cells having different 
crossover frequencies, and the equation for cutoff frequency presented by Jones and Kallio [34] was 
used in this study to determine the crossover frequencies of the cells of interest [53]. The group 
summarised that they had managed to separate low concentrations of cells from all three cancer 
lines, from peripheral blood cells using DEP and concluded that this was because cells from the 
tumour lines were much larger and achieved greater membrane capacitance values than peripheral 
blood cells.
1.3.2.2 Stem Cells
stem cell characterisation is becoming a popular application of DEP research. Flanagan and 
colleagues [58] used DEP to study the dielectric properties of murine neural stem and progenitor 
cells (NSPCs), as well the dielectric properties of their differentiated progeny (astrocytes and
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neurons). They found that the trapping frequencies (i.e. the frequency at which the cell type 
undergoes a strong attraction force to the electrodes) of NSPCs, astrocytes and neurons were all 
different (1000 kHz, 300 kHz and 5000 kHz, respectively) and achieved trapping percentages of 
greater than 95% [58]. Therefore the group concluded that not only could DEP be used to 
differentiate neural stem and progenitor cells from their differentiate progeny, but that the 
difference in trapping frequencies found for the progeny was sufficiently different to distinguish 
which cells would become astrocytes and which cells would become neurons, without the need for 
membrane surface markers [58].
Velugotia and colleagues [59] also studied the dielectric characteristics of stem cells and their 
differentiated progeny using dielectrophoresis, and chose to focus on human embryonic stem cells. 
Using a different equation (shown in equation (9)) than that proposed by Jones and Kallio [34], the 
group found the low frequency crossovers which they then used to find the membrane capacitances 
of eight different cell lines, five of which were human embryonic stem cells (hESCs) and three of 
which were differentiated progeny of three of the hESC lines [59],
In equation (9), Om represents the medium conductivity, rthe  cell radius and Cm the membrane 
capacitance. The authors found that there was a significant amount of overlap for membrane 
capacitance values for the five separate hESC lines and concluded that obtaining pure samples of the 
five separate hESC lines from mixed population samples would not be possible using DEP [59]. 
However, the group found that due to significant differences in crossover frequencies and therefore 
membrane capacitance values, differentiated progeny could be distinguished from their embryonic 
precursors, using DEP, on the basis that they were found to achieve greater levels of membrane 
capacitance than their embryonic precursors [59].
Another highly cited paper which investigated the prospect of using DEP for stem cell analysis, this 
time focusing on tumour-initiating cells (TICs), was authored by Salmanzadeh and colleagues [60]. In 
this study, the authors used contactless-DEP (where the sample being tested was separated from the 
electrodes by thin barriers with insulating properties) to test the dielectric properties of TICs and 
non-TICs which had first been sorted using fluorescence-activated cell sorting (FACS), and then used 
contactless-DEP to sort mixed populations of TIC and non-TIC cells based on the DEP results for the 
sorted populations [60]. The group achieved a trapping efficiency TICs of 61.94% and upon culturing 
cells both the sorted populations (TICs and non-TICs) and non-sorted populations, found that the 
sorted TIC population produced spheroid growths that were larger than the unsorted population
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(3.93 times larger) and the sorted non-TIC population (17.3 times larger) [60]. The group concluded 
that the resulting spheroids confirmed the presence and therefore successful sorting of TICs from  
non-TICs and suggested that this successful sorting was due to the differences in membrane 
capacitance levels of TICs compared with non-TICs, possibly resulting from differences in protein 
expression on the plasma membranes of these cells [60].
1.3.2.3 Cancer
As has been demonstrated, DEP has been used to study the dielectric properties of various different 
cell types, including rare cells and stem cells. DEP has also been incorporated into so called "lab on a 
chip" systems [61, 62], where it has been used to distinguish between live and dead cells [63], to 
distinguish between normal blood cells and those infected with malaria [64], to detect the presence 
of endothelial progenitor cells amongst white blood cell samples [65] and to detect cancer cells [66, 
67].
DEP has been extensively used within the subject area of cancer, to gain a better understanding of 
the biophysical processes associated with this disease, and this was said to be of great to interest to 
HA Pohl prior to his death in 1986 [68]. A selection of papers on this subject area are summarised in 
this section.
Burt and colleagues [69] used DEP to study cells from three Friend murine erythroleukaemia lines 
(MEL) using castellated electrodes, which generated a non-uniform electric field over the frequency 
range 1 Hz to 2 MHz, with five measurements recorded per decade. In this study, cells were also 
treated with hexamethylene bisacetamide (HMBA) or dimethylsulphoxide (DMSO) to study the 
effects of differentiation agents on the dielectric properties of cancer cells [69]. The results from one 
clone suggested that HMBA treatment increased the effective conductivity of the MEL cells, but the 
cell permittivity was unchanged by HMBA treatment [69]. Results from the second line studied 
suggested that HMBA treatment reduced the cell surface charge, but that cell conductivity and 
permittivity were unaffected by HMBA treatment [69]. Cells from the third line tested were treated  
with HMBA, and with DMSO. HMBA treatment resulted in cells losing surface charge, but increased 
their conductivity and permittivity [69]. However, upon treating cells from this line with DMSO 
instead of HMBA, no difference was detected between treated and untreated cells in terms of their 
conductivity, permittivity or surface charge [69]. The authors of this paper also defined the 
properties membrane capacitance (C) and conductance (G) to be C =  and G =  ^ ,  where A is
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the cell membrane area, d is the cell membrane thickness, a is conductivity, £ is membrane 
permittivity and Eq is the permittivity of free space [69]. Upon completion of this study, the authors 
concluded that HMBA treatment reduced the surface charge in all three MEL lines, but only caused 
cells from two of the three lines to differentiate [69]. Two of the three cell lines also saw their 
effective conductivity increase and the authors also concluded that tangential membrane 
conductivity was dominant over trans-membrane conductivity (i.e. charge was conducted across or 
over the cell membranes rather than through them) as HMBA was not judged to have induced 
depolarisation of cell membranes [69].
In the seven years subsequent to the paper by Burt and colleagues [69], Becker and Gascoyne 
produced five papers between them on the application of DEP to cancer research. The first of these 
studies detailed the development of a DEP system allowing 200-300 cells from normal, leukaemic 
and differentiation-induced leukaemic mouse red blood cells to be tested simultaneously using 
interdigitated electrodes supplying a frequency range of 500 Hz to 1 MHz, the results of which were 
analysed using computer-controlled image analysis [70]. Cell movement due to the effects of 
dielectrophoretic force was quantified by subtracting from the light intensity of images recorded 
during application of the in-homogeneous electric field, the initial image of cell positions at time zero 
seconds [70]. The authors found that at 22 kHz, leukaemic cells treated with a differentiation agent 
underwent negative DEP, whilst untreated leukaemic cells underwent positive DEP, and therefore 
could be separated [70]. The authors also found that at a frequency of 30 kHz, they could separate 
healthy mouse red blood cells from leukaemic mouse red blood cells [70].
The aim of the next paper by Gascoyne and colleagues [71] was to use the "computer analysis of 
images" method from the 1992 paper to repeat the experiments from Burt's 1990 paper [69]. The 
authors opted to use the single-shell model, rather than the multi-shell model developed by Irimajiri 
and colleagues [33] because the frequency range being used was comparatively small and covered 
frequencies over which the dispersion would be controlled by the properties of the cell membrane 
[71]. Using the following equation for membrane capacitance, Cmem— where x
£q) represented the membrane permittivity multiplied by the permittivity of free space in Farads per 
meter (F/ m) and d represented the membrane thickness in meters (m), the authors gained values of 
12.6 mF/ m  ^and 8.8 mF/ m  ^for untreated leukaemic cells and leukaemic cells treated with HMBA, 
respectively [71]. The authors also found that HMBA treatment lowered the membrane permittivity 
of leukaemic cells from 6.39 to 4.49, and lowered the membrane conductivity of leukaemic cells from 
5.4 X 10'  ^5 / m to less than 1 x 10'^ 5 / m [71].
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In the paper by Becker and colleagues from 1994, the authors presented a new interdigitated 
electrode array, to not only separate cells of different types, but to remove one type from a mixed 
sample [56]. Blood cells collected from healthy volunteers and diluted with 90 parts phosphate 
buffered saline (Ca^V Mg^  ^free) were mixed in a 3:2 ratio with cultured HL-60 leukaemic cells and re­
suspended at a final concentration containing 3 x 10^ normal blood cells/ ml and 2 x 10^ leukaemic 
cells/ ml in a medium with conductivity 10 mS/ m [56]. The properties of the two populations of cells 
were deduced, prior to trialling the new interdigitated electrode array, using ROT (electrorotation) 
experiments and following the deduction of parameters resulting from these ROT experiments, 
application of a frequency of 80 kHz resulted in HL-60 leukaemic cells being retained while 
erythrocytes flowed out of the electrode array, and no surface-bound markers were used in the DEP 
and ROT testing processes [56].
The following year, Becker and colleagues produced another paper, the aim of which was to separate 
cells from the human metastatic breast cancer cell line MDA231, from T lymphocytes and 
erythrocytes, using a dielectric affinity column containing an interdigitated microelectrode array [55], 
similar to that used previously by the authors to separate HL-60 leukaemic cells from erythrocytes 
[56]. As in the 1994 paper by the authors [56], ROT experiments were conducted prior to the DEP 
separation experiments, in order to determine the dielectric parameters of the three cell types [55]. 
For DEP separation, cells were re-suspended to a final concentration of 1 x lO^malignant cells/ ml 
and 3 x 10^ normal blood cells/ ml, in a medium of conductivity 10 mS/ m. In this study, the authors 
found that the malignant MDA231 cells, T lymphocytes and erythrocytes had quite different DEP 
crossover frequencies (80 kHz, 320 kHz and 450 kHz, respectively) and by applying the single-shell 
model to the ROC spectra, achieved membrane capacitances of 26 mF/ m^ 11 mF/ m  ^and 9 mF/ m ,^ 
respectively [55]. The authors also found that T-lymphocytes achieved the highest internal 
conductivity and permittivity values (0.76 5 / m and 64, respectively) compared with the malignant 
MDA 231 cells (0.62 5 / m and 52, respectively) and normal erythrocytes (0.52 5 / m and 57 
respectively), and reported that tumour cells were retained at a rate of greater than 95%, and upon 
culturing post DEP separation, the MDA231 cells reached a confluence level of 80% within 48 hours, 
with 98% viability [55]. Becker and colleagues concluded that such large changes in membrane 
capacitance values between the three cell lines were indicative of membrane morphological 
differences such as microvilli and folds [55].
The final paper of the series by Becker and Gascoyne in the 1990's [54] built on the work from the 
previous paper by the authors [55], by separating two additional metastatic breast cancer cell lines 
(MDA-435 and MDA-468), as well as the previously used line MDA-231 from human blood samples,
25
collected from volunteers. Again, ROT experiments were conducted prior to DEP separation, to 
provide estimates of the membrane capacitance for the four cell lines examined [54]. However, in 
this study, unlike the previous studies by these authors, fluorescent surface markers were used to 
allow better visualisation of the breast cancer tumour cells [54]. The authors found that all tumour 
cells were purged with an efficiency of greater than 95%, for all ratios of tumour cells: blood cells 
trialled and that three hours post DEP separation, these same tumour cells achieved viabilities of 
95% [54]. Membrane capacitance results were found to differ noticeably for two of the three breast 
cancer cell lines. MDA-231 cells achieved membrane capacitance values of 25.9 mF/ m^ MDA-468 
cells achieved membrane capacitance values of 27.5 mF/ m  ^MDA-435 cells achieved membrane 
capacitance values of 13.5 mF/ m  ^ [54]. All three lines demonstrated significantly greater membrane 
capacitance values than those achieved by erythrocytes, which were found to have relatively smooth 
membranes, achieved membrane capacitance values of 9 mF/ m .^ The authors mention that they 
verified these results using scanning and transmission microscopy to view the membrane surfaces of 
all four cell types however, this data was not shown in the paper [54].
Chen and colleagues produced a study looking at the "lab on a chip" potential of DEP [72]. In their 
paper, the authors state that DEP within chip-based technologies, may be "the most broadly applied 
method" of cell separation [72]. The work detailed in the paper demonstrates the use of an electrode 
system arranged in a checkerboard layout, consisting of 5 x 5 microelectrodes (i.e. 25 in total) 
mounted on a silicon chip, which could be individually addressed by the control system, and allowed 
for more than one array configuration to be used, if desired [72]. Cells from the epithelial carcinoma 
cell line from the cervix (HeLa) were added to human blood, and both were suspended in a medium 
of conductivity 10 pS/ cm [72]. A 6 V peak to peak sinusoidal waveform applied frequencies, starting 
at 10 kHz, to the mixed population [72]. Cells were stained, to aid the process of resolving individual 
cells, and whilst separation of the two types was achieved, the tested cells were not recoverable 
following separation [72].
A number of papers were written by Labeed and colleagues at the University of Surrey, in which DEP 
was used to investigate the dielectric properties of cancer cells undergoing multi-drug resistance and 
apoptosis. In the first of these papers, Labeed and colleagues examined the dielectric properties of 
cells from the human chronic myelogenous leukaemia line K562, and those of cells from the K562AR 
doxorubicin-resistant line [73]. In this study [73], the authors used the same basic suspending 
medium as Gascoyne and colleagues in 1997 [54], but with a conductivity of 2.5 mS/ m. Cell 
collection was counted whilst DEP testing was performed, using needle electrodes [73]. The 
electrodes were energised using a 20V peak to peak voltage, across a frequency range of 10 kHz-20
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MHz, where each frequency was applied for 60 seconds [73]. The cell count was recorded at five 
frequency points per decade, and dielectric properties were arrived at by fitting the single-shell 
model to measured data points [73]. The reported results showed that multidrug resistant (MDR) 
cells from the K562AR line exhibited higher cytoplasmic conductivity values than their non-MDR K562 
counterparts (0.5 5 / m and 0.23 5 / m , respectively), and showed that treatment with an MDR 
modulator had no effect on either cytoplasmic conductivity or membrane capacitance [73]. There 
was also very little, if any difference in membrane capacitance values gained by K562 and K562AR 
cells [73]. These results suggested that the differences between MDR leukaemic cells and non-MDR 
leukaemic cells lay in the cytoplasm of the respective cells and that K562 cells had lower ionic 
content in their cytoplasm than K562AR cells [73]. This study also showed that despite DEP and flow  
cytometry results seemingly being in disagreement with each other, combining the results of both 
suggested that the flow cytometric dye used to compare membrane potential levels (DIOC) acted as 
a substrate for P-glycoproteins giving erroneous results for flow analysis, but that use of the MDR 
modulator XR9576 prevented this error from occurring whilst not affecting the dielectric results 
reported by DEP analysis [73]. The same group also conducted further studies into the mechanisms 
behind multi-drug resistance in a later paper, this time using breast cancer cell lines [74].
In a third paper. Chin and colleagues at the University of Surrey again used DEP to study K562 cells, 
this time investigating the effects of the apoptotic agent staurosporine on these cells, and compared 
the results gained with those from Annexin V-FITC assay to monitor changes in proteins located on 
the cytoplasmic surface of the plasma membrane [75]. The results of the Annexin V assay suggested 
that at 30 and 60 minutes post staurosporine treatment, no signs of early apoptosis were found [75]. 
However, the results of DEP testing suggested that two populations of cells were present within the 
K562 population, at the 30 minute and 60 minute time points, with the second population growing 
from 25% to 33% between the 30 and 60 minute time points [75]. At these time points, one 
population achieved a greater cytoplasmic conductivity value than that of the control cells (0.4 3 / m 
and 0.23 5 / m, respectively), whilst the second population achieved values much lower than both the 
first population and the control population, of 0.05 3 / m at 30 minutes and 0.02 3 / m at 60 minutes 
[75]. The authors suggested that the results could indicate the presence of a population undergoing 
apoptosis or necrosis, given that the second population achieved conductivity values not dissimilar to 
that of the suspending medium, and therefore concluded that DEP testing revealed the early effects 
of apoptosis before they were detected using methods such as the Annexin V assay [75].
In a study by Cristofanilli and colleagues, the authors cultured cells from the human cancer cell line 
MDA-MB-435, injected suspensions into the rear flanks of mice and performed fine needle aspiration
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biopsies of the resulting tumours three weeks later [76]. The cells collected by these fine needle 
aspiration biopsies underwent Papanicolaou staining [76]. Blood samples were also obtained from 
mice. DEP testing was conducted using a method (named "electrosmear") whereby cells suspended 
in solution of conductivity 50 mS/ m flowed over a microscope slide which was adorned with a 
microelectrode array [76]. The microelectrodes were energised using 3.3 V peak to peak AC signals of 
frequencies ranging from 10 kHz to 960 kHz [76]. At some point, all cells (regardless of type) reached 
an area of the slide corresponding to the frequency which the cell was most strongly attracted to, 
depending on the dielectric properties of the cell(s) [76]. DEP tests were conducted on 0.5-1.2 x 10® 
cells/ ml collected from the fine needle aspiration biopsies, and control samples consisting of 
cultured MDA-MB-435 cells mixed with mouse blood cells [76]. The results from the fine needle 
aspiration biopsy (FNAB) cells showed that at frequencies of 40-60 kHz, intact tumour cells were 
attracted to the electrodes, with mitotic tumour cells collecting at the low end of this range, large, 
complex tumour cells collecting in the middle of this range and small cancer cells collecting at the 
high end of this range [76]. Less well preserved tumour cells collected at electrodes supplied by 
frequencies of 60-80 kHz and erythrocytes collected at frequencies above 140 kHz, whilst platelets 
were collected at frequencies greater than 240 kHz [76]. The results also showed FNAB sample 
heterogeneity, but that cells of identifiable type tended to be found at the same electrode regions, 
for each sample [76]. The results of the FNAB DEP tests were also in agreement with the control 
samples containing cancer cells grown in 2D culture conditions [76]. The authors found that the 
tumour cells which collected at 80 kHz were in the early stages of apoptosis, based on their 
comparatively small size and the presence of blebs on their membrane surfaces [76]. At the end of 
this work, the authors concluded that they were able to not only separate cells of different types, but 
also separate cells of the same type depending on whether they were damaged or intact [76]. The 
authors do however concede that one drawback of the system they present is that fresh samples 
must be used [76].
In their 2012 paper, Wu and colleagues [77] detail the range of values for dielectric parameters, that 
are found within DEP literature, including values for membrane thickness that range from 4-10 nm (a 
parameter which is kept constant for the purposes of dielectric parameter calculations, but over 
which there appears to be a general lack of consensus regarding which value to apply when using a 
particular model). Here, this group adopted a membrane thickness value of 5 nm [77]. In this study, 
the dielectric properties of cells from the human colon cancer line HT-29 were tested using DEP, by 
applying AC sinusoidal signals with frequencies ranging from 5 kHz to 20 MHz and a peak to peak 
voltage of 20 V to the cells suspended in a medium which had one of three possible conductivity
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values, 10, 50 or 100 mS/ m [77]. The group found that crossover frequencies of 25 kHz, 120 kHz and 
300 kHz were found for HT-29 cells when they were suspended in media of conductivities equal to 
10, 50 and 100 mS/ m, respectively [77]. Upon fitting the single-shell model to data resulting from 
DEP testing, the authors found that cell interior conductivity and permittivity did not alter with 
increasing medium conductivity, but membrane conductivity and permittivity increased (from 6.63 x 
10 ® to 109.12 X 10‘®S/ m and from 4.48 to 7.67, respectively) with increasing medium conductivity 
(10-100 mS/ m), and attributed this dependence of membrane properties on medium conductivity to 
be due to the presence of an electric double layer [77].
In 2013, Salmanzadeh and colleagues [78] used contactless DEP to study the dielectric properties of 
mouse ovarian surface epithelial (MOSE) cells treated with an anti-tumour agent and a tumour- 
promoting agent, both of which were non-toxic. Approximately 3 x 10® cells/ ml were suspended in a 
medium of conductivity approximately equal to 100 pS/ cm and tested using frequencies ranging 
from 5 kHz-70 kHz [78]. The authors found that neither treatment (anti-tumour or tumour- 
promoting) resulted in a significant difference in membrane capacitance for benign MOSE cells, with 
the control, anti-tumour and tumour-promoting cells achieving values of 16.05,15.26 and 16.15 mF/ 
m ,^ respectively [78]. However, the membrane capacitance for malignant MOSE cells was 
significantly greater than that for benign MOSE cells, with a p value of p< 0.01 [78]. This significant 
difference was reduced when the malignant MOSE cells were treated with the anti-tumour agent, 
resulting in benign and malignant cells then having very similar values for membrane capacitance, 
but no difference was observed between the membrane capacitance of the malignant MOSE cells 
and the membrane capacitance of malignant MOSE cells which had been treated using the tumour- 
promoting agent [78]. The authors concluded that the results suggested benign ovarian cells were 
unaffected by treatment with either anti-tumour or tumour-promoting agents, and that anti-tumour 
agents seemed to selectively affect malignant ovarian cancer cells [78]. The authors also concluded 
that ovarian cancer progression is accompanied by increasing membrane capacitance [78].
1.4 Oral Cancer
In 2012, cancers of the lip and oral cavity (oral cancers) were the 15‘  ^most common cancers, in 
terms of the number of cases, worldwide [79]. Incidence is highest in India, the USA and China, 
respectively, based on the number of cases in 2012 [79]. Age-standardised statistics for Europe 
suggest that incidence of oral cancers is highest in Hungary, Portugal and Slovakia, respectively [79].
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Oral cancers were the 15^  ^most common cause of death due to cancer, worldwide in 2012 and the 
18^  ^most common cause of death due to cancer, in Europe in the same year [79]. The highest age- 
standardised rates of mortality resulting from oral cancers were found for Pakistan, Bangladesh and 
India, respectively [79].
In the UK, oral cancers are the 15^  ^most common cancer type, according to the number of cases in 
2012, being the 12*'’ most common cancer type in UK males in 2012, and the 18*'’ most common in 
women [79]. Within the countries of the UK, Scotland has the highest age-standardised (AS) rate of 
oral cancers, at 11.8, followed by Wales (10.1), Northern Ireland (9.3), with England achieving the 
lowest AS rate (8.6) [80].
The AS incidence of oral cancers has been increasing in the UK for the last 30-40 years, for both 
males and females, with increased incidence in UK men of 32% and increased incidence in UK women 
of 33%, over the last decade alone [80]. Oral cancer incidence in the UK has increased for all age 
groups for both sexes (except that of the male 80+ years age group), with the greatest increases 
seen in the 50-59 years age group, for both males (increased incidence of 202%) and females 
(increased incidence of 131%), using European AS statistics [80]. Oral cancers were the 19*'’ most 
common cause of death due to cancer, in the UK, in 2012, with 74% of those who died being 60 years 
of age or older [81]. Of the 2119 people who died, 67% were men and 33% were women [81]. Again, 
within the countries of the UK, Scotland had the highest AS rate of mortality due to oral cancers (3.7) 
followed by Wales (2.4), however, unlike the trend found for incidence. Northern Ireland had the 
lowest AS rate of mortality (2.3), rather than England (2.4) [81]. It should be noted however, that 
despite incidence rates for oral cancers increasing in the UK for the past several decades, mortality 
rates have remained stable [81].
With respect to those diagnosed with cancer of the oral cavity in Scotland in the years 2003-2007, 
one-year survival rates were 72% for males and 77.1% for females [82]. However, five-years post 
diagnosis the survival rate dropped to 42.9% for males and 56.8% for females [82].
Most lesions occurring in the oral cavity are benign [83]. For example, white patches can be lesions 
caused by local irritation, such as ill-fitting dentures or teeth rubbing against the mucosa, and can be 
likened to calluses of the mouth [84]. However, many benign lesions are similar in appearance to 
malignant lesions and vice versa [83]. Of these malignancies, it has been estimated that greater than 
90% of cancers occurring in the oral cavity and oropharaynx, are squamous cell carcinomas (SCCs)
[83, 85-88].
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Therefore, it is advised that oral SCCs (OSCCs) should be suspected in cases of a single oral lesion 
persisting for more than three weeks [89]. Unfortunately, pain is recognised as a poor indicator of 
stage of oral cancer development [84, 89], as tumours of the floor of the mouth and the tongue can 
be painful at an early stage of disease progression, however patients with buccal and lip tumours 
tend to be at an advanced stage of disease before they are in significant pain [90].
The regions which are most at risk for development of cancer are the floor of the mouth and the 
lateral borders of the tongue, with 40% of oral carcinomas said to originate at the tongue, specifically 
on the ventral surface (underside which contains no taste buds) and the lateral borders [84]. Cancers 
of the oropharyngeal region (the soft palate, base of the tongue and tonsillar region) have similar 
appearances to those of the intraoral cavity, but tend to be discovered later, at which point they are 
larger and of a more advanced stage (therefore more difficult to eradicate successfully through 
treatment) [85, 86].
Neville and Day suggested that oral cancer can be divided into three sub-groups according to 
location: cancers of the intraoral cavity, cancers of the lip and cancers of the oropharynx [84]. 
Unfortunately however, early stage oral cancers and potentially-malignant lesions are very difficult to 
detect and diagnose, as they are often asymptomatic, painless and subtle in appearance [84], like 
that shown in Figure 1.5.
Patients who present with stage I and II tumours of the tongue have approximately a 70% chance of 
survival, but this rate drops drastically to 30% if the patient presents with a stage III or IV tumour
[83], and Neville and Day state that lack of early detection is the cause of many patients presenting 
with late-stage (stage III or IV) disease [84]. Symptoms of late-stage oral cancer include teeth 
loosening, pain, difficulties in swallowing (dysphagia) and speaking (dysarthia) and the appearance of 
neck masses [84].
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Figure 1.5: The subtle leukoplakic lesion contained within the yellow circle was diagnosed by biopsy as severe dysplasia, 
highlighting that the subtlety of the lesion does not translate into a lack of malignant potential. Adapted from [84].
OSCC onset is associated with proliferative phenotype and loss of cellular adherence [91], and 
tumour development is linked to the p53 and pRB pathways, the growth factor TGFB and the 
PI3K/AKT pathway [92]. In a study of the ultrastructure of oral squamous cell carcinoma cells, Tanaka 
and colleagues found that upon viewing oral cells using electron microscopy, epithelial cells from 
non-metastatic lesions had few hair-like cell membrane projections (microvilli) and a large number of 
desmosomes (cell-cell junctions), whilst epithelial cells from metastatic lesions had a small number 
of desmosomes but a large number of microvilli, and the authors suggested that this was suggestive 
of a lack of cell-to-cell adherence (normally accomplished by desmosomes) and an increase in 
activity, normally associated with metastasis [93]. Potential biomarkers for oral cancer include EGFR 
(epidermal growth factor receptor), MYC, VEGF, as well as the alteration of the p53, p l6 , p21 and 
p27 genes and viruses such as HPV and the Epstein-Barr Virus (EBV) [94]. Metastasis of OSCCs is 
linked to the WNT, NOTCH and hedgehog signalling pathways [95]. However, da Silva and colleagues 
suggest that it is unlikely that any one molecular factor determines complex tumour behaviour [91].
Métastasés are most commonly found in the cervical lymph nodes, and are non-deformable, large 
and non-tender upon palpation. At initial presentation, up to 30% of OSCCs have metastasised to the 
cervical lymph node, though this figure increases to 66% if the primary OSCC lesion occurred on the 
tongue, possibly enabled by the rich blood and lymphatic supply of this region [96, 97]. Aside from 
the cervical lymph nodes, distant métastasés are found in the lungs [84].
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Oral cancer patients often develop second primary tumours [91] and this is thought to be 
attributable to the principle of "field cancérisation" of the oral cavity, a term which is credited to 
Slaughter. In 1953, Slaughter and colleagues stated that the diameter (i.e. lateral cancérisation) of 
oral squamous cell carcinoma (OSCC) tumours was greater than the depth achieved, and that this 
difference in lateral spread versus depth was most pronounced in early-stage, small lesions [98]. The 
group stated that epithelium which was beyond the tumour margins frequently showed signs of 
abnormality, often in the form of hyperplasia and hyperkeratinisation (often with fibrosis), and that 
regardless of the tumour size, there were often multiple, independent carcinomas in situ [98]. The 
group investigated this topic of multiple oral tumours further, by reviewing the records of 783 oral 
cancer patients, and found that 88 of those patients (11.2%) had two or more independent tumours 
of the oral cavity, pharynx, larynx, oesophagus and trachea region, and that 48.9% of the 88 patients 
had two tumours in the same area of the oral cavity [98]. This led the group to suggest that these 
results indicated a regional rather than localised level of cancer activity, in which large areas of 
epithelium were being acted upon by a carcinogen, and they termed this "field cancérisation" [98]. 
The group then applied this theory to oral cancers and stated that they arose from multiple sites of 
pre-cancerous abnormalities, rather than from a single cell [98].
Brennan and colleagues conducted a study in which they found tumour-specific p-53 mutations (i.e. 
residual tumour cells related to the tumour) in the surgical margins of 52% head and neck squamous 
cell carcinoma patients, and that these cells were not detected during histopathological assessment
[99].
Braakhuis and colleagues proposed that "field cancérisation" was the presence of one or more areas 
in which epithelial cells possessed genetic alterations and that lesions within a field were monoclonal 
in origin and did not demonstrate invasive or metastatic growth [100]. The authors state that the 
"field cancérisation" theory has also been used to explain the presence of second primary tumours in 
head and neck SCCs [100]. In this paper, Braakhuis and colleagues proposed a model for the 
progression of head and neck cancers, in which a stem cell becomes genetically altered and gains a 
growth advantage, whereupon it produces a lesion consisting of genetically altered daughter cells
[100]. This lesion then grows to become a field, which acts to displace normal epithelium in a lateral 
direction (thus by gaining the larger lateral rather than depth component identified by Slaughter)
[98,100].
Day and Blot conducted a study on the occurrence of second tumours in patients with oral cancers
[101]. The authors used data collected by nine US cancer registries over a period of 14 years, and
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identified 21371 people whose primary cancer was an oral cancer (27% of which were tongue 
cancers, 38% of which were from other oral sites and 35% of which were from the pharynx), 62% of 
whom received radiation therapy for this primary cancer [101]. Confirmation of cancer by 
microscopy was available for 96% of cases examined (both first and second tumours) [101]. Mortality 
rates were found to be high, 31% died within a year of diagnosis, 53% within two years and by five 
years, 78% had died [101]. Day and Blot found that of the 21371 patients with oral cancer, 2287 
(10.7%) developed a second cancer, 35% of which were found in the oral cavity, pharynx and 
oesophagus, 31% of which were in the nasal cavities, larynx and lungs, with the remaining 34% found 
in the other sites including the prostate, urinary system and breast, and that relative risk was 20-fold 
or more for developing second oral and oesophageal cancers [101]. The authors also found that 
those who did have radiation therapy and those who did not had a similar risk of developing second 
cancers [101].
1.4,1 Potentially Malignant Disorders and Dysplasia
Speight and colleagues state that though many oral cancers probably occur in normal oral mucosa 
(estimated by Speight as around 50% [102]), some oral cancers are preceded by a potentially- 
malignant lesion [103]. Potentially malignant lesions can be white patches (leukoplakia), red patches 
(erythroplakia) or patches which contain both white and red elements (erythroleukoplakia), but 
there are also potentially malignant conditions, such as oral submucous fibrosis (OSF) and oral lichen 
planus (OLP) [103]. Reibel stated that malignant transformation of oral potentially-malignant lesions 
ranges from less than 1% to 18%, and that 16-62% of cases of oral squamous cell carcinomas have 
been associated with leukoplakic lesions [104]. Flowever, Reibel also states that rates for malignant 
transformation depend on study design, i.e. whether or not studies carry an element of case-bias 
because they take place in specialist units or hospitals [104]. Work summarising the conclusions of 
the World Flealth Organisation (WFIO) Collaborating Centre for Oral Cancer and Precancer, convened 
in 2005, stated that the preferred nomenclature for any clinical presentation which possessed a risk 
to potentially undergo malignant transformation, be called a "potentially malignant disorder" [105]. 
Flowever, as many publications also use the terms "potentially malignant lesion" and "potentially 
malignant condition", the researcher, whilst acknowledging the preferred term is "potentially 
malignant disorder", uses these alternative, once accepted, terms too. At the same meeting of this 
WHO working group, the idea of having a binary dysplasia grading system was also proposed, to 
reduce grading variablility, whereby dysplasia could either be graded as low risk (showing signs of no.
34
questionable or mild dysplasia) or high risk (moderate or severe dysplasia) [106], though again, in 
much available literature, mild, moderate and severe are commonly used, so these terms have been 
used by the researcher.
Schwimmer first used the term "leukoplakia" to describe a white lesion of the tongue, in 1877 [107], 
and the World Health Organisation later defined leukoplakia as "a white patch or plaque that cannot 
be characterized clinically or pathologically as any other disease." [108]. If biopsy reveals the lesion 
suspected to be leukoplakia to be attributable to any other condition, the term leukoplakia can no 
longer be applied [84]. Leukoplakia is the commonest potentially-malignant lesion (PML) type, as 
Bouquot and colleagues citing the work of Axwell and colleagues, state that it accounts for 80% of 
PMLs [109], and tends to occur on the buccal mucosa (cheek lining), gingiva and lip border, but those 
which progress to dysplasia and carcinoma tend to be found on the floor of the mouth, tongue and 
lip border [103]. Homogeneous leukoplakic lesions are those which not only present a homogeneous 
white colour, but also a smooth, thin, flat lesion surface [110]. Leukoplakic lesions are thought to  
occur in 2-4% of the adult population and transformation to malignancy is thought to occur in 4-6%, 
though this is dependent upon the site in the oral cavity where the lesion occurs [103]. Speight and 
colleagues also cite the work of several groups in stating that though rarely biopsied, leukoplakic 
lesions which are can demonstrate dysplastic changes in 5-25% of cases [103]. Dysplastic leukoplakic 
lesions tend to present as erythroleukoplakic lesions, i.e. as predominantly white patches with areas 
which are red, which Speight and colleagues suggest are due to lack of keratin resulting from 
immature epithelial cells, and these lesions present a greater risk of malignancy of approximately 25- 
33% [103]. Erythroleukoplakic lesions, due to their non-homogeneous colour, can be considered non- 
homogeneous leukoplakic lesions [110]. In 1975, Waldron and Shafer conducted a study on 
leukplakic lesions which had been presented to two pathology departments over a period of 13 years 
[111]. They found that leukoplakias accounted for 6.2% of lesions, and biopsies of these leukoplakic 
lesions revealed that 7.6% of them were SCC, carcinoma in situ or severe dysplasia and 12.2% 
showed mild to moderate dysplasia [111]. Certain oral sites were judged to be high risk, given the 
number of leukoplakic lesions in these areas which were found to be dysplastic or cancerous. 
Leukoplakic lesions of the floor of the mouth were dysplastic or cancerous in 42.9% of cases, and 
dysplasia/ carcinoma was found in 24.2% of tongue leukoplakia, and 20% of lip leukoplakia [111]. 
Silverman and colleagues also conducted a study on oral leukoplakic lesions and found that of 257 
patients who presented with leukoplakic lesions, malignant transformation occurred in 45, giving a 
malignant transformation rate of approximately 17.5% over an average of 8.1 years [112].
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Another type of leukoplakic lesion is the proliferative verrucous leukoplakia, which as the name 
suggests, has a nodular, irregular appearance [103], i.e. could be classed as a non-homogeneous 
leukoplakic lesion [110]. They tend to have a long lifespan, but also tend to undergo dysplastic 
change, and transform into invasive SCCs [103]. Bouquot and colleagues also detail another variation 
of the leukoplakic lesion-palatal leukoplakia (a thick layer of keratin accumulation on the hard 
palate), resulting from reverse smoking, i.e. in which the lit end of the cigarette or cigar is in one's 
mouth, and state that this lesion type is associated with a high incidence of malignant transformation 
[109].
Like leukoplakia, erythroplakia was defined by the WHO as being a lesion (red rather than white) 
whose appearance cannot be diagnosed as any specific clinical condition or disease [108], and is 
often asymptomatic (though some patients describe experiencing a burning sensation) [84].
However, the first use of the term "erythroplakia" was not to describe an oral lesion at all, rather it 
was used by Queyrat to describe a red penile lesion which was precancerous in nature [113]. With 
regards to erythroplakia found in the oral mucosa, erythroplakic lesions are less common than 
leukoplakic lesions and are rare in people under the age of 35 years, however Speight and colleagues 
cite many works which suggest that this lesion type presents a risk of malignant transformation of 
50% or greater [103]. Shafer and Waldron, as they did for leukoplakia, conducted a study of cases 
reported to two pathology departments, this time over a period of 24 years [114]. They found that of 
the 64 354 lesions examined, 58 (0.09%) were cases of erythroplakia, suggesting that erythroplakic 
lesions were much less common than leukoplakic lesions [114]. Shafer and Waldron also found that 
erythroplakic lesions tended to be presented by people of 60-70 years of age [114]. The authors also 
found that of the 65 biopsies performed for the 58 cases, 51% were diagnosed as invasive carcinoma, 
40% as carcinoma in situ or severe dysplasia and 9% were mild to moderate dysplasia, leading the 
authors to conclude that most, if not all, cases of erythroplakia were dysplastic or cancerous [114]. 
Speight and colleagues cite the work of Bouquot and colleagues when stating that when biopsied, 
the vast majority of erythroplakic lesions contain cells of a dysplastic nature [103], and also state that 
erythroplakic lesions commonly present as severe dysplasia or carcinoma in situ, but 5-10% present 
as micro-invasive squamous cell carcinomas [103]. One of the problems in diagnosing dysplasia is 
that it shares histopathological features with normal, regenerating epithelium [103]. However, the 
signs of dysplasia include increased nuclear-to-cytoplasmic ratio, mitoses in the intermediate 
epithelial "prickle" layer, nuclear hyperchromatism (excessive staining of the nuclear area), 
abnormally increased (hyperplasia) proliferation of basal cells, loss of epithelial stratification, loss of 
cell adherence and appearance of keratin pearls [103].
36
other potentially malignant disorders include Candida albicans and oral lichen planus. It has been 
suggested that the fungal infection, Candida albicans, is linked with epithelial dysplasia, and a 
number of leukoplakic lesions seem to be infected by Candida [103], though the malignant 
transformation rate is not known.
The autoimmune disorder lichen planus is thought to be a fairly common disorder affecting mucous 
membranes, and presents in the oral cavity as patterns of white lines, typically in people of middle- 
age [103]. Several studies have also suggested that oral lichen planus is linked to an increased risk of 
oral cancer development [115-117], however Bouquot and colleagues cite a rate of malignant 
transformation of 1% for lichen planus [109], which is in agreement with that stated by van der Waal
[118]. Bouquot and colleagues also state that oral submucous fibrosis is a potentially malignant 
condition with strong links to chewing betel quid, and symptoms include a burning sensation in the 
oral mucosa, ulceration, blanching and fibrous bands forming on the buccal mucosa [109].
Dysplasia is typically classed as one of three grades [102]. Mild dysplasia is diagnosed when basal 
cells proliferate or are found above the basal layer, but that are restricted to the lower 33% of the 
epithelium [103]. In moderate dysplasia, basal cells are found and proliferate in the lower 66.7% of 
epithelium, and in severe dysplasia, basal cells can be found up to the upper third layer of epithelium  
[103], i.e. some basal cells have progressed through to the most superficial of the three epithelial 
layers [103]. Bouquot and colleagues state that oral cancers arising from dysplastic lesions normally 
arise within two to five years, but that attempts to remove dysplasias are complicated by the fact 
that 33% will recur [109]. There has been some debate as to whether carcinoma in situ is a stage 
prior to malignancy or evidence of malignancy, however it is defined by cytological and architectural 
changes spanning the full thickness of the epithelium [102]. This is thought to be quite a rare 
occurrence in the oral cavity, as an intact keratin layer is evident even in the event of severe atypia 
[102].
The variability of dysplasia diagnosis from pathologist to pathologist, and the general difficulties in 
diagnosing what can be minor and subtle dysplastic changes, has been a subject of research. Abbey 
and colleagues investigated the extent to which six board-certified oral pathologists agreed with each 
others' findings for 120 oral biopsies, and the extent to which each pathologist agreed with their own 
findings for the same biopsies several months later [119]. In this study, each pathologist was given 
120 numerically labelled microscope slides, which they were to class as mild, moderate, severe or no 
dysplasia [119]. After several months had passed, the six pathologists re-examined 60 of the original 
microscope slide which had since been re-numbered [119]. The authors found that the degree of
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agreement for the diagnoses from the six pathologists and the pre-determined diagnoses was 
approximately 50.5%, though 85-94.2% of decisions were within one grade of the pre-determined 
diagnoses, and the examiners agreed on the presence of dysplasia found in the original diagnosis in 
81.8% of cases [119]. The authors also found that intra-examiner agreement between first and 
second diagnosis was on average, 50.8%, and agreement to within one grade ranged from 88.3-100%
[119]. Abbey and colleagues concluded that agreement on level of dysplasia was difficult to achieve, 
and is open to interpretation and therefore, variability [119].
1.4,2 Risk Factors
The International Agency for Research on Cancer (lACR) compiled a list of factors showing either 
sufficient or limited evidence of carcinogenic effect in humans [120]. In this report, the lACR listed 
alcohol, tobacco (both smoked and smokeless), betel quid consumption (both with and without 
tobacco), human papillomavirus (HPV) type 16, x-rays and gamma radiation as being risk factors 
backed by sufficient evidence, for cancers of the lip, oral cavity, tonsils, salivary glands and pharynx
[120]. Factors suggested as posing risks for cancer of these regions, but based on limited evidence, 
included solar radiation, HPV type 18, radioiodines, printing processes, exposure to asbestos and 
exposure to second-hand tobacco smoke [120].
Alcohol and tobacco are possibly the two most heavily implicated risk factors for oral cancer. Blot 
stated that risk of cancer development related to alcohol consumption was most strong for oral and 
pharyngeal cancers, and that studies of these cancers provided most clues on the possible 
mechanisms driving alcohol-related cancer development [121]. The author also presented 
information on the multiplicative effect of alcohol consumption and smoking, which suggested that 
the relative risk (i.e. risk compared with that of those who abstained from alcohol and smoking) for 
non-smokers who consumed between five and 40 alcoholic drinks per week was 1.6, but for those 
who drank this amount per week but also smoked 20 or more cigarettes per day for 20 or more 
years, this risk increased to 4.4 [122]. The relative risk was found to be greatest (at 37.7) for those 
who consumed more than 30 alcoholic drinks per week and who had smoked more than 40 
cigarettes per day for more than 20 years [122].
Ogden also conducted a review of the role of alcohol within oral cancer [123]. In his paper, the 
author discussed the issue of comparing studies on alcohol due to different units of measure being 
used, such as units in the UK, ounces in the US [123] and the term "drink" being used in some papers.
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such as that by Blot and colleagues [122]. The author also discussed the possible mechanisms by 
which alcohol affected the oral mucosa, and cited his previous work, in which he and his colleagues 
determined that high alcohol intake significantly reduced the mean cytoplasmic area of buccal cells 
[123], which is of interest given that a common trait of cancer cells is their large nuclear-to- 
cytoplasmic ratio. Ogden also cited the work of Axwell and colleagues who showed that membrane 
transport of oral epithelial cells, through endocytosis, was significantly decreased in people who had 
a high alcohol intake [123]. Squier also referred to a previous study in which he and colleagues 
examined the effects of alcohol, on the oral mucosa of pigs, and found that the permeability of both 
the floor of the mouth and gingiva were increased to one of the ingredients of processed tobacco for 
5% ethanol (but not to 50% ethanol for the gingiva) [16].
Corrao and colleagues conducted a meta-analysis on level of alcohol consumption and the risk for 15 
diseases and found that a significant risk was present for the development of cancers of the oral 
cavity and pharynx [124]. Specifically, upon analysis of 15 studies (one cohort study and 14 case- 
control studies), which presented 4507 cases, they found that relative risk increased from 1.86 for 
consumption of 25 grams of alcohol (approximately two drinks) per day, to 3.11 for 50g per day, to 
6.45 for lOOg per day [124]. Parkin calculated that 30.4% of cancers of the oral cavity and pharynx, in 
the UK in 2010, were attributable to consumption of alcohol, and that this was greater than the 
percentage which could be attributed to alcohol for oesophageal (20.6%) and liver (9.1%) cancers 
combined [125].
Tu rati and colleagues also conducted a meta-analysis on the effects of alcohol as they pertained to 
development of oral and pharyngeal cancers, in which the group combined the results of 49 studies 
for drinking, 33 studies for moderate drinking and 31 studies for heavy drinking [126]. The authors 
found that the relative risk for those who drank alcohol regularly compared with occasional drinkers 
and those who did not drink, was 2.55, and that risk was higher in men (3.12) than in women (1.52) 
[126]. Moderate drinking was defined as consumption of one to two alcoholic drinks per day, and the  
risk in men classed as moderate drinkers was found to be higher than the risk in women (1.28 and 
1.17 respectively) [126]. Risk for heavy drinking (consumption of > four alcoholic drinks per day) 
compared with not drinking at all or occasional drinking, was found to increase to 5.40 [126]. The 
authors also found that smoking increased the risk of developing oral and pharyngeal cancers in 
those who drank, with those who drank but never smoked, or were not current smokers, having a 
risk of 1.32 compared with the risk of 2.92 for those who drank and were current smokers [126]. 
Those who were heavy drinkers but who never smoked/ were not current smokers, had a risk of oral 
and pharyngeal cancer development of 2.54, however the risk was greatly increased for heavy
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drinkers who were current smokers (relative risk = 6.32) [126]. The authors also found that relative 
risk for oral and pharyngeal cancers for those who drank wine was lower than for those who drank 
spirits and those who drank beer (2.12, 2.30 and 2.43, respectively), but that this trend differed in 
heavy drinkers, for whom beer posed the lowest risk, followed by wine, with spirits posing the 
highest risk (4.20,4.92 and 5.20, respectively) [126].
Hashibe and colleagues assessed the independent contributions of alcohol consumption and smoking 
to the development of head and neck cancers, by examining the rates of said cancers in those who 
smoked but did not drink, and in those who drank but did not smoke [127]. The authors grouped 
data from 15 different case-control studies which, when combined, gave results from 10 302 cases 
(people with head and neck cancers) and 15 329 controls [127].They found that the risk of head and 
neck cancers in those who smoked but never drank was 2.13 [127]. However, a relative risk of 1.18 
for those who drank but never smoked suggested that there was no association between risk of 
developing head and neck cancer and alcohol consumption in those who never smoked [127]. A 
relative risk was found (equal to 2.04) however, in those who never smoked but who consumed 
three of more alcoholic drinks per day [127].
In their meta-analysis, Gandini and colleagues calculated a relative risk for current smokers 
developing cancers, with respect to former smokers, as 3.43 for the oral cavity and 6.76 for the 
pharynx [128]. Parkin also conducted a review in which he calculated that 65% of cancers of the oral 
cavity and pharynx in the UK in 2010 were attributable to tobacco smoke through smoking or 
tobacco smoke in the environment (i.e. second-hand smoke) [129].
As stated previously. Parkin and colleagues estimated that over 90% of cancers of the oral cavity and 
pharynx were preventable, because they could be attributed to lifestyle choices [8]. In their paper, 
the authors state, besides the risks posed by alcohol and tobacco, that 57.2% of cases were 
attributable to inadequate consumption of fruits and vegetables in the diet, 12.3% to infections and 
0.6% to occupational exposures [8].
Smokeless tobacco products (for example chewing tobacco and snuff) have also been implicated in 
increased risk of oral cancers. Boffetta and colleagues calculated the relative risk of oral cancer from 
smokeless tobacco products to be 1.8, for the US and Nordic Europe combined [130], i.e. lower than 
the risk of 2.3 found by Hashibe and colleagues [127]. However, the group found that the relative risk 
of oral cancer development in male smokeless tobacco users was 2.6 in both the USA and Canada,
5.1 in India, Bangladesh, Bhutan, Burma, Indonesia, Nepal, Pakistan and Sri Lanka, and 7.3 in Sudan 
[130]. In the USA, 6.6% of cases of oral cancer in males were attributable to smokeless tobacco, as
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were 25% of cases in Bangladesh, Bhutan, Burma, Indonesia, Nepal, Pakistan and Sri Lanka, 26% of 
cases in India and 34% of cases in Sudan [130]. Boffetta and colleagues also state that whilst nicotine 
itself is not a carcinogen, tobacco contains more than 30 carcinogens, including nitrosamines, and 
these carcinogens affect both smokeless tobacco users and smokers [130].
The areca or betel nut, commonly referred to as betel quid when it is rolled in a betel leaf along with 
slaked lime [131], is also a risk factor for oral cancers. Sharan and colleagues published a study in 
which they examined 178 studies related to the role of the betel nut in cancer [131]. Whilst the betel 
nut products are less prevalent in the UK (though there are thought to be 20 commercially available 
betel nut products sold in the UK [131]), Sharan and colleagues state that 40% of the populations of 
India, Nepal and Pakistan have consumed betel quid, with India thought to have the greatest 
population of betel quid consumers, worldwide [131]. However, the product is also consumed on 
mainland China, Taiwan, Thailand, Sri Lanka and Malaysia [131]. Sharan and colleagues also state 
that the majority of betel nut users develop potentially malignant oral conditions and lesions, such as 
leukoplakia and erythroplakia [131]. Jeng and colleagues also confirm this, by stating that many who 
chew betel quid products undergo oral mucosal changes such as epithelial thickening, ulceration and 
inflammation [132], which are all symptoms associated with malignant transformation of oral tissue. 
Trivedy and colleagues detail that parallel, keratotic lines are seen surrounding a central area of red 
tissue in areca nut product users [133]. Trivedy and colleagues also describe betel chewer's mucosa 
as a brown/ red discolouration of the oral mucosa, usually the buccal mucosa (site of betel product 
placement), which demonstrates hyperplasia (proliferation of cells), and cite the works of Merchant 
and colleagues and Ko and colleagues, who found that the relative risk of developing oral squamous 
cell carcinoma was 8.42 with tobacco and 9.9 without tobacco in a study in Pakistan, and 123 in a 
study in Taiwan, respectively [133]. Sharan and colleagues also cite the work of Shiu and colleagues, 
who suggested that elimination of betel nut products could help prevent up to 62% of oral 
leukoplakias and 26% of cases of transformation to oral cancers [131]. Thomas and colleagues 
conducted a study looking at the effects of betel quid without added tobacco and risk for oral cancer 
development [134]. In their study, in which they recruited 143 cases and 477 controls, they found 
that the odds ratio for oral cancer development was slightly lower in those who chewed betel quid 
daily, but did not smoke compared with those who smoked daily but did not chew betel quid (1.76 
versus 1.81) [134]. However, the odds ratio for developing oral cancer in people who both smoked 
daily and who chewed betel quid daily was increased to 4.85 [134].
Human papillomavirus (HPV) infections, thought to be responsible for the vast majority of cases of 
cervical cancer, have also been implicated in the development of head and neck cancers, particularly
41
within the oropharynx region. Schwartz and colleagues conducted a study to examine HPV infection 
as a possible risk factor for oral squamous cell carcinomas (OSCCs), in which they recruited 284 case 
subjects (91.9% of whom had invasive OSCCs and 8.1% of whom had carcinomas in situ, all of which 
had been histologically confirmed as such) and 477 control subjects who had no history of oral 
cancer [135]. Venous blood samples were collected from 91.5% of cases and 93.9% of controls, to 
test for HPV-16, and samples of exfoliated oral cells were collected for DNA extraction and viral 
genotyping, using soft-bristled toothbrushes, from 93.3% of cases and 98.1% of controls [135]. The 
group found that the overall prevalence of HPV-16 DNA was 16.5% in cases of OSCC, and that HPV-16 
DNA was most commonly found in tumours of the tonsils (34.1%) and the oropharynx (36.4%) [135]. 
The group also found that HPV DNA prevalence was similar in the exfoliated samples of cases and 
controls, but that the blood tests for half of the case subjects were positive for HPV-16, compared 
with a third of control subjects [135]. Schwartz and colleagues also reported that the odds ratio for 
developing oral cancer, associated with the presence of HPV-16 DNA was 6.3 [135]. They also found 
that HPV-16 positive results were associated with tumours of the tongue and tonsils, but not the 
floor of the mouth [135].
Herrero and colleagues also conducted a study examining the role of HPV in oral cancer, for the 
International Agency for Research on Cancer (lARC) Study Group, in which they recruited 1670 
patients with cancer of the oral cavity, 255 patients with cancer of the oropharynx and 1732 control 
subjects [136]. They found that HPV DNA was more commonly found in cancers of the oropharynx 
(18.3%) than cancers of the oral cavity (3.9%), and that as is found in genital cancers, HPV-16 was the 
most common HPV type found, and was present in 94.7% of HPV positive cases [136]. The group also 
found that there were no significant differences found between case and control exfoliated samples 
(which were exfoliated using soft-bristled toothbrushes) in terms of their HPV DNA content [136].
In a literature review paper, Syrjanen stated that detection of HPV, most commonly HPV-16 and HPV- 
18 in oral cancers, varied from 20-90% in oropharyngeal carcinomas, but that this variation could be 
partially attributed to inter-study variations in detection methods for HPV and sampling protocols 
[137]. Syrjanen also made reference to previous work in which the author had been the first to 
provide evidence of a role for HPV infection within oral cancers [137]. The author also stated that 
HPV had been found in 51% of tonsillar tumours, and that whilst HPV types 16 and 18 were 
associated with OSCCs, types 6 and 11 were most commonly found in lesions of benign nature [137].
In their review paper, Kreimer and colleagues also found that HPV-16 was the most common type of 
HPV found in head and neck cancers, and in their review study, found HPV-16 was present in 86.7%
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of HPV-positive cases in oropharyngeal cancer and 68.2% of OSCCs [138]. The group also found that 
the prevalence of HPV-16 in cancers of the oral cavity was 16%, whilst prevalence in oropharyngeal 
cancers was 30.9%, whereas HPV-18 prevalence was 8% in oral cavity cancers, but was much less 
prevalent in oropharyngeal cancers, at 1% [138]. In this study, prevalence of HPV in head and neck 
squamous cell carcinomas was highest in Asia, compared with North America and Europe, overall and 
specifically for HPV type 16 [138].
D'Souza and colleagues studied the role of HPV specifically within oropharyngeal cancers, by 
conducting a case-control study, to which they enrolled 100 patients with oropharyngeal cancers as 
cases and 200 patients examined for benign lesions as controls [139]. They found that HPV-16 DNA 
was found in 72% of tumour samples and that oropharyngeal cancer was associated with HPV 
infection (odds ratio = 12.3), but particularly HPV-16 (odds ratio = 14.6) [139]. The group also found 
that development of oropharyngeal cancer was significantly increased with an increasing number of 
sexual partners (p = 0.002 for 26 or more vaginal-sex partners and p = 0.009 for six or more oral-sex 
partners), and the odds ratio for HPV-16 positive oropharyngeal cancers for patients who had six or 
more oral-sex partners was 8.6 (with a p value for significant difference of p < 0.001) [139].
However, there have been suggestions that whilst HPV is linked with the development of 
oropharyngeal cancers, that HPV infection may not lead to a poorer prognosis. Fahkry and colleagues 
conducted a study on the treatment response and survival rates of 96 patients with stage III and IV 
cancers of the oropharynx and larynx, 40% of whom were found to be HPV positive (of which 95% 
were HPV-16 positive) [140]. They found that after chemotherapy was induced, 82% of patients with 
HPV-positive tumours responded to treatment, compared with 55% response of HPV-negative 
tumours, that this response was still greater upon conclusion of chemotherapy treatm ent (84% for 
HPV-positive versus 57% for HPV-negative), and also found that the two-year survival of HPV-positive 
patients of 95% was significantly increased (p = 0.005) compared with that of HPV-negative patients, 
at 62% [140]. These results were similar to those found in another study by Ang and colleagues who 
found that the three-year survival rate for patients with HPV-positive stage III or IV oropharyngeal 
tumours was significantly greater (p < 0.0010) at 82.4%, than those with HPV-negative tumours at 
57.1% [141].
There has also been some suggestion that oral cancers in younger patients should not necessarily be 
attributed to HPV infection. Bragelmann and colleagues cited the works of Lingen and colleagues, 
Siebers and colleagues, and Salem and Kabeya and colleagues when stating that whilst common in 
oropharyngeal cancers, HPV is much less commonly found in tumours of the oral cavity, particularly
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tumours of the tongue, and cited that this was significant give the work of Liang and colleagues, as a 
high number of tongue cancers were found in younger patients to whom the risks posed by chronic 
consumption of alcohol and tobacco did not extend [142]. In their study, Bragelmann and colleagues 
analysed the survival time of 748 patients with advanced-stage head and neck squamous cell 
carcinomas (confirmed by histological records), and found that of the 135 patients under the age of 
45 years, the 24 patients who had tumours of the oral cavity had a 42% five-year survival (37.5% of 
who had never smoked), compared with the 65% five-year survival of 111 patients who had tumours 
not located within the oral cavity [142]. The authors also found that the survival rates for young 
patients with oral cavity cancers were significantly poorer than those for young patients with 
oropharyngeal cancers or non-oral cavity/ non-oropharynx cancers (p = 0.023) [142].
Paget-Bailly and colleagues conducted a study in which they reviewed epidemiological data relating 
to occupational exposures to solvents, hydrocarbons and asbestos and incidence of cancers of the 
oral cavity and oropharynx [143]. The group found, having reviewed 63 publications, that evidence 
suggested that exposure to asbestos (whose fibres are thought to cause chronic irritation of the 
respiratory system) and polycyclic hydrocarbons (such as encountered in steel and iron foundries and 
aluminium mining) was linked with risk for development of oropharyngeal cancers, but that evidence 
suggested that exposure to solvents was not [143].
Pavia and colleagues reviewed the links between consumption of fruits and vegetables and oral 
cancer [144]. Despite finding 71 studies, the authors detailed that only 16 of these studies met 
inclusion criteria to be considered part of their review [144]. Of these 16 studies one was a cohort 
study and 15 were case-control studies [144]. Upon reviewing these studies, the authors found that 
overall, when rates were adjusted for sex, age and consumption of tobacco and alcohol, the risk of 
developing oral cancers was decreased by 49% for fruit intake and by 43% for vegetable intake [144]. 
The group found, based on two studies, that risk reduction associated with vegetable intake was 
greater than risk reduction associated with fruit intake (65% versus 8%), for women, but that this 
trend was reversed for men (25% versus 45%), based on the results of a total of 11 studies [144]. The 
group also found that consumption of green vegetables was associated with 53% lower risk of oral 
cancer development, whilst consumption of citrus fruit was associated with 38% lower risk of oral 
cancer development [144]. Block and colleagues also conducted a review on the link between 
consumption of fruits and vegetables and oral cancer, and found that data from nine studies 
suggested a twofold increase in relative risk of oral cancer development in people who had a low 
intake of fruits and/ or vegetables [145].
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Gaudet and colleagues conducted an analysis on the contribution of body mass index (BMI) to oral 
cancer risk [146]. On evaluation of 17 international studies, \A/hich in total generated results for 
12 716 cases and 17 438 controls, the group found that people with a BMI considered to be lean (< 
18.5 kg/ m )^ had twice the risk of developing cancers of the oral cavity, pharynx and larynx, 
compared with those with a normal BMI {>18.5 kg/ m  ^and <25 kg/ m^), but that those who were 
overweight (BMI > 25 kg/ m  ^and <30 kg/ m )^ or obese (BMI >30 kg/ m^) had a lower risk of oral 
cancers than people of a normal BMI [146].
1.4.3 Diagnosis and Treatment
1.4.3.1 The Conventional Oral Examination (COE)
The standard, accepted method for revealing oral abnormalities, including potentially malignant 
disorders and oral squamous cell carcinomas (OSCCs), is by performing a conventional oral 
examination (COE) [147,148]. Having recorded the patient's medical and social history (including 
noting their exposure to risk factors), the COE is performed under incandescent light, sometimes in 
the form of a head-torch, and involves visual inspection of the face, lips, buccal mucosa (cheek lining, 
both left and right), gingiva, dorsal surface of the tongue (i.e. the surface which contains taste buds), 
lateral aspects of the tongue, ventral surface of the tongue (i.e. the smooth underside), the floor of 
the mouth and the hard and soft palates [149,150]. Gauze can be used to allow better visualisation 
of the rear aspect or the lateral aspects of the tongue [150]. During the COE, bimanual palpation of 
the lymph nodes in the neck also takes place, and enlarged nodes that are not painful upon palpation 
(and therefore are considered unlikely to have arisen due to infection) are regarded with suspicion 
[150]. In a review paper, Lingen and colleagues cited the work of Downer and colleagues, who 
performed a meta-analysis and found the overall sensitivity of the COE to be 85% and the specificity 
to be 97%, however Lingen and colleagues did state that whilst the COE is a useful method for 
discovering potentially malignant disorders (PMDs) and OSCCs, it does not identify oil PMDs and 
OSCCs, nor does it identify the PMDs which are likely to progress to malignancy [148].
Upon identification of a lesion or lesions, the examiner documents details of the duration the lesion 
has persisted for, symptoms associated with lesion development, and any prior diagnostic measures 
or treatments, along with providing a description of the lesion in terms of anatomical site, size, 
colour, texture, and the examiner may photograph the lesion in situ [151].
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1.4.3.2 Diagnosis
The "gold standard" method for diagnosis of oral cancers is histopathological assessment of biopsied 
tissue. Biopsies are collected of tissue suspected as potentially malignant for further analysis through 
histopathological assessment, the most common method of which is scalpel biopsy [151]. An 
incisional scalpel biopsy is performed when there is a suspicion of malignancy, and involves an 
elliptical incision (to aid wound healing) to remove a sample of abnormal tissue, but can also involve 
collection of tissue thought to be normal, from the periphery of the lesion [151]. Excisional biopsy is 
used in cases of tissue suspected to be benign, and involves complete removal of an elliptical-shaped 
sample [151]. Alternatively, in cases of lesions of the buccal mucosa and tongue, punch biopsies can 
be performed, whereby the punch aperture is located over the lesion, and by exerting a downward, 
twisting motion and using curved scissors, a cylindrical section of tissue can be removed [151]. 
However, because the punch biopsy wound shape is circular, it does not heal as easily as the elliptical 
wounds resulting from scalpel biopsies [151]. Fine needle aspiration cytology is used to sample 
tumours of the salivary glands and neck masses [152].
Biopsies are then fixed in 10% formaldehyde-based solution, of volume ten times greater than the 
volume of tissue it is fixing (for no more than 24-48 hours) and sent for histopathological assessment 
[153]. Histopathological assessment involves cutting the tumour or lesion specimen into thin 
sections, which are stained using haematoxylin and eosin (H & E) stains [152]. Haematoxylin is a basic 
dye, which acts by staining structures containing DNA (such as cell nucleoli) and RNA (such as 
ribosomes and rough endoplasmic reticulum) a purple/ blue colour, and eosin is an acidic dye, which 
acts by staining the cytoplasm of cells a red/ pink colour [154].
Upon determining the cancerous nature of OSCCs through biopsy and histopathology, tumours are 
staged, in order to determine treatment options. Tumours can be staged using either the TNM  
(where "T" stands for tumour, "N" stands for lymph nodes and "M" stands for metastasis) system or 
a number system [155]. Stage 0 defines carcinoma in situ with no nodal involvement or distant 
metastasis, stage I defines a tumour of 2 cm or less with no associated nodal involvement or distant 
metastasis and stage II defines a tumour of between 2 cm and 4 cm in size but with no associated 
nodal involvement or distant metastasis [84]. Stage III defines a tumour which is either greater than 4 
cm in size with no associated nodal involvement or distant metastasis, or a tumour up to 4 cm in size 
with no associated distant metastasis but with an ipsilateral lymph node metastasis of 3 cm or less
[84]. The most advanced stage, stage IV, defines any tumour which has invaded structures adjacent
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to it, lymph node métastasés greater than 3 cm in size and occurring either unilaterally or bi-laterally 
or distant métastasés [84].
Imaging techniques such as CT, MRI and PET (positron emission tomography) can also be used to 
study the extent of the primary tumour and spread of this tumour to adjacent, nodal and distant 
sites [156,157]. Computerised tomography (CT) is used to visualise tumours of the oral cavity, whilst 
magnetic resonance imaging (MRI) has proved useful for visualising cancers of the tongue, and 
positron emission tomography (PET) aids visualisation of metastatic spread to lymph nodes [88].
1.4.3.3 Treatment
Surgical excision and/ or radiotherapy are the "gold standard" treatment modalities for oral cancers, 
however, regardless of the treatment administered, the patient may experience xerostomia (dry 
mouth), airway problems and their voice may change, impinging on their quality of life [84]. Surgical 
treatment can involve intervention on a single occasion, whereas a course of radiotherapy can run 
for a period of between six and seven weeks, so surgery could be seen as a preferable option for 
treatment of early stage oral cancers, provided the patient has no contra-indicators preventing them  
from being considered for surgery [158]. In cases of more advanced oral cancers, surgery, 
radiotherapy, chemotherapy or a combination of all three can be offered [158]. Intensity modulated 
radiotherapy (IMRT) has been adopted for treatment of head and neck cancers and is reported to 
result in lower doses of toxicity in normal tissues whilst targeting the tissues of interest and reducing 
xerostomia (dry mouth) and sparing the salivary glands from permanent damage [159]. 
Chemotherapeutic drugs cisplatin, paclitaxel, docetaxel, fluorouracil and methotrexane are used to 
treat oral cancers, and do so by preventing development of potentially-malignant lesions into 
malignant lesions and by preventing secondary potentially- malignant lesions from developing [88]. 
Das and Nagpal cite a study by Brizel and colleagues, which found that a combination of 
chemotherapy and radiotherapy (chemo-radiotherapy) improved relapse-free survival, in cases 
undergoing chemoradiotherapy compared with cases undergoing radiotherapy alone (61% versus 
41%) [88].
All forms of treatment for oral cancers, and cancers in general, have associated risks. Any surgery 
performed under general anaesthesia carries a risk of mortality. According to Das and Nagpal, the 
success of radiotherapy is dependent upon the presence of oxygen, however most oral cancer 
tumours are hypoxic and can therefore have the potential to resist radiotherapeutic treatm ent [88].
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other than xerostomia, radiotherapy can induce other side-effects, such as osteoradionecrosis 
(death of bone tissue) and tooth decay [158]. Side effects of chemotherapy include increased risk of 
infection due to low white cell count, hair loss and numbness and tingling in extremities [160].
Given the potential for development of multiple tumours in oral cancer, and the difficulty in 
identifying tumour margins in order to successfully cure oral cancers through surgical removal of 
tumours, detecting and diagnosing oral cancers at an early stage of their development, prior to 
malignant transformation or métastasés, is of great importance.
1.4.4 Summary
Silverman stated that the most effective means of combating oral cancer is early diagnosis [83]. 
However, there are a number of factors which contribute to being able to achieve this goal. Firstly, 
there is a certain dependence upon the population to be aware of their own level of health, and to 
initiate action to rectify any suspected health problems, by seeking medical attention. With oral 
cancers in mind, this requires the general public to be aware of the symptoms of oral cancers, such 
as sores or lesions in the mouth which fail to heal within a period of approximately three weeks, and 
to seek medical attention in events such as this. Public health awareness campaigns, such as Mouth 
Cancer Action Month, promoted by the British Dental Health Foundation [161], which runs through 
November, play a role in raising this level of awareness.
However, oral cancers are an area of crossover between medical and dental health services, and this 
could lead to some confusion, amongst both patients and clinicians, as to who is best placed to 
examine for oral cancers. Macpherson and colleagues cited that figures from the year 2000 showed 
that only 50% of adults in Scotland, the area of the UK which has the highest rates of oral cancers 
[80], were registered with an NHS dentist [162]. In an earlier publication, for which Macpherson was 
a named author, it was found that members of the public who could be considered as high risk for 
development of OSCCs (for example, those of a low socio-economic status, and/ or those who 
smoked) were unlikely to visit a dentist regularly, but more likely to be registered with and visit a 
general health practitioner [163]. A study conducted by Groome and colleagues in Ontario, Canada 
found that of 2033 patients with invasive OSCCs of the anterior tongue or floor of the mouth in the 
years 1991-2000, 65% were referred by their family doctor and only 35% had a dentist who they saw 
regularly [164].
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Reducing the time taken between initial examination of potentially malignant disorders and OSCCS, 
and diagnosis, and then diagnosis and commencement of treatment, also has to be achieved so that 
early diagnosis can lead to treatment as soon as possible.
However, all of the above assumes that in the event of members of the public becoming aware of 
potentially malignant disorders in their mouths, that they can then access a healthcare provider, be it 
dental or medical, in order to achieve formal diagnosis and treatment. Whilst this may pose less of an 
issue in many countries classed as "developed", this issue is of much greater significance in countries 
where even basic healthcare is inaccessible to large percentages of the population, because of for 
example, geographical location of healthcare facilities and lack of transport to get there, long waiting 
lists to see a healthcare provider due to the service being grossly oversubscribed and lack of funds to 
be able to afford consultation and treatment.
Another factor involved in early diagnosis is early detection of potentially malignant disorders 
(PMDs), which could be accomplished by either making PMDs more visually apparent, or by reducing 
the time taken to ascertain the level of abnormality present and therefore determine if biopsy is 
required without waiting for a period of several weeks or more in order to perform a follow-up 
examination, which the patient may not attend. The techniques and technologies which have been 
employed in an attempt to accomplish these aims are discussed in the chapter following this, which 
serves as an introduction to a preliminary study conducted by the researcher, to determine if 
dielectrophoretic testing of oral brush biopsies could potentially have a role to play within early 
detection, leading to early diagnosis, of oral cancers.
49
1.5 Reference List (Chapter 11
[1] Cancer Fact Sheet Number 297. The World Health Organisation [online]. Updated February 2014. Available from: 
http://www.who.int/mediacentre/factsheets/fs297/en/
[2] Ruddon RW. Cancer Biology (4*  ^Ed). Oxford University Press, Oxford 2007.
[3] Alberts B, Johnson A, Lewis J Raff M, Roberts K, Walter P. Molecular Biology of the Cell (5^  ^Ed). Garland Science, New 
York 2008.
[4] Hanahan D, Weinberg RA. The Hallmarks of Cancer. Ceil 2000; 100: 57-70.
[5] Campisi J. Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors. Ceil 2005; 120: 
513-522.
[6] Sporn MB. The war on cancer. Lancet 1996; 347:1377-1381.
[7] Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Ceil 2011; 144: 646-674.
[8] Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 
2010. British Journal o f Cancer 2011; 105: S77-S81.
[9] Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population. 
internationaiJournai o f Cancer 2013; 132:1133-1145.
[10] emedicine. Head and Neck Cancer-Squamous Cell Carcinoma. [Online]. Available from: 
http://emedicine.medscape.com/article/1289986.
[11] Nanci A. Ten Cate's Oral Histology: Development, Structure, and Function. 7^  ^Ed. Missouri. Mosby Elsevier 2008: pp 
319-357.
[12] Squier C, Kremer MJ. Biology of Oral Mucosa and Esophagus. Journal o f the National Cancer institute Monographs 
2001; 29: pp 7-15.
[13] Squier C, Hill MW. Oral Mucosa. In: Ten Cate AR, (Ed). Oral Histology: Development, Structure and Function. CV Mosby, 
Missouri 1989: pp 341-81.
[14] Scott JH, Symons NBB. The Mucous Membrane of the Mouth and Related Structures. In: introduction to Dental 
Anatomy. 9th Ed. Edinburgh. Churchill Livingstone 1982: 295-319.
[15] Provenza DV, Seibel W. Oral Histology: inheritance and Development. 2nd Ed. Philadelphia: Lea & Febiger 1986.
[16] Squier CA. The Permeability of the Oral Mucosa. Critical Reviews in Oral Biology and Medicine 1991; 2(1): 13-32.
[17] Toyoda M, Sakita S, Kagoura M, Morohashi M. Electron Microscopic Characterisation of Filiform Papillae in the Normal 
Human Tongue. Archives of Histology and Cytology 1998; 61 (3): 253-268.
[18] Pohl HA. The Motion and Precipitation of Suspensoids in Divergent Electric Fields. Journal of Applied Physics 1951; 22 
(7): 869-871.
[19] Definition of Dipole. Oxford University Press. Oxford English Dictionary [online]. Available from: 
http://www.oxforddictionaries.com/definition/english/dipole
[20] Pohl HA, Hawk I. Separation of Living and Dead Cells by Dielectrophoresis. Science 1966; 152 (3722): 647-649.
[21] Pohl HA. Dielectrophoresis: The behaviour of neutral matter in nonuniform electric fields. Cambridge University Press. 
Cambridge, UK, 1978.
[22] Jones TB. Electromechanics of Particles. Cambridge University Press. Cambridge 1995.
[23] Hughes MP. Nanoelectromechanics in Engineering and Biology. CRC Press. Baton Rouge 2003.
50
[24] Pethig R, Kell DB. The passive electrical properties of biological systems: their significance in physiology, biophysics and 
biotechnology. Physics in Medicine and Biology 1987; 32 (8): 933-970.
[25] Muth E. Appearance of Pearl-Chain Formation of Particles in Emulsions Caused by Alternating Fields. Kolloidn Zhurnal 
1927; 41: 97
[26] Liebesny P. Athermic Short Wave Therapy. Archives o f Physical Therapy 1939; 19: 736-740.
[27] Schwan HP in Advances in Biological and Medical Physics. Lawrence JH, Tobias CA {Eds). Academic Press. New York, 
1957; VO 14: page 147.
[28] Pohl HA, Crane JS. Dielectrophoresis of Cells. BiophysicaiJournai 1971; 11: 711-727.
[29] Fricke H. The Complex Conductivity of a Suspension of Stratified Particles of Spherical or Cylindrical Form. Journal of 
Physical Chemistry 1955; 59:168-170.
[30] Pauly H, Packer L, Schwan HP. Electrical Properties of Mitochondrial Membranes. Journal of Biophysical and 
Biochemical Cytology 1960; 7 (4): 589-601.
[31] Schwan HP, Schwarz G, Maczuk J and Pauly H. On the Low-Frequency Dielectric Dispersion of Colloidal Particles in 
Electrolyte So\ut\on. Journal of Physical Chemistry 1962; 66 (12): 2626-2635.
[32] Hanai T, Koizumi N, Irimajiri A. A Method for Determining the Dielectric Constant and the Conductivity of Membrane- 
Bounded Particles of Biological Relevance. Biophysics of Structure and Mechanism 1975; 1: 285-294.
[33] Irimajiri A, Hanai T, Inouye A. A Dielectric Theory of "Multi-Stratified Shell" Model with its Application to a Lymphoma 
Cell. Journal of Theoretical Biology 1979; 78: 251-269.
[34] Jones TB, Kallio GA. Dielectrophoretic Levitation of Spheres and Shells. Journal of Electrostatics 1979; 6: 207-224.
[35] Benguigui L, Lin IJ. More about the dielectrophoretic force. Journal o f Applied Physics 1982; 53 (2): 1141-1143.
[36] Molinari G, Viviani J. Analytical evaluation of the electro-dielectrophoretic forces acting on spherical impurity particles 
in dielectric fluids. Journal o f Electrostatics 1978; 5:343-354.
[37] Benguigui L, Lin IJ. The dielectrophoresis force. The American Journal of Physics 1986; 54 (5): 447-450.
[38] Turcu I, Lucaciu CM. Dielectrophoresis: a spherical shell model. Voumo/ of Physics A: Mathematical and General 1989; 
22: 985-993.
[39] Gimsa J, Marszalek P, Loewe U and Tsong TY. Dielectrophoresis and electrorotation of neurospora slime and murine 
myeloma cells. Biophysical Journal 1991; 60: 749-760.
[40] Huang Y, Holzel R, Pethig R, Wang XB. Differences in the AC electrodynamics of viable and non-viable yeast cells 
determined through combined dielectrophoresis and electrorotation studies. Physics in Medicine and Biology 1992; 37 (7); 
1499-1517.
[41] Grosse C, Schwan HP. Cellular membrane potentials induced by alternating fields. Biophysical Journal 1992; 63:1632- 
1642.
[42] Weiss TF. Cellular Biophysics Volume 2: Electrical Properties. M IT Press. Massachuetts 1996.
[43] Grimnes S and Martinsen OG. Bioimpedance & Bioelectricity Basics. Academic Press. London 2000.
[44] Asa mi K. Characterisation of biological cells by dielectric spectroscopy. Journal of Non-Crystalline Solids 2002; 305: 268- 
277.
[45] Gascoyne PRC, Vykoukal J. Particle separation by dielectrophoresis. Electrophoresis 2002; 23:1973-1983.
[46] Huang Y, Joo S, Duhon M, Heller M, Wallace B, Xu X. Dielectrophoretic Cell Separation and Gene Expression Profiling on 
Microelectronic Chip Arrays. Analytical Chemistry 2002; 74:3362-3371.
[47] Ratanachoo K, Gascoyne PRC, Ruchirawat M. Detection of cellular responses to toxicants by dielectrophoresis. 
Biochimica et Biophysica Acta 2002; 1564:449-458.
51
[48] Gascoyne PRC, Pethig, Satayavivad J, Becker FF, Ruchirawat M. Dielectrophoretic detection of changes in erythrocyte 
membranes following malarial infection. Biochimica et Biophysica Acta 1997; 1323: 240 -250 .
[49] Huang Y, Wang XB, Becker FF, Gascoyne PRC. Membrane changes associated with the temperature -sensitive P85 
(gag-mos)-dependent transformation of rat kidney cells as determined by dielectrophoresis. Biochimica et Biophysica Acta 
1996; 1282: 76-84.
[50] Wang X, Becker FF, Gascoyne PRC. Membrane dielectric changes indicate induced apoptosis in HL-60 cells more 
sensitively than surface phosphatidylserine expression of DNA fragmentation. Biochimica et Biophysica Acta 2002; 1564: 
412-420.
[51] Hyun KA, Jung HI. Microfluidic devices for the isolation of circulating rare cells: A focus on affinity-based, 
dielectrophoresis, and hydrophoresis. Electrophoresis 2013; 34:1028-1041.
[52] Xu GL, Chan MB, Yang C, Sukumar P, Choolani M, Ying JY. Design and Fabrictaion of a Microfluidic Device for Fetal Cells 
Dielectrophoretic Properties Characterisation. Journal of Physics Conference Series 2006; 34:1106-1111.
[53] Gascoyne PRC, Noshari J, Anderson TJ, Becker FF. Isolation of rare cells from cell mixtures by dielectrophoresis. 
Electrophoresis 2009; 30:1388-1398.
[54] Gascoyne PRC, Wang X-B, Huang Y, Becker FF. Dielectrophoretic Separation of Cancer Cells from Blood. IEEE 
Transactions on Industry Applications 1997; 33 (3): 670-669.
[55] Becker FF, Wang X-B, Huang Y, Pethig R, Vykoukal J, Gascoyne PRC. Separation of human breast cancer cells from blood 
by differential dielectric affinity. Proceedings o f the National Academy o f Science USA 1995; 92:860-864.
[56] Becker FF, Wang X-B, Huang Y, Pethig R, Vykoukal J, Gascoyne PRC. The removal of human leukaemia cells from blood 
using interdigitated microelectrodes. Journal o f Physics D: Applied Physics 1994; 27: 2659-2662.
[57] Huang Y, Yang J, Wang XB, Becker FF, Gascoyne PRC. The removal of human breast cancer cells from hematopoietic 
CD34{+) stem cells by dielectrophoretic field flow fractionation. Journal o f Hematotherapy and Stem Cell Research 1999; 8; 
4 8 1 ^ 9 0 .
[58] Flanagan LA, Lu J, Wang L, Marchenko SA, Jeon NL, Lee AP and Monuki ES. Unique Dielectric Properties Distinguish 
Stem Cells and Their Differentiated Progeny. Stem Cells 2008; 26: 656-665.
[59] Velugotia S, Pells S, Mjoseng HK, Duffy CRE, Smith S, De Sousa P and Pethig R. Dielectrophoresis based discrimination of 
human embryonic stem cells from differentiating derivatives. Biomicrofluidics 2012; 6: 044113.
[60] Salimanzadeh A, Romero L, Shafiee, Gallo-Villanueva RC, Stremler MA, Cramer SD, Davalos RV. Isolation of prostate 
tumor initiating cells (TICs) through their dielectrophoretic signature. Lab on a Chip 2012; 12:182-189.
[61] Medoro G, Guerrieri R, Manaresi N, Nastruzzi C and Gambari R. Lab on a Chip for Live-Cell Manipulation. IEEE Design 
and Test o f Computers 2007; 24 (1): 26-36.
[62] Cetin B, Li D. Lab-on-a-chip device for continuous particle and cell separation based on electrical properties via 
alternating current dielectrophoresis. Electrophoresis 2010; 31:3035-3043.
[63] Chiou PY, Ohta AT, Wu MC. Massively parallel manipulation of single cells and microparticles using optical images. 
Nature 2005; 436: doi: 10.1038.
[64] Gascoyne P, Mahidol C, Ruchirawat M, Satayavivad J, Watcharasit P, Becker FF. Microscample preparation by 
dielectrophoresis: isolation of malaria. Lab on a Chip 2002; 2:70-75.
[65] Ng SY, Reboud J, Wang KYP, Tang KC, Zhang L, Wong P, Moe KT, Shim W, Chen Y. Label-free impedance detection of 
low levels of circulating endothelial progenitor cells for point-of-care diagnosis. Biosensors and Bioelectronics 2010; 25: 
1095-1101.
[66] Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LWMM, 
Hayes DF. Circulating Tumor Cells, Disease Progression and Survival in Metastatic Breast Cancer. The New England Journal 
o f Medicine 2004; 351: 781-791.
52
[67] Gupta V, Jafferji I, Garza M, Melnikova VO, Hasegav\/a DK, Pethig R, Davis DW. ApoStream™, a new dielectrophoretic 
device for antibody independent isolation and recovery of viable cancer cells from blood. Biomicrofluidics 2012; 6:024133.
[68] Swamy NVVJ, Westhaus PA. Tribute Biography: Professor Herbert A. Pohl. IEEE Transactions on Electrical Insulation 
1986; El-21 (5): 682.
[69] Burt JPH, Pethig R, Gascoyne PRC, Becker FF. Dielectrophoretic characterisation of Friend murine erythroleukaemic 
cells as a measure of induced differentiation. Biochimica et Biophysica Acta 1990; 1034:93-101.
[70] Gascoyne PRC, Huang Y, Pethig R, Vykoukal J, Becker FF. Dielectrophoretic separation of mammalian cells studied by 
computerised image analysis. Measurement Science and Technology Journal 1992; 3:439-445.
[71] Gascoyne PRC, Noshari J, Becker FF, Pethig R. Use of Dielectrophoretic Collection Spectra for Characterizing Differences 
between Normal and Cancerous Cells. IEEE Transactions on Industry Applications 1994; 30(4): 829-833.
[72] Cheng J, Sheldon EL, Wu L, Heller MJ, O'Connell JP. Isolation of Cultured Cervical Carcinoma Cells Mixed with Peripheral 
Blood Cells on a Bioelectronic Chip. Analytical Chemistry 1998; 70: 2321-2326.
[73] Labeed FH. Coley HM, Thomas H, Hughes MP. Assessment of Multidrug Resistance Reversal Using Dielectrophoresis 
and Flow Cytometry. BiophysicaiJournai 2003; 85: 2028-2034.
[74] Coley HM, Labeed FH, Thomas H, Hughes MP. Biophysical characterisation of MDR breast cancer cell lines reveals the 
cytoplasm is critical in determining drug sensitivity. Biochimica et Biophysica Acta 2007; 1770: 601-608.
[75] Chin S, Hughes MP, Coley HM, Labeed FH. Rapid assessment of early biophysical changes in K562 cells during apoptosis 
determined using dielectrophoresis. International Journal of Nanomedicine 2006; 1 (3): 333-337.
[76] Cristofanilli M, Krishnamurthy S, Das CM, Reuben JM, Spohn W, Noshari J, Becker F, Gascoyne PRC. Dielectric cell 
separation of fine needle aspirates from tumor xenografts. Journal o f Separation Science 2008; 31:3732-3739.
[77] Wu L, Yung LYL, Lim KM. Dielectrophoretic capture voltage spectrum for measurement of dielectric properties and 
separation of cancer cells. Biomicrofluidics 2012; 6:014113.
[78] Salmanzadeh A, Elvington ES, Roberts PC, Schmelz EM, Davalos RV. Sphingolipid metabolites modulate dielectric 
characteristics of cells in a mouse ovarian cancer progression model. Integrative Biology 2013; 5:843-852.
[79] GLOBOCAN 2012. International Agency for Research on Cancer [online]. Available from: 
http://globocan.iarc.fr/Pages/online.aspx
[80] Oral cancer incidence statistics. Cancer Research UK [online].Last updated: 11 June 2014. Available from: 
http://www.cancerresearchuk.org/cancer-info/cancerstats/tvpes/oral/incidence/
[81] Oral cancer mortality statistics. Cancer Research UK [online].Last updated: 8 September 2014. Available from: 
http://www.cancerresearchuk.org/cancer-info/cancerstats/tvpes/oral/mortalitv/
[82] ISD National Services Scotland. Trends in Cancer Survival in Scotland, 1983-2007. Available from: 
http://www.isdscotland.0rg/Health-Topics/Cancer/Cancer-Statistics/Head-and-Neck/#mouth
[83] Silverman S. Early Diagnosis of Oral Cancer. Cancer 1988; 62:1796-1799.
[84] Neville BD, Day TA. Oral Cancer and Precancerous Lesions. CA: A Cancer Journal For Clinicians 2002; 53:195-215.
[85] Neville BW, Damm DD, Allen CM, Bouquot JE. Oral & Maxillofacial Pathology. 2nd Ed. WB Saunders, Philadelphia 2002: 
pp 337-369.
[86] Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers: The outcomes, the trends, the challenge. 
Journal of the American Dental Association 2001; 132:7S-11S.
[87] Silverman S Jr. Epidemiology. In: Silverman SJr (Ed). Oral Cancer. 4th Ed. BC Decker Inc, Hamilton, Canada; 1998: pp 1- 
6.
[88] Das BR, Nagpal JK. Understanding the biology of oral cancer. Medical Science Monitor 2002; 8 (11): RA258-267.
53
[89] Bagan J, Sarrion G, Jimenez Y. Oral cancer: Clinical features. Oral Oncology 2010; 46:414-417.
[90] Barnes L, Everson JW, Reichart P, Sid ran sky D (ed). Pathology and genetics of head and neck tumours. lARC Press, Lyon, 
France; 2005.
[91] da Silva SD. Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Wolgar JA, Bradford CR, Rodrigo JP, Rinaldo A, Hier MP, 
Kowalski LP. Advances and applications of oral cancer basic research. Oral Oncology 2011; 47:783-791.
[92] Leemans ChR, Braakhuis BJM, Brakenhoff RH. Molecular biology of head and neck cancer. Nature Reviews Cancer 
2011;11: 9-22.
[93] Tanaka N, Sugihara K, Odajima T, Mimura M, Kimijima Y, Ichinose S. Oral squamous cell carcinoma: electron 
microscopic and immunohistochemical characteristics. Medical Electron Microscopy 2002; 35:127-138.
[94] National Centre for Biotechnology Information [online] Available from: http://www.ncbi.nlm.nih.gov.
[95] Geiger TR, Peeper DS. Metastasis mechanisms. Biochimica et Biophysica Acta 2009; 1796:293-308.
[96] Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastasis from squamous carcinoma of the oral 
cavity. Cancer 1990; 66:109-113.
[97] Ho CM, Lam KH, Wei Wl, Lau SK, Lam LK. Occult lymph node metastasis in small oral tongue cancers. Head Neck 1992; 
14: 359-363.
[98] Slaughter DP, Southwick HW, Smejkal W. "Field Cancerization" in Oral Stratified Squamous Epithelium: Clincial 
Implications of Multicentric Origin. Cancer 1953; 6 (5): 963-968.
[99] Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch W M  et al. Molecular Assessment of Histopathological Staging in 
Squamous Cell Carcinoma of the Head and Neck. The New England Journal o f Medicine 1995; 332 (7): 429-435.
[100] Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A Genetic Explanation of Slaughter's Concept of 
Field Cancerization: Evidence and Clinical Implications. Cancer Research 2003; 63:1727-1730.
[101] Day GL, Blot WJ. Second Primary Tumors in Patients with Oral Cancer. Cancer 1992; 70 (1): 14-19.
[102] Speight PM. Update of Oral Epithelial Dysplasia and Progression to Cancer. Head and Neck Pathology 2007; 1: 61-66.
[103] Speight PM, Farthing PM, Bouquot JE. The pathology of oral cancer and precancer. Current Diagnostic Pathology 
1996; 3:165-176.
[104] Reibel J. Prognosis of Oral Premalignant Lesions: Significance of Clinical, Histopathological and Molecular Biological 
Characteristics. Critical Reviews in Oral Biology and Medicine 2003; 14 (1): 47-62.
[105] Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of 
the oral mucosa. Journal o f Oral Pathology & Medicine 2007; 36: 575-580.
[106] Warnakulasuriya S. Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, 
utility, weaknesses and scope for improvement. Journal o f Oral Pathology & Medicine 2008; 37:127-133.
[107] Schwimmer E. Die idiopathischen Schleimhautplaques der Mundhohle (Leukoplakia buccalis). Archives of 
Dermatology and Syphilis 1877; 9: 570-611.
[108] Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. WHO Collaborating Centre for Oral Precancerous Lesions. Definition of 
leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surgery, Oral Medicine, Oral Pathology 1978; 46: 
518-539.
[109] Bouquot JE, Speight PM, Farthing PM. Epithelial dysplasia of the oral mucosa-Diagnostic problems and prognostic 
features. Current Diagnostic Pathology 2006; 12:11-21.
[110] van der Waal I, Schepman KP, van der MeiJ EH, Smeele LE. Oral Leukoplakia: a Clinicopathological Review. Oral 
Oncology 1997; 33 (5): 291-301.
54
[111] Waldron CA, Shafer WG. Leukoplakia Revisited: A Clinicopathological Study 3256 Oral Leukoplakias. Concer 1975; 36: 
1386-1392.
[112] Silverman Jr S, Gorsky M, Lozada F. Oral Leukoplakia and Malignant Transformation: A Follow-Up Study of 257 
Patients. Cancer 1984; 563-568.
[113] Queyrat L. Erythroplasie de gland. Bull Sac Franc Derm Syph 1911; 22: 378-382.
[114] Shafer WG, Waldron CA. Erythroplakia of the Oral Cavity. Cancer 1975; 36:1021-1028.
[115] Silverman S Jr, Gorsky M, Lozada-Nur F,Gianotti K, Francisco S. A prospective study of findings and management in 
214 patients with oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology 1991; 72:665-670.
[116] Barnard NA, Scully C, Eveson JW, Cunningham S, Porter SR. Oral cancer development in patients with oral lichen 
planus. Journo/ of Oral Pathology & Medicine 1993; 22:421-424.
[117] Eisenberg E. Oral lichen planus: A benign \es\on. Journal of Oral and Maxillofacial Surgery 2000; 58:1278-1285.
[118] van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and 
present concepts of management. Oral Oncology 2009; 45:317-323.
[119] Abbey LM, Kaugers GE, Gunsolley JC, Burns JC, Page DG, Svirsky JA et al. Intraexaminer and interexaminer reliability in 
the diagnosis of oral epithelial dysplasia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 
1995; 80 (2): 188-191.
[120] International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence 
in humans. Volumes 1 to 105*. Available from: http://monographs.iarc.fr/ENG/Classification/index
[121] Blot WJ. Alcohol and Cancer. Cancer Research 1992; 52: 2119s-2123s.
[122] Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin 5 et al. Smoking and Drinking in Relation 
to Oral and Pharyngeal Cancer. Cancer Research 1988; 48: 3282-3287.
[123] Ogden GR. Alcohol and oral cancer. Alcohol 2003; 35:169-173.
[124] Corrao G, Bargnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. 
Preventative Medicine 2004; 38: 613-619.
[125] Parkin DM. Cancers attributable to consumption of alcohol in the UK in 2010. British Journal o f Cancer 2011; 105:514- 
518.
[126] Tu rati F, Garavello W, Tramacere I, Pelucchi C, Galeone C, Bagnardi V et al. A Met-analysis of Alcohol Drinking and 
Oral and Pharyngeal Cancers: Results from Subgroup. Alcohol and Alcoholism 2013; 48 (1): 107-118.
[127] Hashibe M, Brennan P, Benhamou 5, Castellsague X, Chen C, Curado MP. Alcohol Drinking in Never Users of Tobacco, 
Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International head and 
Neck Cancer Epidemiology Consortium. Journal o f the National Cancer Institute 2007; 99: 777-789.
[128] Gandini S, Botteri E, lodice S, Boniol M, Lowenfields AB, Maisonneuve P, Boyle P. Tobacco smoking and cancer: A 
meta-analysis. International Journal of Cancer 2008; 122:155-164.
[129] Parkin DM. Tobacco-attributable cancer burden in the UK in 2010. British Journal o f Cancer 2011; 105: 56-513.
[130] Boffetta P, Hecht 5, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncology 2008; 9: 667-675.
[131] Sharan RN, Mehrotra R, Choudhury Y, Asotra K. Association of Betel Nut with Carcinogenesis: Revisit with a Clinical 
Perspective. PLoS ONE 2012; 7 (8): e42759.
[132] Jeng JH, Chang MC, Hahn U. Role of areca nut in betel quid-associated chemical carcinogenesis: currnt awareness and 
future perspectives. Oral Oncology 2001; 37:477-492.
[133] Trivedy CR, Craig G, Warnakulasuriya S. The oral health consequences of chewing areca nut. Addiction Biology 2002;
7:115-125.
55
[134] Thomas SJ, Bain G , Battistutta D, Ness AR, Paissat D, Maclennan R. Betel quid not containing tobacco and oral cancer: 
A report on a case-control study in Papua New Guinea and a meta-analysis of current evidence. InternationaiJournai of 
Concer 2007; 120:1318-1323.
[135] Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM  et al. Oral Cancer Risk in Relation to Sexual 
History and Evidence of Human Papillomavirus \nfect\on. Journal o f the National Cancer Institute 1998; 90 (21): 1626-1636.
[136] Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P et al. Human Papillomavirus and Oral Cancer: The 
International Agency for Research on Cancer Multicentre Study. Journal of the International Cancer Institute 2003; 95 (23): 
1772-1783.
[137] Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. Journal o f Clinical Virology 2005; 32S: S59-S66.
[138] Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human Papillomavirus Types in Head and Neck Squamous Cell 
Carcinomas Worldwide: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention 2005; 14 (2): 467-475.
[139] D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch W M  et al. Case-Control Study of Human Papillomavirus 
and Oropharyhngeal Cancer. The New England Journal of Medicine 2007; 356:1944-1956.
[140] Fahkry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H et a l . Improved Survival of Patients With Human 
Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial. Journal o f the National 
Cancer Institute 2008; 100 (4): 261-269.
[141] Ang KK, Harris J, Wheeler R, Weber R, Rosenthal Dl, Nguyen-Tan PF et al. Human Papillomavirus and Survival of 
Patients with Oropharyngeal Cancer. The New England Journal of Medicine 2010; 363: 24-35.
[142] Bragelmann J, Dagogo-Jack I, El Dinali M, Strieker T, Brown CD, Zuo Z et al. Oral cavity tumours in younger patients 
show poor prognosis and do not contain viral RNA. Oral Oncology 2013; 49: 525-533.
[143] Paget-Bailly S, Cyr D, Luce D. Occupational exposures to asbestos, polycyclic aromatic hydrocarbons and solvents, and 
cancers of the oral cavity and pharynx: a quantitative literature review. International Archives of Occupational and 
Environmental Health 2012; 85: 341-351.
[144] Pavia M, Pileggi C, Nobile GA, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: a 
meta-analysis of observational studies. American Journal of Clinical Nutrition 2006; 83:1126-1134.
[145] Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. 
Nutrition and Cancer 1992; 18 (1): 1-29.
[146] Gaudet M M , Olshan AF, Chuang SC, Berthiller J, Zhang ZF, Lissowska J et al. Body mass index and the risk of head and 
neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) 
Consortium. International Journal of Epidemiology 2010; 39:1091-1102.
[147] Scully C, Bagan JV, Hopper C, Epstein JB. Oral cancer: Current and future diagnostic techniques. American Journal o f 
Dentistry 2008; 21:199-209.
[148] Lingen MW , Kalmar JR, KarrisonT, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. 
Oral Oncology 2008; 44:10-22.
[149] Mouth Cancer: Referral Guides for GPs. Cancer Research UK. Available from: 
http://publications.cancerresearchuk.org/cancertvpe/mouth
[150] Cancer Screening Protocols. The Oral Cancer Foundation website. Available from: 
http://oralcancerfoundation.org/discoverv-diagnosis/screening.php
[151] Avon SL, Klieb HBE. Oral Soft-Tissue Biopsy: An Overview. Journal of the Canadian Dental Association 2012; 78: C75.
[152] Speight P, Jones A, Napier S. Tissue pathways for head and neck pathology: May 2014 (Document Number G077). 
Produced by the Royal College of Pathologists. Available from: http://www.rcpath.org/publications- 
media/publications/datasets/datasets-TP
56
[153] Helliwell T, Woolgar J. Dataset for histopathology reporting of mucosal malignancies of the oral cavity: Novermber 
2013 (Document Number G llO ). Produced by the Royal College of Pathologists. Available from: 
http://www.rcpath.org/publications-media/publications/datasets/datasets-TP
[154] Anderson J. An Introduction to Routine and Special Staining. Leica Biosystems [online]. Available at: 
http://www.leicabiosvstems.com/pathologvleaders/an-introduction-to-routine-and-special-staining/
[155] Grade and Stage of Mouth Cancers page. Cancer Research UK website. Last Updated: 22 March 2013. Available from: 
http://www.cancerresearchuk.org/about-cancer/tvpe/mouth-cancer/treatment/grade-and-stage-of-mouth-cancers
[156] Som PM, Curtin HD, Mancuso AA. An imaging-based classification for the cervical nodes designed as an adjunct to 
recent clinically based nodal classifications. Archives of Otolaryngology- Head & Neck Surgery 1999; 125:388-396.
[157] Robbins KT. Integrating radiological criteria into the classification of cervical lymph node disease. Archives of 
Otolaryngology- Head & Neck Surgery 1999; 125: 385-387
[158] Genden EM, Ferlito A, Silver CE, Takes RP, Suarez C, Owen RP et al. Contemporary management of cancer of the oral 
cavity. European Archives of Oto-Rhino-Laryngology 2010; 267:1001-1017.
[159] Bucci MK, Bevan A, Roach III M. Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond. CA 
Cancer Journal fo r Clinicians 2005; 55:117-134.
[160] Chemotherapy for head and neck cancer. Macmillan Cancer Support [online]. Available from: 
http://www.macmillan.org.uk/Cancerinformation/Cancertvpes/Headneck/Treatingheadneckcancers/Chemotherapv.aspx
[161] Mouth Cancer Homepage. British dental Health Foundation [online]. Available from: http://www.mouthcancer.org/
[162] Macpherson LMD, McCann MF, Gibson J, Binnie VI, Stephen KW. The role of primary healthcare professionals in oral 
cancer prevention and detection. British Dental Journal 2003; 195:277-281.
[163] Haughney MGJ, Devennie JC, Macpherson LMD, Mason DK. Integration of primary care dental and medical services: a 
three year study. British Dental Journal 1998; 184:343-347.
[164] Groome PA, Rohland SL, Hall SF, Irish J, Mackillop WJ, O'Sullivan B. A population-based study of factors associated 
with early versus late stage oral cavity cancer diagnoses. Oral Oncology 2011; 47: 642-647.
57
Chapter 2. Dielectrophoresis of Oral 
Ex Vivo Cells Collected using Brush 
Biopsies
2.1 Introduction
The work presented in this experimental chapter focuses upon the use of dielectrophoretic testing to 
characterise normal, dysplastic and cancerous ex vivo oral mucosal cells, collected by brush biopsies, 
for the purpose of determining if dielectrophoretic testing of oral brush biopsies could provide the 
basis of a non-invasive oral cancer identification kit.
This chapter begins with an introduction to the techniques and technologies which have been 
employed thus far in an attempt to aid early diagnosis of oral cancer, followed by details of the 
materials used in this study and the methods employed, the results of this study and a discussion of 
the implications of these results.
The work in this chapter is based on a manuscript submitted to and accepted (pending revisions) by 
the journal Cancer Epidemiology, Biomarkers and Prevention.
2,1.1 Toluidine Blue
Toluidine Blue (tolonium chloride) is a metachromatic dye, which stains tissues high in DNA and RNA 
content [1], and is therefore used to stain dysplastic and neoplastic tissues because they contain 
greater quantities of nucleic acids than normal tissue [2]. It can be used to demarcate the margins of 
cancerous and dysplastic lesions [2], and was used by Richart as a test for dysplasia and carcinoma in 
situ, for cervical cancers in 1963 [3]. Patients rinse their oral cavity with 1% acetic acid, then gargle 
touidine blue solution. Persistent blue stains are a positive result, and should be biopsied 
immediately or re-examined in the same manner 14 days later [4]. Dark blue staining is a positive 
result (i.e. indicative of dysplasia or neoplasia), light blue is classed as a doubtful result and no 
staining is a negative result (i.e. no tissue abnormality) [2].
In a study by Epstein and colleagues, 81 lesions from 46 patients with a mean age of 63.5 years, of 
whom 24 were men and 22 were women, were biopsied (using punch or wedge biopsies), regardless
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of level of toluidine blue staining [1]. The 81 lesions were identified in clinical examinations, of which 
48 were deemed "clinically suspicious" and 33 were deemed "clinically benign" [1]. Staining with 
toluidine blue was positive for 33 of 81 lesions, "equivocal" for 20 of 81 lesions, and no staining was 
observed for 28 of 81 lesions [1]. Histological examination was performed for all biopsy samples and 
resulted in samples being classed as benign, dysplastic (mild, moderate or severe), carcinoma in situ 
or invasive carcinoma [1]. There was no difference found in detection of mild-severe dysplasia for the 
conventional exam compared with the results of toluidine blue staining [1]. This suggests that 
toluidine blue is no more effective at detecting dysplasia than visual examination. The authors state 
that the specificity of both the clinical evaluation and toluidine blue staining was approximately 50% 
[1]. The sensitivity of the clinical evaluation was 78%, whilst the sensitivity of toluidine blue was 
100% [1], but these figures only refer to carcinoma in situ and invasive carcinoma. However, 
toluidine blue had a value for sensitivity for dysplasia, of 71% [1]. If all forms of dysplasia were to be 
considered as "abnormal" lesions, then the sensitivity (when considering both dysplasia and cancer 
as positive results) of toluidine blue in this study would have been 60%. It was of interest that the 
authors of the study chose to deem only carcinomas in situ and invasive carcinomas as positive 
histological results. Given that the sample population of patients all had histories of previous 
malignancies, early detection of dysplasia may have been of interest in these patients, and if so, 
would have required any form of dysplasia to be considered a histologically significant finding. Also, 
there were no study participants with no history of oral malignancies, to act as controls.
In another study, Zhang and colleagues sampled 100 lesions from 100 patients with "oral 
premalignant lesions" (OPLs), using toluidine blue staining and also performed biopsies and 
histological analysis. Of the 100 lesions, histopathology results showed 19 lesions to not be 
dysplastic, 64 lesions to present low-grade dysplasia and 17 lesions to present high-grade dysplasia 
[5]. From these lesions, toluidine blue stained positively for five of the non-dysplastic lesions, 15 of 
the low-grade dysplastic lesions and 16 of the high-grade dysplastic lesions [5]. Therefore, toluidine 
blue gave a positive result (stained) for 94% of high-grade dysplastic lesions, but only gave a positive 
result for 23% of low-grade dysplastic lesions. Therefore, the results of this study suggested that 
toluidine blue performed well when applied to severely dysplastic lesions, but did not make mild to 
moderately dysplastic lesions any more apparent than they would have been under visual 
examination. This study did however follow the progress of the 100 study participants for a period of 
44 + 26 months, with follow-up appointments and staining every six months, and found that 15 of 
the OPLs progressed to oral squamous cell carcinomas (OSCCs) [5]. Of the 15 OSCCs in total, 12 had 
stained with toluidine blue and three had not, and of the 100 OPLs in total, three of the 64 (5%)
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toluidine blue negative lesions developed into OSCC and 12 of the 36 (33%) toluidine blue positive 
lesions developed into OSCC [5], potentially showing that toluidine blue staining was an indicator for 
increased risk of malignant transformation. However, no results were given showing a comparison of 
toluidine blue results with results of visual clinical evaluation, therefore it cannot be determined, 
from this study, whether toluidine blue offered any advantages over the conventional oral 
examination.
2.1.2 Tissue Reflectance and Chemiluminescence
Chemiluminescence involves the use of a blue-white light source to illuminate areas of the oral cavity 
which contain abnormal lesions, following a rinse with 1% acetic acid [4]. Acetic acid is used to 
remove cell debris and possibly to dehydrate cells to allow better viewing of their nuclei, with cells 
which have a large nuclear to cytoplasmic ratio appearing "aceto-white", and normal tissue retaining 
a blue colouring [4].
2.1.2.1 Vizilite
Fa rah and McCullough conducted a pilot study to determine the efficacy of the Vizilite™ (Zila 
Pharmaceuticals, Phoenix, Arizona) chemiluminescence detection system, which the authors state, at 
the time of writing, was widely used in US dental practices despite a lack of evidence to support its 
use [6]. Fa rah and McCullough also state that the acetic acid rinsing agent, according to the 
manufacturers, is supposed to result in cytoplasmic dehydration, which in turn is meant to visually 
enhance leukoplakic lesions whilst making normal tissue appear dark with a blue tone [6]. The 
authors recruited 55 patients (26 males of mean age 56.81 + 2.2 years and 29 females of mean age 
58.7 + 2.47 years) attending a specialist oral medicine service for evaluation of an oral white lesion, 
over a three month period, to their trial [6]. Lesions were inspected by two oral medicine specialists, 
who conducted oral exams and digital palpation under incandescent light, using two dental mirrors 
and gauze [6]. This exam was then repeated using the Vizilite™ system, by getting patients to first 
rinse their mouths with 1% acetic acid solution for 60 seconds and then the light source (giving an 
output of 430-580 nm) was assembled, and the exam using Vizilite™ took place [6]. Biopsies were 
taken, under local anaesthesia from all lesions and subjected to routine histopathology [6]. Of the 
male participants, 13 were smokers, and there were eight female study participants who smoked [6]. 
The authors identified 55 primary lesions, and a further 25 satellite (small, secondary) lesions upon
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Visual examination of the oral cavities of the 55 patients [6]. Whilst the authors found that the 
Vizilite™ system obtained a marginally improved visibility of lesions, and defined the borders of a 
further 5-6% of lesions, compared with the oral examination, they also found that all lesions, 
regardless of type appeared "aceto-white" and that the system failed to distinguish between 
hyperplasia, inflammation, dysplasia and carcinoma [6]. Therefore, whilst achieving a sensitivity of 
100% (because all lesions, regardless of nature, appeared "aceto-white"), the system obtained a 0% 
specificity score and an accuracy score of 18.2%, and the authors concluded that there was little or 
no benefit in using this system [6]. The authors stated at the time of writing that the manufacturers 
were adding toluidine blue (toluidine chloride) to the system [6]. This product has since become 
commercially available as is marketed as Vizilite Plus.
The Vizilite® system which included TBIue (toluidine blue) was the subject of a study by Epstein and 
colleagues [7]. The authors recruited 84 patients, of mean age 59.64 + 12.53 years, to their study, 
who presented a total of 97 suspicious lesions, and these lesions were first examined by conventional 
oral exam under incandescent light, and then examined using the chemiluminescent light source 
(Vizilite®) after patients had rinsed their mouths for 30-60 seconds with 1% acetic acid solution [7]. 
Lesions were then successively swabbed with acetic acid and TBIue, and the lesions re-examined 
under incandescent light [7]. All lesions were then biopsied using punch or scalpel biopsies followed 
by histopathological assessment [7]. The authors state that following consultation with regulatory 
experts and medical experts, they deemed lesions which were mildly or moderately dysplastic as 
"non serious pathology", lesions demonstrating severe dysplasia, carcinoma in situ or squamous cell 
carcinoma (SCC) as "serious pathology" and lesions classed as benign were lesions showing no 
evidence of dysplasia [7]. The authors reported that of the 84 patients enrolled in this study, all of 
whom presented with a lesion, 79.8% had a prior, historic diagnosis of oral cancer or white lesions
[7]. Histopathological analysis confirmed that of the 97 lesions biopsied, 43 showed no dysplasia, 19 
were mildly dysplastic, 15 were moderately dysplastic, seven were severely dysplastic, four were 
carcinomas in situ and nine were squamous cell carcinomas (SCCs) [7]. There was no overall 
improvement found by using Vizilite® compared with the conventional exam, in terms of lesion 
brightness or sharpness, as brightness was reported as showing a slight or marked improvement for 
47% of lesions (excluded two lesions counted as "missing") and sharpness was reported as showing a 
slight or marked improvement for 46% of lesions (excluded two lesions counted as "missing") [7]. 
However, the authors report that chemiluminescence improved the brightness and sharpness of 
lesions in 61.86% of cases. They also report that 55% of severely dysplastic lesions, carcinomas in situ 
and SCCs were more visually apparent using the chemiluminescent exam [7], but it is difficult to
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verify this result, as brightness and sharpness data was not given in terms of lesion nature. The 
authors also report that the TBIue had 20 true positives (as there were 20 lesions classed as 
demonstrating "serious pathology", giving it a sensitivity of 100% [7]. However, of these 20 samples, 
ambiguous TBIue staining, rather than positive staining, was observed for three of the nine SCC 
lesions, one of the four carcinoma in situ lesions and one of the seven severely dysplastic lesions, 
meaning that TBIue positively identified 67% of SCCs, 75% of carcinomas in situ and 86% of severely 
dysplastic lesions. This was a point of interest, as TBIue appeared to be more able to correctly 
identify severe dysplasia than SCCs. For lesions which were mildly or moderately dysplastic, TBIue 
provided equivocal or negative stains for 58% and 53% of lesions, respectively [7]. The authors also 
stated that this study used Vizilite® and "the additive value of an application o f ... toluidine blue" [7], 
although no results were reported in terms of results using both Vizilite® and TBIue combined. It was 
also noted that the paper's conflict of interest statement named two of the listed authors as sitting 
on the advisory board of the company responsible for both the Vizilite® and TBIue products.
Awan, Morgan and Warnakulasuriya also conducted a study using the Vizilite™ system, to examine 
oral potentially malignant lesions (OPMLs) presented by 126 patients [8]. Lesions were examined 
visually under incandescent light, before the patients rinsed their mouths with 1% acetic acid 
solution [8]. The Vizilite™ light stick was then activated, emitting light of a wavelength 430-580 nm, 
and the examination using Vizilite™ took place [8]. Lesions were then sampled via surgical biopsies, 
and a histopathological assessment was conducted by three pathologists [8]. In total, 126 lesions 
were examined, of which 70 were erythroplakia/ leukoplakia, 32 were oral lichen planus, nine were 
chronic hyperplastic candidiasis, two were oral submucous fibrosis and 13 were frictional keratosis
[8]. For erythoplakic /  leukoplakic lesions, the authors found that chemiluminescence obtained a 
value of 77.1% for sensitivity and 26.8% for specificity, but the value for sensitivity dropped to 55.6% 
for erythroplakia [8], suggesting that chemiluminescence was less able to identify erythroplakic (red) 
lesions and better at identifying leukoplakic (white) lesions. The authors also found that whilst 
chemiluminescence correctly identified 77.3% of dysplastic lesions, non-dysplastic (i.e. benign) 
lesions were also stained aceto-white, leading to a specificity of 27.8% [8]. The authors detailed 
advantages of the Vizilite™ system, including ease of use, real-time results and a lack of operator 
variability, but listed a number of disadvantages, including high recurrent cost (for consideration for 
use in low-income countries) and an increase in salivation induced by the acetic acid solution which 
resulted in tissue reflectance [8]. The authors also discuss that their results were similar to those 
found by Fa rah and McCullough [6], but that a greater range of oral conditions were examined in this 
study, including erythroplakia, whilst Farah and McCullough's study was limited to examining
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leukoplakic lesions [8]. Awan and colleagues concluded by stating that the Vizilite™ system could not 
adequately discriminate between high and low risk OPMLs, and therefore caution should be 
exercised when using it [8].
2.1.2.2 Microlux DL
The Microlux DL system (AdDent Inc, Conneticut, USA) involves the patient rinsing their oral cavity 
with 1% acetic acid, then a dentist or other healthcare provider examining the oral cavity using the 
Microlux Transilluminator, which is a battery operated LED light source with attached glass DL 
Lightguide [9].
McIntosh and colleagues state that at the time of writing their paper, the claims by the manufacturer 
of Microlux DL that it could help locate oral tissue which was abnormal in nature by making 
"irregular" cells more apparent, were unsubstantiated [10]. In this study, the authors examined 50 
"clinically suspicious" white oral lesions in 50 patients of average age 56.6 years, 23 of whom were 
male and 27 of whom were female [10]. For all lesions, conventional oral exams with digital 
palpation were performed under incandescent light and using two dental mirrors and gauze [10]. 
Following the conventional oral exam, the authors used the Microlux DL system, first without the 1% 
acetic acid rinse and then with the acetic acid rinse, and then used an LED headlight, to examine the 
lesions [10]. Incisional biopsies followed by histopathological assessment were performed for all 
lesions, and dysplasia was considered to be a positive indicator of disease [10]. The authors found 
the sensitivity of the Microlux DL system to be 77.8% and the specificity to be 70.7%, and found that 
it increased the lesion border distinction, compared with distinction gained using the conventional 
oral exam (70% versus 52%, respectively of lesions with distinct borders) [10]. However, they found 
that the acetic acid rinse offered little improvement over the lesion enhancement offered by the 
Microlux DL light component alone, that the glass diffuser affixed to the Microlux DL light source did 
not appear to perform any task other than to make the light "softer", and that the LED headlight 
offered a better view of the area of interest, enhanced lesion border distinction and enhanced lesion 
visibility better than the Microlux DL, and that both emitted the same wavelengths of light [10]. The 
group also found that the Microlux DL had a positive predictive value of 36.8% and was poor at 
distinguishing between malignant lesions, potentially malignant lesions and benign lesions [10]. The 
conclusion of the authors was that there was a lack of evidence in support of using the Microlux DL 
as an adjunct to the conventional oral exam [10].
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2.1.3 Raman Spectroscopy
Raman spectroscopy involves an inelastic scattering (i.e. photons of light have different frequencies 
after interaction with a sample) of monochromatic light, often provided by a laser [11].
The "Raman effect" is named after the Indian physicist Sir Chandrasekhara Venkata Raman, who 
published observations on this effect in 1928, and occurs when photons of light incident on 
molecules, rather than being scattered with an unchanged energy level, are scattered with a 
different energy level due to the molecules they are incident upon giving or taking energy from the 
photons [12]. This results in the scattered photons having a different wavelength to the original light 
beam [12]. When incident upon a sample, the laser light source induces a dipole moment and 
deforms molecules, which in turn causes vibration at a certain frequency [11]. When the molecule 
emits photons of the same frequency as those from the source, Raleigh scattering occurs, which is 
the case on 99.999% of occasions [11]. When the molecule emits photons of a lower frequency than 
those from the source (i.e. the molecule receives some of the energy from the photon), this is called 
Stokes scattering [11]. When the molecule emits photons of a higher frequency than those from the 
source (i.e. the molecule gives the photons energy), this is called anti-Stokes scattering [11]. Stokes 
and anti-Stokes scatter only occurs in 0.001% of cases, so filters are often used to distinguish these 
signals from those resulting from Raleigh scatter [11].
Li and colleagues used Fourier transform near infrared (FT-NIR) Raman spectroscopy to test ex vivo 
tissue samples, obtained via biopsy, from 58 OSCC patients and 32 oral leukoplakia (OLK) patients, as 
well as samples deemed to be normal oral mucosa, from the surgical margins of OSCC lesions from 
28 patients [13]. All samples were examined by histopathologists, and in total the group tested 60 
OSCC samples, 64 OLK samples and 62 normal samples [13], suggesting more than one sample was 
obtained and tested for participants from the OLK and normal groups. The authors did not appear to 
report the results for all of these samples considered together rather, they used 40 samples from  
each of the three groups as training sets and used 20 OSCC samples, 24 OLK samples and 22 normal 
samples to form a calibration set [13]. The sensitivities and specificities for OSCC versus normal and 
OSCC versus all leukoplakia types were good for the training set and the calibration set (all were 
above 90%) [13]. However, the sensitivity of the training set, when considering OLK versus normal 
tissue, dropped to 68% and obtained a value for specificity of 85%. This value of sensitivity increased 
to 72% when intermediate and high-grade hyperplasia was considered within the OLK group, but the
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specificity decreased to 81.8% [13]. For the calibration test group for OLK versus normal, the 
sensitivity achieved was 71.4% and the specificity was 83.3% [13]. These results suggest that FT-NIR 
Raman spectroscopy can distinguish between OSCC and normal tissue well, but is less able to 
distinguish between OLK tissue and normal tissue. However, this could either be due to a lack of 
sensitivity of the system to the differences between leukoplakic tissue and normal tissue, or because 
the normal tissue collected from tumour margins was of varying degrees of normality, due to the 
effects of field cancérisation.
Singh and colleagues stated that most cases of second primary tumours (SPTs) in the oral cavity are 
considered inoperable, and therefore treatment for patients with SPTs is often palliative [14]. The 
authors state that identification of cancer-field-effects (CFEs) and malignancy-associated-changes 
which precede SPTs could prove to be a screening aid and in their study, using non-invasive Raman 
spectroscopy to study cancerous lesions, tissue which appeared normal but was contralateral to a 
tumour, tissue from healthy controls with no existing cancer and no tobacco habit, tissue from 
participants with no existing cancer but a tobacco habit, and tissue from participants with no tobacco 
habit but who had a diagnosis of cancer [14]. In total, 84 participants were recruited to the study. 
From 40 participants with tobacco-associated OSCC lesions of the buccal mucosa, 192 Raman spectra 
were collected from the OSCC lesions and 170 from sites contralateral to these lesions [14]. The 
groups composed of healthy control participants with no tobacco habit and healthy participants with 
a tobacco habit, had 15 participants each, and 150 Raman spectra were collected from each of these 
groups [14]. Spectra (60 of) were also recorded from a group 14 participants with no tobacco habit, 
from tissue contralateral to an OSCC lesion [14]. Spectra were obtained, after participants had rinsed 
their mouths with distilled water, using a commercially-available Raman spectrometer, which 
consisted of a diode laser of wavelength output 785 nm, a charge-coupled device and a 
spectrograph, and these spectra were averaged for each of the five tissue groups [14]. The authors 
found that spectra from healthy controls demonstrated high lipid content, whilst spectra from OSCC 
lesions showed high protein content, loss of lipids, but showed the presence of DNA and 
haemoglobin [14]. The group also used "leave-one-spectrum-out- cross-validation" (LOOCV) 
algorithms for pattern recognition, and found that LOOCV was less effective at correctly recognising 
the group that the tissue had come from, and that the Raman system overall could correctly identify 
OSCC lesions in 86.5-93.8% of cases, healthy control tissue in 96-98.7% of cases and normal tissue 
contralteral to an OSCC lesion in non-smokers in 86.7%-90% of cases, but was less able to identify 
contralateral normal tissue consistently correctly (69.4%-84.1%), and healthy tissue from participants 
with smoking habits (68.7%-82%) [14]. It could be seen as difficult to truly assess the performance of
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this system, given that the authors did not detail what was done in the case of normal tissue which 
was classed by the system as tumour tissue, i.e. had the system identified suspicious tissue which 
appeared to be normal upon visual examination, or not. Also, no explanation was given as to why 
approximately 10 spectra were collected per participant.
Valdez and colleagues described Raman spectroscopy as a measure of inelastic scattering of light 
following excitation using a monochromatic laser source, and state that Raman spectra are 
"fingerprints" of molecular vibrations, which are in turn related to chemical bonds, and that the 
Stokes region of the spectra is the area of biochemical significance [15]. The authors also state that 
the problem of tissue autofluorescence, which can interfere with Raman spectra and has been 
detailed as a disadvantage of using Raman spectroscopy, is avoided by using near-infrared lasers 
[15]. Another point the authors note is that whilst Raman spectroscopy has been used to study 
malignant changes of the breast, blood, stomach and lung, among others, the studies on head and 
neck squamous cell carcinomas, of which oral squamous cell carcinomas are just one type, are few  
[15]. In their study, the authors recorded five Raman spectra for each ex vivo tissue sample, gained 
by biopsy, and averaged these five spectra together to give one, mean spectrum [15]. Tissue biopsies 
were received from 24 male Otolaryngeal patients aged 54-66 years, with no squamous cell 
carcinoma who smoked more than 20 cigarettes per day and consumed more than 20 g of alcohol 
per day (approximately 25 ml or 2.5 units of pure alcohol [16]) [15]. Five biopsies were collected from 
male squamous cell carcinoma patients, aged 50-60 years, with the same alcohol and tobacco habits 
as the control group [15]. The group found that Raman spectroscopy results showed that the protein 
index of carcinoma tissue was significantly greater than that of healthy tissue (1.20 + 0.10 versus 0.87 
+ 0.09), that the lipid index of healthy tissue was significantly greater than carcinoma tissue than for 
healthy tissue (0.20 + 0.02 versus 0.14 + 0.02) and that the phenylalanine index was significantly 
greater for carcinoma tissue than healthy tissue (19.1 + 1.9 versus 10.0 + 0.7) [15]. These results 
suggested that carcinoma tissue contained more proteins and phenylalanine than healthy tissue, and 
that healthy tissue had a higher lipid content that carcinoma tissue, which placed these results in line 
with the literature, according to the authors [15]. The authors also found that their Raman 
spectroscopy system accurately assessed 91.3% of healthy tissue as being healthy tissue and 89.3% 
of carcinoma tissue as being carcinoma tissue [15]. Whilst there were a limited number of carcinoma 
biopsy samples tested using Raman spectroscopy, the authors make it clear that this is a pilot study, 
thus suggesting that this is a preliminary finding and whilst the control group could be considered not 
to be "healthy", given they were undergoing surgery and general anaesthesia for investigation of
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"other ailments", it would have been questionable ethically for participants who were judged to be 
truly healthy, to have tissue extracted surgically under general anaesthesia.
2.1.4 Electrical Impedance Sensing
Arias and colleagues used electric cell-substrate impedance sensing (EClS), where biological cells are 
cultured on an electrode surface, to study the cellular properties of oral cancer cells, including the 
reaction of said cells to nicotine and cisplatin (an anti-cancer drug) [17]. The authors cite Giaever and 
Keese as being the first to use impedance to study adherent cell lines in 1984 [17], in which they 
were able to continuously monitor the behaviour of fibroblasts by culturing them on gold electrodes 
and exposing them to oscillating electric fields which were externally supplied [18].The authors used 
a tongue OSCC cell line CAL27 and seeded them at 5000 cells per well in 16-well E plates (each well 
contained an array of circle-on-line microelectrodes) for 20 hours, having been treated with either 
cisplatin only, or cisplatin and nicotine (to test the anti-apoptotic effects of nicotine), at 
concentrations of 5 ,1 0 ,1 5 , 20 and 25 pM for cisplatin and 0.1, 0 .5 ,1 , 5 and 10 pM nicotine [17].
Cells not treated with cisplatin or nicotine were seeded at a variety of concentrations [17]. The 
authors found that 10% cell coverage of electrodes (found to be greater than 1000 cells per well and 
slightly less than 5000 cells per well) was needed to gain an impedance-based cell index [17]. The 
authors showed that treatment with 5 pM cisplatin was evident using EClS after 20 hours, but when 
15, 20 and 25 pM of cisplatin were used, cell index, which was indicative of the concentration of 
cells, dropped 1-3 hours post-treatment [17]. Changes in morphology resulting from treatm ent using 
20 pM cisplatin were not evident visually until 5 hours after treatment [17], suggesting that EClS 
detected changes associated with apoptosis before they were visually apparent. The authors also 
found that 18 hours after adding 0.1 pM nicotine and 20 pM cisplatin, the oral cancer cells showed 
no difference compared with 20 pM cisplatin treatment alone, but upon using 0 .5 ,1  and 5 pM  
nicotine, the apoptotic effects of cisplatin seemed to be reduced, as the cell index increased [17].
Sun and colleagues [19] also used bioimpedance to study tongue OSCC and normal tongue tissue, but 
conducted in vivo measurements rather than measurements of cells cultured on microelectrodes, 
such as those used for electric cell-substrate impedance sensing. In their study. Sun and colleagues 
recruited 12 tongue cancer patients of mean age 51 + 5 years, seven of whom were men and five of 
whom were women, and 12 healthy subjects of mean age 48 + 6 years, six of whom were men and 
six of whom were women [19]. Impedance measurements were made using disposable probes, 
consisting of four, one millimetre in diameter silver electrodes, arranged in a square configuration on
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a plastic bar, attached to an impedance analyser [19]. For each participant tested, measurements 
were recorded for two tongue sites [19]. For OSCC patients, one recording was taken whilst the 
electrodes were on the cancerous lesion and the second sample was taken from a tongue location 10 
mm from the OSCC lesion (this sample was deemed to be healthy) [19]. For healthy participants, the 
second sample was also taken from a tongue location 10 mm from the first sample [19]. A voltage of 
200 mV and frequencies of 20 Hz, 50 kHz, 1.3 MHz, 2.5 MHz, 3.7 MHz and 5 MHz were applied to the 
tissue at each tongue site, for each participant, and a total of three tests were performed (i.e. one 
test was one run of all the frequencies listed) for each sample [19]. Oral temperatures pre and post 
test were also recorded for each participant, and no significant differences were found for any 
participant in terms of their pre and post test temperature, with the temperature range for both 
being 36.6-36.8°C, therefore temperature was not considered to affect impedance measurements 
[19]. The authors found that impedance decreased with increasing frequency for both normal tongue 
tissue and cancerous tongue tissue, and found that cancerous tongue tissue achieved significantly 
lower impedance values than both normal samples from OSCC patients and from samples (both) 
from healthy participants, at 20 Hz and 50 kHz, and attributed this as possibly being a result of 
cellular arrangement in the superficial layer differing from normal to cancerous tissue [19].
Liju Yang was again one of the authors of a study examining the properties of CAL27 oral cancer cells 
cultured on an electric cell-substrate impedance sensing (EClS) microelectrode system. In this study, 
Mamouni and Yang looked specifically at the resistance and capacitance components of CAL27 OSCC 
cells and non-cancerous Het-IA  oral epithelial cells, using interdigitated microelectrodes composed 
of 50,15  pm wide finger electrodes with 15 pm spaces between them [20]. Electrochemical 
impedance sensing (EIS) tests were performed in one of two types of media, cell culture medium or 
0.1 M PBS with 50 mM [Fe(CN)g]^"^% and a frequency range of 10 Hz-1 MHz was used at amplitudes 
of + 50 mV, at room temperature [20]. The authors found that cellular capacitance for oral cancer 
cells was much lower than that for normal oral epithelial cells (184.4 pF versus 640.8 pF), but that 
cellular resistance of oral cancer cells was greater than that of normal oral epithelial cells (99.08 Q 
versus 25.46 Q), and found that the redox probe [Fe(CN)6]^”'^ '‘“ should not be used for continuous 
measurement tests [20].
2.1.5 Tissue Fluorescence and Autofluorescence Spectroscopy
Tissue components such as elastins, collagens and keratins are endogenous fluorophores (i.e. they 
naturally fluoresce), and fluoresce when exposed to a high intensity light source [4]. Factors such as
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increased thickness of the epithelium, and altered collagen content and vascularity therefore alter 
the fluorophore concentration [4].
In a review of the use of autofluorescence spectroscopy in oral oncology. De Veld and colleagues cite 
the work of Profio and colleagues on bronchial fluorescence for lung tumour localisation in 1977 as 
discovering that endogenous (naturally occurring) fluorescence could be used for cancer detection 
[21]. The authors also state that the concentration of fluorophores can be altered by disease, nuclear 
size, epithelial thickness, collagen content and blood concentration [21].
De Veld and colleagues also conducted a study, in which they examined the autofluorescence of 88 
benign, 11 dysplastic and 16 cancerous lesions from 155 patients, and the autofluorescence of 
normal oral tissue from 70 healthy volunteers, and biopsies were performed for all dysplastic and 
cancerous lesions [22]. The group found, using the in vivo fluorescence testing system they 
presented, that they achieved a sensitivity of 89% and a specificity of 71% when distinguishing 
between lesions (benign, dysplastic and cancerous combined) and healthy oral tissue [22]. However, 
they found that they were less able to distinguish between dysplastic/ cancerous lesions and benign 
lesions, with the area under the receiver operating characteristic (ROC) curve being less than 0.65, 
and concluded from their results and those they found in literature, that correctly identifying lesion 
types (i.e. as benign, dysplastic and cancerous) was not possible [22].
Ingrams and colleagues conducted a study on the autofluorescence properties of healthy tissue and 
benign, dysplastic and cancerous oral tissue, all collected via biopsy, however in this study, the 
authors combined normal tissue and benign lesions and classed them as normal, and combined 
dysplastic and cancerous lesions and classed them as abnormal [23]. Healthy samples were collected 
from patients undergoing biopsies for suspicious lesions, from a corresponding anatomical site which 
was deemed to be normal on visual inspection [23]. All biopsies underwent histopathological analysis 
[23].The system the group used produced excitation spectra of 250-500 nm and collected emission 
spectra of 350-700 nm [23]. The group found that differences between normal and dysplastic tissue 
were most marked at an excitation wavelength of 410 nm, and found that they achieved a sensitivity 
of 90% and a specificity of 91% when distinguishing between normal/benign tissue and dysplastic/ 
cancerous tissue [23]. However, no details were given on the grade of dysplastic lesions or cancerous 
lesions.
Wang and colleagues also used tissue which had previously been extracted via biopsy in their study 
on autofluorescence of oral tissue, and studied 16 cancerous tissue samples and 16 corresponding 
patient-matched normal tissue samples [24]. Using excitation wavelengths of 280-340 nm, they
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found emission peaks at wavelengths in the range 330-470 nm, and found that they achieved a 
sensitivity of 81.25% and a specificity of 93.75% when they used a pair of excitation wavelengths 
(280 nm and 330 nm) when distinguishing between normal tissue and oral cancer tissue [24].
Gillenwater and colleagues conducted an in vivo study examining the fluorescence spectra of healthy 
oral tissue from eight non-smoking, healthy volunteers and from 12 patients with pre-malignant/ 
cancerous oral tissue (from whom patient-matched normal samples were tested) and found that 
they achieved a sensitivity and specificity of 94.1% and 100%, respectively when distinguishing 
between abnormal and normal oral tissue, using excitation wavelengths of 337 nm and 410 nm [25]. 
In this study, mildly, moderately and severely dysplastic lesions were used, and the authors stated 
that sample sizes were small [25].
Müller and colleagues used a combination of intrinsic fluorescence, diffuse reflectance and light 
scattering spectroscopy, called trimodal spectroscopy, to distinguish between 19 dysplastic /1 2  
cancerous tissue samples and 16 normal tissue samples from 15 patients with known malignancies 
and from 38 samples from eight healthy volunteers, in vivo [26]. Biopsies were performed on all 
tissue types from patients with malignancies, but not from healthy volunteers. The group found, 
when using optical fibres to deliver excitation wavelengths and collect emission wavelengths, that 
the sensitivity and specificity of trimodal spectroscopy were 96% and 96% respectively, for 
dysplastic/ cancerous versus normal tissue and achieved a sensitivity and specificity of 64% and 90% 
respectively for dysplastic versus cancerous tissue [26]. The results of this study show that this form 
of fluorescence spectroscopy is less able to distinguish the true nature of dysplastic samples, and no 
information was given as to how well the system could distinguish between dysplastic and normal, or 
dysplastic and benign lesions.
Rahmen and colleagues used a modified commercially available LED headlight, optical filters and a 
CCD camera to create a portable fluorescence spectroscopy unit for in vivo testing [27]. They 
sampled 261 sites in 76 patients and 90 sites from 33 healthy volunteers, and found that using 
differences in blue fluorescence intensity, the sensitivity and specificity were 92% and 84% 
respectively, and using differences in green to red fluorescence intensity, the sensitivity and 
specificity were 90% and 87% respectively, for neoplastic versus non-neoplastic tissue [27].
However, the group found that benign lesions demonstrating melanosis lost fluorescence, 
complicating results (though these lesions, according to the authors, were more apparent as being 
benign under white light), and biopsies were not performed on all samples from patients [27].
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Schwarz and colleagues also developed a portable fluorescence microscopy detection kit, using LEDs 
to produce excitation at a wavelength of 385 nm [28]. Tissue of 28 patients, just prior to surgery, was 
sampled and punch biopsies were collected from suspicious/ cancerous lesions and from tissue 
which appeared to be normal from a contra-lateral site, with normal and benign lesions classed here 
as normal [28]. Using this system, the authors achieved values for sensitivity and specificity of 84% 
and 91% respectively when testing non-keratinised oral tissue sites and values for sensitivity and 
specificity of 86% and 83% respectively when testing keratinised oral tissue sites [28].
2.1.5.1 VELscope
Within fluorescence spectroscopy, the VELscope™ device (LED Medical Diagnostics Inc, Georgia USA), 
specifically, has received much attention with regards to its potential use for distinguishing normal, 
benign, dysplastic and carcinoma oral tissue. Visually Enhanced Lesion Scope, or VELscope™ as it is 
better known, is a portable unit with a hand-held scope (see Figure 2.1) [4]. The scope emits a light of 
wavelength 400-460 nm (i.e. blue coloured light), which makes normal tissue appear pale green in 
colour and abnormal (dysplastic or neoplastic) tissue appear dark, due to a lack of fluorophores [4]. 
Abnormal tissue fluorescence patterns can be caused by increased vascularisation, breaking of 
collagen links in the connective tissue layer, the presence of light absorbing pigments and increased 
epithelial metabolic rate [29].
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Figure 2.1: Image showing the VELscope Vx handheld visual enhancement tool by LED Medical Diagnostic Inc. Image 
courtesy of Introducing the VELscope VX product document, available from 
http://www.velscope.com/education/downloads-center/
A paper which appeared to introduce the VELscope™ device was that by Lane and colleagues, which 
described VELscope being used in a pilot study to examine dysplastic and squamous cell carcinoma 
(see) lesions from 44 patients [30]. The authors state that the system is composed of a metal-halide 
arc lamp, which produces near UV/ blue light and an emission filter which rejects the blue emission 
light and accepts red and green light [30]. When the VELscope™ was focused upon normal oral 
mucosa, the tissue appeared pale green, but abnormal tissue appeared dark green or black [30]. All 
44 of the study participants had dysplastic and SCC lesions which had previously been biopsied and 
during a follow-up visit, all lesions were first examined using what the authors described as "white 
light", then using the fluorescence visualisation system (VELscope™), and then biopsied again with 
subsequent histopathological evaluation [30]. From these 44 patients, 50 lesions were examined 
using fluorescence visualisation and biopsied [30]. Of these 50 lesions, 33 were invasive SCCs, 11 
were severely dysplastic or carcinomas in situ, and six were ruled as normal tissue [30]. Fluorescence 
visualisation was lost (i.e. the tissue appeared dark green or black, indicating abnormality) for all 33 
invasive SCC lesions and 10 of the 11 severely dysplastic/ carcinoma in situ lesions, whilst none was 
lost (i.e. the tissue was pale green, indicating normal tissue) for all six of the normal samples [30]. 
These results gave fluorescence visualisation using VELscope™ a sensitivity of 98% and a specificity of 
100% [30]. The authors stated that this device targeted fluorescence from the cellular metabolism
72
indicator flavin adenine dinucleotide (FAD), as FAD fluorescence occurs at 450 nm and 515 nm, but 
also stated that the greatest loss of fluorescence is thought to result from damage to and destruction 
of the extracellular matrix, due to disruption of collagen fibres (which are thought to fluoresce 
strongly when excited by light of 410-470 nm and produce emission spectra ranging from 475-540  
nm), and increased haemoglobin content resulting in absorption of light at 420 nm [30]. No mildly or 
moderately dysplastic or benign lesions were sampled in this study, and no details were supplied as 
to whether lesions were erythroplakic or leukoplakic. Also, no details were given as to whether the 
system here could distinguish between severely dysplastic lesions, carcinomas in situ or invasive 
SCCS. However, the authors do state that this is a pilot study, and it also appears to be a "proof of 
concept" study for the use of this fluorescence visualisation device, which would be later know as 
VELscope™, therefore, the paper introduces the VELscope™ system and verifies that it can distinguish 
between severely abnormal tissue and normal tissue, therefore Justifying additional research into its 
potential use for oral cancer detection.
Just as they did for the Vizilite ™ system [8], Awan, Morgan and Warnakulasuriya conducted a study 
into the efficacy of the VELscope™ device for the detection of oral potentially malignant lesions 
(OPMLs) and benign lesions [31]. In total, 126 lesions from 126 patients with suspect lesions, were 
examined in this study, of which 70 were erythroplakia or leukoplakia, 32 were oral lichen planus or 
lichenoid reaction, 13 were frictional keratosis, nine were chronic hyperplastic candidiasis and two  
were oral submucous fibrosis [31]. All lesions were first examined under incandescent light, then 
using the VELscope, the outcome of which, as defined by the manufacturers (LED Medical Diagnostics 
Inc.), could be either fluorescence visualisation loss (FVL) or fluorescence visualisation retention 
(FVR) [31]. Biopsies were also performed on lesions from 116 patients (though the authors do not 
state what the lesion types were from the 10 patients who did not undergo surgical biopsy) and 
histopathological assessments were performed by an oral pathologist [31]. Awan and colleagues 
found that the sensitivity and specificity of VELscope™ for leukoplakic/ erythroplakic lesions were 
87.1% and 21.4% respectively and FVL was 100% for erythroplakic lesions, however 78.6% of benign 
lesions also showed FVL (hence the specificity value of 21.4%), with 69.2% of frictional keratosis 
showing FVL [31]. These results suggested that unlike the Vizilite™ system, VELscope™ was able to 
identify erythroplakic lesions, but it was unable to differentiate inflammation from leukoplakia/ 
erythroplakia. For lesions which were mildly, moderately or severely dysplastic, the group found the  
sensitivity and specificity of the VELscope™ system to be 84.1% and 15.3% respectively, with five of 
the seven dysplastic lesions which showed FVR being mild in nature and the remaining two being 
moderate [31]. These results tend to suggest that the VELscope™ system could identify severely
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dysplastic lesions well, but could neither identify nor distinguish between mildly dysplastic, 
moderately dysplastic and benign lesions, as 84.7% [31] of benign lesions showed FVL. The authors 
also compiled a list of advantages and disadvantages of the VELscope™ system [31]. They listed ease 
of use, non-invasiveness, production of real-time results and no requirement for reagents as 
advantages, but listed high initial set-up costs and low specificity for dysplasia, as disadvantages [31]. 
The authors concluded by stating that additional studies were required to examine the role 
VELscope™ could play in primary care settings [31].
Similarly, just as they did for Vizilite™ [6] and Microlux DL [10], Fa rah and colleagues also conducted 
a study to evaluate the use of VELscope for detection of suspicious oral lesions [32], however the 
authors also examined erythroplakic lesions in this study, unlike in their previous studies. In this 
study. Fa rah and colleagues examined lesions which were white or a mixture of white and red and 
were deemed by general practitioners as suspicious, presented by 112 patients over a six month 
period, with the proviso that none of these patients had been diagnosed as cases of dysplasia or 
squamous cell carcinomas (SCCs) [32]. Conventional oral exams (COEs) were performed (visual exam 
with digital palpation) under incandescent light, followed by examination using VELscope™ [32]. 
Lesions for which autofluorescence was lost were classed as positive results and lesions for which 
autofluorescence was retained were classed as negative results [32]. Following COE and VELscope 
examinations, all lesions were biopsied under local anaesthesia for histopathological examination 
[32]. Of the 112 patients who presented with suspicious lesions, 46 were men of mean age 57.8 + 
11.88 years and 66 were women of mean age 59.08 + 12.8 years [32]. The authors found that 
VELscope™ enhance the visual appearance of 41 lesions, but not so as to distinguish between benign 
and dysplastic lesions, but that VELscope™ did reveal five lesions which were not detected by COE, 
one of which was found to be moderately dysplastic [32]. Fa rah and colleagues found that the 
sensitivity and specificity of VELscope™ were 30% and 63% respectively, the sensitivity and specificity 
of the COE were 25% and 82% respectively, and that examination combining the COE and VELscope™ 
provided a sensitivity of 46% and a specificity of 68% [32]. When considering COE alone, VELscope™ 
alone and a combination of both COE and VELscope, the authors found the COE to be the most 
accurate exam method at 69%, with a combination of COE and VELscope™ achieving an accuracy of 
63%, and VELscope™ achieving an accuracy of 55% [32]. The authors found that VELscope™ 
overestimated the number of lesions it deemed abnormal, and could not distinguish between 
benign, inflamed, dysplastic and malignant lesions, and stated that clinical interpretation of 
blanching was problematic [32]. The authors concluded by stating that VELscope™ was useful, but
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failed to distinguish between benign lesions, potential malignancies and malignancies, when used by 
trained oral specialists [32].
In a study by Scheer and colleagues, lesions from 64 patients (39 of whom were male and 25 of 
whom were female, with a mean age of 59.8 years) were examined using both a standard oral exam 
and VELscope™, with lesions for which fluorescence visualisation loss (FVL) was encountered being 
ruled as dysplastic or malignant [33]. Of the 64 patients, 20 had previously been diagnosed with oral 
cancer, and all lesions were biopsied and histopathological assessments were subsequently 
performed, following VELscope™ examination [33]. The authors stated that as 20 of the 64 patients 
were high-risk cases due to prior history of oral cancer, the results from their study could not be 
extrapolated to the general population [33]. The results reported in this study show that VELscope 
correctly identified all of the eight cancerous lesions seen, both of the moderately dysplasic lesions 
seen and both of the severely dysplastic lesions seen, by observing a loss of fluorescence [33]. 
However, results also showed that despite correctly identifying 36 of 40 (90%) hyperkeratotic benign 
lesions, VELscope™ examination identified one of the three chronically inflamed lesions (33%), four 
of six cases of lichen planus (67%) and the single case of granulated tissue as being positive for 
disease [33].The authors calculated sensitivity and specificity of the VELscope™ system to be 100% 
and 80.8%, respectively [33]. However, the results for sensitivity were based on correctly identifying 
four cases of dysplasia, of which none were mild, and eight cases of carcinoma, of which six were 
classed as grade two or three [33]. The specificity results reflect the fact that of the 52 benign lesions 
tested, 40 were cases of hyperkeratosis, from which the VELscope correctly identified 36 as being 
benign [33]. However, when excluding these hyperkeratotic lesions, the VELscope™ system 
specificity dropped to 50%. The authors concluded by stating that VELscope™ results should be 
analysed with caution, as benign lesions also showed stain patterns, and suggested more studies 
would be required to assess the role VELscope™ could play in screening [33].
McNamara and colleagues also attempted to determine the extent to which VELscope™ could 
discriminate between dysplastic/squamous cell carcinoma (SCC) lesions and benign lesions [34]. A 
total of 130 patients, 67 of whom were men and 63 of whom were women, with a mean age of 45.4 
years, were recruited to the study [34]. All patients underwent the conventional oral exam (COE) 
first, performed under incandescent light, and then underwent examination using the VELscope™ 
device [34]. Within two weeks of these examinations being performed, scalpel biopsies were 
performed on lesions which appeared potentially malignant during the COE and/ or lesions which 
exhibited fluorescence loss (indicative of tissue pathology), and underwent histopathological 
analysis, performed by two pathologists [34]. Normal tissue was not biopsied [34]. From these 130
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patients, 95 lesions were identified during COEs, five of which were deemed "clinically suspicious" 
[34]. Using VELscope™, fluorescence was lost for 59 lesions and retained by the remaining 36 lesions
[34]. The authors state that no additional abnormalities were found using VELscope™ that had not 
already been detected using the COE [34].Of the 59 lesions which demonstrated loss of fluorescence, 
32 were biopsied, 14 had resolved themselves by the follow-up appointment (which was scheduled 
to provide a decision on whether or not a biopsy would be required), two underwent fungal culture 
rather than scalpel biopsy (and were found to be Candida albicans), one underwent exfoliative biopsy 
rather than scalpel biopsy (and was found to be the herpes virus) and there were 10 patients who 
had no follow-up data [34]. Of the 32 lesions demonstrating fluorescence loss which also underwent 
scalpel biopsies, one was found to be a Kaposi sarcoma (i.e. cancerous), one was found to be severe 
epithelial dysplasia and the remaining 30 were benign lesions [34]. Therefore, the VELscope had a 
false-positive rate of 93.8% [34]. The authors also noted that both the dysplastic and malignant 
lesions presented in the same HIV-positive patient [34]. Of the 36 lesions which retained 
fluorescence, 32 were deemed not to be suspicious and no follow-up data was recorded (though it is 
uncertain if this is because the tissue had been deemed normal) and four were deemed to be 
"clinically suspicious" during COE [34]. Two of these lesions were resolved by the follow-up 
appointment but the two which had not were biopsied, one of which was benign but the other was 
moderate epithelial dysplasia [34]. Therefore, of the 34 biopsied lesions, one was malignant, two  
were moderate-severe epithelial dysplasia and 31 were benign [34]. it would have been of interest to 
see how the VELscope™ system classed a greater sample size of dysplastic samples, as it would seem 
a little misleading to base sensitivity on the nature of three samples, and would have also been 
interesting to see how the VELscope™ classed mildly dysplastic lesions in this study. However, the 
results of this study suggested [34], as those of Fa rah and colleagues [32], and Awan and colleagues 
[31] did, that VELscope™ was poor at discriminating benign lesions from dysplastic and malignant 
lesions. The authors concluded that VELscope™ did not provide any additional benefits to the 
conventional oral exam and given the false negative finding and high number of false positives, 
McNamara and colleagues stated their results did not support use of VELscope™ for screening of 
patients who were asymptomatic [34].
In a relatively recent paper, Hanken and colleagues examined the difference between conducting a 
conventional oral exam (COE) under white light, and conducting a COE under white light, followed by 
examination of using the VELscope™ device [35]. The authors recruited 120 patients with potentially 
malignant lesions to their study, and split the patients into two groups of 60 [35]. For the first group 
(group one), only COE was used as an examination method, but for group two, COE followed by
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VELscope examination was used [35]. All lesions, regardless of the group the patient was assigned to, 
were biopsied and underwent histopathological analysis [35]. The authors found that the sensitivity 
and specificity of the COE, i.e. for group one which contained two cancerous lesions, 52 dysplastic 
lesions and six benign lesions, were 75.9% and 33.3% respectively and that the sensitivity and 
specificity for the COE followed by VELscope examination, i.e. for group two which contained one 
cancerous lesion, 47 dysplastic lesions and 12 benign lesions, were 97.9% and 41.7% respectively
[35]. However, no details were given as to how many of the dysplastic lesions displayed mild, 
moderate or severe dysplasia, nor were there details on the specific nature of the benign lesions 
(which represented 15% of the total number of sampled lesions) [35]. Given these omissions, it is 
difficult to determine how well the VELscope™ system distinguished between benign and dysplastic 
lesions in this study. The authors conclude by stating that results from VELscope™ examinations 
should be treated with caution given the number of false positives obtained, and that the VELscope™ 
method was highly subjective [35].
Recently, Petruzzi and colleagues published a paper in which they compared the abilities of toluidine 
blue and VELscope™ to differentiate between benign, dysplastic and cancerous oral lesions [36]. The 
authors recruited 49 patients of mean age 56.7 years, 27 of whom were male and 22 of whom were 
female, to their study [36]. Patients first underwent a conventional oral examination under 
incandescent light, during which suspicious lesions were identified and evaluated. Then, the same 
lesions were evaluated using the VELScope™ device, following which staining with toluidine blue (Zila 
Pharmaceuticals, Phoenix, Arizona) was performed, by patients rinsing their mouths for 20 seconds 
using 30 ml 1% acetic acid solution, then rinsing for 20 seconds with water, followed by 20 seconds 
of rinsing/ gargling 10 ml of toluidine blue (TB) solution followed by 20 seconds of rinsing with 30 ml 
1% Acetic acid solution and finally rinsing with water [36]. All lesions were biopsied and underwent 
histopathological assessment [36]. In total, 56 lesions were examined in this study, 26 of which were 
benign, with 13 being mildly dysplastic, two being moderately dysplastic, four being severely 
dysplastic and 11 were oral squamous cell carcinomas (OSCCs) [36]. When mild dysplasia was an 
indicator of disease, the sensitivity and specificity of TB were 80% and 61.54% respectively, and 
sensitivity and specificity of VELscope™ were 70% and 65.62% respectively [36]. When mild dysplasia 
was not considered an indicator of disease, the sensitivity and specificity of TB were 88.24% and 
51.28% respectively, and sensitivity and specificity of VELscope™ were 76.47% and 51.28% 
respectively [36]. The results gained in this study show both VELscope™ and TB to be able to 
distinguish between dysplastic/ OSCC lesions and benign lesions, though just as was found in many 
other studies, the false positive rate of VELscope™ was high, as 42.3% and 48.7% of benign lesions
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lost fluorescence when mild dysplasia was considered as pathology and when it was not, respectively
[36]. However, what could not be ascertained from the paper was how well either VELscope™ or TB 
identified mildly dysplastic lesions, how well either system differentiated between different grades of 
dysplasia (as dysplastic lesions were only considered with OSCC lesions, not separately), what the 
nature of the benign lesions were, and what stage or grade of disease the OSCC lesions were.
De Veld and colleagues stated in conclusion to their review of autofluorescence spectroscopy and 
imaging that, at the time of writing, analysis of literature had shown that distinguishing between 
benign and potentially malignant tissue was not possible [21], and upon reviewing the results from 
most of the VELscope™ studies discussed here, this is still arguably the case today.
2.1.6 Brush Biopsies
Whilst the oral brush biopsy, in itself, does nothing to aid visualisation of lesions which are not 
obvious upon visual examination, they do provide a minimally invasive (i.e. do not require general, or 
in most cases any local, anaesthesia) form of tissue sampling. If the brush biopsy could be coupled 
with a method for analysing the collected ex vivo oral cells, which provided results quickly and in an 
inexpensive manner, this could confirm the histological nature of lesions which require referral to 
specialists or scalpel biopsy, which may in turn lessen the time taken between initial presentation of 
lesions and diagnosis and treatment.
Ogden conducted a number of studies on the properties of oral mucosa, investigated using 
exfoliative cytology. In one such study in 1993, Ogden and colleagues compared the keratin profiles 
of normal and malignant oral tissue, using Cytobrush biopsy brushes (manufactured in 1993 by 
MedScan, Colgate Medical Ltd, England) [37]. The group collected brush biopsies from the lesion, 
confirmed to be oral cancer by biopsy, and normal tissue from a site contralateral to the cancerous 
lesion, for each of 20 patients, created smears from them, fixed them using a commercially available 
fixative spray and stored the smears at -70°C until testing [37]. Testing involved staining for eight 
monoclonal antibodies and counterstaining with Mayer's haematoxylin [37]. The group found that 
significant differences were found between normal and cancerous oral tissue in terms of the 
expression of keratins 8 ,18  and 19, and the authors detail that keratins 8 and 18 are not normally 
encountered in oral mucosa and that keratin 19 expression is normally limited to cells from the basal 
layer, and therefore concluded that the presence of these keratins could be a marker for malignancy
[37]. The authors did however encounter issues with cell yield which limited staining for some
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keratins [37], but the authors did not comment much upon this, and whether this was a problem 
associated with the brush biopsy itself.
Kammerer and colleagues also used Cytobrush es, (though the model used in their study was the 
Cytobrush® Plus GT by MedScan, Malmo, Sweden), to collect oral cells for the purpose of early 
detection of oral cancer [38]. In this study, the authors used morphological cytology and DNA-image- 
cytometry (DNA-ICM) to test cells collected from 88 lesions from 70 patients (45 of whom were male 
and 25 of whom were female), excluding all lesions which were cancerous in appearance or had been 
confirmed as such by biopsies [38]. Brush biopsies were collected by completing 10 revolutions of the 
brush over the lesion site (which resulted in most cases, according to the authors, in pinpoint 
bleeding), smearing the contents of the brush onto four pre-charged glass microscope slides and 
fixing the samples using ethyl alcohol [38]. One of these slides was sent to pathology for 
haematoxylin-eosin staining, two were used for DNA-ICM and one was retained for reference [38]. 
However, it is not clear if the authors were able to divide cells equally between all four slides, and if 
so, how. Of the 88 lesions sampled, histological assessment confirmed 28 as cases of leukoplakia, 15 
as cases of oral lichen planus, eight as cases of inflammation, 12 as cases of dysplasia and 25 as cases 
of T1 oral carcinoma [38] (tumour of 2 cm or less). The authors found that, excluding one sample due 
to insufficient cell yield, DNA-ICM detected high risk or malignant lesions (cancerous lesions or SIN 2 
and 3 dysplastic lesions) in 21 of 30 cases and correctly identified all benign lesions, leading to a 
sensitivity of 70% and a specificity of 100%, compared with a sensitivity of 55% and a specificity of 
100% for cytology [38]. Upon combining cytology and DNA-ICM, the authors found the sensitivity 
was raised to 77% [38]. The authors note in this study that they encountered sampling errors, which 
they defined as no abnormal cells being apparent in some samples [38], but this may be because the 
brush the group used appears to be a brush developed specifically for use on cervical mucosa, not 
the oral mucosa, and there is no indication by the authors that this brush is claimed to be able to 
sample cells from the basal layer as well as the intermediate and superficial layers.
Maurer and colleagues conducted a study in which they used matrix-assisted laser desorption/ 
ionisation time of flight mass spectrometry (MALDI-ToF MS) on normal and cancerous tissue 
collected via brush biopsies [39].Brush biopsies collected cells from cancerous lesions and from  
tissue, deemed to be healthy, from the contralateral buccal mucosa from 26 patients (19 of whom  
were men and 7 of whom were women) [39]. Initially, the group found that mass spectra of 
cancerous tissue and normal tissue were similar, but after applying an optimisation algorithm, the 
group reported that they achieved a sensitivity of 92% and a specificity of 95% for normal versus 
cancerous tissue [39]. The group then collected a single brush biopsy from each of an additional
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group of 26 patients, from which they received 11 samples of oral cancer, 11 samples of potentially 
malignant lesions and four normal samples [39]. Using the MALDI-ToF MS system, the group 
correctly identified all cancer samples, but Judged one potentially malignant sample to wrongly be 
cancerous, and achieved a level of sensitivity of 100% and a level of specificity of 93% for this small, 
blinded study [39].
One of the most frequently referred to brush biopsy packages is the Oral CDx® (CDx Diagnostics, 
Suffern, New York) system, therefore it is the papers on this system which the researcher will focus 
upon.
2.1.6.1 Oral CDx
The Oral CDx system (Oral CDx® Diagnostics, Suffern, New York) consists of two parts: a biopsy brush, 
which the manufacturer claims can sample cells from the superficial, intermediate and basal layers of 
the oral mucosa, and the computer analysis package at the Oral CDx® Diagnostics pathology 
laboratory (i.e. brush biopsy samples collected by clinicians are sent to this lab for analysis) [40]. The 
software which performs this cellular analysis is based upon algorithms developed for a US 
Department of Defence neural networking project conducted by the CEO and founder of CDx 
Laboratories, Mark Rutenberg, and these algorithms were first applied to software for the analysis of 
Papanicolau stains from cervical biopsies (PAPNET) [41]. However, the version adapted for oral 
cancer diagnostic purposes selects the 200 "most suspicious" cells from an estimated 100 000 cells 
collected by the brush biopsy and "flags" them for further analysis by pathologists, prior to a decision 
being rendered [40].
The US Collaborative Oral CDx®Study Group published a paper, authored by Sciubba, in which they 
compared the results gained by the Oral CDx® system with those from histopathological assessment 
of scalpel biopsies [42]. The group recruited 945 patients, with a mean age of 55 years, to their 
study, 443 of whom were male and 502 of whom were female [42]. Of these patients, 63% did not 
smoke and 51% did not drink alcohol [42]. From these patients, who were recruited in the course of 
routine clinical practice, samples were taken of lesions which were suspicious or innocuous [42]. If 
the visual appearance of lesions was "suspicious", the Oral CDx® was performed, followed by scalpel 
biopsy and associated histopathology [42]. If lesions appeared "innocuous" i.e. were judged not to 
require follow-up, they were tested using the Oral CDx® only (i.e. scalpel biopsies were not 
performed on these lesions) [42]. If however, the Oral CDx® results showed an "innocuous" lesion to
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be abnormal, then scalpel biopsy was performed, if the investigator thought this was necessary [42]. 
Sciubba states that the Oral CDx® brush was designed to sample cells from all three epithelial layers 
of the oral mucosa, superficial, intermediate and basal [42]. To collect brush biopsy samples, the 
brush was rotated five to ten times over the site of the lesions while applying pressure, such that 
pinpoint bleeding was observed, and this stage was performed without local anaesthesia [42]. Then, 
the brush contents were transferred to a bar-coded glass slide, covered with fixative (to avoid 
contact with air and subsequent drying of the sample) and after 15 minutes (in which time the 
fixative dried) the slide was placed in a plastic container, which along with a bar-coded, completed 
requisition form was added to addressed mailing package and sent to the OralScan (now Oral CDx® 
Diagnostics) laboratory in New York [42]. The author states that upon arriving at the Oral CDx® 
Diagnostics laboratory, the slides were stained using the modified Papanicolau method (though 
exactly what this involved was not detailed) and then scanned by neural networking algorithms for 
image detection of pre-malignant and cancerous cells [42]. These cells were then selected to be 
reviewed by pathologists, and diagnosis was based on the pathologists' decision, rather than the 
computer program diagnosing the sample [42]. The samples could be classified according to one of 
four decisions, negative for abnormality, positive for abnormality, atypical (abnormal, but with 
uncertain significance) or inadequate (too few cells present, therefore incomplete sample) [42].
From the 945 recruited patients, 298 lesions were deemed to be "suspicious" and 647 were deemed 
to be "innocuous", therefore 298 lesions underwent testing using both the Oral CDx® and scalpel 
biopsy and 647 lesions were tested using the Oral CDx®, of which 29 were deemed abnormal by the 
Oral CDx® and so underwent scalpel biopsy testing too [42]. Results from histopathology of the 327 
scalpel biopsies performed on suspicious lesions (including the 29 found to be abnormal by Oral 
CDx®) found 131 dysplastic/ malignant lesions and 196 benign lesions [42]. The Oral CDx® system 
reported positive results (i.e. confirmation of dysplasia/ carcinoma) for 78 of 131 dysplastic /  
carcinoma lesions and atypical results for the remaining 53 lesions found to be dysplastic/ carcinoma 
lesions [42]. The Oral CDx® system also identified 182 of the 196 benign lesions as being negative for 
dysplasia/ carcinoma, but classed the remaining 14 benign lesions as atypical [42]. The group 
reported that the "positive" result Oral CDx® system had a specificity of 100% and the "atypical" 
result had a specificity of 92.9% [42]. The group presented figures for sensitivity, for the Oral CDx® of 
100% and >96% (though the author does not detail how this was calculated) [42]. If an "atypical" 
result is considered to identify dysplasia/ carcinoma, the sensitivity of the Oral CDx® system was 
100%. However, there could be an argument for judging "atypical" results from "suspicious" lesions 
as not identifying dysplasia/ carcinoma, as the decision regarding sample nature is then passed back 
to the clinician who sampled the lesion in the first place, who originally thought the lesions could be
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dysplastic or cancerous. In this case, the sensitivity of the Oral CDx® system for "suspicious" lesions 
would be 62.7%. However, as an "atypical" result would highlight a lesion as "suspicious" when it had 
been classed as "innocuous" by the sampling clinician, there may be a case for including the 
"atypical" results with the "positive" results for "innocuous" lesions, and therefore the sensitivity of 
the Oral CDx® system for "innocuous" lesions would be 100%. Another point to note was that of the 
16 "innocuous" lesions which gained a "positive" Oral CDx® result, two did not undergo scalpel 
biopsy and of the 114 which gained an "atypical" result, 99 did not undergo scalpel biopsy [42]. 
Sciubba noted that 7% of the samples collected using the Oral CDx® system were found to be 
"inadequate" [42]. Sciubba also states that the Oral CDx® and fine needle aspiration are similar in 
that both achieve high values for sensitivity and specificity [42], though this could be disputed for 
Oral CDx® based on the results of this study, and suggests that the accuracy of exfoliative cytology is 
poor compared to that of Oral CDx®, though no values for accuracy are given for the latter in this 
paper [42]. Sciubba did concede that the majority of lesions (calculated to be 65.4%) examined in this 
study did not undergo scalpel biopsy [42]. It would be ethically questionable to perform scalpel 
biopsies on healthy individuals, and in this study, no brush biopsies were collected from normal oral 
tissue from healthy volunteers, to determine how well the Oral CDx® system distinguished between 
healthy oral tissue and benign oral lesions. However, no details were given as to the nature of the 
benign lesions, or the number and grade of the dysplastic and cancerous lesions. Therefore, it could 
be seen as being quite difficult to assess the ability of the Oral CDx® system to correctly define 
dysplastic and cancerous oral lesions, given the results presented in this study.
Christian conducted a study in which 93 oral lesions (62 of which presented in men and 31 of which 
presented in women) from 89 participants, who were all dentists or dental hygienists, were sampled 
using the Oral CDx® system [43]. Of interest, given the sample population, 25% of lesions had 
developed unnoticed and no lesions were obviously dysplastic or cancerous [43]. Of the 93 lesions, 
none were "inadequate" samples, one was positive and six were "atypical". Subsequent histological 
examination of scalpel biopsies proved the "positive" sample as dysplastic, one of the "atypical" 
samples to be negative and two of the "atypical" samples to be dysplastic [43]. Histological 
examination was not performed for three of the six "atypical" samples, as two resolved without 
intervention (suggesting they could have been false positive results) and one was being monitored by 
the participant [43]. It could be said that the "atypical" result for the Oral CDx® system makes 
calculation of false positive and false negative results a little complicated- "atypical" could be ruled 
as indicative of disease and therefore a positive result indicates the presence of dysplasia or 
carcinoma, however "atypical" could be viewed as a failure to classify a sample as either positive or
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negative for disease. In this study, it could be argued that none of the lesions sampled were 
suspected as dysplasia or carcinoma, and therefore an "atypical" result could be viewed as a positive 
indicator of dysplasia/ carcinoma, in which case, excluding the one lesion which was "atypical", did 
not undergo scalpel biopsy and was being monitored (as the nature of this lesion was unknown) the 
Oral CDx® system correctly identified 50% (three of six) of the "positive" samples as being dysplastic/ 
cancerous and incorrectly identified 50% (three of six) of the "positive" samples as dysplastic/ 
cancerous when they were found to be benign [43].
A paper by Scheifele and colleagues commences with the author detailing results found by different 
groups, citing the work of Sciubba [42] and Christian [43] as gaining positive results for the Oral CDx® 
system, but cites the 150 false positives of 298 cases found by Svirsky and colleagues in their study, 
and the 84% false positive rate quoted by Rick and colleagues in their letter to editor [44]. In this 
study, Scheifele and colleagues collected 103 Oral CDx® brush biopsies from 96 lesions, presented by 
80 patients of mean age 58.6 + 13.1 years (47 of whom were male and 33 of whom were female), 
and all lesions had undergone scalpel biopsy either one month before or after the Oral CDx® brush 
biopsy [44]. In this study, "atypical" and "positive" findings by Oral CDx® were counted as being 
positive for disease [44]. Histological results showed 60 lesions to be oral leukoplakia, 17 lesions to 
be oral lichen planus, nine lesions to be dysplastic and 17 lesions to be oral squamous cell carcinomas 
(OSCCs) [44]. Of the 103 brush biopsies performed, seven were deemed "inadequate" (six of which 
were leukoplakic and one of which showed oral lichen planus), 68 were "negative"( of which 51 were 
leukoplakic, 15 showed oral lichen planus and two were dysplastic, i.e. false negatives), 10 were 
"atypical" (of which one was leukoplakic and one showed oral lichen planus, i.e. these were false 
positives, five were dysplastic and 3 were OSCC) and 18 were "positive" (of which two were 
leukoplakic, i.e. false positives, two were dysplastic and 14 were OSCC) [44]. The authors stated that 
if "atypical" results were considered positive indicators of disease, the sensitivity was 92.3% and the 
specificity was 94.3% for the Oral CDx® system [44]. However, the authors also re-calculated the 
sensitivity and specificity for the case where "atypical" results were not indicative of disease, and 
found them to be 61.5% and 97.1% respectively [44]. The authors acknowledged that their study 
could be seen to be biased in that Oral CDx® brush biopsies were performed on hospital patients and 
this was not a population representative of a population which would present to a general health 
practitioner, and that only samples which warranted scalpel biopsy (i.e. were clinically suspicious) 
were sampled using Oral CDx® [44]. The authors did not however discuss why they had calculated 
sensitivity and specificity for positive results which did not included "atypical" results, nor did they
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give details of the grade of the dysplastic and OSCC lesions sampled in this study, therefore making it 
difficult to ascertain to what extent the Oral CDx® system aided diagnosis.
The same volume of the journal Oral Oncology which featured the paper of Scheifele and colleagues
[44] also featured a paper on the efficacy of the Oral CDx® brush biopsy system, by Poate and 
colleagues [45]. In their study, Poate and colleagues sampled lesions presented by 120 patients who 
reported to the Eastman Dental Institute Oral Medicine unit [45]. Patients whose Oral CDx® results 
were "positive" or "atypical" were offered scalpel biopsies with associated histopathological analysis, 
as were patients whose Oral CDx® results were "negative", but whose lesions were judged by an 
specialist in oral medicine to be "suspicious" [45]. No samples were collected from lesions which 
were obvious cases of carcinoma, in this study [45]. Of the 120 Oral CDx® brush biopsies performed, 
10 (8.3%) were deemed "inadequate" [45]. Two patients elected to undergo an additional brush 
biopsy and the remaining eight samples were tested using incisional biopsy instead, and removed 
from the study. Therefore results from 112 brush biopsies from 112 patients were included in the 
study results [45]. Of these 112 patients of mean age 55.7 years, 50 were male and 62 were female
[45]. Incisional biopsy results showed seven lesions to be malignant, 14 to be dysplastic, 28 to be 
benign, and the remaining 63 were deemed negative on visual examination so did not undergo 
incisional biopsy (i.e. no incisional biopsy was performed for 56.3% of lesions in this study) [45]. Oral 
CDx® brush biopsy results showed one lesion to be "positive", 36 lesions to be "atypical" (of which 19 
were benign and 3 were deemed negative by visual examination) and 75 to be "negative" (of which 
one lesion was malignant and five lesions were dysplastic) [45]. The group stated that Oral CDx® 
failed to distinguish between benign and dysplastic lesions, as 67.9% of benign lesions were found to 
be "atypical" [45], and six of the 21 dysplasia/ OSCC lesions were found to be "negative" by Oral 
CDx®, i.e. six of 21 dysplastic/ OSCC lesions were false negatives. Poate and colleagues calculated 
that the sensitivity was 71.4% and the specificity was 32%, for the Oral CDx® system [45], however, if 
"atypical" was considered not to indicate disease (as all lesions were deemed "suspicious" upon 
clinical examination), then the sensitivity dropped to 4.8%. The group acknowledged that all of the 
lesions sampled in this study were clinically "suspicious" and therefore the population tested was not 
representative of the general population [45], but no details were given as to the grade of dysplastic 
lesions, or the nature of benign lesions which were incorrectly deemed "atypical".
Hall reported the results of a study in which a brush biopsy training programme for senior dental 
students at Ohio State University, using the Oral CDx® system, was evaluated [46]. In this study, 
students were instructed to rotate the brush five to ten times over a lesion whilst exerting pressure, 
and to continue until pinpoint haemorrhaging was evident [46]. Lesions from which brush biopsies
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could be taken were encountered in one in every 20 patients, whilst the mean age of the total 
patient population was 57 years, the mean age of the patients from whom Oral CDx® brush biopsies 
were taken was 74 years [46], suggesting that the population of patients with clinically suspicious 
lesions deemed to be "brushable" were older patients. Hall reported that of the 81 brush biopsies 
taken, 30% did not contain populations representative of the basal layer, and were deemed "sub- 
optimal" (17 brush biopsies) or "inadequate" (seven brush biopsies) [46]. This finding tended to 
suggest that experience and practice was required to successfully perform Oral CDx® brush biopsies, 
and that this may limit their use within settings where the clinician is not experienced in taking brush 
biopsy samples.
Casparis and colleagues conducted a recent study on the use of the Oral CDx® system for "detection" 
of potentially malignant oral disorders [47]. In their study, the group collected 263 brush biopsies 
(176 of which were from men and 87 of which were from women) from 200 patients, but excluded 
cases suspicious of malignancy, ulcerative lesions (in which all layers of epithelia would not be 
present) and hyperkeratotic conditions [47]. The Oral CDx® system classed 204 lesions as "negative", 
seven as "positive", 39 as "atypical" and 13 as "inadequate" [47]. Seventeen scalpel biopsies were 
performed on 17 of the negative results, of which one sample was found to be mildly dysplastic and 
another sample was found to be moderately dysplastic (i.e. these two samples were false negatives) 
[47]. Of the 29 scalpel biopsies performed on the 39 "atypical" lesions, 19 were found to show no 
dysplasia and of the scalpel biopsies performed on all "positive" lesions (seven of), one was mildly 
dysplastic, three were severely dysplastic and three were oral squamous cell carcinomas (OSCCs)
[47]. Of the three scalpel biopsies performed on 13 of the "inadequate" samples, two showed no 
dysplasia, however one was found to be OSCC [47].The authors state that the sensitivity was 90% 
and the specificity was 44.1% for the Oral CDx® system [47], however this seems to be based on the 
ability of the Oral CDx® to correctly identify severe dysplasia or OSCC, rather than all forms of 
dysplasia and OSCC. In the 1999 paper by Sciubba, a positive result is deemed to be indicative of 
epithelial dysplasia (grade not specified) [42], and upon re-calculating the sensitivity to include all 
dysplastic samples in the study by Casparis and colleagues [47] deemed to be "positive" or "atypical" 
lesions, the sensitivity of Oral CDx® drops to 85%. However, if only "positive" results are deemed to 
correctly identify disease, then the sensitivity drops further, to 35%. Of the 36 lesions sampled which 
were found to show no dysplasia (i.e. were benign), 52.8% were classed as "atypical" rather than 
"negative" by the Oral CDx® system, suggesting that this system had difficulty identifying benign 
lesions correctly, contributing to the low specificity value [47]. Given the inability to correctly define 
benign lesions and the fact that two dysplastic lesions were false negatives, the results of this study
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suggest the Oral CDx® system is potentially limited in its ability to correctly identify benign and 
dysplastic lesions, but this is not a conclusion the authors specifically make in this paper.
Weigum and colleagues also used the Oral CDx® brush, but did not submit the collected brush 
biopsies to the Oral CDx® Diagnostics laboratory, instead the group tested the brush biopsy samples 
using a nano-bio-chip (NBC) sensor they had developed [48]. The microfluidic NBC was a multi­
layered structure featuring a membrane with pores of 0.4 pm in size, to capture particles >0.4 pm in 
diameter in order to label them using fluorescent stains, for analysis of protein and/ or nucleic acid 
content [48]. Sample delivery was achieved by a peristaltic pump, which had a six-port injection valve
[48]. Brush biopsies were collected using Oral CDx® brushes, by rotating the brush 10-15 times across 
the lesion surface, until pinpoint bleeding was observed [48]. Cells were released from the brush by 
agitation in cell culture medium (Eagle's MEM plus L-glutamine plus 10% FBS) for 15-30 seconds, and 
were then centrifuged, re-suspended in FBS and 10% DMSG and stored at -80°C until they were due 
to be tested [48]. Preparation of samples for analysis involved thawing them, fixing them using 
formaldehyde and storing them in PBS with 0.1% bovine serum albumin added (PBSA), for a period of 
one week [48]. Cell labelling involved capturing 2500-5000 cells, which were suspended in 50% 
glycerol in PBSA, on the membrane, and immunoreagents were delivered in a sequential manner to 
the cells [48]. Next, images were recorded of the stained cells and image analysis was performed 
using custom-made macros. A total of 51 parameters, including nine morphological parameters, 
were extracted or calculated for each cell in each sample [48]. Brush biopsies were collected from 41 
patients, 66% of whom were male, presenting with visible leukoplakic or erthyroplakic lesions (the 
nature of these lesions was confirmed by scalpel biopsy and associated histopathological analysis) 
and 11 healthy volunteers with no oral abnormalities or diseases (only one of whom smoked), 55% of 
whom were male [48]. The group selected cellular and nuclear area, nuclear-to-cytoplasmic ratio, 
and mean intensity of epidermal growth factor receptor (EGFR) staining as early markers for oral 
cancer [48]. A total of 45 brush biopsies were collected from 41 patients, and histopathological 
assessment diagnosed three samples as benign, eight samples as moderately or severely dysplastic 
and 34 samples as invasive OSCC [48]. However, two OSCC samples were sacrificed during assay 
development, and one OSCC and one dysplastic sample were excluded as they contained inadequate 
cell content, leaving 41 patient brush biopsy samples [48]. A total of 11 brush biopsies were collected 
from 11 healthy volunteers, therefore a total of 52 brush biopsies were analysed in this study [48]. 
The group found that when they combined all three markers they had selected for oral cancer, 
cellular and nuclear area, nuclear-to-cytoplasmic ratio, and mean intensity of epidermal growth 
factor receptor (EGFR) staining, they achieved a sensitivity of 97% and a specificity of 93%, for the
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identification of OSCC and moderately-to-severe oral dysplasia [48]. The authors acknowledged that 
the clinical implications of this study were limited by small sample sizes, particularly for the dysplastic 
group, and that OSCC samples outweighed the number of dysplastic samples, as 60% of the brush 
biopsy samples were cancerous in nature [48]. However, the group achieved high values for 
sensitivity and specificity for the population they sampled in this paper, and stated that the next 
stage of their study using this nano-bio-chip sensor device would involve approximately 850 patients 
who presented with clinically "innocuous" lesions [48].
2.1.6.2 Rovers Biopsy Brush
Yang and colleagues used the Rovers Orcellex brush (Rovers Medical Devices B.V., The Netherlands), 
used in the study presented by the researcher in this experimental chapter, to collect oral cells from 
healthy tissue, potentially malignant oral lesions and oral squamous cell carcinoma (OSCC) lesions, to 
identify a biomarker for oral cancer, using mass spectrometry-based proteomics [49]. The authors 
collected brush biopsies from oral tissue of 10 healthy volunteers, and from normal and abnormal 
tissue (potentially malignant lesions or OSCC lesions) from 11 dysplasia patients and 11 OSCC 
patients [49], though the authors did not state if the nature of lesions had been confirmed using 
scalpel biopsy and histopathologcial analysis and if so, what the time difference was between scalpel 
biopsy and brush biopsy. From their results, the authors identified secretory leukocyte protease 
inhibitor as a marker for oral cancer, from cells collected via brush biopsy, as levels were found to 
decrease in potentially-malignant tissue, compared with healthy tissue, and decrease further still in 
OSCC tissue [49].
2,1.7 Summary
Several literature review papers have been published, which have attempted to elucidate the clinical 
impact of many of the methods, techniques and technologies developed to aid early diagnosis of oral 
cancer. Patton and colleagues conducted one such literature review [50]. In their paper, this group 
found that the sensitivity of toluidine blue (TB) varied in literature, from 38-98% and specificity 
varied from 9-93% [50]. Upon reviewing papers on Microlux DL, the group concluded that no papers 
met with their inclusion criteria for analysis in this literature review paper, in 2008 [50]. Patton and 
colleagues found that whilst values for the sensitivity of Vizilite® reached 100%, it consistently 
achieved 0% specificity [50]. Lingen and colleagues stated in their paper that the conventional oral
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exam (COE), a visual exam performed under incandescent light, achieved a sensitivity in the range of 
60-97% and a specificity of greater than 90%, but stated that the COE fails to identify all potentially- 
malignant lesions, and cannot detect which lesions are likely to undergo malignant transformation 
[51]. When reviewing brush biopsy literature, Lingen and colleagues state that they show promise, 
but emphasise that studies must provide scalpel biopsy results for clinically innocuous lesions, and 
suggest that brush biopsies could be an advantage in cases of multiple lesions or in cases where 
patients are unlikely to return for follow-up exams or surgical referrals [51]. With regards to studies 
using toluidine blue staining for lesions visualisation, Lingen and colleagues listed a number of 
problems common to these studies, including rare use of histological diagnosis, varying methods for 
achieving stains and confusion over interpretation of equivocal staining [51]. The authors of this 
paper also found that evidence in support of reflective tissue fluorescence, such as is employed by 
the Vizilite® system, was limited and again, many studies did not perform scalpel biopsies to confirm 
lesion nature, but the authors did state that results for studies using VELscope™ were promising, but 
information regarding the ability of VELscope™ to identify potentially-malignant lesions was lacking
[51]. Perhaps the most telling of conclusions on all of the methods, technologies and techniques 
reviewed here, was provided by a report detailing the findings and recommendations of a panel 
convened by the American Dental Association Council on Scientific Affairs, in which the panel stated 
that there was "insufficient evidence" that commercially-available autofluorescence systems, tissue 
reflectance systems, transepithelial cytology systems, and the toluidine blue staining system, 
provided detection beyond that achieved by the conventional oral exam with tactile examination
[52].
In summary, many research groups have attempted to develop technologies or methods to aid the 
early diagnosis of oral cancer, including optical-based solutions for improved visualisation of lesions, 
such as toluidine blue, Vizilite®, Microlux DL and VELscope™. Others have attempted to characterise 
cells collected from benign, dysplastic and cancerous oral lesions using brush biopsies as a non- 
invasive method for cell collection, such as Oral CDx®. However, none of these commercially 
available methods have been able to demonstrate the consistent ability to distinguish between 
benign and dysplastic oral lesions. This, in part has been due to the design of some studies, in that 
performance of some techniques has been difficult to gauge due to factors such as small or non­
existent benign and dysplastic sample groups, lack of lesion nature confirmation through scalpel 
biopsy and histopathological analysis and combining dysplastic lesions with carcinoma lesions when 
summarising results. It has been widely acknowledged that identification of dysplastic lesions at an
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early stage would contribute to the early diagnosis of oral cancer. However, all of the methods 
reviewed above have yet to achieve this, on a consistent basis, to-date.
2.1.8 Dielectrophoretic Studies of Oral Cancer
Studies have previously been conducted using dielectrophoresis (DEP) to characterise oral cancer 
cells, at the University of Surrey. The first, by Broche and colleagues, used DEP to characterise cancer 
cells from the H357 (human tongue cancer) line and cells from a line of human epidermal 
kératinocytes transfected with human papillomavirus 16 (HPV-16) to become immortalised (but 
which possessed no tumorigenic ability, and were therefore classed as non-cancerous cells), called 
UP [53]. Both sets of cells were centrifuged three times prior to DEP testing, and re-suspended at a 
concentration of approximately 3 x 10^ cells/ ml in a conductive medium, composed of 8.5% (w/v) 
sucrose and 0.3% (w / v) dextrose, which was adjusted to a conductivity level of 5 mS/ m using PBS
[53]. DEP testing was conducted using the needle electrodes system detailed in a previous paper [54] 
and frequencies of 1 kHz-20 MHz, at five frequencies per decade, were applied for a period of 60 
seconds each, after which time the number of cells which had collected at the electrodes were 
counted [53]. At least five DEP experiments were performed for both cell lines, and the results for 
each cell line were averaged, then modelled using the single-shell model (details of which can be 
found in the Dielectrophoresis section of the General Introduction of this thesis) [53]. The group 
found that the oral cancer H357 cells started collecting at frequencies less than 5 kHz, whilst the UP 
cells started collecting at frequencies above 10 kHz [53]. Modelled data suggested that the H357 oral 
cancer cells had larger cell radii than the UP cells (9.1 + 3.4 pm versus 7.0 + 2.0 pm) and achieved a 
larger mean membrane capacitance value than UP cells (17.7 mF/ m  ^versus 11.3 mF/ m^), but found 
that the cytoplasmic conductivity of H357 oral cancer cells were less than that of UP cells (0.3 5 / m 
versus 0.45 5 / m) [53]. The group cited that the decrease in cytoplasmic conductivity of the H357 
cells may have been due to the increased cell radius, and hence a possible dilution of ions, or it 
stated that it could have been due to ion channel expression or intracellular pH differences, though 
further testing would have been necessary to prove these theories [53]. The group also stated that 
the increased membrane capacitance could have been the result of the membrane of H357 cells 
being more ruffled than those of UP cells, resulting in larger surface areas and hence larger values for 
capacitance [53].
Following on from this "proof of concept" study, the group published a paper, authored by Mulhall, 
in which DEP was used to investigate the dielectric properties of normal cells from the human oral
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kératinocyte (HOK) line, dysplastic cells from the dysplastic oral keratinocyte (DOK) line and cells 
from two oral cancer cell lines, H357 (as was used in the previous study) and H157 (squamous cell 
carcinoma of the buccal mucosa) [55]. As in the previous study [53] cells from each line were re­
suspended in conductive medium composed of sucrose and dextrose, which was adjusted to a final 
conductivity of 5mS/ m, but in this study, the final concentration of cells was approximately 2 x 10® 
cells/ ml and a different electrode setup was used [55]. The DEP Well^ electrode (referred to in this 
paper as the DEP-microwell electrode system), which is the same as that used by the researcher in 
this experimental chapter, allowed both positive and negative DEP to be observed [55]. AC signals of 
frequencies ranging from 4 kHz to 20 MHz, at five frequencies per decade, were applied to cells 
suspended in their conductive medium which had been added to the DEP-microwell aperture, so that 
the cells were bounded circumferentially by electrodes [55]. A MATLAB script had been developed, 
to allow the change in light intensity as a function of time to be normalised with respect to an image 
taken of the cells suspended in the Well, prior to AC signals being applied [55]. The spectra resulting 
from a full frequency run (4 kHz- 20 MHz) were modelled, again using the single-shell model (with a 
correlation of > 0.9) and cell radii were estimated by measuring the cell diameters of 50 cells per 
experiment, using image analysis software [55]. The group found that the normal oral cells of the 
HOK line achieved the lowest values for membrane capacitance (0.69 + 0.06 pF/ cm^), followed by 
the cells of the DOK line which achieved a greater value (1.09 + 0.2 pF/cm^) and the oral cancer cells 
from the H157 and H357 achieved the greatest values, at 1.43 + 0.45 pF/ cm^ and 1.51 + 0.26 pF/ 
cm^ respectively [55]. These results suggest that membrane capacitance increases with increasing 
malignancy, and differences between the HOK, DOK and cancerous membrane capacitances were all 
statistically significant [55]. The group also found that HOK cells achieved significantly higher 
cytoplasmic conductivity (0.71 + 0.08 5 / m) than cells from both the cancer cell lines H357 (0.26 + 
0.26 5 / m) and H157 (0.25 + 0.10 5 / m), and that cytoplasmic conductivity decreased with increasing 
malignancy, as DOK cells achieved a lower value than HOK cells but a greater value than H357 and 
H157 cells, at 0.42 + 0.26 5 / m [55].
The work contained in this experimental chapter focuses on work which the researcher undertook, 
that followed-on from the work of Mulhall and colleagues, in which cells from normal, dysplastic and 
cancerous oral tissue were sampled using brush biopsies, tested using dielectrophoresis (DEP) and 
methods for results analysis were trialled to correctly distinguish cells from these different tissue 
types, based on their dielectric properties.
 ^The electrodes within the DEPtech DEP Well electrode system are often referred to, from this point on, as 
Well electrodes or Wells. Well is capitalised to allow the noun (i.e. the electrodes) to be distinguished from the 
adjective and adverb "well".
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2.2 Methods
The following section explains in detail, the methods employed when undertaking this study. 
Specifically, this section details the criteria and protocol employed to collect oral brush biopsy (OBB) 
samples from study participants, OBB sample preparation prior to DEP testing, the DEP testing 
protocol and the methods employed to analyse the results of DEP testing.
This study was conducted as a blind study: the researcher was unaware of the nature of the samples 
(carcinoma, dysplastic or normal) upon receipt. This information was acquired after DEP experiments 
had been performed and data modelled, to prevent any suggestion of researcher-biased results.
2,2.1 Oral Brush Biopsy Sample Procurement
Prior to commencement of the study and undertaking any experimental work, a favourable ethical 
opinion was granted by the following committees: the Centre of Research Ethical Campaign (COREC), 
the University of Surrey Ethical Committee, the University College, London (UCL) Ethical Committee 
and by the research and development groups at both University College Hospital, London (235 
Euston Road, London N W l 2BU) and Bradford Royal Infirmary (Duckworth Lane, Bradford BD9 6RJ). 
Details of study participant inclusion and exclusion criteria can be found in Appendix 1.
OBB samples were collected from three population sub-groups; patients presenting (to either the 
Oral Medicine and Head and Neck Cancer clinics of the University College London Hospital NHS 
Foundation Trust (UCLHT) London, or the Oral and Maxillofacial Surgery Department at Bradford 
Teaching Hospital, Bradford) with one or more lesions confirmed by histopathologists as oral 
squamous cell carcinoma (OSCC), patients presenting to the aforementioned clinics with 
histopathologically confirmed dysplasia, and attendees of UCLHT clinics for non-mucosal disease. 
Non-mucosal disease included oro-facial pain and dental conditions, but only those who presented 
with no diagnosis (past or present) or evidence of OSCC or dysplasia were included in the study. From 
these population sub-groups, four OBB sample classification groups were formed; OSCC, Dysplasia, 
Healthy (i.e. the control group) and Normal from OSCC/ Dysplasia. Samples classed as Normal from  
OSCC/ Dysplasia were collected from OSCC and dysplasia patients, from oral tissue contra-lateral to 
the cancerous or dysplastic lesion site. The true normality of cells located in tissue adjacent to a 
cancerous or dysplastic lesion is discussed in Section 1.4, however the principle reason for collection
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of such samples was to permit inter-patient sample variability (potentially leading to errors) to be 
taken into account.
Verification of OBB sample nature, for OSCC and dysplastic samples, was determined by scalpel 
biopsy and histopathology. OSCC and dysplastic OBB samples were collected in the period between 
initial diagnostic scalpel biopsy and subsequent treatment (namely surgical resection). Participants 
recruited for the Healthy control group did not undergo scalpel biopsies and subsequent 
histopathology, in accordance with the principle of nonmaleficence [56]. Rather, mucosa sampled for 
this control group was deemed healthy through visual inspection by experienced clinicians.
2,2.2 OBB Sample Preparation for DEP Testing
The minimally-invasive Rovers® Orcellex® Brush (Rovers Medical Devices B.V., The Netherlands) was 
selected for use in this study because this product was supplied independent of a cytological analysis 
package. OBB sampling was performed by trained clinicians in accordance with the manufacturer's 
instructions for cell collection, by rotating the brush circumferentially on the tissue region of interest, 
for up to ten rotations. The brush head was then separated from the handle and suspended in 
approximately 6 ml sample storage medium (Figure 2.2), containing High Glucose (4.5g/L) DMEM 
with L-glutamine (Biosera, Ringmer, UK) supplemented with 5 ml of combined 100 units/ml penicillin 
and 100 pg/ml streptomycin (Sigma Aldrich, Poole, UK). Vials containing sampled specimens were 
labelled with an anonymised alpha-numeric code, and stored at 2-8°C. All OBB samples were 
transported to the University of Surrey, Guildford for DEP testing.
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Figure 2.2: Graphical summary of the sample collection protocol undertaken by trained clinicians. The image of the storage 
vial is how the OBB sample appeared upon receipt by the researcher. Photo of how the OBB sample was collected (showing 
the brush being applied to a tongue) was supplied by Rovers Medical Devices B.V., The Netherlands and used with 
permission.
Prior to DEP testing, a low-conductivity iso-osmotic DEP testing medium was prepared, containing 17 
mM glucose and 248 mM sucrose in de-ionised water [57]. The conductivity of this medium was then 
adjusted to 5 mS/m by addition of phosphate-buffered saline (PBS), and verified using a Jenway 470 
Conductivity Meter (VWR Jencons, Leicestershire, UK).
Upon receiving an OBB sample vial, the brush head contained was agitated briefly within the vial, 
using a vortex mixer, to dislodge any cells still adhering to the bristles of the brush head and, in 
sterile conditions, the brush head was then removed from the vial using tweezers and discarded. The 
exfoliated oral cells suspended in culture medium were then briefly subjected to the vortex mixer 
once more, to re-suspend the cells evenly within the culture medium, prior to photographing the 
sample. Then, 10 pi of the OBB sample was extracted, added to a haemocytometer counting area, 
counted and photographed. The vial containing the OBB sample was then placed in an ultrasonic 
bath for 90 seconds and filtered through a sterile 100 pm pore-size cell strainer into a 50 ml universal 
container, to disaggregate cell "clumps" (i.e. to create a single cell suspension). The cell strainer was 
then "flushed through" with 5 ml high glucose (4.5 g/ L) DMEM with L-glutamine (supplemented with 
100 units/ ml penicillin and 100 pg/ ml streptomycin). At this point, the OBB sample was transferred 
via pipette to a 15 ml centrifuge tube, and centrifuged at 259 times gravity (g) for 10 minutes, at 
approx 4°C.
After centrifugation, the DMEM supernatant was removed, and the cell pellet was re-suspended 
using 1 ml DEP testing medium, to which another 4 ml DEP testing medium is added (i.e. the cell
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pellet was re-suspended in a total of 5 ml DEP testing medium). The cell solution was then 
centrifuged a second time, at 259 g for 10 minutes, at approx 4“C. Following this second round of 
centrifugation, the DEP testing medium supernatant was removed, and the cell pellet was again re­
suspended in 5 ml DEP testing medium. The cell solution was then centrifuged for a third and final 
time, at 259 g for 10 minutes, at approx 4°C.
Following this final centrifugation "spin", the DEP testing medium supernatant was removed, the cell 
pellet re-suspended in 200 pi DEP testing medium and transferred to an Eppendorf. Prior to DEP 
experimentation, 10 pi of the OBB sample was extracted, added to a haemocytometer counting area, 
counted and photographed.
2.2.3 DEP Testing Protocol
DEP experiments were conducted using a prototype 3DEP DEP-Well electrode chip and reader 
system (DEPtech, East Sussex, UK), variations of which are detailed in prior publications [58-60]. Each 
DEP experiment using this system approximated DEP force (as defined by equation 3 in Section 1.3.1) 
by quantifying cell motion in response to application of a non-uniform AC electric field, by measuring 
change in light intensity as a function of both time and distance (Well radius) for each frequency 
applied to the cell solution (cells from the sample being tested suspended in DEP testing medium).
The DEP-Well chip (DEPtech, East Sussex, UK) used in this study and shown in Figure 2.3, hosted 
several identical Well electrodes, each with an aperture diameter of 0.75mm and a Well depth of 
1.54mm, sealed on the inferior surface by a glass cover-slip to allow both light transmission but filling 
of only the Well of interest. Each Well, only one of which was selected for use during experiments, 
was composed of seven insulator layers of 150 pm-thick FR4 (fibreglass reinforced epoxy) 
sandwiched between eight conductor layers of gold-plated copper (top and bottom layers were 35 
pm in thickness, six remaining layers were 70 pm in thickness).
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Figure 2.3: Photographie close-up of a cluster of three DEP-Well electrode areas and how this cluster appeared on visual 
inspection of a DEP-Well chip.
Five frequencies per decade were used over a range of 4 kHz to 20 MHz to test each OBB sample and 
the DEP-Well electrode chip was energised by a 10 V peak-to-peak sinusoidal signal from a Digimess 
FG 100 function generator (Digimess, Reading, UK), whose output was monitored using a ISO-Tech 
IDS710 digital oscilloscope. For each frequency tested, approximately 5 pi of cell solution was 
injected (using a pipette with a bent tip to permit more precise Well filling) into the area bounded by 
the We!! e!ectrode on the DEP-Wel! chip, which was mounted above the light source of a Nikon 
Eclipse 50i upright microscope (Nikon, Surrey, UK) and viewed at 4x magnification. This filling 
continued to the point at which there was an excess of cell solution over the Well aperture area. A 
glass cover-slip (large enough to cover the area of the Well aperture) was then laid slowly at an angle 
to this excess (to reduce the possibility of trapping air in the Well). An AVT Dolphin F145B digital 
interface camera (Allied Vision Technologies, Germany), affixed to the microscope and connected to 
a PC, captured images of the cell solution into the area bounded by the Well electrode using 
SmartView for WDM software version 0.1.3.3 (supplied with the aforementioned camera). This 
experiment setup is shown in labelled photograph in Figure 2.4.
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Figure 2.4: Photograph illustrating the main pieces of equipment comprising the DEP testing setup. A close-up of the DEP- 
Well chip can be seen in Figure 2.3.
The "Preview" button (Figure 2.5) was then selected to view the contents of Well in real-time prior to 
experiment commencement, to ensure that the whole of the Well area was in view and that no 
bubbles were present within the Well. Next, the frequency to be applied to the contents bounded by 
the Well electrode was entered into the GUI (Figure 2.5), in kilohertz.
Selecting the "Start experiment" button (Figure 2.5) commenced the application of AC signals at the 
selected frequency to the contents bounded by the Well electrode. Images were captured 
immediately prior to signal application ("zero seconds", to allow normalisation of the change in light 
intensity to this point) and every three seconds thereafter, for a period of 60 seconds. A MATLAB 
(The MathWorks Inc, Nantick, MA, USA) script was then used to assess the change in light intensity 
over the period that the electric current was applied and as a function of Well radius. A change in 
light intensity was observed when either positive or negative DEP occurred. Given that the electrodes 
were located around the perimeter of the Well aperture, and that the Well electrode chip was placed 
above the upright microscope light source, but below the camera capturing cell movement 
(recording images every three seconds over the course of each 60 second run, for each frequency 
tested), positive DEP was seen to occur when the cells in solution moved towards the Well aperture 
perimeter, thus allowing more light from the upright microscope to pass up through the centre of the
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Well and be received by the camera unit above the Well. Conversely, negative DEP was seen to occur 
when the cells in solution were repelled by the electrodes round the perimeter of the Well, towards 
the centre of the Well aperture, thus impeding the amount of light from the upright microscope 
which could be received the the camera unit. The short video in Appendix 2 shows both positive and 
negative DEP occurring (not in real time-sped up), for two separate frequencies, for one OBB sample. 
Positive DEP shows the oral cells in solution moving towards the edges of the grey-coloured Well 
aperture area and during negative DEP, the cells appear to move towards the centre of the Well 
aperture area, creating a shadow in this region and decreasing the amount of light able to transmit 
through the Well.
3  DEP_well_centre [s3
- Data capture-
Save images on
Set Path
Filename
Time [sec] 
Interval [sec]
60
r-D a ta  analysis
Start Experiment
Bands 10 1
j Preview j j Intensay line {
[— Camera Settings 
Brightness
Contrast 
Resolution:
100
50
640 X 480
No Display
-Signal Generator- 
Frequency [kHz]
1
Voltage [Vpp]
10
-Waveform—  
Sine 
O  Square 
O Triangel
Offset Voltage [V] Port
0 C0M1
g  Oscilloscope Port 
Vpp last run: NA
COM3
Run Signal Generator
Threshold, 20
Min Rad 10
-Setup 
Chip ID
Well used [ 
Diameter [umf
-Sample information- 
Cell Type
Concentration
Conductivity medium
Growth condition
Treatment
Remarks
Operator
Path to Save: C:1DEP_well\data
Figure 2.5: The MATLAB graphic user interface (GUI) used in this study, named "DEP_well_centre", to control the DEP test 
settings applied for each frequency run, over the course of each DEP experiment.
Images were captured immediately prior to signal application ("zero seconds") and every three 
seconds thereafter, for a period of 60 seconds. A MATLAB (The MathWorks Inc, Nantick, MA, USA) 
script was then used to assess the change in light intensity over the period that the electric current 
was applied and the change in light intensity was normalised to the image captured at time zero 
seconds.
At the end of each frequency run, the glass cover-slip was removed, the Well was flushed through 
with fresh DEP testing medium and then dabbed dry. These steps ensured the results produced 
reflected the intrinsic frequency response of the cells, rather than the effects of prolonged cellular 
exposure to electric current.
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This outlined protocol was repeated for each frequency tested.
2.2.4 Analysis of DEP Results
Three methods were employed for the analysis of the raw results of DEP testing in this study: 
modelling of raw DEP spectra using the single-shell model, calculation of the frequency span of the 
transition region of the DEP spectrum influenced by membrane properties, and calculation of median 
membrane midpoint frequencies. Statistical tests were then performed to determine whether 
employment of these methods resulted in a parameter or parameters for which there were 
significant differences, between the compared OBB sample nature sub-groups.
2.2.4.1 Modelling Raw Results from DEP Testing
2 .2 .4 .1 .1  S a m p le  D ie le c tr ic  C h a ra c te ris tic s  b y  F it t in g  S in g le -S h e ll M o d e l C urve
Cell radii for OBB samples from the OSCC, Dysplastic, Healthy and Normal from OSCC/ Dysplastic 
populations were approximated by loading images recorded during the cell count into the software 
program ImageJ (NIH, USA). ImageJ converted the number of pixels in the selected image into a 
length, selected to be a micrometer (pm) length for these experiments. This was achieved by 
selecting an image that showed part of the larger peripheral counting squares (4 of, arranged into 
smaller 4 x 4  squares) of the haemocytometer. Each side of each of these 16 smaller squares was 
known to be 250 pm, and so this was used, along with the measurement gained by tracing a line 
across one of the sides of these squares (to provide the pixel value for the known distance), to 
convert pixel numbers into micrometer length within the selected image.
The diameters of 50 cells within the selected image were then measured to provide a mean cell 
radius value for each OBB sample. The method for identifying 50 cells was as follows: starting at the 
top left hand corner of the image and working to the top right hand corner, then moving vertically 
down the image slightly and counting from right to left. By doing so, cells were not "selected" due to 
size or appearance, instead a more objective procedure was used that could be repeated for all 
experiments. A line was drawn horizontally, straight through the centre of each cell, from left to right 
cell border and this distance measured. After 50 cells were counted, the measurements were
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summarised and a value for the mean cell diameter was produced in micrometers, from which the 
cell radius was then found by dividing the mean cell diameter by two.
Having gained an approximate mean radius for the cells examined during each DEP experiment, the 
raw DEP spectra from each could be modelled using the single-shelled model [61-63] employed by 
the graphic user interface "DEP_well_plotter" ([59, 60] introduce DEP Well fabrication and data 
acquisition, respectively). A curve governed by the parameters determining the Clausius-Mossotti 
Factor (see equations 3 and 4 of [60]) was fitted to each raw data DEP spectrum. This was achieved 
by entering values for cytoplasmic conductivity (S/m) and permittivity, and membrane conductivity 
(S/m) and permittivity, as well as inputting values for mean cell radius and constant values for 
medium conductivity and permittivity and membrane thickness (values shown in Figure 2.6), as per 
the single-shelled model. This model was subsequently used to estimate values for the following 
cellular dielectric properties: cytoplasmic conductivity (S/m) and permittivity, and membrane 
conductivity (S/m) and permittivity.
Two more cellular dielectric properties, membrane conductance (Gmem, or "Ggf" in Figure 2.6) and 
membrane capacitance (Cmem, or "CEf" in Figure 2.6), were then calculated, by applying the estimated 
values for membrane conductivity [(Jmem) sod permittivity [Emem ) to the following equations [64]:
_ gmem x^O 
^ mem ~  j
Where Eg is the permittivity of free space (8.854187817X 10'^  ^F/m) and d is the cell membrane 
thickness in meters.
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Figure 2.6: DEP_well_plotter GUI used to model raw results from DEP analysis. All fields with numerical values assigned 
were kept constant (i.e. radial bands, evaluation time, scale factors, number of shells considered, membrane thickness [65], 
medium conductivity and medium permittivity).
"Best-fit" was achieved when the highest value for the correlation coefficient (R) was found. DEP 
spectra which achieved an R value > 0.9 between the raw experimental data and the "best-fit" curve 
representing the Clausius-Mossotti Factor (CMF) were deemed model-able and retained for further 
analyses whilst those spectra with an R value < 0.9 were disregarded for the purposes of further 
analyses.
2 .2 .4 .1 .2  P a t ie n t-M a tc h e d  D E P  S p e c tra
Modelled DEP spectra from the same patient (i.e. patient-matched spectra) were also evaluated in 
this study. This was the reasoning behind the collection and DEP testing of normal OBB samples 
(samples collected from a site contra-lateral to the OSCC or dysplastic lesion), and would allow inter­
patient sample variability to be taken into account.
Patient-matched spectra were used to identify whether or not a consistent shift took place, from the 
spectra of one sub-group compared with another (e.g. when comparing OSCC spectra with healthy 
spectra), and to determine if notable differences between the sub-groups were present that could 
perhaps be masked in statistical tests, due to for example, low sample numbers within some of the 
sub-groups.
1 0 0
A small-scale study was also conducted using patient-matched Healthy OBB samples, to determine if 
the site within the oral cavity from which the OBB sample was collected had an effect on the 
dielectric parameters resulting from modelling using the single-shell model. This was achieved by 
comparing OBB samples collected from the buccal (cheek lining) region with those collected from the 
tongue.
2.2A.2 Frequency Span of the Membrane Transition Region of DEP 
Spectra
Another parameter used in this study to attempt to differentiate between OBB samples types was 
the difference, in kilohertz, between the frequency for which the highest change in light intensity 
value was gained and the frequency marking the start of the membrane transition (transition regions 
labelled on Figure 2.7).
As with calculation of the median membrane midpoint frequency, the point at which the membrane 
transition started had to first be defined. For this parameter, the membrane transition was deemed 
to have started at the data point after which all subsequent data points followed an upward trend to 
the maximum change in light intensity value.
Using Figure 2.7 below as an example, the maximum change in light intensity value was found at 400 
kHz, and the data points subsequent to that found at 2.5 kHz follow an upward trend, therefore the 
approximate span of the membrane transition region would be 397.5 kHz for that OBB sample.
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Figure 2.7: A DEP spectrum modelled using the single-shell model, which indicates the areas of the spectrum influenced by 
membrane, suspending medium and cytoplasmic properties.
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This calculation was performed for all successfully tested OBB samples and underwent statistical 
tests to determine if it could be used to discriminate between OBB samples from the OSCC, Normal 
from OSCC/ Dysplastic, Healthy and Dysplastic sub-groups.
2.2.4.3 Median Membrane Midpoint Frequency Analysis
2 .2 .4 .3 .1  T h e o iy
The purpose of examining dielectric parameters is usually to gain a greater understanding of the 
nature of the cells examined, as is the case in both research chapters following this one. Any clear 
and significant differences could, in theory, be used subsequently to distinguish one sample type, 
from another. This is particularly relevant in the study described here, because the highly 
heterogeneous nature of the OBB samples tested meant that it would be very difficult to attribute 
dielectric characteristics, such as membrane capacitance, to any one cell type contained in each 
sample. Therefore, as well as examining OBB sample dielectric characteristics, a novel method was 
developed to distinguish OBB samples from different sub-groups from one another. Median 
membrane midpoint frequencies were calculated from the results generated from DEP testing, using 
the method outlined in this section. Calculation of these frequencies, then application of numerical 
thresholds, provided an alternative approach to possible differentiation of OSCC, Dysplastic and 
Healthy OBB samples.
The theory underpinning the median membrane midpoint frequency stemmed from equation (3). 
Introduced by Benguigui and Lin [66], equation (3) defines the real part of the frequency-dependent 
Clausius-Mossotti Factor {RelKio))])  for the low frequency dispersion (i.e. the part of the DEP 
spectrum governed by the properties of the cells' plasma membranes) as:
E z - E l  . _______ 3(0-2^1 ~  ,
82  +  2 E i  Tmw{(^2  +  2 o - i ) 2  ( l  +  ^
Above, Si and % are the permittivities of the suspending medium and cells respectively, oj and are
the conductivities of the suspending medium and cells respectively, w is the angular frequency in
radians per second (defined as cu =  2 n f ,  where /  is frequency in Hz) and Tmw is the Maxwell-Wagner 
relaxation time, defined as:
£2+£i
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The assumption that the conductivities and permittivities of the cells being tested, together with the 
conductivity and permittivity of their suspending medium, remained constant for the duration of 
each DEP experiment, allowed for the simplification of equation 3 which was then re-written as:
Re[Kdù))] = Q +
7 ( 1  -I- oF-qr)
( 5 )
The constant Q was substituted for the constant p  was substituted for 3((T2^i — atid
the constants/and ^  were substituted for +  2<7i)^ and respectively. For w ^ 0  and
limits of Q +p//an6  Q were found, respectively. Therefore, the constant Q was equal to the 
highest value for change in light intensity.
Similarly, by making C =  { In c p f ,  equation (5) could be re-written as:
Re[K{(û)] = Q +
7 ( 1  +  C / 2 )  7 1 +  C /2
( 6 )
By then denoting the difference between the limits, — -  , as 71, equation (6) could be written as:
Re[K(^(o)] =  Q
(1  +  C /2 )
( 7 )
Re-arrangement of equation (7) to find C for each frequency and associated change in light intensity 
value, the membrane midpoint frequency, for each data point on the membrane transition region, 
was calculated using equation (8):
/ m m  — (8 )
The final step was to calculate the median membrane midpoint frequency from the values, for 
each DEP spectrum. The method for achieving the median membrane midpoint frequency for each 
successfully tested OBB sample is summarised in Figure 2.8, working from left to right. The graphic
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on the left shows an actual raw data spectrum collected from one OBB sample, with two transition 
regions (membrane transition at low frequencies and cytoplamic transition at higher frequencies). 
Modelling of DEP data typically results in producting of a spectrum similar to that seen in the middle 
and right most graphics in Figure 2.8, i.e. a plateau region at low frequencies, followed by a transition 
region defined by cell membrane properties (again at low frequencies), which then levels out to form 
an upper plateau (indicated as Q in Figure 2.8). Though not indictaed in Figure 2.8, this upper plateau 
is then followed by a second transition region at higher frequencies (which is defined by cell 
cytoplamic properties), and a lower plateau level at higher frequencies (like that seen at low 
frequencies). As only the membrane region was examined using the median membrane midpoint 
frequency, the cytoplasmic transition region and lower plateau (which would be a mirror image 
about the vertical axis at the end of the upper plateau region, in the middle and right graphics of 
Figure 2.8) are not shown. In raw data, such as that in the left graphic in Figure 2.8, the plateau 
regions can be difficult to discern visually.
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Figure 2.8: Graphic representation of the process for determining the median membrane midpoint frequency for, each 
spectrum produced as a result of DEP testing. Indicated are the limits generated from equation 5, which form the upper and 
lower plateaus for each combination shown in Table 2.1.
2 .2 A .3 .2  D e te rm in a t io n  o f  P la te a u  Levels
Clearly, in order to determine which data points constituted the membrane transition region and 
therefore contributed to the calculation of the median membrane midpoint frequency for each DEP 
spectrum, the thresholds bounding this region had to be defined first.
Assuming that the membrane transition region would occur in one frequency decade and that this 
transition region would encompass approximately 80% of the overall change in light intensity [67], 
arbitrary values of 10% and 90% of the highest value found for change in light intensity (denoted as 
Q, in the section preceding this) were chosen as the starting plateau threshold values. Therefore, all
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values for change in light intensity <90% and >10% of the value of Q were considered to be part of 
the membrane transition region. A value for A, for each DEP spectrum, could then be defined as the 
difference between the threshold values of the upper and lower plateau regions, i.e. 90% of Q -  10% 
of Q.
However, noise produced by the testing platform or the contents of the cell samples being tested 
could have erroneously placed data points outside the bounds of the membrane transition region. 
Therefore, a number of different combinations of plateau threshold levels were investigated, all of 
which are listed in Table 2.1.
Combination
Name
Upper Pteteau Level Lower Piateau Level ]
Combination 1 Mean Upper 90% Lower 10%
Combination 2 Mean Upper 90% Mean Lower 10%
Combination 3 Mean Upper 90% Lower 41%
Combination 4 Mean Upper 90% Mean Lower 41%
Combination 5 Mean Upper 90% Lower 13%
Combination 6 Mean Upper 90% Mean Lower 13%
Combination 7 Mean Upper 90% Lower 25%
Combination 8 Mean Upper 90% Lower 30%
Combination 9 Mean Upper 90% Lower 27%
Combination 10 Mean Upper 90% Lower 15%
Combination 11 Mean Upper 90% Lower 20%
Combination 12 Upper 95% Lower 25%
Combination 13 Upper 95% Lower 13%
Combination 14 Upper 85% Lower 25%
Combination 15 Upper 85% Lower 13%
Table 2.1: Table detailing all the combinations of upper and lower plateau values used for analysis. The threshold 
percentage values for the lower plateau level had a greater range than those of the upper plateau level because data points 
from the low frequency range were potentially subject to naturally occurring sources of error such as electro-osmosis.
2.2.4.4 Statistical Analysis
Statistical analysis of the study results was conducted using IBM SPSS Statistics version 19.0 (SPSS Inc. 
Chicago, IL), to test if any of the variables examined resulted in significant differences between the
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OBB sample types: OSCC, Dysplastic, Healthy and Normal from OSCC/ Dysplastic. Statistical tests 
were not performed for patient-matched samples, except for those comparing healthy buccal and 
healthy tongue samples.
For the dielectric parameters resulting from the employment of the single-shell model (including 
those from patient-matched healthy buccal and tongue samples) and the calculated frequency span 
of the membrane transition region, the following method was applied. The Kolmogorov-Smirnov test 
for normality was performed on each data set. If all data sets to be compared were deemed 
normally distributed, the t-test was employed to determine if statistically significant differences were 
present. Otherwise, the Mann-Whitney U test for non-parametric data was employed. A p value of 
0.05 was set as the level of significance.
A different approach was used to investigate the median membrane midpoint frequency results. ROC 
(Receiver Operator Characteristic) curves were constructed using SPSS, to determine which of the 15 
combinations listed in Table 2.1 yielded optimum results of sensitivity and specificity for the 3DEP 
DEP-Well system.
The null hypotheses for this body of work, to be accepted or rejected depending on the results of the 
conducted statistical analysis were as follows:
1. There were no statistically significant differences in dielectric, frequency span of membrane 
transition or median membrane midpoint frequency properties of the OSCC sub-group 
compared with the Healthy sub-group.
2. There were no statistically significant differences in dielectric, frequency span of membrane 
transition or median membrane midpoint frequency properties of the Dysplastic sub-group 
compared with the Healthy sub-group.
3. There were no statistically significant differences in dielectric or frequency span of 
membrane transition properties of the OSCC sub-group compared with the Dysplastic sub­
group.
4. There were no statistically significant differences in dielectric or frequency span of 
membrane transition properties of the Healthy sub-group compared with the Normal from 
OSCC/ Dysplastic sub-group.
The purpose of the statistical tests were primarily two-fold: to determine if the DEP testing system 
described here could firstly differentiate between OBB samples from the OSCC and Healthy sub­
groups (as theoretically these sample types would be situated at either end of a tissue normality
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scale) and secondly, could differentiate between OBB samples from the Dysplastic and Healthy sub­
groups. If the DEP testing set-up, used in this study could distinguish between OBB samples from 
OSCC and healthy tissue, and distinguish between OBB samples from dysplastic and healthy tissue, 
then it could provide a viable basis upon which to design a-DEP based early diagnosis of oral tissue 
abnormality kit.
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2.3 Results
In total, 132 OBB samples were collected from 69 consenting participants, of which 107 OBB samples 
were successfully tested using DEP (i.e. yielded results, producing a model-able DEP spectrum). The 
flow chart in Figure 2.9 indicates the quantity of successfully tested samples collected by each clinical 
centre and hence the number of samples contained within each OBB sample classification group.
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D ental Institu te
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N orm al from  
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(N = 7 )
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(N = 2 1 )
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(N =20 |
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Figure 2.9: Flow chart indicating the tissue nature and number of samples collected by clinicians at each clinical centre. The 
UCL Eastman Dental Institute is situated at the summit of this hierarchical diagram because this it was through this clinical 
centre (and lead study clinician Dr Stefa no Fedele) that collaboration with UCLH and Bradford Royal Infirmary were 
organised.
The numbers shown in the flowchart In Figure 2.9 include samples of the same histo-pathological 
nature extracted from the same patient (e.g. two OSCC samples from one patient because the 
patient had two, distinct OSCC lesions). These samples are henceforth referred to as duplicates. 
Duplicate samples were included in the sample sub-groups undergoing statistical testing where the 
purpose was purely to determine the ability of the DEP-Well testing system to distinguish between 
one sub-group and another. Duplicate samples were not considered when the sample population 
was meant to more closely reflect the population of participants providing samples.
2.3.1 Methods Using the Single-Shell Model
2.3.1.1 Dielectric Properties of OBB Samples
Firstly, the dielectric properties of the OBB samples from the OSCC, Dysplastic, Healthy and Normal 
from OSCC/ Dysplastic groups were determined by modelling DEP spectra from each OBB sample
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using the single-shell model, as outlined in the Methods section. Table 2.2 reports the mean + 
standard errors of mean values gained for the dielectric characteristics cytoplasmic conductivity, 
membrane conductance and membrane capacitance. Also noted in Table 2.2 are the cell radii 
approximate measurements, as these were required to model the DEP spectra, and the number of 
OBB samples which generated each mean value.
Of the 107 samples collected (including duplicates), 35.5% were OSCC samples, 11.2% were 
dysplastic, 33.6% were normal samples collected from OSCC and dysplasia patients (from a tissue site 
contra-lateral to that of the sampled OSCC or dysplastic lesion) and 19.6% were samples of healthy 
oral tissue. Of the 89 samples which did not include duplicates, 36% were OSCC, 11.2% were 
dysplastic, 12.4% were Healthy and 40.5% were normal samples collected from OSCC and dysplasia 
patients.
Histo-pathological Nature
OSCCIncluding 
Duplicates 
(Same 
Histo- 
pathological 
Type from 
Same 
Patient)
Excluding 
Duplicates 
(Same 
Histo- 
pathological 
Type from 
Same 
Patient)
Norm al from  
OSCC/ Dysplastic
Healthy
Dysplastic
Norm al from  
OSCC/ Dysplastic
Healthy
Dysplastic
36 27.3 + 0.7
12 25.2 + 0.9
36 27.3 + 0.7
10 25.6 + 0.9
Cytoplasmic Membrane Membrane
Conductivity Conductance Capacitance
(mS/ m) (S/ m )^ (mF/ m )^
169.0 + 24.9 3.1+ 0.3
6.5+ 2.6
269.0 + 75.3 3.1+ 0.5
169.0 + 24.9 3.1+ 0.3
257.8 + 86.8 3.0 + 0.6
Table 2.2: Summary of the number of each sample type (OSCC, Dysplastic, Healthy and Normal from OSCC/ Dysplastic) 
collected during this study, the mean + standard error cell radii approximations and the mean + standard error values for 
each sample type resulting from modelling using the single-shell model. This table also allows comparison of OBB sub­
groups which contain one sample per participant for each sub-group ("excludes duplicates" rows in green) with sub-groups 
which contain more than one sample per participant for each sub-group ("includes duplicates" rows in plum/ pink).
Upon evaluation of Table 2.2, it is apparent that OSCC samples achieved the lowest mean cell radius 
of the four tissue sub-groups tested, 22.7 + 0.6 pm when duplicates were included and 22.0 + 0.6 pm 
when duplicates were excluded. Both the population of samples including and excluding duplicates 
followed the same trend in sample cell radii size-samples from the OSCC sub-group achieved the 
lowest value, followed by samples from the Dysplastic sub-group, then the samples from the Normal
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from OSCC/ Dysplastic sub-group and finally, those samples from the Healthy sub-group achieved the 
largest mean cell radii values (30.2 + 0.4 pm and 30.6 + 0.6 pm for inclusion and exclusion of 
duplicates, respectively). These large differences in mean values (and associated standard errors) 
between the four OBB tissue type sub-groups translated into statistically significant differences for 
OSCC versus Healthy, OSCC versus Healthy and Normal from OSCC/ Dysplasia, OSCC versus 
Dysplastic, Dysplastic versus Healthy and Normal from OSCC/ Dysplastic versus Healthy (Table 2.3).
The range of mean cytoplasmic conductivity values gained by samples from the four OBB sub-groups 
was small, when duplicate samples were included: 46-55 mS/m. Of note is the large standard error 
achieved by samples from the Dysplastic group, the value of which was 23.9% of the mean. This small 
range is reflected in the results seen in Table 2.3, where no significant differences were found 
between the sub-groups. However, the range of mean cytoplasmic conductivity values when 
duplicates were excluded, increased. The lowest value found was 36 mS/m for the Dysplastic group 
and the highest value found was 57 mS/m for the OSCC group, a difference of statistical significance 
(p=  0.048) upon consulting Table 2.3.
Whilst the Dysplastic group achieved the lowest cytoplasmic conductivity values, the same group 
achieved the greatest values of membrane conductance, both when duplicates were included (269.0 
+ 75.3 S/m^) and excluded (257.8 + 86.8 S/m^). The lowest values of membrane conductance were 
achieved by samples from the Healthy and Normal from OSCC/ Dysplastic groups, both when 
duplicates were included and excluded. However, the only significant difference found for membrane 
conductance was for OSCC versus samples from both the Healthy and Normal from OSCC/ Dysplastic 
groups, when duplicates were excluded (p = 0.034). It is possible that no significant differences were 
found between OBB samples from the Dysplastic and either or both of the "normal" groups (Healthy 
and Normal from OSCC/ Dysplastic) because the standard errors for the Dysplastic group were large, 
28% of the mean when duplicates were included and 33.7% of the mean when duplicates were 
excluded.
The only dielectric parameter for which there was a significant difference, between OBB samples of 
the OSCC and Healthy groups, both for included and excluded duplicates, was membrane 
capacitance (p = 0.007 and p = 0.045 respectively, in Table 2.3). The results in Table 2.2 show OBB 
samples from the Healthy group achieved the highest membrane capacitance values (6.5 + 2.6 mF/ 
m  ^when duplicates were included and 9.0 + 5.0 mF/ m  ^when duplicates were excluded). Of note in 
Table 2.2 is that the OSCC group did not achieve the smallest mean membrane capacitance value, 
both the Healthy and Normal from OSCC/ Dysplastic groups achieved lower values with low
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associated standard errors. However, membrane capacitance data from both the OSCC and Healthy 
groups was not normally distributed, whilst data from the Normal from OSCC/ Dysplastic and 
Dysplastic groups was normally distributed.
Including Cell Radius p = 0 .000 p = 0 .000 p = 0 .038 p = 0 .000 p = 0 .000
Duplicates
(Same
Cytoplasmic
Conductivity
p = 0 .559 p = 0 .234 p = 0 .392 p =0.542 p = 0 .338
Histo-
pathological
M em brane
Conductance
p = 0 .384 p = 0.061 p = 0 .668 p = 0 .319 p = 0 .164
Type from  
Same 
Patient)
M em brane
Capacitance
p = 0 .007 p = 0 .034 p = 0.375 p = 0 .326 p = 0 .210
Excluding Cell Radius p = 0 .000 p = 0 .000 p = 0 .004 p = 0 .000 p = 0 .010
Duplicates
(Same
Cytoplasmic
Conductivity
p = 0 .057 p = 0 .082 p = 0 .048 p = 0 .217 p = 0 .785
Histo-
pathological
M em brane
Conductance
p = 0 .496 p = 0 .034 p = 0 .948 p = 0 .650 p = 0 .236
Type from  
Same 
Patient)
M em brane
Capacitance
p = 0 .045 p = 0.172 p = 0 .805 p = 0 .264 p = 0 .259
Table 2.3: Summary of results of statistical tests, for cell radius and calculated sample dielectric properties investigated 
using DEP testing. The p value was set at p -  0.05.
2.3.1.2 Patient-Matched DEP Spectra
DEP spectra from the same patient or participant were compared in this study for two reasons.
Firstly, to evaluate if a consistent trend could be found for OSCC versus normal tissue and dysplastic 
versus normal tissue in terms of their DEP spectra (e.g. spectral shift or crossover frequencies) and 
therefore if patient-matched data could be used to differentiate between OSCC and Healthy or 
Dysplastic and Healthy OBB samples. Secondly, to examine the effects of both intra- and inter-patient 
DEP spectrum variability, as they are both potential sources of error.
2 .3 .1 .2 .1  OSCC vs. N o rm a l P a t ie n t  M a tc h e u  D E P  S p e c tra
A total of 23 patient-matched DEP spectra, i.e. where both the OSCC and Normal from OSCC spectra 
were model-able, were produced (Figures 2.9-2.14) from 23 OSCC patients.
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Figure 2.9: Patient-matched DEP spectra, modelled using the single-shell model, each comparing an OSCC OBB sample and 
a Normal from OSCC OBB sample, collected from a site contra-lateral to the site of the OSCC lesion from tissue deemed to 
be normal (by the trained clinicians collecting the OBB samples). Samples shown are BRD_03 vs. BRD_04 (top left), BRD_11 
vs. BRD_12 (top right), BRD_17 vs. BRD_18 (bottom left) and BRD_27 vs. BRD_28 (bottom right). Samples with "BRD" in 
their name were collected by trained surgeons and nurses at Bradford Royal Infirmary.
Upon viewing Figure 2.9, it appears that all four patient-matchecJ spectra differ from each other. A 
plot from one patient (BRD_17 vs. BRD_18) shows a clear shift of the OSCC spectrum to the right of 
the normal spectrum. Another plot shows only the normal spectrum to have a low frequency 
crossover (BRD_03 vs. BRD_04), contrary to what is suggested by the plots of both BRD_11 vs. 
BRD12 and BRD_27 vs. BRD 28. The plot of BRD_11 vs. BRD12 shows the OSCC and normal DEP 
spectra to be almost identical, particularly at low frequencies, whereas the plot of BRD 27 vs.
BRD 28 shows neither the OSCC spectrum nor the normal spectrum to have a low frequency 
crossover.
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Figure 2.10: Patient-matched DEP spectra, modelled using the single-shell model, each comparing an OSCC OBB sample and 
a Normal from OSCC OBB sample. Samples shown are BRD_29 vs. BRD_30 (top left), BRD_33 vs. BRD_34 (top right), BRD_39 
vs. BRD_40 (bottom left) and BRD_41 vs. BRD_42 (bottom right).
A similar lack of consensus of DEP spectral properties is apparent when viewing Figure 2.10. Of the 
plots from four different patients, two show positive DEP to occur over a smaller range of 
frequencies for the normal spectrum compared to the OSCC spectrum (BRD_29 vs. BRD_30 and 
BRD_33 vs. BRD 34) but the remaining two plots show the opposite to be true (BRD_39 vs. BRD_40 
and BRD 41 vs. BRD_42). Of these four plots, three show both the OSCC and normal spectra to have 
lower (and upper) crossover frequencies (BRD 33 vs. BRD 34, BRD_39 vs. BRD 40 and BRD 41 vs. 
BRD 42). However, in the plot showing BRD_29 vs. BRD 30, only the normal spectrum had crossover 
frequencies.
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Figure 2.11: Patient-matched DEP spectra, modelled using the single-shell model, each comparing an OSCC OBB sample and 
a Normal from OSCC OBB sample. Samples shown are BRD_45 vs. BRD_46 (top left), BRD 47 vs. BRD_48 (top right), BRD_49 
vs. BRD_50 (bottom left) and BRD_53 vs. BRD_54 (bottom right).
Two plots in Figure 2.11 show positive DEP to occur over a narrower range of frequencies for OSCC 
spectra than for normal spectra (BRD_45 vs. BRD_46 and BRD_49 vs. BRD_50). Both these plots 
suggest that there is no low frequency crossover for either the OSCC spectra or the normal spectra. 
Also in Figure 2.11, the plot of BRD_53 vs. BRD_54 shows the OSCC and normal spectra to be similar 
in shape and character from 16-100 kHz, but shows that only the normal spectrum has a low 
frequency crossover. Of note in Figure 2.11, is how similar the OSCC and normal spectra are in the 
plot showing BRD 47 vs. BRD 48, in stark contrast to the BRD_45 vs. BRD 46 and BRD 49 vs.
BRD SO plots.
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Figure 2.12: Patient-matched DEP spectra, modelled using the single-shell model, each comparing an OSCC OBB sample and 
a Normal from OSCC OBB sample. Samples shown are BRD_57 vs. BRD_58 (top left), BRD_63 vs. BRD_64 (top right), BRD_67 
vs. BRD_68 (bottom left) and BRD_71 vs. BRD 72 (bottom right).
As is the case in Figures 2.9-2.11, Figure 2.12 features plots in which the OSCC and normal spectra 
are almost identical (BRD_57 vs. BRD_58 and BRD_71 vs. BRD_72), and plots in which the OSCC and 
normal spectra differ but for which a consistent trend is not seen (BRD_63 vs. BRD_64 and BRD_67 
vs. BRD_68).
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Figure 2.13: Patient-matched DEP spectra, modelled using the single-shell model, each comparing an OSCC OBB sample and 
a Normal from OSCC OBB sample. Samples shown are MF_05 vs. MF_06 (top left), MF_07 vs. MF_08 (top right), MF_10 vs. 
MF_09 (bottom left) and MF_13 vs. MF_14 (bottom right). Samples with "MF" in their name were collected by trained 
maxillofacial surgeons and nurses at University College Flospital London.
Of the plots shown in Figure 2.13, MF_10 vs. MF_09 shows the OSCC and normal spectra to be 
similar in shape and characteristics and MF_05 vs. MF_06 suggests that both the OSCC and normal 
spectra to have very similar low crossover frequencies. The plot of MF_13 vs. MF_14 shows positive 
DEP to occur over a narrower range of frequencies for the OSCC spectrum compared with the normal 
spectrum, whilst in the plot of MF_07 vs. MF_08 the range for frequencies over which positive DEP 
occurs are similar, but the normal DEP spectrum appears to be shifted to the right of the OSCC 
spectrum.
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Figure 2.14: Patient-matched DEP spectra, modelled using the single-shell model, each comparing an OSCC OBB sample and 
a Normal from OSCC OBB sample. Samples shown are MF_15 vs. MF_16 (top left), OBB_134 vs. OBB_135 (top right) and 
OBB_162 vs. OBB_163 (bottom left). Samples with "OBB" in their name were collected by the study's lead clinician Dr 
Stefa no Fedele at the UCL Eastman Dental Institute, London.
Finally, when viewing Figure 2.14, two of the three plots shown, MF_15 vs. MF_16 and OBB_134 vs. 
OBB_135, suggest positive DEP occurs over a smaller frequency range for OSCC spectra compared 
with normal spectra, and that OSCC spectra have a greater low crossover frequency than normal 
spectra. The plot of 0 B B 1 62  vs. 0 B B 1 63  however shows the OSCC and normal spectra to be very 
similar.
2.3.1.2.2 Dysplastic vs. Normal Patient-Matched DEP Spectra
Figure 2.15 shows patient-matched plots of dysplastic DEP spectra vs. normal DEP spectra.
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Figure 2.15: Patient-matched DEP spectra, modelled using the single-shell model, each comparing a Dysplastic OBB sample 
and a Normal from Dysplastic OBB sample, collected from a site contra-lateral to the site of the dysplastic lesion from tissue 
deemed to be normal (by the trained clinicians collecting the OBB samples). Samples shown are BRD_09 vs. BRD_10 (top 
left), MF_17 vs. MF_18 (top right), OBB_110 vs. OBB l l l  (middle row, left) and 0B B 1 1 2  vs. 0B B 1 1 3  (middle row, right), 
OBB_133 vs. OBB_132 (bottom left) and OBB_136 vs. OBB_137 (bottom right). Samples with "BRD" in their name were 
collected by trained surgeons and nurses at Bradford Royal Infirmary, those with "MF" in their name were collected by 
trained maxillofacial surgeons and nurses at University College Flospital London, and those with "OBB" in their name were 
collected by the study's lead clinician Dr Stefa no Fedele at the UCL Eastman Dental Institute, London.
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Of the six plots in Figure 2.15, one (OBB_110 vs. 0BB_111) shows the dysplastic spectrum to be 
similar in shape and character (e.g. no low crossover frequency) to the normal spectrum and one 
(OBB_133 vs. 0B B 132 ) shows positive DEP to occur over a smaller frequency range for the normal 
spectrum compared with dysplastic spectrum. Whilst inter-patient variability of DEP spectra is clear 
for Dysplastic vs. Normal OBB samples, 66.7% of the plots in Figure 2.15 share a common feature- 
four (BRD_09 vs. BRD_10, MF_17 vs. MF_18, 0BB_112 vs. 0BB_113 and OBB_136 vs. OBB_137) show 
positive DEP to occur over a smaller frequency range for dysplastic spectra compared with normal 
spectra.
2.3.1.2.3 OSCC V5. Dysplastic Patient-Matched DEP Spectra
The samples collected yielded only one patient-matched OSCC vs. Dysplastic plot, shown in Figure 
2.16. Figure 2.16 shows the DEP spectrum produced by the Dysplastic sample does not undergo any 
negative DEP, whereas the spectrum produced by the OSCC sample does undergo both negative and 
positive DEP and therefore has crossovers.
Palieni matched DEP Spectra OBB 164 (OSCC) vs OBB 166 (Dysplastic)
A OSCC
0  Dysplastic
■0 5
Frequency (Hz)
Figure 2.16: Patient-matched DEP spectra, modelled using the single-shell model, comparing an OSCC OBB sample 
(OBB_164) and a Dysplastic OBB sample (OBB_165), collected by the study's lead clinician Dr Stefa no Fedele at the UCL 
Eastman Dental Institute, London.
2.3.1.2.4 OSCC vs. OSCC Patient-Matched DEP Spectra
Two OBB samples from OSCC lesions were sampled and both tested, successfully producing model- 
able DEP spectra, from five patients. These patient-matched OSCC vs. OSCC spectra are shown in 
Figure 2.17.
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Figure 2.17: Patient-matched DEP spectra, modelled using the single-shell model, each comparing two OSCC OBB samples, 
collected by the study's lead clinician Dr Stefa no Fedele at the UCL Eastman Dental Institute, London. Samples shown are 
OBB_148 vs. OBB_149 (top left), OBB_150 vs. 0BB_151 (top right), OBB_156 vs. OBB_157 (middle row, left) and OBB_166 
vs. OBB_167 (middle row, right) and 0 B B 1 6 8  vs. OBB_169 (bottom left).
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It can be seen that, despite being sampled from OSCC lesions from the same patient, four of the five 
plots show differing DEP spectra, whilst only one (OBB_156 vs. OBB_157) shows the two DEP spectra 
to be almost identical. Of note, the plot of 0 B B 1 6 8  vs. OBB 169 shows the two OSCC DEP spectra 
to have different shapes, as one of the OSCC samples produced a spectrum which showed no 
negative DEP occurring and a narrow frequency range between the membrane-associated and 
cytoplasmic-associated transition regions.
2.3.1.2.5 Dysplastic vs. Dysplastic Patient-Matched DEP Spectra
Figure 2.18 shows two plots comparing the DEP spectra resulting from two dysplastic samples each 
being collected from two patients.
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Figure 2.18: Patient-matched DEP spectra, modelled using the single-shell model, comparing two Dysplastic OBB samples, 
collected by the study's lead clinician Dr Stefa no Fedele at the UCL Eastman Dental Institute, London. Samples shown are 
OBB_146 vs. OBB_147 (left), OBB_152 vs. OBB_153 (right).
It would be expected that if the degree of dysplasia (i.e. mild, moderate or severe) was the same for 
both samples from each patient, then the DEP spectrum from each should have been very similar. 
This appears to be correct for the plot of 0B B 1 52  vs. OBB_153, where both spectra are overlapping 
and look to have very similar low frequency crossovers. However, the spectra shown in the plot of 
0 B B 1 4 6  vs. 0B B 1 47  are not similar to the same extent as 0 B B 1 5 2  vs. OBB_153, and neither 
OBB_146 nor 0 B B 1 47  demonstrate a low frequency crossover.
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2.3.1.3 Examination of DEP Spectra and Statistics fo r Healthy Buccal vs. 
Healthy Tongue
Statistical tests and participant-matched DEP spectra were used to investigate if different tissues 
within the oral cavity (in this case from buccal and tongue tissue) produced OBB samples with 
different dielectric characteristics.
Table 2.6 details the mean + standard error values recorded for samples collected from the buccal 
and tongue regions, following successfully modelling of the raw results of DEP testing of OBB samples 
from both tissue regions.
Cell Radius (pm)
Cytoplasmic 
Conductivity 
(mS/ m)
Membrane 
Conductance 
(S/ m")
Membrane 
Capacitance 
(mF/ m )^
wêêB S bBÊÊ
Oral Region 
Samples Recovered 
From
Buccal (N= 11)
Tongue (N = 6)
Table 2.6: Summary of mean + standard error values for cell radius, and cellular dielectric parameters, gained when OBB 
samples were collected from healthy buccal tissue (row in plum) compared with samples collected from healthy tongue 
tissue (row in green).
From the results shown in Table 2.6, it can be seen that the mean cell radius for cells collected from 
the buccal region in healthy tissue is greater than the mean cell radius for cells collected from the 
tongue region in healthy tissue, and small associated standard errors elevates this difference to a 
significant level, gaining a p value of p = 0.038 in Table 2.7. This was the only significant difference 
found for samples from the two different regions of the oral cavity (Table 2.7). OBB samples from 
healthy buccal tissue achieved a mean membrane capacitance level three times greater than that 
achieved by OBB samples from healthy tongue tissue (9.3 mF/ m  ^and 3.2 mF/ m^ respectively) but 
the standard error for buccal OBB samples was 52.7% of the mean value and the standard error for 
tongue OBB samples was 25% of the mean value, therefore no significant difference was found in 
terms of membrane capacitance.
1 2 2
Sample Cell Radii and Dielectric Healthy Buccal vs. Healthy Tongue 
Parameters OBB Samples
Cell Radius 
Cytoplasmic Conductivity 
M em brane Conductance 
M em brane Capacitance
p = 0.038 
p = 0.089 
p = 0.966 
p = 0.404
Table 2.7: Summary of results of statistical tests, for cell radius and calculated sample dielectric properties investigated 
using DEP testing, comparing OBB samples from buccal tissue with those from tongue tissue. The p value was set at p = 
0.05.
Four participant-matched DEP spectra, showing the DEP spectra resulting from one buccal and one 
tongue OBB sample per participant, are shown in Figure 2.19. As with the patient-matched spectra 
shown previously in this Results section, there appears to be a degree of inter-participant variability. 
In two of the four plots (0BB_118 vs. 0 B B 1 1 9  and OBB_122 and OBB_123) the DEP spectrum from 
the tongue sample is shifted to the right of the DEP spectrum from the buccal sample, but in the 
remaining two plots in Figure 2.19 (0BB_116 vs. 0BB_117 and 0 B B 1 21  and OBB_120), the DEP 
spectrum from the tongue sample has a narrower frequency range between the membrane- 
associated and cytoplasmic-associated transition regions than the DEP spectrum from the buccal 
sample.
It is noticeable however, that all four plots in Figure 2.19 follow a basic trend; the membrane- 
associated transition of DEP spectrum from the tongue sample is shifted to the right of the 
membrane-associated transition of DEP spectrum from the buccal sample.
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Figure 2.19: Participant-matched DEP spectra, modelled using the single-shell model, each comparing a Healthy OBB 
sample from buccal tissue and a Healthy OBB sample from tongue tissue, collected by the study's lead clinician Dr Stefa no 
Fedele at the UCL Eastman Dental Institute, London. Samples shown are 0BB_116 vs. 0BB_117 (top left), 0BB_118 vs. 
0BB_119 (top right), 0B B 1 2 1  vs. OBB_120 (bottom left) and OBB_122 vs. 0B B 1 2 3  (bottom right).
2.3.2 Methods Using Raw Data Generated bv DEP Testing
The results presented thus far in this section were generated having modelled the DEP spectrum 
gained by each OBB sample, using the single-shell model. However, two variables were also explored, 
which did not require application of the single-shell model. Rather, they were generated using the 
raw change in light intensity as a function of frequency, time and Well radius data output from each 
DEP experiment on each sample. To be able to compare the results gained using these variables with 
those gained using the single-shell model, only those samples considered model-able were used to 
investigate the two variables detailed below.
124
2.3.2.1 Frequency Span of the Membrane Transition Region of DEP 
Spectra
The first of the two variables investigated which used raw DEP data, was the frequency span of the 
membrane transition region of the DEP spectra, i.e. the difference between the frequency at which 
the membrane transition was deemed to have ended and the frequency at which it was deemed to 
have started. Details on how these start and end points were determined are given in the Methods 
section of this chapter.
Mean Length (kHz) of the Membrane Transition Region from DEP Spectra 
(inciuding Dupiicates)
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Figure 2.20: Mean + standard error bar chart for the frequency span in kilohertz of the membrane transition region. The 
sub-groups used to generate this bar chart included duplicates. The bar chart which resulted when duplicates were 
excluded is not shown, as the trend was identical, but the mean values were marginally different (as can be seen in Table 
2 .8 ).
Upon viewing the results show in the bar chart in Figure 2.20, there is a notable difference in mean 
frequency span of the membrane transition region values achieved by the OSCC and Healthy groups, 
and between the OSCC and Dysplastic groups, even when standard errors are considered. The OSCC 
group achieved the highest mean value, 560.4 + 70.4 kHz and the Healthy group achieved the lowest 
mean value, 226.7 + 51.3 kHz (according to the results in Table 2.8). Table 2.8 also gives the result for 
the Dysplastic group as 269.3 + 67.7 kHz. These mean and associated error values resulted in 
significant differences being found for the OSCC group vs. Healthy group (p = 0.000) and for the OSCC 
group vs. Dysplastic group (p = 0.005). No other significant differences were found when duplicates
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were included in the test populations (Table 2.9), although the test for the Normal from OSCC/ 
Dysplasia group vs. the Healthy group gained a p value of p = 0.057.
It is noticeable in Figure 2.20 and Table 2.8 that whilst the OSCC group and the Healthy group 
achieved the highest and lowest mean values for frequency span of the membrane transition region, 
respectively (as may be expected, given these two tissue types should be the most different of the 
four), the Normal from OSCC/ Dysplastic group achieved a value that was higher than that of the 
Dysplastic group and lower than that of the OSCC group.
Normal from 
OSCC/ Dysplastic Healthy Dysplastic
Table 2.8: Summary of the mean + standard error values for the frequency span of the membrane transition region, 
comparing values gained when duplicates were included with those gained when duplicates were excluded.
OSCC vs. 
Healthy
OSCC vs. 
Dysplastic
Dysplastic
vs.
Healthy
Normal 
from OSCC/ 
Dysplasia vs. 
Healthy
Length of 
Membrane
Transition Region p = 0 .000  p = 0 .005  p = 0 .183  p = 0 .057
(kHz), Including 
Duplicates 
Length of 
Membrane
Transition Region p = 0 .002  p = 0 .065  p = 0 .244  p = 0 .076
(kHz), Excluding 
Duplicates
Table 2.9: Summary of results of statistical tests, for the frequency span of the membrane transition region, upon 
comparison of the OBB sub-groups listed. The p value was set at p = 0.05.
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23.2.2 Median Membrane Midpoint Frequency
The second of the two variables investigated which used raw DEP data, was the median membrane 
midpoint frequency. Using the upper and lower plateau combinations listed in Table 2.1 (Methods 
section) the median membrane midpoint frequencies (MMMFs) were generated. ROC curves were 
used to determine the sensitivity and specificity, for OSCC vs. Healthy, and Dysplastic vs. Healthy, 
achieved for each of the 15 combinations in Table 2.1. The ROC curves of the three combinations 
which achieved the highest values for sensitivity and specificity for both OSCC vs. Healthy and 
Dysplastic vs. Healthy are shown in Figures 2.21 and 2.22, respectively.
Figure 2.21 and Table 2.10 give details of the combinations which achieved the highest values for 
sensitivity and specificity when investigating how precisely the DEP testing setup and M M M F analysis 
of raw DEP results could distinguish between OSCC and Healthy OBB samples.
ROC Curve: OSCC vs. Healthy OBB Samples
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Figure 2.21: ROC (Receiver Operator Characteristic) curves produced using the "ROC curve" function in SPSS, for the three 
combinations (combinations 1 ,13 and 5 from Table 2.1 in the Methods section) which resulted the highest percentage 
sensitivities and specificities when comparing median membrane midpoint frequencies of OSCC and Healthy OBB samples.
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Mean Lower
Upper 90% 10%
j Upper 95% jI Lower 
1 13%
Mean Lower
Upper 90% 13%
Mean Upper
90%'Lower 0.792
10%
Upper 95%- 0.811Lowerl3%
Mean Upper
90%-Lower 0.805
13%
Sensitivity Specificity
Decision
Threshold
Frequency
(kHz)
81.6%
84.2%
78.9%
81.0% 46.Î
76.2% 38.7
81.0% 50.7
Table 2.10: Summary of the numerical results associated with the ROC curves shown in Figure 2.21.
Upon evaluation of the results shown in Table 2.10, it can be seen that Combinations 1 ,13  and 5 
achieved the highest values of sensitivity and specificity for OSCC vs. Healthy. Of these. Combination 
1 achieved values for sensitivity and specificity which were both above 80% (81.6% and 81.0%, 
respectively), when the threshold frequency was set to 46.8 kHz. This result implied that the DEP 
testing and M M M F analysis set-up was able to correctly identify OSCC OBB samples in 81.6% of cases 
and was able to correctly identify Healthy OBB samples in 81% of cases. The highest value for 
sensitivity was achieved by Combination 13 (84.2%), however this was seemingly at the expense at 
the level of specificity achieved (76.2%).
Figure 2.22 and Table 2.11 give details of the combinations which achieved the highest values for 
sensitivity and specificity when investigating how precisely the DEP testing setup and M M M F analysis 
of raw DEP results could distinguish between Dysplastic and Healthy OBB samples.
128
ROC Curve: Dysplastic vs. Healthy OBB Samples
g0)(O
0 .2-
0 .0-
0.4 0.6
1 - Specificity
Source of the Curve
Median Membrane Mdpolnl 
“ Frequency from Ban 13 
(kHz)
Median Membrane Mdpoini
-  Frequency from Ban 14 
(kHz)
Median Membrane Mdpoini 
Frequency from Bqn 15 
(kHz)
Median Membrane Mdpoini
-  Frequency from Bin 4 
(kHz)
Reference Line
Figure 2.22: ROC curves for the four combinations (combinations 13 ,14 ,1 5  and 4 from Table 2.1 in the Methods section) 
which produced the highest percentage sensitivities and specificities when comparing median membrane midpoint 
frequencies of Dysplastic and Healthy OBB samples. Four rather than three combinations are detailed because two of the 
ROC curves shown generated identical percentage levels for sensitivity and specificity (Table 2.11).
Upper Lower Upper 95%-
95% 13% Lower 13%
Upper j Lower Upper 85%-
85% 1 25% , Lower 25%
Upper Lower Upper 85% -
85% 13% Lower 13%
M ean M ean M ean Upper
Upper Lower 90%  - M ean
90% 41% Lower 41%
0.698 66.7% 85.7% 45 .0
0.683 66.7% 85.7% 49 .1
0.667 66.7% 81.0% 37.4
0.725 66.7% 75.0% 43 .6
Table 2.11: Summary of the numerical results associated with the ROC curves shown in Figure 2.22.
As is evident upon viewing Table 2.11, four combinations are listed, as Combinations 13 and 14 
achieved the same levels of sensitivity and specificity (66.7 % specificity and 85.7 % sensitivity). Of 
note, all four combinations listed in Table 2.11 achieved sensitivities of 66.7%, which meant all four 
combinations correctly identified dysplastic OBB samples in 66.7% of cases.
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2.4 Discussion
The aim of this study was to determine if the DEP testing (DEPtech 3DEP DEP-Well) and analyses 
systems presented in this study could be used to distinguish between cells collected via brush biopsy 
from cancerous oral tissue, potentially-malignant oral tissue and normal oral tissue. Fulfilment of this 
aim would suggest that the DEPtech 3DEP DEP-Well system, in conjunction with sampling via oral 
brush biopsy, could then form the basis of a minimally-invasive early diagnosis test kit for oral cancer 
and potentially-malignant lesions.
In this section, the researcher will interpret, and seek to provide implications and supply context for, 
the results presented in the preceding section. The limitations of this study in its current form will be 
discussed, as will possible solutions for the removal of these limitations and ideas for future 
development of the study.
2.4,1 Dielectric Properties of Oral Brush Biopsy Samples
The ex-vivo study presented in this chapter succeeded in-vitro work by Mulhall and colleagues [55], 
in which the dielectric characteristics of normal oral primary cell-line kératinocytes, pre-cancerous 
cell-line kératinocytes and cancerous cell-line kératinocytes were examined using the 3DEP DEP-Well 
testing system used in this study. The work by Mulhall and colleagues concluded that oral cancer 
cells achieved greater membrane capacitance values than oral dysplastic cells, which achieved 
achieved greater membrane capacitance values than normal oral cells, but found the opposite trend 
for cytoplasmic conductivity.
In the present study however, the OBB sample group which achieved the greatest mean membrane 
capacitance was the Healthy group (6.5 + 2.6 mF /m^), and the lowest mean membrane capacitance 
was achieved by samples from the Dysplastic and the Normal from OSCC/ Dysplastic groups (3.1 + 0.5 
mF/m^ and 3.1 + 0.3 mF/ m^ respectively). OBB samples comprising the OSCC group achieved the 
greatest mean cytoplasmic conductivity (55 + 5 mS/ m), with OBB samples comprising the Healthy 
group achieving the second greatest mean cytoplasmic conductivity (52 + 3 mS/ m).
The disparity between the ex vivo results presented in this study and the in vitro results presented in 
the study by Mulhall and colleagues could be partly due to the heterogeneity of OBB samples, be 
they from healthy, dysplastic or cancerous tissue. Rovers Medical Devices B.V., the manufacturers of 
the 0  reel lex brushes used in this study, state that their brushes collect cells from all layers of oral
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epithelial tissue [68]. This implies that oral epithelial cells from four different layers in keratinized 
tissue and five different layers in non-keratinzed tissue [69], each possessing a different phenotype 
according to the layer they constitute [69], would theoretically be found in samples from healthy, 
normal oral epithelial tissue. Additionally, after performing the recommended 10 rotations of the 
brush head during the brush biopsy procedure [68], erythrocytes (red blood cells, RBCs) were also 
regularly found, in small concentrations, in Healthy OBB samples. If epithelial cells from each layer 
were to be considered as distinct cell types, for the purposes of modelling (as they possessed 
different radii and phenotypes), and if RBCs were also present, that would result in five or six 
different cell types being present in OBB samples from healthy oral tissue. This number does not 
included a variety of other cell types such as melanocytes and Langerhans cells also found in normal 
oral epithelium [69]. The number of different cell types contained in dysplastic and OSCC samples 
would theoretically be even greater, due to the presence of immune cells (such as macrophages, 
leukocytes and lymphocytes) and cancer-associated fibroblasts [69].
Therefore, the DEP spectra produced by OBB samples from all four tissue groups examined in this 
study, were in fact mean spectra produced by contributions from the multiple cell types present in 
each sample. Whilst significant differences between OSCC and Healthy OBB samples were found 
when examining membrane capacitance (p = 0.007 when duplicate samples were included and p = 
0.045 when duplicate samples were excluded), it remains to be seen which of the multiple cell types 
contained within each OBB sample contributed to this significant difference. Membrane capacitance 
reflects the ability of the plasma membrane to store electrical charge, and increased surface area 
results in an increase in membrane capacitance. The surface area of the membrane can be increased 
due to the presence of microvilli, membrane folds or any form of membrane protrusion. However, it 
is not possible, in the present form of this study, to attribute this increased membrane capacitance of 
cells from healthy tissue when compared to cells from OSCC tissue, to one particular cell type.
One other significant difference in dielectric properties was found. Upon consulting the results 
shown in Table 2.3, the mean cytoplasmic conductivity of cells from OSCC samples was significantly 
different to that of cells from samples of oral dysplasia (p = 0.048). However, this difference was not 
considered significant when the previously excluded samples were included (Table 2.3 of the Results 
section). Cytoplasmic conductivity, the ability of the cell cytoplasm to conduct electric charge, is 
indicative of cytoplasmic ionic content but, as was the case with membrane conductance, it is not 
possible to attribute the increased value for cells from OSCC samples compared with cells from 
samples of oral dysplasia, to the ionic content of one cell type. No significant differences were found, 
for any of the OBB sample classification groups examined, in terms of membrane conductance when
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duplicate samples were included, though a significant difference was found for OSCC vs. All Normal 
(Healthy and Normal from OSCC/ Dysplasia) samples when duplicates were excluded (p = 0.034,
Table 2.3).
Of note, other than for mean cell radius (a variable not determined by DEP testing, rather required 
for calculation of two dielectric properties), there were no significant differences in dielectric 
properties found when comparing cells from Dysplastic OBB samples with cells from Healthy OBB 
samples. This result suggested that the dielectric properties cytoplasmic conductivity, membrane 
conductance and membrane capacitance could not be used to differentiate between dysplastic and 
healthy oral tissue.
Considering the highly heterogeneous nature of OBB samples, it is possible that the disparity 
between the results in the present study and those in the study by Mulhall and colleagues is also 
partly due to the application of a model (the single-shell model) which assumes all cells to be 
spherical, and of similar radii (as only one mean radius value is considered). It could therefore be 
argued that the application of this model to OBB samples, was inappropriate, hence the reason 
behind the development and examination of two, novel variables in this study: the frequency span of 
the membrane transition region of DEP spectra and the median membrane midpoint frequency.
2.4.2 Frequency Span of the Membrane Transition Region
The first of two novel variables examined in this study was the frequency span of the membrane 
transition region. This variable was defined as the difference between the frequency for which the 
highest value of change in light intensity was found and the frequency whose associated change in 
light intensity value was followed by a trend in increasing change in light intensity values.
Upon consulting the results shown in Tables 2.8 and 2.9, the mean frequency span of the membrane 
transition region of OSCC DEP spectra (560.4 + 70.4 kHz) was significantly greater than the mean 
frequency span of the membrane transition region of Healthy DEP spectra (226.7 + 51.3 kHz), 
achieving a p value of p = 0.000. The mean frequency span of the membrane transition region of 
OSCC DEP spectra was also significantly greater than the mean frequency span of the membrane 
transition region of Dysplastic DEP spectra (269.3 + 67.7 kHz), achieving a p value of p = 0.005.
These results suggest that the gradient of the membrane transition region of OSCC DEP spectra was 
less than the gradient of the membrane transition region of both Healthy OBB samples and
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Dysplastic OBB samples. Many of the membrane transition regions, particularly those of OSCC 
samples, occurred over a wide range of frequencies, more than the one decade (i.e. the end point 
frequency being a multiple of 10 of the start point frequency) estimated by Broche and colleagues 
[67]. However, this again could be due to the lack of adherence of OBB samples to the assumptions 
made when employing the single-shell model.
Of note, as was found when examining the sample dielectric properties, no significant differences 
were found when comparing cells from Dysplastic OBB samples with cells from Healthy OBB samples, 
when using the frequency span of the membrane transition region as the variable of choice.
2.4.3 Median Membrane Midpoint Frequency
The second of two novel variables examined in this study was the median membrane midpoint 
frequency. This, in short, involved the calculation of a midpoint frequency for all points considered to 
be part of the low frequency dispersion (governed by the properties of the cell membrane), and of 
these midpoints, finding the median value.
Theoretically, this would lessen the impact of data points in the raw DEP spectra considered to be 
outliers (i.e. not following any trend adhered to by the data points before and after it), which had a 
great impact on the results of modelling and use of the correlation R value. The median membrane 
midpoint frequency also dispensed with the need to consider cell radius, which was required to be 
estimated to calculate the dielectric properties membrane conductance and membrane capacitance. 
The results of applying the plateau level combinations in Table 2.1 (Methods section), which gained 
the highest values of sensitivity and specificity when comparing OSCC and Healthy OBB samples, can 
be seen in Figure 2.21 and Table 2.10 in the Results section of this chapter.
Combination 1 was the only combination tested which gained sensitivity and specificity values 
greater than 80%, achieving a sensitivity of 81.6% and a specificity of 81.0%. For this combination, 
data points of a value of 90% or greater of the maximum value of change in light intensity were 
considered part of the plateau signalling the end of the membrane transition region, then an average 
of these data points was found, to provide a mean value for this plateau (variable Q in equation 7), 
whilst the lower plateau was deemed to consist of data points with a value of 10% or lower of the 
maximum change in light intensity. However, the percentage sensitivity found for Combination 1 was 
not the greatest value achieved, using median membrane midpoint frequencies to differentiate 
between OSCC and Healthy OBB samples.
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The highest value achieved for sensitivity was 84.2%, found for Combination 13 whose plateaus were 
deemed to consist of data points with a change in light intensity value of 95% or greater of the 
maximum change in light intensity and those with a change in light intensity value of 13% or less of 
the maximum change in light intensity. This increase in sensitivity was seemingly at the expense of 
the level of specificity achieved, as this was less than 80% (76.2%). The third highest values of 
sensitivity and specificity were achieved by use of Combination 5 (sensitivity = 78.9% and specificity = 
81%).
Achieving high values for sensitivity and specificity when comparing OSCC OBB samples with samples 
collected from normal oral epithelial tissue was considered essential, as the purpose of this study 
was not only to evaluate the ability of the current DEP testing and analysis setup to distinguish 
between OSCC and Healthy OBB samples, but to evaluate the ability of the current setup to 
distinguish between Dysplastic and Healthy OBB samples. Figure 2.22 and Table 2.11 summarise the 
best results achieved for sensitivity and specificity when comparing Dysplastic OBB samples with 
Healthy OBB samples. For all four of the best combinations listed in Table 2.11, the sensitivity 
remained constant at 66.7%, indicating that the DEP testing setup and subsequent analysis of results 
using M M M F correctly identified dysplasia in 66.7% of Dysplastic OBB samples. Three of the four 
combinations (13 ,14  and 15) all achieved specificities of >80%, meaning the DEP testing setup and 
subsequent analysis of results using M M M F correctly identified normal tissue in >80% of Healthy 
OBB samples. When OSCC and Dysplastic samples were grouped together as Abnormal OBB samples, 
and tested against Healthy OBB samples using ROC curves the highest values of sensitivity and 
specificity were 80% and 76.2% respectively, achieved by Combination 13 at a decision threshold of 
38.7kHz.
Upon comparison with diagnostic and detection devices and methods for oral cancer and pre­
malignancy, detailed in published literature, the testing system presented in this study, combining 
brush biopsies with DEP testing, with results analysis using the median membrane midpoint 
frequency as a discriminating factor, achieved results similar to some, but with lower sensitivity and 
specificity than others. A review by Trullenque-Eriksson and colleagues [70] stated that the 
sensitivities of the VELscope and Oral CDx systems ranged from 98-100% and 71.4%-100, respectively 
and specificities ranged from 94-100% and 32-100%, respectively. Therefore, upon comparison with 
these results, the results gained in this study, when considering OSCC and Dysplastic OBB samples as 
one grouping, were better than results reported by some groups for Oral CDx, but rendered this 
system as noticeably less sensitive and specific than the VELscope autofluorescence system. 
Therefore, in order to be considered as a potentially valuable tool for the early diagnosis of oral
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cancer, the DEP testing system coupled with analysis of the median membrane midpoint frequency 
would have to achieve an overall sensitivity of 90% or greater, to compete with other technologies in 
published literature.
One point to note, however, is that not all studies evaluating oral cancer diagnostic and detection 
methods performed scalpel biopsy with associated histopathological analysis for all suspicious lesions 
analysed, a point made by both Lingen and colleagues [51] and Fedele [71]. All samples from OSCC 
and dysplastic lesions analysed in the study presented here were tested using the "gold standard" 
scalpel biopsy. Of interest, one study which evaluated the performance of the VELscope system for 
recognizing potentially malignant lesions, in which scalpel biopsies were performed in all cases, 
found the highest level of sensitivity achieved by the VELscope (when combine with the conventional 
oral exam) was 46%, with a specificity of 69% [32]. Another study, evaluating the Oral CDx system, 
which also performed scalpel biopsies on all suspicious lesions whose results contributed to the 
calculations of sensitivity and specificity, found the values of each to be 71.4% and 32%, respectively 
[45]. Therefore the DEP-Well system combined with M M M F analysis of DEP raw results obtained 
higher values of sensitivity and specificity than the VELscope system and the Oral CDx system, when 
compared with the results from studies which verified abnormal tissue using scalpel biopsies, and 
sampled not Just severe, but mild and moderate dysplasia.
2.4.4 Patient-Matched DEP Spectra
Patient-matched data modelled using the single-shell model was also analysed in this study, as a 
possible method to remove inter-patient variability as a source of error, by comparing samples of 
OSCC and dysplasia with samples from oral tissue which appeared on visual inspection by trained 
clinicians, to be normal.
However, on visual inspection of Figures 2.9-2.14 for OSCC vs. Normal and Figure 2.15 for Dysplastic 
vs. Normal, it is apparent that there is no clear trend for either OSCC or Dysplastic OBB samples upon 
comparison with Normal OBB samples. In fact, in some cases, the DEP spectra are almost identical, 
even when comparing OSCC and Normal. These results perhaps explain why few significant 
differences were found between Dysplastic and Healthy samples, in Tables 2.2 and 2.3.
Figures 2.17 and 2.18 do however demonstrate the intra-patient variability of DEP spectra, by 
comparing patient-matched OSCC samples and patient-matched Dysplastic samples, respectively.
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This degree of variability in samples from the same type of tissue, from the same patient could 
explain the large standard errors seen in Table 2.2.
Crossover frequencies were not evaluated in this study, as upon consultation with the patient­
matched DEP spectra in Figures 2.9-2.15, numerous DEP spectra did not have a low frequency 
crossover, so this could not be used to consistently distinguish between OSCC and Normal, and 
Dysplastic and Normal OBB samples.
2.4.5 Effect of Differing Oral Tissue Sites on Dielectrophoretic 
Results
Statistical tests were also performed on a small data set, to investigate the effect of the location 
within the oral cavity of tissue sampled on dielectric properties, using participant-matched samples 
of the buccal and tongue regions from the Healthy classification group.
Upon consulting Table 2.7 it is clear that no significant differences were found for dielectric 
properties, but only for mean cell radius (p = 0.038). However, in Table 2.6, the mean value of 
membrane capacitance achieved by buccal cells was approximately three times greater than that 
achieved by tongue cells. However, the associated standard error value was 52.7% of the mean 
value, therefore there was no significant difference in terms of membrane capacitance, between 
healthy buccal and tongue OBB samples.
It is the opinion of the researcher that this part of the current study should be investigated further, 
using more participant-matched samples to create a larger sample size and therefore more robust 
statistical tests, as the tongue is composed of a different type of mucosa (specialized mucosa) from 
that of the buccal region (lining mucosal) [69]. The gingiva and hard palate regions are composed of a 
third, different type of mucosa (masticatory mucosa) [69], so perhaps participant-matched samples 
from these regions should also be investigated using DEP. Consideration of these differences in 
mucosa could lead to a reduction in the values of some standard errors found in this study.
2.4.6 Optimisation of OBB Sample Collection and Preparation
Whilst conducting this study, the researcher attempted to optimise the sample preparation protocol, 
in a number of ways, to try to ensure the majority, if not all, OBB samples could be tested
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successfully using DEP (i.e. produce a raw DEP spectrum). The researcher and the lead clinician in this 
study, Dr Stefa no Fedele, also optimised the sample collection protocol.
One variable which had a significant effect on whether or not an OBB sample could actually be 
tested, was the concentration of erythrocytes (RBCs). Whilst small concentrations of RBCs were 
found in numerous Flealthy OBB samples, the concentration of RBCs in some OSCC samples allowed 
very little movement of any cell types to be tracked using DEP, rendering some samples unable to be 
tested. Another issue with high RBC concentrations was that at some point, the DEP spectrum of the 
whole OBB sample appeared to mimic what would be expected if an RBC only sample was tested, i.e. 
a spectrum undergoing strong negative DEP at low frequencies, and achieving a high value for low 
frequency crossover.
In an attempt to remedy this problem, the researcher introduced exposure of OBB samples to an 
ultrasonic bath into the sample preparation protocol, prior to centrifugation. This was performed for 
all samples listed in Results section of this chapter, but was trialled using OBB samples collected from 
the lip ulcer and normal lip tissue from a healthy participant. Samples collected from the ulcerated 
area contained extremely high concentrations of RBCs, but upon microscopic examination, epithelial 
cells appeared to be present. The OBB sample of the lip ulcer was first photographed using the setup 
detailed for the inverted microscope in the Methods section, placed an ultrasonic bath for two 
minutes and then photographed after ultrasonic exposure. The visual results of before and after 
sonication for two minutes can be seen in Figure 2.23.
Before Sonication: After Sonication:
■■■ . . .
Figure 2.23; Visual demonstration of the result of exposure of RBCs to two minutes in an ultrasonic bath. The epithelial cells 
in the "after" photo were not added following exposure to the ultrasonic bath-they were present but barely visible in the 
photo on the left. Also, there is very little, if any evidence of damage to the epithelial cells in the "after" photo, i.e. 
membranes appear intact and there is no evidence of lysed epithelial cells.
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DEP tests were also performed on the sample featured in Figure 2.23, post ultrasonic bath treatment 
and a second sample collected from the ulcerated area, but not exposed to the ultrasonic bath (i.e. 
had the appearance of the "before" photo in Figure 2.23). The DEP spectra resulting from these tests 
can be seen in Figure 2.24.
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Figure 2.24: Comparison of DEP spectra resulting from testing of two OBB samples of a lip ulcer. It can be seen that despite 
epithelial cells being present in both samples, the DEP spectrum for "no sonication" has strong negative DEP at low 
frequencies and a high value for low frequency crossover (Y = 0), as would be expected from a RBC DEP spectrum. However, 
the "sonication" spectrum appears to have a completely different shape, with a lower value for crossover frequency 
indicating greater cell radius, than was found for the "no sonication" spectrum.
Having established that high concentrations of RBCs could be eradicated by exposing OBB samples to 
an ultrasonic bath, the researcher then investigated the effects of ultrasonic exposure time. Three 
OBB samples were provided by a healthy participant, and the samples were exposed to the ultrasonic 
bath, for 60-120 seconds at a time, for times ranging from two or three minutes to 35 minutes. The 
results of visual microscopic examination indicated signs of damage to epithelial cells (irregular, 
discontinuous membranes and particulate that appeared to be burst cells) after 20 minutes 
cumulative exposure. The results for exposure times less than 20 minutes are shown in Figure 2.25.
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Figure 2.25: Comparison of photographs taken at time points between zero seconds of exposure (i.e. prior to ultrasonic 
bath exposure) and 10 minutes of exposure, for each of the three healthy OBB samples tested, provided by the same 
participant.
The most apparent finding upon consulting Figure 2.25 was that there was very little microscopic 
evidence of difference, let alone damage to the epithelial cells tested, between the cells in the 
images at time "0 minutes" compared with those at time "10 minutes". This suggested that exposure 
of cells in OBB samples to ultrasonic waves for 10 minutes or less, for 60-120 seconds at a time, 
would not damage the cells. Flowever, this was not verified using any other methods, (e.g. scanning 
electron microscopy to examine the effects on membrane features), so the researcher limited this 
exposure time to 90 seconds, for each sample tested in this study, and to allow direct comparison of 
all OBB samples, all OBB samples were exposed to the ultrasonic bath for 90 seconds, prior to 
centrifugation. Sonication was performed prior to centrifugation to ensure all traces of lysed RBCs 
were removed prior to DEP testing, and would therefore not alter the conductivity of the DEP testing 
medium.
Another additional step that was added to the OBB sample preparation protocol was filtration of the 
OBB sample whilst suspended in cell culture medium, through a nylon mesh cell strainer. This step
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was added to ensure the removal of cell "clumps" that could not be disaggregated, as well as 
"clumps" of keratin or any other large foreign bodies contained in the sample. If these large bodies 
were not removed, they would act to block the Well aperture area, preventing cellular movement 
and rendering DEP unsuccessful.
Finally, the researcher also trialled a new brush (the Orgenex) produced by Rovers Medical Devices 
B.V., which was specifically designed with a smaller brush head for collecting OBB samples from small 
lesions, rather than collecting more "normal" tissue bounding the edges of the lesion margins. DEP 
tests were performed on a total of three OBB samples collected from a healthy participant, and cell 
counts were performed on these samples and three additional samples. Two of the three samples 
collected using the Orgenex brush failed to produce DEP spectra. The third sample tested did 
produce a DEP spectrum, but multiple repeats of some data points were required. The mean number 
of cells collected using the Orgenex, when the cells from the OBB sample were re-suspended in 0.2 
ml DEP testing medium, was 0.15 x 10® cells/ ml in 0.2 ml. The mean number of cell collected from 
normal tissue, sampled using the Orcellex brush used for all OBB sampling in this study, was 0.75 x 
10® cells/ ml in 0.2 ml. Therefore the cell yield using the Orgenex brush was five times less than the 
cell yield of the Orcellex brush. Additionally, no RBCs were apparent in samples collected using the 
Orgenex brush, suggesting that this brush failed to penetrate to the vascular layer, calling into 
question quite how many cell layers could be sampled using this brush. Therefore, only the Rovers 
Orcellex brush was used for OBB sample collection in this study.
2.4,7 Limitations and Options for Future Development of the 
Current Study
The study presented here was a preliminary investigation of the ability of the 3DEP DEP-Well testing 
system, coupled with various forms of post-DEP results analysis, to distinguish between OBB samples 
collected from cancerous, dysplastic and healthy tissue from the oral mucosa. Therefore, because of 
the preliminary nature of this study, there are a number of areas within the study which could be 
improved upon or expanded upon in future.
This study was a small-scale study, which was later expanded upon, by having two clinical sites 
regularly contributing OBB samples (the UCL Eastman Dental Institute, London and the Bradford 
Royal Infirmary, Bradford), rather than just one. In total, 128 OBB samples were collected: 52 of 
which formed the OSCC group, 14 of which formed the Dysplastic group, 23 of which formed the
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Healthy group and 39 of which formed the Normal from OSCC/ Dysplastic group. Comparison of 
these numbers with those at the beginning of the Results section {Figure 2.9) indicated that 26.9% of 
OSCC samples, 14.3% of Dysplastic samples, 8.7% of Healthy samples and 7.7% of Normal from 
OSCC/ Dysplastic samples were not tested successfully using the DEP and results analysis system 
detailed in this study. The main factor behind DEP testing of OSCC samples proving unsuccessful was 
poor sample quality or insufficient cell yield, and low cell yield was the reason behind both 
unsuccessfully tested Dysplastic samples. Poor sample quality (ruptured cells and high 
concentrations of bacteria) were responsible for the two unsuccessful Healthy samples, and a 
technical issue (requiring testing system repair) rendered two Normal from OSCC/ Dysplastic samples 
unsuccessful. Therefore, the majority of samples not able to be tested successfully, were rendered so 
by the quality of the OBB samples themselves. This is a limitation of the study which may not be 
easily removed, as removing bacteria from all samples, if possible, would alter the intrinsic properties 
of the samples (i.e. concentration of bacteria could be indicative of tissue normality or abnormality), 
and some lesions, by nature, contain less cells that could be sampled (e.g. ulcers).
Another limitation of this study is the small sample sizes for each of OBB sample classification groups. 
Future studies would have to seek to increase numbers in all groups, but could also collect dysplastic 
samples from a variety of different grades of dysplasia (mild, moderate and severe), samples from 
benign lesions and potentially malignant lesions.
This study also did not investigate the false-negative rate for Normal from OSCC/ Dysplastic and 
Healthy OBB samples. This has been cited in publication as a drawback of many other studies. 
However, this study was a minimally invasive investigation, which was why brush biopsies were 
selected for sample collection. Therefore, to verify the nature of apparently healthy tissue from 
otherwise healthy volunteers using scalpel biopsies would be against the principle of 
nonmaleficence.
There are also a number of ways in which this study could be expanded. Given the link between HPV 
incidence and oral cancer [72], it would be pertinent to include DEP testing of HPV -positive and 
HPV-negative populations in both the OSCC and Healthy groups.
Data mining of epidemiological details from patients and participants from whom samples were 
collected would also be an interesting addition to the study. Details such as age, smoking status, an 
estimate of weekly alcohol consumption, a diet diary, HPV status and general state of oral hygiene, 
could be used to develop a risk score, which could in turn be considered along with the results of DEP 
testing to provide a dysplastic-to-OSCC development probability score.
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Finally, a more in-depth analysis of dielectric properties of OBB samples from each of the four 
classification groups could be performed. Separation of cell types would allow the proportions of 
certain cell types (e.g. the concentration of RBCs and basal cells) to be used to determine the status 
of samples, as tissue polarisation which dictates tissue architecture is lost in the development of 
severe dysplasia and OSCC. Also, identification and removal of cornified cells (effectively a dead cell 
layer which provides protection from underlying structures) may help improve the success rate of 
DEP testing of some samples. Separation of the different cell types contained within OBB samples, 
and subsequent DEP testing of these separated populations would then allow dielectric properties, 
such as cytoplasmic conductivity, membrane conductance and membrane capacitance to be 
attributed to one cell type, rather than a sample of multiple cell types, as was the case in this study at 
present. Once these dielectric properties were attributed to a particular cell type, then the reasons 
for resulting levels of conductivity, conductance and capacitance could be further examined and 
potentially verified, through the use of methods such as scanning electron microscopy and patch- 
damp.
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2.5 Conclusions
The study presented in this chapter investigated the ability of the DEPtech 3DEP DEP-Well testing 
system to distinguish between oral brush biopsies of four distinct tissue-state classifications: OSCC, 
Dysplastic, Healthy and Normal from OSCC/ Dysplastic.
DEP testing was performed as outline in the Methods section of this chapter, and the results of DEP 
testing of the aforementioned brush biopsies were analysed using two main methods: employment 
of the single-shell model, and analysis of raw change in light intensity as a function of frequency, 
time and Well aperture radius.
Employment of the single-shell model yielded a significant difference in mean membrane 
conductance between samples comprising the OSCC group and samples comprising the Healthy 
group (p = 0.007).
The single-shell model was also used to investigate the dielectric properties of buccal and tongue 
samples from tissue from healthy participants, however no significant differences were found for 
cytoplasmic conductivity, membrane conductance or membrane capacitance.
Possible reasons for high error values were apparent upon viewing patient-matched DEP spectra, 
which provided evidence of large inter- and intra-patient variations.
Sensitivity and specificity values were generated for this DEP testing system, based on analysis of 
results using a novel parameter, the median membrane midpoint frequency. Calculation of this 
parameter, using the raw results of DEP testing, yielded a sensitivity of 81.6% and a specificity of 
81.0% for OSCC vs. Healthy OBB samples, a sensitivity of 66.7% and a specificity of 85.7% for 
Dysplastic vs. Healthy OBB samples and a sensitivity of 80.0% and a specificity of 76.2% for Abnormal 
(OSCC and Dysplastic) vs. Healthy OBB samples.
In conclusion, all methods of analysing the results generated by DEP testing, using the DEP-Well 
setup, demonstrated in this study, could differentiate well between OSCC OBB samples and Healthy 
OBB samples, despite the highly heterogeneous nature of OBB samples, but were either unable to 
distinguish, or correctly identified just 66.7% of cases of oral dysplasia. If the DEP testing and analysis 
system presented here was to be used for the purposes of early diagnosis of oral tissue abnormality, 
the level of sensitivity achieved would have to be improved upon.
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Chapter 3. An Introduction to Cancer 
Stem Cells
As outlined by Hanahan and Weinberg in their "Hallmarks of Cancer" paper [1], one of the 
characteristics acquired by normal cells which have undergone or are undergoing malignant 
transformation (i.e. to cancer cells), is the potential for limitless self-replication. Another type of cell 
is characterised by its limitless self-replication potential: stem cells. The concepts of cancer cells 
having similar traits to stem cells, and the role of actual stem cells within tumour development and 
progression, has implications for those with cancer, including those with oral cancer, in terms of 
metastasis and treatment success. Therefore, given that metastasis is the main cause of death in 
cancer, and the rate of recurrence and low five-year survivial rate for oral cancers, the research 
detailed in Chapters 4 and 5 of this thesis focused upon the study of oral cancer stem-like cells. 
Specifically, in Chapter 4 rate of adherence to collagen IV was explored as a non-invasive biomarker 
to identify oral cancer cells with differing stem-like properties, following which these different oral 
cancer stem-like cell populations were then tested using dielectrophoresis. In Chapter 5, 
dielectrophoresis was used to study the electrophysiological properties of oral cancer stem-like cells 
with two different phenotypes: those with a mesenchymal-like phenotype which had undergone an 
epithelial-to-mesenchymal transition or "EMT", and those with an epithelial-like phenotype. This 
topic was of particular interest given the links between the motility of cells with a mesenchymal 
phenotype, and metastasis. However, at this point, it is pertinent to provide an introduction to the 
fields of stem cell and cancer stem cell research, to explain in greater detail the role of cancer stem 
cells and stem-like cells within cancer in general, and within oral cancer specifically.
There are two main types of stem cells in humans, those from the embryo and those found at stages 
later than the embryonic stage and present through the course of adult life. The former are termed 
"embryonic" stem cells and the latter are termed "somatic" stem cells. The difference between stem 
cells from these two groups, which is related to the stage of human development at which they 
appear, is their level of plasticity i.e. how many different types of the cells within the body they can 
form. Embryonic stem cells have the potential to produce any of the cell types found within the 
body, i.e. they are pluripotent. Somatic cells, by contrast are multipotent, meaning they can form 
many types of cells, within their tissue of origin. Situated deep in tissue layers, such as the basal layer 
in epithelial tissue, somatic stem cells are responsible for the renewal, and therefore repair, of tissue. 
The level of plasticity of stem cells is an indicator of how undifferentiated they are. All stem cells are
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undifferentiated, as they are the cells of origin for all tissue types, however because somatic stem 
cells are restricted to producing tissue-specific cells, they are considered less undifferentiated than 
embryonic stem cells. Another type of stem cells, which can be produced in vitro, are induced- 
pluripotent stem cells. These are cells which were originally differentiated, but which have 
undergone a transformation to convert them to pluripotent stem cells [2].
Stem cells can either undergo symmetrical or asymmetrical cell division. Symmetrical division 
involves the stem cell dividing to produce either two daughter stem cells or two daughter cells which 
are fated to differentiate, and asymmetrical division involves the stem cell dividing to produce one 
daughter stem cell and one daughter cell which is fated to differentiate [3]. Logically, the aim of 
symmetrical division is to amplify either the number of stem cells, or the number differentiated cells 
comprising the tissue (e.g. when cells are lost due to traumatic injury), whereas asymmetrical 
division seems to suggest an adherence to homeostasis [3].
In 1961, research by Till and McCulloch suggested that colonies of cells were clones resulting from 
very few or even a single cell, given that in order to obtain a single colony in animal models, 
approximately 10^ cells had to be injected and of the cells in the colony, the majority were 
differentiated [4]. Research conducted by the same authors in 1963 showed thatfour of 42 mouse 
marrow cell colonies contained cells with abnormal karyotypes (which represented cells able to re­
populate hematopoietic organs) and that of the cells within these colonies, 95% or more had at least 
one marker which characterised the colony [5]. This suggested that cells from these four colonies 
were clones of a single cell which possessed a chromosomal abnormality, caused by radiation 
exposure [5] and this confirmed the findings from the authors' previous paper, suggesting that one 
cell could be responsible for all the cells within a colony.
Inevitably, comparisons were then made between the manner in which cancer cells initiate and 
maintain tumour growth and subsequent metastatic spread, and the manner in which stem cells 
produce, maintain and renew normal tissues and organs. This comparison then leads to the question, 
"do stem cells undergo a transformation to become cancer stem cells which are then responsible for 
cancer development, proliferation and metastatic spread (and thereby follow a hierarchical model 
where each stage of differentiation is irreversible [6], or do progenitor cells (cells with stem-like 
properties excluding unlimited self renewal [7] within tumours gain the ability for limitless self­
renewal and thereby transform themselves into cancer stem cells?". Reya and colleagues thought it 
possible that normal stem cells could be targeted in cancer development, given that normal cancer 
cells already have the capacity for unlimited self-renewal, therefore fewer mutations would probably
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be required to maintain this trait than to activate it, and because stem cells have a greater lifespan 
than mature cells and therefore would be exposed to potential mutations for longer periods of time 
[8]. The authors concluded that tumorigenic cells could be considered to be stem cells that have 
undergone abnormal processes of organogenesis [8], thus producing tumours rather than tissues and 
organs. The question of how cancer stem cells come into being has been the source of much debate, 
amongst leading researchers within the field of cancer research. In the following section, some of the 
key aspects of the cancer stem cell theory will be discussed, as will the methods for identifying 
cancer cells with stem-like properties, and specifically how DEP has been employed within this field 
of cancer research.
3.1 Cancer Stem Cell Theories
The question outlined previously, regarding whether cancer stem cells exist naturally or are 
produced by the transformation of tumour progenitor cells to acquire the limitless self-renewal 
associated with stem cells, was the topic of an American Association of Cancer Research (AACR) 
workshop. It was also mentioned, in a paper produced in 2006 summarising the outcomes of this 
workshop [9], that it was entirely possible that both pathways could be followed (and that which 
was, was probably determined by the tissue site of the primary tumour), but that both of these 
theories conflicted with the commonly held theory at that point in time, which stipulated that all 
cells within a tumour had the capacity to form the tumour (i.e. the stochastic model). It was also 
identified at this workshop that there was a pressing need to define what constituted a cancer stem 
cell. The group arrived at the decision that a cancer stem cell was a cell within the tumour which 
possessed two key characteristics: the ability to self-renew, and to create the heterogeneous 
lineages of non-tumorigenic cells which constituted the tumour [9]. However, no mention was made 
of whether or not poorly differentiated tumours resulted from cancer stem cells (CSCs)-the definition 
seems to state that CSCs must have the potential to produce a heterogeneous population, rather 
than the progeny of CSCs being fated  to comprise a highly heterogeneous tumour population. What 
was mentioned was the use of terminology concerning CSCs, in that terms such as "tumour- 
initiating" and "tumorigenic cell" were applied when cells appeared to possess CSC properties but for 
whom experimental confirmation of tumour formation and continuous growth had not been 
performed. However, no mention was made as to whether this should become a convention, 
whereby cells which were suspected to have CSC properties should only be termed "cancer stem
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cells" upon experimental confirmation and that until such time, should be referred to using a 
selection of approved terms.
It was suggested that the characteristics defining CSCs could only be evaluated experimentally, by 
establishing that the cells in question could form and sustain a tumour, through serial transplantation 
into a mouse model [9]. However, it was acknowledged that the time required to successfully 
perform serial transplantation into animal models (estimated by the group as approximately six 
months) would make this method extremely difficult to undertake if high throughput studies for e.g. 
anti-cancer drug development were being conducted, and therefore attention should be turned to 
the development of alternative, reliable assays [9]. Another pitfall of transplantation assays, the 
ability of cells to either survive more or less easily in the surrogate model than the original host, was 
also acknowledged by the group [9].
The definition of a cancer stem cell appeared to be influenced by research on human acute myeloid 
leukaemia (AML) like that presented by Bonnet and Dick [10], in which CSCs were defined by their 
ability to form human AML tumours when transplanted into irradiated non-obese diabetic/ severe 
combined immunodeficient (NOD/ SCID) mice [9]. Results from the study by Bonnet and Dick also 
showed that the CSC population possessed the same biomarkers as normal human haematopoietic 
progenitors (CD34^CD38 ), suggesting in turn that the AML CSCs were in fact normal stem cells which 
had been transformed into cancer stem cells [10]. It was recognised in the paper by Clarke and 
colleagues that this conclusion had led to an interpretation of CSCs that created a degree of 
confusion-that whilst CSCs may originate from normal stem cells which become cancer stem cells 
through mutation(s), it is also conceivable that CSCs could be formed by progenitor cells, which 
themselves can self-replicate, having acquired the ability to do so in a limitless manner, through a 
multi-step process of transformations, driven by mutations [9]. This observation then led onto the 
conclusion that given the highly heterogeneous nature of cancer, the theory for CSC development 
which applied for one cancer type may not necessarily be directly applicable to others [9].
This has obvious implications for identification of cancer stem cells, in that what may be a biomarker 
for cancer stem cells from one cancer type may not identify cancer stem cells from other types of 
cancer. The group also stated that it was "not sufficient" to identify CSCs using membrane surface 
biomarkers, or side populations, without also performing tumour formation assays, as biomarkers for 
CSCs are also common to normal stem cells, and even differentiated cells, and presented the CD44, 
Bmi-land Notch markers, among others, as examples of this [9].
151
The group also stated that, like stem cells in normal tissues, the cancer stem cell theory stipulates 
that CSCs are a minority population within the tumour, which only occasionally enter the cell cycle, 
therefore making them resistant to many conventional cancer treatments which target cells within 
the cell cycle [9], and evaluate success of treatment based on tumour size reduction. However, the 
group did concede that normal and cancerous breast stem cells appear to cycle regularly, and 
therefore, the length of time spent in or out of the cell cycle, along with biomarkers selection, should 
not be assumed to be the same for all cancer types. The group did however add that highlighting 
specific genes which determined stem-like properties may be an important research step for anti­
cancer drug development [9].
Wicha [11], re-introduces a concept presented a century previously by Paget called the "soil and seed 
hypothesis", in which tumour cells are likened to the seeds and the environment at a distant site is 
likened to the soil. This metaphor emphasises the role of both intrinsic cellular properties, such as 
genetic mutations (seed), and extrinsic properties of the environment in which a tumour seeks to 
grow (soil), also known as the tumour microenvironment. The author, Wicha, then adds to this 
imagery by defining the role of cancers stem cells as the "lethal seeds", and that they too are 
dependent upon their environment, termed the "stem cell niche", for development of métastasés 
[11]. Wicha also lends support to the cancer stem cell theory, stating that in studies conducted by 
himself [12], and Ponti and colleagues [13], the concentration of cancer stem cells represented 
anywhere from 1%-10% of the total cell concentration within both primary and metastatic lesions 
[11]. However, the author also supports the view of Clarke and colleagues [9] that 
immunohistochemical staining is potentially limited in terms of the number of biomarkers that can 
be studied simultaneously [11].
In a paper from the same year, Wicha and colleagues [12] show that research into tissue-specific 
stem cells and their role within cancer, though the subject of increasing interest, was in fact being 
conducted over 30 years ago by researchers such as Till [4] and Pierce [14]. The authors also stated 
that there were several characteristics of cancer stem cells that had been found in common with 
normal stem cells, namely the abilities to self-renew, differentiate and migrate, as well as possessing 
active telomerase expression, being able to increase cell membrane transport activities and avoiding 
apoptosis, and that sharing these properties in common meant that both normal and cancer stem 
cells share several biomarkers, such as CD44 and CD133, and integrins a6 and p i and dysregulation 
of pathways such as W nt and Hedgehog [12]. This has the implication that whilst researchers and
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clinicians think they are studying or treating cancer stem cells, they are in fact selecting all stem cells, 
be they cancerous or normal. The fact that Wnt signalling is common to both normal and cancer 
stem cells was also mentioned by Reya and Clevers [15].
The point was also made, as it was by Clarke and colleagues [9], that the cancer stem cells model 
proposed a very different mechanism for tumour development than the previously held "stochastic" 
theory (deemed a "paradigm shift" in thinking by the authors), in that rather than cells being 
transformed into cancer cells via random mutations and subsequent clonal selection, stem and 
progenitor cells avoid regulatory pathways and through self renewal, generate progeny which 
undergo further genetic changes towards becoming true cancer stem cells [12]. Another point of 
agreement between this paper and that by Clarke and colleagues was that, rather than use of a 
limited number of biomarkers to isolate and characterise cancer stem cells, genetic signatures alone, 
or in correspondence with biomarkers may hold more promise, citing the work by Glinsky and 
colleagues [16] as a successful example, in which an 11-gene signature regulated by the marker Bmi 
was associated with poor prognosis in 10 distinct human cancers.
The authors also discussed the impact of the cancer stem cell theory on cancer treatment, and 
suggested that treatments should look to target a purified population of cancer stem cells, but that 
this would require the system by which success of cancer treatments is judged, i.e. by achieving 
tumour shrinkage of 50% or more, to be revised [12]. A subsequent paper, by Boman and Wicha [17] 
suggested targeting stem cells undergoing symmetric division (i.e. those producing either two 
daughter stem cells or two daughter cells fated to differentiate), but acknowledge that this would 
have to work in coordination with a method which differentiates normal from cancer stem cells to 
avoid depletion of normal stem cells required for recovery. The same paper by Boman and Wicha 
also suggested that mathematical modelling and in vitro spheroid formation assays could be used 
prior to xenotransplantation models (i.e. transplanting human tissue into mice) [17].
The potential misunderstandings surrounding the cancer stem cell theory hinted at in the paper by 
Clarke and colleagues [9] were the subject of a paper by Jordan [18]. Jordan puts forward the idea 
that the term "cancer stem cells" has itself led to confusion, by implying that cancer stem cells (CSCs) 
are transformed normal stem cells, and states that this label represents the functional properties 
rather than the ancestry of the cells in question [18]. Jordan takes this line of thinking a stage further 
by stating that any cell, normal or malignant, which possesses the functional properties of a stem cell 
should be deemed as such, and that this removes any ambiguity [18]. However, it could also be the
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case that confusion has arisen not so much from misunderstandings about the definition of a CSC, 
but rather whether or not a lack of adherence to the cancer stem cell model precludes cells from 
being considered as CSCs, for example if a population of cells can be functionally described as stem 
cells, but represent greater than 10% of the total cell population. The author also mentions that 
behaviours and phenotypes demonstrated by normal stem cells may not be attributable to cancer 
stem cells [18]. This makes logical sense, given the heterogeneous nature of cancer, a factor further 
acknowledged by the author when stating that behaviours and specific immunophenotypes may 
change in the course of disease progression in one patient, let alone from patient to patient. This was 
illustrated in a study on CSCs in AML by Bonnet and Dick [10], in which the estimated CSC 
compartment in three patients was 0.2 per 10® cells, but was 100-200 per 10® cells for another 
patient, and 49 per 10® cells for yet another patient. No mention was made by Jordan as to whether 
this could lead to an issue in cell lines derived from the same patient i.e. that they may not 
demonstrate the patient-to-patient heterogeneity once transplanted into murine systems, or if this 
issue is nullified because transplantation into multiple murine subjects would then mimic multiple 
complex organisms (such as different human patients), because the murine subjects have differing 
tumour microenvironments. This intra- and inter-patient variability would make modelling of disease 
progression, and treatment, much more difficult to achieve, especially if the genetic and general 
cellular properties of the CSC population was not stable, as this could then lead to the issues seen in 
treating bulk tumour cells (e.g. drug resistance) [18].
A paper by Quintana and colleagues also critically examined the part of the cancer stem cell model 
that seemed to suggest that cancer stem cells were a rare, minority population [19]. The group 
studied the tumorigenesis of single melanoma cells, isolated using flow cytometry of xenographed 
tumours from four patients [19]. In doing so, they found that 69 tumours formed from 254 single 
human melanoma cells, and from one patient, 65% of single melanoma cells formed tumours [19]. 
This result and others from this paper suggested that tumorigenic cells were not rare, they were 
commonplace in melanomas, regardless of whether the cells came from xenografts or patients. The 
group also stated that they found no marker which distinguished tumorigenic from non-tumorigenic 
cells [19].
Jordan did highlight that one property, given the functional definition of a cancer stem cell, which is 
common to all CSCs is self-renewal and highlighted the works of Jamieson and colleagues [20] and 
Peacock and colleagues [21] as showing promising results for blocking of self-renewal pathways such
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as Wnt and Hedgehog [18]. However, no mention is made as to how CSCs would be differentiated 
from normal stem cells which also share these properties.
Jordan summarised by stating that there were three issues that needed to be addressed with regards 
to CSCs: establishing how tumours arise from CSCs and to develop treatments based on either 
targeting a minority population or to target cells with stem-like properties instead, developing and 
vetting systems to assess the functional ability of CSCs, and as stipulated by Wang [22], to develop 
clinical endpoints more adept at assessing the role of CSCs in disease progression and treatment 
response [18].
The suitability of studying cancer stem cells using cell lines was discussed in a paper by Locke and 
colleagues [23], in which the authors acknowledged that cell morphological heterogeneity and 
suspicions of adaptation to in vitro culture conditions [24, 25] had led some to question the validity 
of in vitro CSC research. However, the authors stated that other research findings had suggested that 
stem cell behaviours were retained in cancer cell lines and that this coupled with the difficulties 
posed by studying CSCs in vivo meant in vitro CSC studies had a role within CSC research [23]. The 
authors also suggest that cell morphological heterogeneity should not be unexpected, given that 
even normal kératinocytes display a range of distinct colonies in vitro [23]. The colonies, termed as 
holoclones, meroclones and paraclones are thought be derived from, and contain, stem and 
amplifying cells [26], where holoclones are tight, compact, round colonies, meroclones are 
intermediate colonies and paraclones are loose, irregular colonies [23]. In their paper, Locke and 
colleagues found that formation of these colonies (holoclones, meroclones and paraclones), was a 
shared characteristic of both normal and malignant cell lines given that they formed in a seven cell 
line panel [23]. The authors chose three criteria to define cancer stem cells in their study: ability to 
self-renew extensively, generation of a hierarchy of cells and production of differentiated cells [23]. 
They found that CD44 staining was restricted to holoclones and that holoclones also stained for ESA, 
whilst meroclones stained weakly for ESA [23]. They also found that BrdUrd staining was greatest in 
holoclone and early paraclone colonies, indicating that both these colony types witnessed high rates 
of proliferation [23]. The group found that cells isolated from holoclones satisfied all three of these 
criteria, whilst cells isolated from meroclones and paraclones were not able to generate all three 
types of colony [23], and therefore cells from holoclones presented as cancer stem-like cells (rather 
than cancer stem cells, as no studies were conducted using xenotransplantation). The authors did 
however, find that the ability of single holoclone cells to produce holoclone colonies varied greatly, 
from 47%-100% [23]. However, the overall conclusion of this paper was that colonies of stem-like,
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proliferative cells and differentiated cells are very similar in malignant cell lines compared to those 
from normal epithelium [23], again verifying that there are a number of characteristics common to 
both normal and cancer stem cells.
Gupta and colleagues also critically assessed the cancer stem cell model in their 2009 paper [27]. 
They came to the same conclusion as Jordan [18], regarding the potential for misinterpreting CSCs as 
being transformed normal stem cells, and agreed with Clarke and colleagues [9] that CSCs may vary 
in concentration from one cancer type to another. The authors also paid tribute to Lapidot and 
colleagues [28], Al-Hajj and colleagues [29], and Singh and colleagues [30] as contributing pioneering 
works on understanding the roles of CSCs within leukaemia and in solid tumours from the breast and 
brain [27]. Gupta and colleagues, again like Clarke and colleagues did in their 2006 paper [9], 
examined the use of mouse models for transplantation assays, emphasising that experimental design 
is a factor in the estimation of the CSC concentration and tumour-forming ability, which is influenced 
by vascularisation of transplant site, constituents of the extracellular matrix and available growth 
factors, as well as immunocompetence, pH and oxygen levels of the murine host [27]. The authors 
suggest that concentration of CSCs could be presented as being relative to the animal model from 
which they came, but that to truly model the tumour microenvironments encountered by human 
cancers, multiple host animal models would be required [27].
Shackleton and colleagues also critically assessed the cancer stem cell model [31]. They observed 
that research had suggested that many cancers did appear to follow the cancer stem cell model, such 
as leukaemias [10], breast cancers [29] and brain cancers [32]. However, the authors state that there 
was no concrete evidence that the difference between tumorigenic and non-tumorigenic cells from 
these cancers arose due to epigenetic rather than genetic differences [31]. The authors state that 
some cancers may be better described using the stochastic model (also known as the clonal 
evolution model), especially if cells with tumorigenic capability are not rare and organisation is not 
necessarily hierarchical [31], and state that neither model is mutually exclusive [31]. The authors also 
remark that tumorigenic cells are not necessarily more resistant to therapy than their non- 
tumorigenic counterparts, as in the case of testicular cancers [31]. The authors of this paper also 
highlighted issues that occur with murine models, namely that the level of immunodeficiency of mice 
used greatly affects the proportion of tumours that will form and that proliferation and survival of 
some cells will be compromised due to incompatibility of murine ligands and human receptors, again 
potentially giving rise to erroneous results [31].
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Members of the same group then investigated whether or not melanomas were hierarchically 
organised cancers, and therefore sought to determine if phenotypic diversity between tumorigenic 
and non-tumorigenic melanoma cells resulted from the cancer stem cell model, or the clonal 
evolution model [33]. This group also sought to determine if melanoma cells possessed a phenotypic 
plasticity, allowing them to switch between tumorigenic and non-tumorigenic phenotypes [33]. They 
found that 30% of single melanoma cells formed tumours, and of the single melanoma cells obtained 
from patients with stage III disease, 28% formed tumours [33]. In fact, the group reported that they 
found high concentrations of tumorigenic cells from patients of each stage of disease (l-IV) and from 
xenografted tumours [33]. The group also found, that contrary to popular theory, the growth rate of 
melanoma tumours was not dependent upon the concentration of tumorigenic cells [33]. Of the 85 
markers the group used to distinguish tumorigenic from non-tumorigenic melanoma cells, they found 
that none accomplished this in a robust manner and tumours with similar growth rates were formed 
from phenotypically diverse melanoma sub-groups, which produced tumours possessing the 
phenotypic diversity of the tumours which produced the single melanoma cells, suggesting 
reversibility of marker expression [33]. The authors stated that whilst their results suggest that 
melanomas do not follow the cancer stem cell model, this did not mean other cancers would not or 
could not, but that it would be of great importance to discover which cancers did in order to design 
effective anti-cancer therapies [33].
An editorial piece by Jones also stated that the cancer stem cell concept would account for the 
"minority" of cancer patients for whom treatment is curative, if CSCs were resistant to treatments 
aimed at eradicating tumour bulk [34].
Gach and colleagues also acknowledged the difficulties of attempting to isolate cancer stem cells, 
when they attempted to do so in their study into CSCs from pancreatic adenocarcinomas [35]. The 
group used the CD44, CD24 and CD326 surface markers to select for cells with stem-Iike properties 
from the bulk cancer cell population, where the cancer stem-like cells were positive for all three 
biomarkers (i.e. CD44VCD24VCD326'^), as these markers had been shown in a study by Li and 
colleagues [36] to possess increased invasive and proliferative capacity and were able to form 
tumours in mouse models [35]. The group stated that magnetic activated cell sorting (MACS) 
followed by fluorescence activated cell sorting (FACS), used in many studies to isolate rare cells, such 
as cancer stem cells, prove difficult (in the case of MACS) when using more than one surface marker, 
and FACS of rare cells can result in low sort yields [35]. Therefore, the group developed large array 
micropallets (1350 x 950 micropallets), coated with fibronectin, which were used to culture
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pancreatic cancer cells, before a fluorescence microscope and camera, controlled using a MATLAB 
program, were used to identify stained cells [35]. The group found they were able to separate 
pancreatic cancer cells, 60% of which then formed colonies and 35% of which had mammospheroid 
phenotypes and retained their CD44VCD24VCD326^ expressions [35].
In summary, there are two main theories which seek to explain tumour development and 
heterogeneity: the clonal evolution (stochastic) model and the cancer stem cell (CSC) model. The 
former stipulates that cancer can be initiated in any cell which receives enough genetic "hits", which 
then passes these genetic abnormalities onto daughter cells giving them a selective advantage, and a 
clonal colony is formed. The latter model proposes that within tumours there are a sub-group of cells 
which tend to be in the minority that drive tumour development, called cancer stem cells, and these 
cells possess the functional characteristics of normal stem cells. However, there are many unresolved 
questions regarding which cancers follow which model, how best to ascertain the presence of cancer 
cells with stem-like qualities as biomarkers show varying abilities to be able to differentiate 
tumorigenic and non-tumorigenic cells and how to standardise testing criteria for stem- like cells, 
especially with regards to mouse models.
3.2 Oral Cancer Stem Cells
In 2004, Braakhuis and colleagues stated that stem cells in oral mucosa had yet to be definitively 
identified, and so in a paper they presented [37] they proposed a genetic model for the progression 
of oral squamous cell carcinomas, based on clonal evolution. The group stated that somatic oral stem 
cells could be found in the basal layer of oral mucosa, whilst more differentiated cells, which were 
not themselves terminally differentiated, were termed transit amplifying cells and could be found in 
the basal and suprabasal layers in oral mucosa [37]. Braakhuis and colleagues suggested that as stem 
cells had the longest lifespan, these were the cells most likely to be the cells of origin for oral cancers, 
and that oral cancer manifested itself as a cluster of cells (patch) in which p53 was mutated [37]. The 
group proposed a theory (the "patch-field carcinoma model"), whereby upon an oral stem cell 
receiving one or more genetic "hits" (one of which was probably alteration of p53), it forms a patch 
consisting of daughter cells carrying these genetic alterations [37]. Further genetic alterations then 
cause the stem cell to escape the bounds of normal stem cell regulations, which give it a growth 
advantage. This then results in lateral expansion of the patch and symmetric division would allow for 
expansion of stem cell numbers, thus providing more target cells for genetic "hits" [37]. Multiple
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clones develop and expand within the field and selection of these clones results in invasive 
carcinoma with the potential to metastasise [37]. The authors suggest that this model could explain 
tumour re-growth following surgical tumour resection [37].
In the same year, Mackenzie studied the colony forming characteristics of oral squamous cell 
carcinomas (OSCCs), using an organotypic culture method, in which OSCC cell lines were grown on 
collagen IV matrices plated with normal oral fibroblasts and normal oral kératinocytes [38]. This 
resulted in each of the OSCC lines reforming an altered epithelium with a stratified structure, but 
failed to produce well-differentiated epithelium, and no stratum corneum was formed [38]. Instead, 
the tumour cells clustered in the basal layer creating colonies [38]. Cells from the OSCC lines were 
also found to be able to survive and proliferate when the cells represented 0.1% of the plating 
mixture [38]. However, it was noted by the author that 90% of the OSCC cells which were plated to 
form cultures did not survive, and the author suggested that this could mean that malignant oral cells 
were highly heterogeneous and only contained a small fraction of cells with clone-forming abilities 
[38].
Prince and colleagues [39] used head and neck squamous cell carcinomas (HNSCC) rather than 
specifically focusing upon oral squamous cell carcinomas, in their study. The group used two mouse 
models to examine the characteristics of tumours from HNSCC patients, the non-obese diabetic/ 
severe combine immunodeficient (NOD/ SCID) model and the Rag2/ cytokine receptor common y- 
chain double knockout (Rag2yDK0) model [39]. The group found that 52% (13/ 25) of the samples of 
patient tumours implanted into the mouse models, yielded tumours and that growth rates were 
similar for both mouse models, leading the group to conclude that either mouse model could be 
used [39]. In this paper, the group also detailed that from nine patients, among the samples they 
collected, three were from the tongue and two were from the floor of the mouth, and histology 
showed that the tumours ranged from poorly differentiated to well differentiated [39]. The group 
used the CD44 marker, and seven markers grouped together, which they called lineage markers, to 
separate non-epithelial from epithelial cells (Lin), and found that CD44^Lin' cells produced tumours 
which contained both CD44^Lin' and CD44'Lin' cells, concluding that the CD44^Lin' population 
contained the HNSCC stem cell population [39]. They group also found that BMI staining of the nuclei 
of cells within the CD44^Lin' population, given that BMI had been implicated in the self-renewal of 
cells from other cancers, verified that the CD44^Lin' population contained HNSCC stem cells [39]. A 
point of note was that the group noted that 20 of 31 injections of cells which stained for CD44, i.e. 
were CD44^Lin", formed tumours when a minimum of 5 x 10^ cells were injected, but they also found 
that one of 40 injections in which cells stained CD44'Lin‘ yielded tumours and that they failed to form
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tumours when 5 x 10® cells were used [39]. This could suggest that if the CD44 Lin‘ population did 
contain cancer stem cells (CSCs), they were very rare rather than not present at all, and this would 
follow the cancer stem cell model.
Chiou and colleagues found that cells from one highly malignant OSCC cell line and cells from one 
less malignant OSCC line, enriched for stem-like properties using FACS, expressed greatly increased 
levels of three genes associated with stem and progenitor cells, Oct-4, Nanog and Nestin, compared 
with their parental OSCC cells [40]. These stem-like cells from the highly malignant cell line also 
formed tumours in two of three mice, compared with its parent line (not enriched for stem-like cells) 
which produced tumours in one of three mice and required more cells to do so (1 x 10® versus the 1 x 
10"^  required for the stem-like cells) [40]. The group also found that increased Oct-4, Nanog and 
CD133 expression correlated with advanced-stage OSCC and therefore poor prognosis, with 
increased Nanog expression giving the worst predicted patient survival [40].
Locke and colleagues found upon examining 15 HNSCC lines (many of which were from the oral 
cavity) that despite small differences between the cell lines, all tended to form three distinct types of 
colony, holoclones, meroclones and paraclones and that these formations were maintained as the 
colonies grew [23]. As stated previously in the "Cancer Stem Cell Theories" section, of the three 
colony formations, cells constituting the holoclones were able to reproduce cells demonstrating the 
full range of phenotypes from the cell line from which the holoclones came [23]. The group also 
identified that holoclone cells adhered more quickly to their growth surfaces than cells from the 
other two colony formations, and therefore concluded that rapid adherence correlated with 
increased clonogenicity [23]. Holoclone cells were deemed to be the source of the rest of the cell 
population, and the group concluded that HNSCCs contained a sub-population of cells possessing 
unlimited self-renewal and the ability to produce proliferating and differentiated progeny [23]. This 
in turn suggested that HNSCCs, or at least those examined in this study [23], followed the cancer 
stem cell model. Members of the same group verified these results and found that two additional 
lines created from patient tumours also followed the same colony formation and hierarchy patterns, 
with holoclone cells, concluded to be the most stem-like, staining for CD44, p i integrin and E- 
cadherin [41].
Further analysis of oral CSC biomarkers was conducted by AbdulMaJeed and colleagues, who used 
the putative stem cell markers ALDHl, CD271, CD44 and CD24 to examine 385 paraffin-embedded 
samples of normal, dysplastic (ranging from moderate to severe) and cancerous oral tissue [42]. They 
found that three of the four markers, ALDHl, CD44 and CD24, stained with higher intensities for
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OSCC tissue compared with normal tissue, and that the intensity of ALDHl and CD24 staining 
correlated with increased disease severity, with the latter being able to distinguish non-malignant 
and OSCC tissue [42]. The group also found that ALDHl staining was increased for severe dysplasia 
versus moderate dysplasia and normal mucosa [42]. The group concluded that CD24 achieved 
sensitivity and specificity scores of 70.9% and 75.3% respectively for OSCC versus non-malignant 
tissues, 68.9% and 80% respectively for dysplastic versus normal tissues, and 63.6% and 35.9% 
respectively for severe versus moderate dysplasia [42]. This suggested that CD24 staining of putative 
stem cells could be used to differentiate OSCC tissue from normal tissue, but showed limited ability 
to differentiate grades of dysplasia and dysplastic versus normal tissue on the basis of their putative 
stem cell populations.
The studies reviewed tended to use biomarkers, such as CD44, p i integrin and E-cadherin, to 
distinguish stem-like from non-stem like cells in oral cancer cell lines. However, as Gonzalez-Moles 
and colleagues point out in their review of the cancer stem cell hypothesis as it pertains to oral 
cancers, few of these markers have been found to reliably enrich for oral cancer stem cells, as they 
also enrich for non-stem cells, and normal stem cells [43]. Gonzalez-Moles and colleagues also 
identify excretion of Hoechst dye, and expression of ABCG2, Bmi-1 and Oct-4 as markers of cancer 
stem cells in HNSCCs, but state that these marker procedures are not suitable for routine application. 
The authors do however suggest that CD44 expression could be lost because, like E-cadherin, it could 
be involved in the epithelial-to-mesenchymal transition and mesenchymal -to-epithelial processes 
(EMT and MET, respectively) [43]. A point of note is that the authors of many papers have not 
mentioned the potential advantage of having a recognised panel of cell lines, for specific cancers 
such as OSCCs (separated from the general category of HNSCCs), to allow "like-for-like" comparisons 
to be made, without heterogeneity of cells within different lines contributing errors.
What is clear is that the number of biomarkers for cancer stem cells that have been trialled in oral 
cancer, is low (especially when comparing work in OSCC with that of Quintana and colleagues who 
used 85 biomarkers to examine CSCs within melanomas [33]) and many studies do not use the gold 
standard serial xenotransplantation to verify results. Therefore, more research appears to be 
required to find alternative biomarkers for oral cancer stem-ness, or to develop a system whereby 
the area of difference between oral cancer stem-like cells (OCSCs) and oral cancer non-stem like cells 
(be it intracellular, e.g. from the cytoplasm or genetic material, or related to the cell membrane) 
could be identified prior to an exhaustive test of biomarkers being conducted.
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3.3 Dielectric and DEP Studies of Normal and 
Cancer Stem and Stem-Like Cells
Dielectrophoresis (DEP) is one such testing method which would allow the bulk dielectric properties 
of the cytoplasm and cell membrane to be examined, and could potentially narrow-down the range 
of biomarkers to ones specific to either the cell interior or the cell membrane. A number of studies 
have been conducted using dielectrophoresis (DEP) to examine the dielectric properties of normal 
stem cells and cancer stem cells, a selection of which will be analysed in this section, along with 
studies in which alternative testing techniques were used to investigate or employ the dielectric 
properties of said cell types.
Pethig and colleagues, when reviewing the applications of DEP within stem cell research, stated that 
where specific biomarkers are not known, or where their application could result in undesirable 
interactions with cells, then DEP could be used, as DEP does not require parallel use of biomarkers or 
labels and can be used for the isolation and separation of cells [44]. The author also states that the 
first DEP experiments on stem cells were conducted by himself, Talary and colleagues [45,46] in 
which they isolated and separated haematopoietic stem cells, defined by staining for CD34 (i.e. 
CD34^), from marrow and peripheral blood cells.
Ron and colleagues used dielectric spectroscopy to study bone marrow-derived, pre-osteoblastic 
mesenchymal cells (MBA-15) [47]. The group used this technique to study the permittivity response 
of these cells, which were treated for 96 hours with steroidal hormones dexamethasone and 17p- 
Estradiol to achieve differentiated phenotypes [47]. The group used the results of atomic force 
microscopy (AFM) to produce a model which split the MBA-15 cells into four regions, the 
nucleoplasm, the nuclear envelope, the cytoplasm and the cell membrane, and examined the 
permittivity of the cells using a frequency range of 1 kHz-100 MHz [47]. They found that the 
permittivity of the membrane and nuclear envelope of the MBA-15 cells increased significantly when 
treated with dexamethasone [47]. The group also found that treatment with 17^- Estradiol was 
found to result in a significant decrease in membrane permittivity, and significant increases in 
conductivities of the cytoplasm, nucleoplasm and nuclear envelope, when compared with control 
cells [47]. The authors therefore concluded that this proof-of-concept study showed that dielectric 
spectroscopy could be used to detect differing differentiation pathways of stem cells [47].
Bagnaninchi and Drummond showed that electric cell-substrate impedance sensing (EClS) could be 
used for real-time monitoring of differentiation of adult stem cells, specifically adipose-derived stem
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cells (ADSCs) [48]. In their study, the authors subjected non-differentiated ADSCs, osteo-induced 
ADSCs and adipo-induced ADSCs to a frequency range of 62.5-64 kHz for a period of greater than two 
weeks (at which point staining was performed to determine if differentiation had occurred), to 
examine the complex impedance of the respective cell types, using two eight-well plates in which 
each well featured 40 gold microelectrodes [48]. Significant differences in impedance between the 
osteo-induced and adipo-induced ADSCs were encountered at 12 hours post induction at frequencies 
of 4-16 kHz, but at 64 kHz the difference between the mean values of the two groups was optimised, 
from the 135 hour time point onward [48]. Significant differences in impedance between adipo- 
induced and non-induced ADSCs were also found at the 121 hour time point [48]. The observation 
that osteo-induced and adipo-induced ADSCs could be distinguished using EClS after 12 hours was 
significant, because morphological changes were only apparent using micrographs after two days
[48]. Mean cell membrane capacitance was also found to be significantly different for cells from the 
two differentiation lines, with adipo-induced ADSCs achieving a significantly greater value than 
osteo-induced ADSCs (2.25 ± 0.27 pF/ cm  ^and 1.72 ± 0.10 pF/ cm^ respectively), four days post­
induction [48]. Significant differences in mean cell membrane capacitance were also found between 
adipo-induced ADSCs and non-differentiated ADSCs at the four, seven and 15 day time points (1.65 ± 
0.07 pF/ cm^) and mean membrane capacitance of osteoblasts decreased significantly as 
differentiation progressed (1.43 ± 0.08 pF/ cm^) [48]. These results suggested that mean membrane 
capacitance could be used as a marker for ADSC differentiation at early time points [48]. The authors 
also succeeded in conducting real-time monitoring over 17.5 days, i.e. for a longer period than that 
estimated to be required for stem cell differentiation to occur [48].
Velugotia and colleagues also studied the dielectric properties of stem and differentiating cells, 
though they focused upon human embryonic stem cells (hESCs) and used DEP, rather than 
impedance sensing, to investigate the cellular dielectric properties [49]. The group analysed 
crossover frequencies (i.e. the frequencies at which cells are not polarised and therefore undergo no 
DEP force) and mean membrane capacitance values obtained for four hESC lines, one transgenic 
derivative of one of the four hESC lines, one line created by supplementing one of the four hESC lines 
with bone protein, and two lines which were mesenchymal-like derivations of two of the four hESC 
lines [49]. After obtaining single-cell suspensions using fluorescence activated cell sorting (FACS), the 
group tested cells from all lines using an interdigitated array electrode system, by suspending the 
cells in an isotonic medium with a conductivity of 33 mS/ m, and applying sinusoidal signals with 
frequencies from 10 kHz to 200 kHz (in steps of 10 kHz) to them [49]. The group found that due to 
overlapping values for membrane capacitance, different hESC lines could not be distinguished to the
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extent that would result in pure samples of each line being obtained from mixed samples [49]. They 
did find that crossover frequencies for undifferentiated and differentiated lines were sufficiently 
different that separation should be possible (68.4 + 16.2 kHz versus 26.1 + 7.4 kHz and 101.6 + 25.8 
kHz versus 26.2 + 7.6 kHz), and also found whilst crossover frequencies obtained for three of the 
undifferentiated lines were very similar (68.4 + 16.2 kHz, 68.2 + 22 kHz and 63.8 + 14.7 kHz), one line 
was sufficiently different that it could be distinguished from the other three lines (101.6 + 25.8 kHz)
[49]. The authors also found that membrane capacitance values were significantly increased in 
differentiated progeny compared with undifferentiated hESCs [49]. The authors therefore concluded, 
just as Bagnaninchi and Drummond [48] did in their study, that membrane capacitance could be used 
as a marker for stem cell differentiation [49].
Dielectrophoresis has also been used by Flanagan, Lee and colleagues, at the University of California, 
Irvine to study neural stem cells [50-53]. In the first of four papers on the subject, Flanagan and 
associates used a microfluidic device to test mouse neural stem/ progenitor cells (NSPCs), 
differentiated astrocytes and differentiated neurons using dielectrophoresis [50]. Frequencies 
ranging from 25 kHz-10 MHz were applied to induce positive DEP (which resulted in cells being 
attracted to (trapped) at the electrode edges [50]. Astrocytes trapped at the lowest frequencies (300 
kHz), whilst neurons trapped at the highest frequencies (5 MHz) and NSPCs trapped at 1 MHz [50]. 
The group also found that NSPCs at early and late stage of development could be distinguished using 
DEP, as late stage NSPCs trapped at lower frequencies than early stage NSPCs, but that these 
populations could not be distinguished by staining for the biomarkers Sox2 and Nestin [50].
The same group then went on to use dielectrophoretic testing to examine the membrane properties 
of human and mouse NSPCs, using a frequency range of 10 kHz- IM H Z  [51] but in this study, used the 
DEP Well 3D electrode system, developed and detailed in a study by Hoettges and colleagues [54]. 
Using the single-shell model (detailed in Section 1.3 of this thesis) the group calculated values for 
membrane conductance and capacitance. They found that the hNSPC cell most likely to form 
neurons achieved significantly lower membrane capacitance values than hNSPC cells likely to form  
astrocytes (7.6 + 0.3 mF/ m  ^and 9.9 + 0.2 mF/m^ respectively) [51]. The group also analysed mouse 
NSPCs with different abilities to generate neurons, and found that NSPCs which were neurogenic 
achieved lower values for membrane capacitance than gliogenic NSPCs (8.2 + 0.5 mF/ m  ^and 10.7 +
0.6 mF/m^ respectively) [51]. Therefore, the group found that membrane capacitance was inversely 
related to neurogenic potential in both human and mouse NSPCs. The group also found that 
crossover frequency was increased with neuronal fate, i.e. cells most likely to differentiate into 
neurons had higher crossover frequencies than cells most likely to differentiate into glia [51].
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However, in this study, membrane conductance did not show a consistent correlation with NSPC 
fate, for either human or mouse cells [51].
In their next paper, the group described the development of a DEP-activated cell sorter (DACS) 
device, designed with the aim of separating mouse NSPCs from neurons [52]. The DACS device 
featured three trapping regions situated along a channel, each of which contained individually- 
addressable intercastellated electrodes and collection wells [52]. The electrodes were energised with 
AC 8 V peak-to-peak signals and a different frequency was applied to each of the 3 sets of electrodes
[52]. NSPCs and neurons were mixed to give a ratio of 1:1, and a concentration of 10® cells/ ml was 
used for each sample [52]. Maximum trapping of NSPCs occurred at frequencies of 100-200 kHz 
whilst maximum trapping of neurons occurred at 400-500 kHz, and the group found that neurons 
were enriched 1.4 fold using a frequency range of 400 kHz-5 MHz [52].
Most recently Nourse, Prieto and colleagues used the same DACS device to examine the effects of 
three factors on the membrane capacitance of mouse NSPCs: cell size, membrane surface 
glycosylation (whereby n-linked glycosylation results in charge-storing carbohydrates being added to 
proteins found on the cell membrane) and resting membrane potential (RMP, measured using 
whole-cell patch clamp) [53]. The group found that neurogenic progenitors (NPs) were enriched at 
higher frequencies than astrogneic progenitors (APs) (300-400 kHz versus 0-200 kHz, respectively) 
and that DACS at high frequencies resulted in an increase in NPs collected, compared with FACS using 
the PSA-NCAM biomarker, and the authors concluded that this showed DACS to be a more robust 
method to indicate NSPC fate potential than biomarker-assisted FACS [53]. The group also found 
that cell size (cell diameter) and resting membrane potential showed no significant differences 
between NPs and APs, suggesting that ion channel activity did not contribute to NSPC fate potential
[53]. In order to determine if glycosylation contributed to membrane-specific electrophysiological 
properties, the group treated cells with two glycosylation inhibitors, swainsonine (SW) and 
deoxymannojirimycin (DMJ) and found that the threshold frequency (the frequency at which cells 
underwent positive DEP) for cells treated using both glycosylation inhibitors were lower than the 
threshold frequency of untreated cells (62.6 kHz for SW treated cells, 55.4 kHz for DMJ treated cells 
and 79.6 kHz for untreated cells) [53]. Therefore, the group concluded that differences in 
glycosylation could account for the differences in membrane electrophysiological properties 
associated with NSPC fate potential [53].
The dielectric properties of cancer stem cells have also been studied by a number of groups. Huang 
and colleagues used dielectrophoretic field-flow-fractionation (DEP-FFF) to separate human breast
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cancer cells from haematopoietic CD34* stem cells whilst both were mixed at a ratio of 3:2 and 
suspended in an isotonic medium of conductivity 10 mS/ m [55], The authors used eight 
interdigitated electrodes glued end to end, to which they applied a 4V peak-to-peak signal and either 
trapping frequencies of 5 kHz and 40 kHz or a sweep of frequencies in the range 15-35 kHz (swept 
frequency protocol) [55]. When a frequency of 40 kHz was applied to the cell mixture, the breast 
cancer cells were trapped using positive DEP and the haematopoietic CD34* stem cells were carried 
out of the electrode area by fluid flow [55]. When a frequency of 5 kHz was applied, the 
haematopoietic CD34* stem cells were trapped using positive DEP and the breast cancer cells were 
carried out of the electrode area by fluid flow. Using the swept frequency protocol, the 
haematopoietic CD34* stem cells were quickly carried out of the electrode area by fluid flow, 
whereas the breast cancer cells were only carried slowly through the electrode chamber [55]. The 
group also performed electro rotation tests to determine the dielectric properties of both the 
haematopoietic CD34* stem cells and the breast cancer cells, and used the single-shell model to 
derive the dielectric parameters membrane capacitance, internal conductivity of cells and internal 
permittivity of cells [55]. The group found that the membrane capacitance of breast cancer cells was 
much greater than that of haematopoietic CD34* stem cells (23.0 + 7.1 mS/ m  ^and 10.2 + 1.5 mS/ 
m ,^ respectively), however breast cancer cells achieved lower values for internal conductivity (0.55 +
0.10 5 / m) and internal permittivity (107.0 + 29.5) than their haematopoietic CD34* stem cell 
counterparts (conductivity = 0.71 + 0 .1 1 5 / m and permittivity = 141.2 + 28.0) [55]. The group 
concluded that both sort methods (trapping and swept frequency protocols) resulted in yields of 
>99% purity for haematopoietic CD34* stem cells and >95% of sorted cells were found to be viable 
post-sort [55].
Salmanzadeh and colleagues used contactless DEP to separate tumour-initiating prostate cancer cells 
from non-tumour initiating prostate cancer cells, where contactless DEP (cDEP) was performed by 
electrodes being inserted in channels which were separated from the sample testing channel by 
insulative barriers, therefore preventing them from coming into contact with the cells being tested 
[56]. Tumour-initiating cells were defined as aldehyde dehydrogenase positive cells (ALDH^), whilst 
non-tumour -initiating cells where denoted ALDH" [56]. Applying frequencies from 100 kHz to 600 
kHz and using a DEP buffer medium of conductivity 10 mS/ m, the group found that the difference 
between the onset of trapping and complete trapping for ALDH^ cells was least at a frequency of 600 
kHz, therefore this frequency was used for separation of ALDH^and ALDH' prostate cancer cells [56]. 
The sorted ALDH^ and ALDH’ cells, as well as an unsorted control group, were examined for spheroid 
growth after three weeks, and the group found that the size of spheroids generated by the tumour-
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initiating prostate cancer cells (ALDH^) were 3.93 times larger in size than those formed by the mixed 
control, and 17.3 times larger in size than those formed by the non-tumour-initiating prostate cancer 
cells (ALDH ) [56]. The authors suggested, in conclusion, that due to the frequencies used (<1 MHz), 
the differences between the tumour-initiating and non-tumour initiating prostate cancer cells may 
have been due to differential expression of membrane surface proteins [56].
Oz and colleagues studied the dielectric properties of stem versus differentiated embryonal 
carcinoma cells using electrical cell-substrate impedance sensing (EClS), and induced differentiation 
using retinoic acid and a panel of six other differentiation agents [57]. The group applied 2 xlO"*cells 
per well, with each well containing 40 gold electrodes and measured the impedance having applied a 
frequency of 45 kHz, every five minutes for 96 hours [57]. The group found that differentiation of 
embryonal carcinoma cells was triggered by reduction of 0CT4, and they found that using EClS they 
were able to monitor differentiation onset at 20 hours post-induction, i.e. when phenotypic 
expressions and gene expression patterns were not apparent [57].
There are far less studies focused upon examining the dielectric properties of stem versus non-stem 
cells and stem and stem-like cells within cancer, than studies using biomarkers to characterise these 
groups of cells, despite methods like DEP being label-free and non-invasive. It can also be seen upon 
reviewing results of the various studies discussed that there does not appear to be a consistent trend 
in membrane capacitance, with regards to stem cells versus more differentiated cells, but that 
membrane characteristics seem to be the distinguishing factor for stem and differentiated cells 
particularly membrane capacitance. Therefore, in the two experiment chapters examining the 
dielectric characteristics of stem-like oral cancer cells, membrane capacitance was a factor under 
close scrutiny.
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Chapter 4. Dielectrophoresis of Oral 
Cancer Stem-Like Cells, Using Rate of 
Collagen IV Adherence as a Marker 
for Tumorigenic Ability
4.1 Introduction
The work presented in this experimental chapter is the first of two chapters in which 
dielectrophoresis (DEP) was used to investigate the dielectric properties of oral cancer stem-like 
cells.
In the study presented in this chapter, rate of adherence to the basal lamina component collagen IV 
was used as a marker for stem-ness, removing the need to pre-sort cells to be tested using DEP, using 
magnetic activated cell sorting (MACS) or fluorescence activated cell sorting (FACS). Verification of 
the results of DEP testing was achieved by performing scanning electron microscopy (SEM) and using 
mouse models to test the tumour formation of cells characterised according to their stem-ness.
The chapter begins with an introduction on the use of adherence as a marker for stem cell-like 
properties, and this is followed by details of the methods and materials used within this study, the 
study results and a discussion of these results.
The work contained within this chapter is based on the following published paper (a copy of which 
can be found in Appendix 3), for which the researcher was a listed author: Liang X, Graham KA, 
Johannessen AC, Costea DE, Labeed FH. Human oral cancer with increasing tumorigenic abilities 
exhibit higher effective membrane capacitance. Integrative Biology 2014; 6: 545-554.
4,1,1 Use of Adherence as Marker for Stem-Like Cells
Jones and Klein recently stated that relatively little research has focused upon stem cells of the oral 
epithelium, as compared with stem cells in other tissues [1] however, somatic stem cells of the oral 
mucosa are thought to reside in the area of the epithelial rete ridges (i.e. the basal layer of the oral 
epithelium) [2]. The proximity of the basal lamina to this area has led to the suggestion that
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components of the basal lamina could form part of the stem cell niche or microenvironment, and 
therefore could potentially be used to enrich for stem-like oral cells, including cancer stem-like cells. 
The basal lamina typically contains fibrous proteins and glycosaminoglycans (which usually form 
proteoglycans). The fibrous proteins commonly found in basal laminae are laminin, nidogen, 
fibronectin and collagen IV [3]. The role of collagen IV is to provide tensile strength to the basal 
lamina [3], and its role in the stem cell niche has been investigated by Kim and colleagues [4], 
Strachan and colleagues [5] and Igarashi and colleagues [6].
In their study, Kim and colleagues [4] grouped human epidermal kératinocytes (obtained from 
foreskins resulting from child circumcisions) into groups according to their rate of adherence to 
collagen IV, a ligand of p i  integrin [4]. When the epidermal cells were plated onto 100 mm dishes 
coated (overnight at 4°C) with 20 pig/ ml collagen IV and incubated at 37“C, cells which adhered to 
the collagen IV coating within 10 minutes were deemed "rapidly adhering" (RA) [4]. Those cells which 
failed to adhere were incubated for a further 24 hours, after which time, those cells which adhered 
were deemed "slowly adhering" (SA) and any cells which had again failed to adhere were deemed 
"non-adhering" (NA) [4]. Using FACS, the group found that RA epidermal cells expressed high levels 
of a6 integrin and low levels of CD71, whereas SA cells expressed low levels of each and NA cells 
expressed low levels of a6 integrin and high levels of CD71 [4]. RA cells were also found to be small 
cells which had a higher nuclear-to-cytoplasmic ratio than SA and NA cells, and NA cells were found 
to be the largest cells of the three sub-groups, with the lowest nuclear-to-cytoplasmic ratio [4]. These 
results were verified using transmission electron microscopy, which also showed cells from the SA 
and NA groups to have more tonofilaments and "well-developed organelles" [4].
In their study, Strachan and colleagues also used rate of collagen IV adherence to distinguish sub­
groups of murine epidermal keratinocyte cells, but they deemed "rapidly adherent cells" (RACs) as 
kératinocytes which adhered to 10 pg/ ml collagen IV within five minutes and "not rapidly adherent 
cells" (NACs) as those which failed to adhere after 20 minutes [5]. However, this group found that 
whilst the colony forming efficiency of RACs was five times greater than that of NACs at two weeks, 
by four weeks, the colony forming efficiency of RACs was only two times greater than that of NACs, 
and the group also found that NACs had greater long-term proliferative potential in vitro [5]. The 
group also found that NACs contained significantly more repopulating cells than RACs, after nine 
weeks, and concluded that rapid adhesion to collagen IV was inversely related to long-term 
repopulating ability [5].
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Igarashi and colleagues used rate of adhesion to collagen IV in an attempt to isolate putative oral 
epithelial stem cells from rabbits [6]. In this study, cells which adhered to collagen IV within 10 
minutes were "rapidly adherent cells" (RAC), cells which attached after a further 16 hours were 
slowly adherent cells (SAC) and those cells which failed to adhere were non-adherent cells (NAC)
(ref). Like Strachan and colleagues, this group found that RAC cells had the greatest colony forming 
efficiency, compared with SAC (and NAC cells ceased growing and died) [6]. However, unlike Strachan 
and colleagues, Igarashi and colleagues concluded that the RAC sub-group contained some slow- 
cycling cells identified by BrdU positive staining (suggestive of stem cells) and progenitor cells [6].
It is clear that there is a general lack of agreement in the studies mentioned, regarding whether or 
not cells which adhere rapidly to collagen IV are enriched for stem-like cells. However, none of the 
three studies above focused upon human oral epithelial cells or cancer cells.
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4.2 Methods
Cell culture and scanning electron microscopy were performed by Dr Xiao Liang (The Gade Institute 
for Pathology, University of Bergen), and DEP experiments were performed by Dr Xiao Liang, Dr 
Fatima Labeed (Centre for Biomedical Engineering, University of Surrey) and Professor Daniela 
Costea (The Gade Institute for Pathology, University of Bergen). The electrode and DEP testing setup 
used in this study were the same as those used for the study in the preceding experimental chapter,
i.e. the electrode used to perform DEP testing was the DEPtech 3DEP DEP-Well chip and the 
experiment setup is shown in Figure 2.4 in the Methods section of Chapter 2.
In this study, the researcher provided technical assistance during DEP experiments and assisted in 
modelling data and performing statistical analysis.
4.2.1 Cell Culture
Four human oral cell lines constituted the panel whose cellular dielectric characteristics were 
examined in this study: one dysplastic (sample of origin rated mild to moderate in nature) line known 
as DOK and three squamous cell carcinoma lines known as H357, CaLH3 and OSCCl. DOK [7] and 
H357 [8] are commercially available lines [9,10] originating from the tongue, and CaLH3 and OSCCl 
were lines derived from tumours having gained patient consent, and developed in-house at Queen 
Mary's School of Medicine and Dentistry in Whitechapel, London [11] and the University of Bergen in 
Bergen, Norway [12], respectively.
All four lines were cultivated in humidified incubators at 37°C in a 5% C02: 95% air mix. Three lines, 
DOK, H357 and CaLH3, were grown in FAD medium, consisting of three parts Dulbecco's Modified 
Eagle's Medium (DMEM, Sigma Aldrich, St. Louis, MO, USA): one part Hams F12 medium (Sigma 
Aldrich, St. Louis, MO, USA) supplemented with 10% Foetal Bovine Serum (Sigma Aldrich, St. Louis, 
MO, USA), 50 pg/ml L-ascorbic acid (Sigma Aldrich, St. Louis, MO, USA), 25 pg/ml Bovine Pituitary 
Extract (Invitrogen, USA), 20 pg/ml L-glutamine (Sigma Aldrich, (St. Louis, MO, USA), 20 pg/ml 
transferrin (Sigma Aldrich, St. Louis, MO, USA), 5 pg/ml insulin (Novo Nordisk, Bagsværd, Denmark) 
and 0.4 pg/ ml hydrocortisone (Sigma Aldrich, St. Louis, MO, USA). The OSCCl line was grown in 
Keratinocyte Serum Free Medium (KSFM, Invitrogen, USA) supplemented with the following products 
supplied by GibcoBRL (Grand Island, NY, USA): 25 pg/ ml Bovine Pituitary Extract, 0.25 pg/ml
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amphotericin B, 1 ng/ml Epidermal Growth Factor, 100 units/ml penicillin and 100 pg/ml 
streptomycin.
Cells from all four lines were cultivated until reaching a confluence level of approximately 60-70%. 
Just prior to reaching this point, tissue culture dishes of 100mm diameter (Sigma Aldrich, St. Louis, 
MO, USA) were evenly coated with 10 pg/ml human collagen IV (BD Biosciences, Franklin Lakes, USA) 
diluted by 10 mM acetic acid (Sigma Aldrich, St. Louis, MO, USA) and incubated, at room 
temperature, for one hour. Following this incubation period, superfluous collagen IV solution was 
aspirated and the collagen IV-coated dishes were washed twice using phosphate buffered saline 
(Sigma Aldrich, St. Louis, MO, USA), in a manner which would not disturb the collagen IV coating but 
would remove traces of acetic acid. The dishes were then subjected to UV radiation overnight to 
sterilise them, prior to housing any cells.
Upon reaching the aforementioned confluence level, cultivation was ended and the cells were 
released from their culture flasks using 0.25% Trypsin-EDTA (Sigma Aldrich, St. Louis, MO, USA). 
Subsequent to Tryspin neutralisation and generation of single cell solutions, these disaggregated cells 
were added to the prepared tissue culture dishes (whereby the contents of each culture flask were 
added to separate collagen IV -coated culture dishes) and placed in a humidified incubator, at the 
settings mentioned previously. After a period of 10 minutes, cells that remained unattached were 
removed and added to a fresh, sterile collagen IV coated dish. The cells that did adhere to the 
collagen IV coating within 10 minutes underwent trypsinisation followed by Trypsin neutralisation, 
and were deemed to be rapidly adherent cells (RAC). Those cells which did not adhere within 10 
minutes were incubated for a further 30 minutes. After this additional period of 30 minutes, those 
cells attached to the collagen IV coating underwent trypsinisation followed by Trypsin neutralisation, 
and were deemed to be middle adherent cells (MAC), and those cells which had again failed to 
adhere to collagen IV were deemed to be late adherent cells (LAC).
A stock solution of the hyaluronic acid synthesis inhibitor 4-Methylumbelliferone (4-MU, Sigma 
Aldrich, St. Louis, MO, USA) was prepared by dissolving in distilled water, to achieve a concentration 
of 0.3 mM. This stock solution was diluted using the cell culture medium of the cells (from the CaLH3 
and OSCCl lines) of interest for 4-MU testing. For treatment with 4-MU, cells from the CaLH3 and 
OCCl lines were cultivated using the methods outlined until a confluence level of 50% was reached, 
at which point the cells were incubated in 4-MU supplemented culture medium for 48 hours.
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4.2.2 Preparation for DEP Testing
Having been sorted into three adherence sub-groups (rapid, middle and late), cells from each sub­
group were centrifuged three times at 190 g, at room temperature for five minutes per occasion: 
once suspended in the cell culture medium for that line (plus neutralised Tryspin from the collagen IV 
detachment process) to form a cell pellet, and twice subsequently whilst suspended in DEP testing 
medium, to remove all traces of highly conductive cell culture medium, prior to DEP testing. This DEP 
testing medium consisted of 17 mM dextrose and 248 mM sucrose [13], the conductivity of which 
was adjusted to be 10 mS/m and verified using a Jenway 470 conductivity meter (VWR Jencons, 
Leicestershire, UK).
Following the third round of centrifugation, the supernatant was aspirated and discarded, and the 
cells were re-suspended in fresh DEP testing medium, from which a small volume was extracted. To 
this volume, the same volume of Trypan Blue (Sigma Aldrich, St. Louis, MO, USA) was added and the 
resulting solution was added to the counting area of Bürker haemocytometer. The total cell yield and 
percentage viability were recorded for each sub-group tested, and dilution was performed if 
necessary, to achieve an approximate cell concentration of 1.2 x 10® cells/ml. The cells were then 
photographed using an AVT Dolphin F145B digital interface camera (Allied Vision Technologies, 
Germany) mounted to a Nikon Eclipse TS 100 inverted microscope (Nikon, Surrey, UK). The 
photographs were shot and processed using SmartView for WDM version 0.1.3.3 (the software 
supplied with the aforementioned camera) while the cells were in the haemocytometer counting 
chambers, to provide a visual record of cell yield and viability, sample condition and to permit mean 
cell radii measurements to be approximated prior to DEP results analysis.
4.2.3 DEP Testing Protocol
All DEP tests in this study were conducted using a 3DEP DEP-Well 3D electrode chip (DEPtech, East 
Sussex, UK) [14], as was the case for the proceeding experimental chapter (Chapter 2). Each DEP Well 
chip contained a number of identical Well electrodes (Figure 4.1), each measuring 750 jim in 
diameter and all connected to a common ground supply. Each Well was composed of seven insulator 
layers of 150 pm-thick FR4 (fibreglass reinforced epoxy) sandwiched between eight conductor layers 
of gold-plated copper (top and bottom layers were 35 pm in thickness, six remaining layers were 70 
pm in thickness).
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To perform DEP testing, the DEP-Well chip was mounted upon the stage of a Nikon Eclipse 50i 
upright microscope (Nikon, Surrey, UK) and set to be viewed at 4x magnification. The chosen DEP- 
Well electrode, which was the chosen electrode for all DEP tests in this study, was connected to a 
FGIOO Function Generator (Digimess, Reading, UK) set to provide a sinusoidal output of amplitude 
lOV peak-to-peak and this output was monitored through connection to an ISO TECH Digital Storage 
IDS 710 oscilloscope. An AVT Dolphin F145B digital interface camera (Allied Vision Technologies, 
Germany) affixed to the upright microscope to record cell movement within the DEP-Well over the 
course of each frequency run, was connected to a PC and controlled using a MATLAB-based graphic 
user interface (GUI) created by Dr Kai Hoettges, a screenshot of which is shown (Figure 4.2).
Figure 4.1: A. Photograph of DEP-Well 3D electrode chip, with a single DEP-Well electrode highlighted (inside blue circle). B. 
Shows a diagram of a single Well electrode with the banding areas identified, as they would be by the MATLAB GUI 
controlling the DEP experiments.
For all experiments, the following experimental parameters were applied and kept constant:
•  Time [sec] = 60
•  Interval [sec] = 3
The "Time [sec]" parameter in Figure 4.2 was the period of time in seconds that each frequency run 
lasted (i.e. the period for which AC signals were applied to the Well electrode) and the "Interval 
[sec]" parameter dictated how frequently images were captured to determine the change in light 
intensity as a function of time (i.e. in this case, in steps of three seconds). The details of parameters 
used to generate each model are given in the Analysis of Results section of this chapter.
The protocol for all DEP experiments was as follows. Firstly, the cell solution to be tested was mixed, 
to re-suspend cells throughout the testing medium. Next, approximately 5 pi of cell solution was 
extracted, using a pipette. The end of the attached tip was then bent, to allow more precise filling of
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the Well. Cell solution (i.e. cells from the adhesion sub-group being tested, suspended in DEP testing 
medium) was then applied into the Well electrode to the point at which there was an excess of cell 
solution over the Well aperture area. A glass cover-slip (large enough to cover the area of the Well 
aperture) was then laid slowly at an angle to this excess (to reduce the possibility of trapping air in 
the Well).
The "Preview" button (Figure 4.2) was then selected to view the contents of the Well in real-time 
prior to experiment commencement, to ensure that the whole of the Well area was in view and that 
no bubbles were present within the Well. Next, the frequency to be applied to the contents bounded 
by the Well electrode was entered into the GUI (Figure 4.2), in kilohertz. The range of frequencies 
applied to produce a full DEP spectrum was constant for each experiment; 1 kHz to 20 MHz using five 
frequencies per decade. Selecting the "Start experiment" button (Figure 4.2) commenced the 
application of AC signals at the selected frequency to the contents bounded by the Well electrode. 
Images were captured immediately prior to signal application ("0 seconds", to allow normalisation of 
the change in light intensity to this point) and every three seconds thereafter, for a period of 60 
seconds. A MATLAB (The MathWorks Inc, Nantick, MA, USA) script was then used to assess the 
change in light intensity over the period that the electric current was applied and as a function of 
Well radius. At the end of each frequency run, the glass cover-slip was removed, the Well was 
flushed through with fresh DEP testing medium and then dabbed dry. This protocol was repeated for 
each frequency tested.
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Figure 4.2: The MATLAB graphic user interface (GUI) used in this study to control the DEP test settings applied for each 
frequency run, over the course of each DEP experiment.
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4.2.4 Scanning Electron Microscopy
Scanning electron microscopy (SEM) was employed in this study to provide visual evidence of cell 
membrane surface topography for cells from the three adhesion sub-groups, and to investigate the 
effects of 4-MU treatment.
Cells from the CaLH3 and H357 lines were cultivated and RAC, MAC and LAC populations were gained 
from each, using the same methods as outlined previously in this section. Subsequent to detachment 
from the collagen IV-coated dishes, the cells were counted and single cell suspensions (each 
containing approximately 500 cells) were created. Poly-lysine cover-slips coated with collagen IV, 
employing the same method as was employed to coat the tissue culture dishes mentioned 
previously, were added to 24-well plates (VWR International AS, Oslo, Norway). The single cell 
suspensions were then given a period of 90 minutes, at 37 °C, in which to adhere to the coated 
cover-slips.
Upon completion of this period, the cells were fixed for two hours at 4“C using 2% (volume/volume) 
glutaraldehyde in 0.1 M phosphate buffer (pH = 7.2). Prior to performance of SEM, the cells 
underwent ethanol dehydration and critical point drying before being mounted on aluminium stubs 
and coated with evaporated carbon. SEM was then performed, using a Jeol JSM-7400 field emission- 
scanning electron microscope.
4.2.5 Analysis of DEP Results
4.2.5.1 Modelling Raw Results from DEP Testing
4 .2 .5 .1 .1  C e llu la r  D ie le c tr ic  C h a ra c te ris tic s  b y  F it t in g  S in g le -S h e ll M o d e l C unæ
Cell radii for the RAC, MAC and LAC populations from all four cell lines were approximated by loading 
images recorded during the cell count into the software program ImageJ (NIH, USA). ImageJ 
converted the number of pixels in the selected image into a length, selected to be a micrometer (pm) 
length for these experiments. After 50 cells were counted, a value for the mean cell diameter was 
produced in micrometers, from which the cell radius was then found by dividing the mean cell 
diameter by two. Whilst cell radius is not a dielectric parameter, an estimation of mean cell radius 
was required for calculation of variables which were dielectric parameters (membrane conductance 
and membrane capacitance).
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Having gained an approximate mean radius for the cells examined in each DEP experiment, for the 
RAC, MAC and LAC populations from each cell line, the raw DEP spectra from each experiment (i.e. a 
plot of the change in light intensity as a function of frequency, time and Well radius) could be 
modelled using the single-shell model [15-17] employed by the graphic user interface 
"DEP_well_plotter", as was done in the experiment chapters preceding and succeeding this. To 
summarise briefly, a curve governed by the parameters determining the Clausius-Mossotti Factor 
(see equations 3 and 4 of [18]) was fitted to the raw data DEP spectrum from each experiment. This 
was achieved by entering values for cytoplasmic conductivity (S/m) and permittivity, and membrane 
conductivity (S/m) and permittivity, as well as inputting values for mean cell radius and constant 
values for medium conductivity and permittivity and membrane thickness (values shown in Figure 
4.3), as per the single-shell model. This model was subsequently used to estimate values for the 
following cellular dielectric properties: cytoplasmic conductivity (S/m) and permittivity, and 
membrane conductivity (S/m) and permittivity.
Two more cellular dielectric properties, membrane conductance (Gmem, or "gspec" in Figure 4.3) and 
membrane capacitance (Cmem, or "cspec" in Figure 4.3), were then calculated, by applying the 
estimated values for membrane conductivity [Omem) and permittivity {£mem ) to the following 
equations [19]:
G m em  =  ^  (D
r  -  ^m em xgp
^mem ~  ^
Where Eq is the permittivity of free space (8.854187817X 10'^  ^F/m) and d is the cell membrane 
thickness in meters.
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Figure 4.3: DEP_well_plotter GUI used to model raw results from DEP analysis. All fields with numerical values assigned 
were kept constant (i.e. radial bands, evaluation time, scale factors, number of shells considered, membrane thickness [20], 
medium conductivity and medium permittivity). This was the same GUI used in both the experimental chapter preceding 
and succeeding this.
"Best-fit" was achieved when the highest value for the correlation coefficient (R) was found. DEP 
spectra which achieved an R value > 0.9 between the raw experimental data and the "best-fit" curve 
representing the Clausius-Mossotti Factor (CMF) were deemed model-able and retained for further 
analyses whilst those spectra with an R value < 0.9 were disregarded for the purposes of further 
analyses.
4.2.5.2 Analysis of Modelled Results
The results reported in the section of the study succeeding this are those reported in the paper upon 
which this chapter is based [21].
4 .2 .5 .2 .1  A n a ly s is  o f  C e llu la r  D ie le c tr ic  P ro p e rtie s
Two sets of results were produced from modelling the raw DEP spectra from each experiment of 
each collagen IV adherence sub-group, from each cell line. The first set of results produced were the 
actual values gained for cell radius and dielectric properties cytoplasmic conductivity, membrane 
conductance and membrane capacitance. The second set of results produced were the values for
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MAC and LAC relative to the values for RAC, i.e. the value for RAC was set to 1.0, for all parameters 
tested and the relative values of MAC and LAC were calculated to be the actual values MAC and LAC 
as fractions of the actual value for RAC.
4 .2 .5 .2 .2  S ta tis t ic a l A n a ly s is
All statistical analysis was performed using SPSS Statistics 19.0 software (SPSS Inc., Chicago) and a p 
value of 0.05 was chosen, as the sample sizes in this study were relatively small. The Kolmogorov- 
Smirnov test for normality was performed on each data set. If all data sets were deemed normally 
distributed, the t-test was employed to determine if statistically significant differences were present. 
Otherwise, the Mann-Whitney U test for non-parametric data was employed.
The null hypotheses for this body of work, to be accepted or rejected depending on the results of the 
conducted statistical analysis were as follows:
1. There was no statistically significant difference in cellular dielectric properties of the rapidly- 
adherent cell (RAC) population compared with the middle adherent cell (MAC) population, 
for cell line CaLH3.
2. There was no statistically significant difference in cellular dielectric properties of the middle 
adherent cell (MAC) population compared with the late adherent cell (LAC) population, for 
cell line CaLH3.
3. There was no statistically significant difference in cellular dielectric properties of the rapidly- 
adherent cell (RAC) population compared with the late adherent cell (LAC) population, for 
cell line CaLH3.
4. There was no statistically significant difference in cellular dielectric properties of the rapidly- 
adherent cell (RAC) population compared with the middle adherent cell (MAC) population, 
for cell line H357.
5. There was no statistically significant difference in cellular dielectric properties of the middle 
adherent cell (MAC) population compared with the late adherent cell (LAC) population, for 
cell line H357.
6. There was no statistically significant difference in cellular dielectric properties of the rapidly- 
adherent cell (RAC) population compared with the late adherent cell (LAC) population, for 
cell line H357.
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7. There was no statistically significant difference in cellular dielectric properties of the rapidly- 
adherent cell (RAC) population compared with the middle adherent cell (MAC) population, 
for cell line OSCCl.
8. There was no statistically significant difference in cellular dielectric properties of the middle 
adherent cell (MAC) population compared with the late adherent cell (LAC) population, for 
cell line OSCCl.
9. There was no statistically significant difference in cellular dielectric properties of the rapidly- 
adherent cell (RAC) population compared with the late adherent cell (LAC) population, for 
cell line OSCCl.
10. There was no statistically significant difference in cellular dielectric properties of the rapidly- 
adherent cell (RAC) population compared with the middle adherent cell (MAC) population, 
for cell line DOK.
11. There was no statistically significant difference in cellular dielectric properties of the middle 
adherent cell (MAC) population compared with the late adherent cell (LAC) population, for 
cell line DOK.
12. There was no statistically significant difference in cellular dielectric properties of the rapidly- 
adherent cell (RAC) population compared with the late adherent cell (LAC) population, for 
cell line DOK.
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4.3 Results
As alluded to in the Methods section of this study, the results presented here are the results 
presented in the paper [21] upon which this chapter is based.
4.3.1 Dielectric Properties of Cells with Differing Rates of 
Adherence to Collagen IV: Rapidly Adherent Cells fRAC) vs. 
Middle Adherent Cells fMAO vs. Late Adherent Cells fLAC)
The dielectric properties cytoplasmic conductivity, membrane conductance and membrane 
capacitance were examined in this study, using DEP testing. DEP tests were performed on the RAC, 
MAC and LAC collagen IV adherence sub-groups from the CaLH3, H357, OSCCl and DOK cell lines and 
the resulting spectra from each were modelled using the single-shell model. Results were generated 
from spectra from three DEP experiments for the CaLH3 line, two DEP experiments for the H357 and 
OSCCl lines, and four DEP experiments for the DOK line.
Figures 4.4 and 4.5 and Table 4.1 show the mean membrane capacitance values achieved by the RAC, 
MAC and LAC sub-groups, for all four cell lines examined. The DOK line was considered separately as 
it was an oral dysplastic line, rather than an oral cancer line.
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Mean Membrane Capacitance for the CaLH3, H357 and
0SCC1 Cell Lines: RAC vs. MAC vs. LAC
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Figure 4.4: Mean + standard error of the mean (SE) bar chart for mean membrane capacitance, comparing the values 
gained by cells from the CaLH3, H357 and OSCCl lines, for RAC, MAC and LAC.
Upon viewing Figure 4.4 it is evident that for each of the three oral cancer cell lines (CaLH3, H357 and 
OSCCl), cells from the RAC sub-group achieved the greatest mean membrane capacitance, followed 
by cells from the MAC sub-group, with cells from the LAC sub-group achieving the lowest mean 
membrane capacitance. Therefore, when the results from each of the three lines were grouped 
together to provide mean values for RAC, MAC and LAC, the RAC value (19.24 + 3.11 mF/ m^) was 
greater than both the MAC value (15.06 + 2.75 mF/ m )^ and the LAC value (10.08 + 1.66 mF/ m^). 
Figure 4.4 also suggests that CaLH3 cells achieved the greatest levels of membrane capacitance, 
followed by cells from the H357 line, with cells from the OSCCl line achieving comparatively low 
levels of membrane capacitance.
Also evident upon viewing Figure 4.4 is that there appear to be significant differences between the 
RAC and LAC, and MAC and LAC sub-groups for all three cancer lines tested, as there are noticeable 
differences in mean values and the error bars depicting standard errors do not overlap (see Table 4.1 
for numerical values). This result is confirmed by the p values shown in Table 4.2, which show not 
only that the differences between RAC and LAC (p = 0.000) and MAC and LAC (p = 0.018) were 
significant but that the difference between RAC and MAC was also significant (p = 0.026)
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CaLH3
OSCCl
Cancer
Total
DOK
Cytoplasmic Conductivity 
(S /m )
0.18 + 0.21 + 0.29 +
0.04 0.07 0.10
454.03 
+ 63.66
585.72
+
243.76
n 3“ ,6 4  i  28.61
425.55 379.43
+ 93.01 +55.83
Membrane Capacitance 
(m F/ m^)
27.23 + 25.00 + 23.25 +
14.53 12.45 13.34
Table 4.1: Summary of the results for the cellular dielectric parameters cytoplasmic conductivity, membrane conductance 
and membrane capacitance, for the RAC, MAC and LAC collagen IV adherence sub-groups, for all four cell lines used in this 
study. Results are expressed as mean + standard error of the mean.
Collagen IV Adherence 
Sub-groups Tested 
(CaLHS, H357 and OSCCl)
Results of Paired T-Tests 
for Membrane Capacitance
RAC [Relative) vs. MAC [Relative) p = 0.026
MAC [Relative) vs. LAC [Relative) p = 0.018
RAC [Relative) vs. LAC [Relative) p = 0.000
Table 4.2: Summary of results of t-tests for statistical significance, using relative values for cellular dielectric properties (i.e. 
values of MAC and LAC were a percentage of the values gained by RAC). RAC, MAC and LAC values consisted of the results 
from the CaLH3, H357 and OSCCl cell lines. The p value was set at p = 0.05.
The same pattern of decreasing mean membrane capacitance from RAC to MAC to LAC was also 
observed for the DOK cell line (Figure 4.5 and Table 4.1). However, as the mean values in Figure 4.5 
appear to be very similar in value and the standard error of mean values are large, the verification 
that no significant differences existed between the adherence sub-groups by the p values shown in 
Table 4.3 (all p values > 0.4) was not an unexpected result.
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Figure 4.5: Mean + standard error of the mean (SE) bar chart for mean membrane capacitance, comparing the values 
gained by cells from the DOK line, for RAC, MAC and LAC.
Collagen IV Adherence 
Sub-groups Tested 
(DOK)
Results of Paired T-Tests 
for Membrane Capacitance
RAC (Relative) vs. MAC [Relative) p = 0.975
MAC [Relative) vs. LAC [Relative) p = 0.423
RAC [Relative) vs. LAC [Relative) p = 0.704
Table 4.3: Summary of results of t-tests for statistical significance for the DOK cell line, using relative values for cellular 
dielectric properties (i.e. values of MAC and LAC were  a percentage of the values gained by RAC). The p value was  set at p
0.05.
Figure 4.6 summarises the results gained for mean membrane conductance by the RAC, MAC and 
LAC sub-groups of the CaLH3, H357 and OSCCl lines, with the corresponding numerical values shown 
in Table 4.1. It is evident that both the CaLH3 and H357 sub-groups follow the same trend, while the 
sub-groups from OSCCl follow a different trend altogether. For both CaLH3 and H357, cells from the 
MAC sub-group achieved higher mean membrane conductance values than the cells from the RAC 
and LAC sub-groups (Table 4.1). However, for the OSCCl line, cells from the RAC sub-group achieved
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the highest mean membrane conductance, followed by cells from the MAC sub-group, with the LAC 
sub-group achieving the lowest value for the OSCCl line, but the highest membrane conductance 
value for the LAC sub-groups, from the three cancer cell lines (Table 4,1). Of note in Figure 4.6 is the 
magnitude of the standard errors achieved by the CaLHS and H357 MAC sub-groups (40.1% and 
22.8% respectively).
Mean Membrane Conductance for the CaLHS, H357 
and 0SCC1 Cell Lines: RAC vs. MAC vs. LAC
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Figure 4.6: Mean + standard error of the mean (SE) bar chart for mean membrane conductance, comparing the values 
gained by cells from the CaLHS, H357 and OSCCl lines, for RAC, MAC and LAC.
Figure 4.7 shows the DOK cell line achieved the same RAC-MAC-LAC trend as the CaLH3 and H357 cell 
lines, for mean membrane conductance, i.e. the MAC sub-group achieved the greatest value for 
membrane conductance. However, for DOK, LAC cells achieved a greater mean value for membrane 
conductance than RAC cells (Table 4.1).
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Figure 4.7: Mean + standard error of the mean (SE) bar chart for mean membrane conductance, comparing the values 
gained by cells from the DOK line, for RAC, MAC and LAC.
As was observed for membrane conductance in Figure 4.6, the CaLH3 and H357 lines followed the 
same trend, which was different to the trend observed for the OSCCl line, for mean cytoplasmic 
conductivity (Figure 4.8). However, in Figure 4.8 unlike in Figure 4.6, it can be seen that the greatest 
values for cytoplasmic conductivity were achieved by the LAC sub-group, for both CaLH3 and H357. 
For these lines, the RAC and MAC values for membrane conductance were of very similar magnitude, 
with the RAC sub-group achieving a marginally higher value than the MAC sub-group (values in Table 
4.1). In fact, the values for RAC, MAC and LAC for both the CaLH3 and H357 sub-groups were very 
similar in value. However, the values for RAC, MAC and LAC are noticeably smaller in magnitude for 
the OSCCl line, and fail to follow the same trend as was observed for the other two cancer cell lines. 
The OSCCl RAC, MAC and LAC sub-groups follow the same trend for cytoplasmic conductivity (Figure 
4.8) as was observed for this cell line for membrane conductance (Figure 4.6) and membrane 
capacitance (Figure 4.4), i.e. the RAC sub-group achieved the greatest value, followed by the MAC, 
then the LAC sub-groups. No significant differences were found between RAC, MAC and LAC 
populations when the relative results for CaLHS, H357 and OSCCl were combined (p > 0.1), or for the 
DOK line relative results were used (p > 0.1).
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Figure 4.8: Mean + standard error of the mean (SE) bar chart for mean cytoplasmic conductivity, comparing the values 
gained by cells from the CaLH3, H357 and OSCCl lines, for RAC, MAC and LAC.
The DOK line however, followed a different RAC-MAC-LAC trend to that observed for the CaLH3 and 
H357 (in contrast to what was observed for membrane capacitance), and OSCCl lines. As was 
observed for the CaLH3 and H357 lines, the LAC sub-group gained the highest mean cytoplasmic 
conductivity value. Unlike what was observed for the CaLH3 and H357 lines, the MAC sub-group 
achieved the second highest value for mean cytoplasmic conductivity while the RAC group achieved 
the lowest value (see Table 4.1 for values).
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Figure 4.9; Mean + standard error of the mean (SE) bar chart for mean cytoplasmic conductivity, comparing the values 
gained by cells from the DOK line, for RAC, MAC and LAC.
Upon evaluation of the results shown in Figures 4.4-4.9 and Tables 4.1-4.3, the differences between 
the RAC, MAC and LAC sub-groups appeared to be centred around the membrane dielectric 
properties, particularly membrane capacitance.
4.3.2 Effect of 4-Methylumbelliferone Treatment on 
Membrane Capacitance
Further investigation of cell membrane properties was conducted for the CaLH3 and OSCCl cell lines. 
Cells from the RAC, MAC and LAC sub-groups for both lines were exposed to 4-MU for a period of 48 
hours and then tested using the DEP testing protocol outlined in the Methods section of this chapter. 
The results of this 4-MU exposure on membrane capacitance were compared to the membrane 
capacitance results shown in Table 4.1.
Figure 4.10 shows the comparison of the membrane capacitance values gained by untreated CaLH3 
RAC, MAC and LAC cells with the membrane capacitance values gained by RAC, MAC and LAC CaLH3 
cells treated with 4-MU. It is evident upon viewing Figure 4.10 that the cells treated with 4-MU  
achieved lower values of membrane capacitance than their untreated counterparts. The highest
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value achieved for membrane capacitance by untreated CaLH3 cells was 23.39 mF/ m^ achieved by 
the RAC sub-group. However, the highest membrane capacitance value recorded for CaLH3 cells 
treated with 4-MU was approximately half the value achieved by untreated RAC CaLH3, at 11.74 mF/ 
m^ and was found for the MAC sub-group (Table 4.4).
Of note, the percentage difference between the untreated cells and the cells treated with 4-MU was 
greatest for the RAC sub-group at 55.5% (Table 4.4).
Mean Membrane Capacitance for the CaLH3 Cell Line: 
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Figure 4.10: Mean + standard error of the mean (SE) bar chart for mean membrane capacitance for the CaLH3 cell line, 
comparing values gained by cells from the RAC, MAC and LAC sub-groups when treated with 4-MU, with the values gained 
by cells from the same sub-groups which did not undergo 4-MU treatment.
A similar marked difference in membrane capacitance for untreated versus 4-MU treated cells was 
not observed however for the OSCCl cell line (Figure 4.11). In Figure 4.11 it can be seen that the 
mean membrane capacitance values achieved by the RAC sub-groups for untreated versus 4-MU  
treated OSCCl cells were almost identical, i.e. 4-MU treatment did not appear to have a notable 
effect on the membrane capacitance of rapidly adherent OSCCl cells.
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Of interest, however, were the results gained by OSCCl cells from the MAC and LAC sub-groups in 
Figure 4.11, which showed that not only had 4-MU treatment not resulted in a reduced mean 
membrane capacitance value for each, the membrane capacitance for both MAC and LAC was 
increased following 4-MU treatment (values shown in Table 4.4). This was the opposite results to 
that found for 4-MU treatment of CaLH3 cells.
Mean Membrane Capacitance for the 0SCC1 Cell 
Line: Treated with 4-MU vs. Non-Treated
□  r a c
□  m a c
□  l a c
Non-Treated
OSCCl
Treated
Error bars: + /-1  SE
Figure 4.11: Mean + standard error of the mean (SE) bar chart for mean membrane capacitance for the OSCCl cell line, 
comparing values gained by cells from the RAC, MAC and LAC sub-groups when treated with 4-MU, with the values gained 
by cells from the same sub-groups which did not undergo 4-MU treatment.
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Table 4.4: Summary of the results for the cellular dielectric parameters cytoplasmic conductivity, membrane conductance 
and membrane capacitance, for the RAC, MAC and LAC collagen IV adherence sub-groups, for the two cell lines used to test 
the effects of 4-MU in this study-CaLHS and OSCCl. Results are expressed as mean + standard error of the mean.
The membrane capacitance results achieved for both the CaLH3 and OSCCl lines, when comparing 
the effects of 4-MU treatment on the RAC, Mac and LAC sub-groups, were investigated further using 
t-tests.
Table 4.5 shows the results of t-tests performed on the membrane capacitance values gained by the 
CaLH3 line and Table 4.6 shows the results of t-tests performed on the membrane capacitance values 
gained by the OSCCl line.
Collagen IV  Adherence 
Sub-groups Tested 
for the Effects of 4-MU Treatment 
on CaLH3 Cell Line
Results of T-Tests 
for Membrane Capacitance
RAC (Treated) vs. RAC (Non-Treated) p = 0.031
MAC (Treated) vs. MAC (Non-Treated) p = 0.118
LAC (Treated) vs. LAC (Non-Treated) p = 0.218
Table 4.5: Summary of results of t-tests for statistical significance comparing cells from the CaLH3 line which had been 
treated with 4-MU with those which were not treated. The actual numerical values gained for cell membrane capacitance, 
rather than the relative values were used in these statistical tests. The p value was set at p = 0.05.
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Collagen IV Adherence 
Sub-groups Tested 
for the Effects of 4-MU Treatment 
on OSCCl Cell Line
Results of T-Tests 
for Membrane Capacitance
RAC (Treated) vs. RAC (Non-Treated) p = 0.908
MAC (Treated) vs. MAC (Non-Treated) p = 0.240
LAC (Treated) vs. LAC (Non-Treated) p = 0.608
Table 4.6: Summary of results of t-tests for statistical significance comparing cells from the OSCCl line which had been 
treated with 4-MU with those which were not treated. The actual numerical values gained for cell membrane capacitance, 
rather than the relative values were used in these statistical tests. The p value was set at p = 0.05.
The only p value less than 0.05 was achieved when comparing untreated RAC with 4-M U treated RAC 
cells from the CaLH3 line (p = 0.031). All other test groupings, MAC vs. MAC and LAC vs. LAC for 
CaLH3 and RAC vs. RAC, MAC vs. MAC and LAC vs. LAC for OSCCl, achieved p values in excess of 0.1, 
indicating small, if any, differences of no statistical significance.
Scanning electron microscopy was then used to investigate the membrane morphologies of 
untreated and 4-MU treated CaLH3 cells, in an attempt to explain the results of DEP testing. The 
resulting images can be seen in Figure 4.12.
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Figure 4.12: Scanning electron microscopy images showing the shape (A-C and G-l) and membrane topographies (D-F and J- 
L) of untreated cells (A-F) and cells treated with 4-MU (G-L), from the RAC, MAC and LAC sub-groups, from the CaLH3 line.
Images A and B of Figure 4.12 show RAC and MAC cells to have a spherical shape, whilst LAC cells 
appear to have a flatter shape (C). Images D-F show magnified images focusing on the membranes 
from images A- C, respectively and show untreated RAC CaLH3 cells to have membranes more rich in 
membrane protrusions and "ruffles" than their MAC counterparts, and which are much more 
abundant than was found for their LAC counterparts.
Treatment with 4-MU seems to have altered the shape of RAC and MAC cells upon comparing images 
A and B with images G and H, respectively in Figure 4.12. Comparison of images D and J, images E 
and K and images F and L suggests that as well as altering the shape of RAC and MAC cells in 
particular, treatment with 4-MU diminished the membrane features of RAC, MAC and LAC CaLH3 
cells. Images for each of the sub-groups following 4-MU treatment (J-K) show cell membranes much 
less abundant in protrusions and "ruffles" than images for untreated cells from each of the sub-
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groups (D-F). Of interest, image K of Figure 4.12 appears to show MAC cells to have a smooth 
membrane surface, smoother than that of RAC (image J) and LAC (image L). However, there appear 
to be fissures on the MAC cell membrane surface, and these too (together with protrusions) 
contribute to membrane capacitance.
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4.4 Discussion
The aim of this study was to use rate of adherence to collagen IV as a marker for oral cancer stem- 
ness/ tumorigenic potential, and to investigate the dielectric properties of the cells contained within 
the resulting adherence sub-groups (rapidly adherent, middle adherent and late adherent) using 
dielectrophoresis (DEP).
4.4.1 Dielectric Properties of Oral Cancer and Dysplasia Cells 
from the RAC. MAC and LAC Sub-groups
Prior to DEP testing, cells from the panel of the four cell lines used in this study, CaLH3, H357, OSCCl 
and DOK, were separated into three sub-groups depending on their rate of adherence to collagen IV. 
Collagen IV is a constituent of the lamina propria in oral mucosa, a layer which is situated inferior to 
the layer containing oral stem cells [22]. This led to the suggestion that collagen IV is a component of 
the stem cell environment and therefore could be used to enrich for populations of oral cells with 
stem-like properties. Studies by Strachan and colleagues [5] and Change and colleagues [23] found 
that populations which adhered rapidly to collagen IV were enriched for stem cells, in normal 
epithelium from human, rabbit and murine sources, and a study by Wu and colleagues found rapid 
adherence to collagen IV enriched populations for stem cells in hepatic carcinomas [24]. Therefore, it 
was understood prior to DEP testing, that the RAC population from each line would be most enriched 
for stem-like cells, followed by the MAC population, with the LAC population least likely to contain 
cells with stem-like/ tumorigenic properties.
The results shown in the section preceding this (see Table 4.2) suggest that populations of oral 
cancer cells enriched for stem-like cells, by virtue of their rapid rate of adherence to collagen IV 
(RAC), achieved significantly greater mean membrane capacitance than populations less or not 
enriched for oral cancer stem-like cells, MAC (p = 0.026) and LAC (p = 0.000). Results from DEP also 
suggested that whilst neither the MAC nor the LAC populations were enriched for stem-like oral 
cancer cells, MAC cells achieved significantly higher membrane capacitance than LAC cells (p =
0.018). Scanning electron microscopy (SEM) images (Figure 4.12, D-F) of cells from the CaLH3 line 
revealed the membrane surfaces of RAC cells to be abundant in membrane protrusions, whilst those 
of MAC cells were less abundant in membrane protrusions and the membranes of LAC cells had 
noticeably fewer membrane protrusions than either MAC or RAC cells. This tended to suggest that 
the greater amount of membrane protrusions achieved by RAC cells was the reason for cells from
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this sub-group achieving greater values for membrane capacitance, than cells from the MAC and LAC 
sub-groups. Theoretically, this was plausible, as membrane capacitance is influenced by the surface 
area of the cell. However, membrane capacitance is also influenced by membrane thickness and 
membrane composition (e.g. the proteins present and the number of ion channels present) [13]. As 
membrane thickness was assumed to be constant for all cells from each sub-group from each cell line 
analysed, these differences in membrane capacitance for RAC, MAC and LAC cells could also have 
been due to membrane composition. Therefore a method was used to investigate the role of 
membrane protrusions in determining the membrane capacitance of RAC, MAC and LAC populations.
As alluded to in the Methods and Results sections, exposure to 4-MU was used to investigate the role 
of membrane protrusions in determining the membrane capacitance of RAC, MAC and LAC 
populations. The sodium salt 4-MU acts to inhibit hyaluronic acid synthesis and had been shown by 
Twarock and colleagues [25] to smoothen membrane borders and destroy filopodia. Upon exposure 
to 4-MU for 48 hours, the results in Figure 4.10, Table 4.4 and Table 4.5 showed the membrane 
capacitance achieved by RAC, MAC and LAC cells from the CaLH3 line to have decreased, to an extent 
that was deemed significant for treated versus untreated RAC populations (p = 0.031). No significant 
differences were found between the treated and untreated MAC, and LAC populations, prompting 
the conclusion that membrane protrusions such as filopodia and membrane ruffling were the reason 
that the CaLH3 RAC sub-group achieved significantly greater values for membrane capacitance than 
the CaLH3 MAC and LAC sub-groups. This result also appeared to be confirmed by images J-L of 
Figure 4.12 in the Results section.
However, treatment of OSCCl cells with 4-MU did not achieve the same result as was achieved by 
CaLH3 cells. Upon viewing Figure 4.11 and Tables 4.4 and 4.6, it is clear that not only was the mean 
membrane capacitance of RAC cells treated with 4-MU almost identical to the value gained by 
untreated RAC cells, the membrane capacitance of OSCCl MAC and LAC cells appeared to increase 
following treatment with 4-MU. This could suggest that membrane protrusions were not the only or 
main contributing factor in untreated OSCCl RAC cells achieving greater values of membrane 
capacitance than MAC and LAC cells, and therefore that membrane composition may have been the 
factor determining membrane capacitance for OSCCl cells (though this was not investigated in this 
study).
Non-obese diabetic/ severe combined immunodeficiency (NOD/ SCID) mice of 6-8 weeks old, kept in 
a pathogen -free  isolation facility under a 12 hour day/ night cycle were used (by Dr Liang and 
Professor Costea, as approved by the Norwegian Animal Research Authority) to investigate the
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tumour-forming ability of RAC, MAC and LAC cells from the OSCCl line. Dilute RAC, MAC and LAC 
populations, suspended in 50 ml matrigel (BD Biosciences), were injected into the tongues of 
NOD/SCID mice (N = 35) resulted in tumour formation levels of 82% for RAC, compared with 58% for 
MAC and 46% for LAC. Tumours from RAC populations also formed seven days earlier than tumours 
from LAC populations, when 1000 cells were injected into the tongues of NOD/ SCID mice. These 
results seem to confirm the theory that RAC populations contain a higher proportion of stem-like 
cells than the MAC and LAC populations.
Whilst differences were found between RAC, MAC and LAC cells for the three oral carcinoma lines 
used in this study, in terms of membrane capacitance, no significant differences were found between 
the RAC, MAC and LAC sub-groups for the dysplastic oral line DOK, for cytoplasmic conductivity, 
membrane conductance or membrane capacitance (Table 4.3, Figure 4.7 and Figure 4.9). This could 
indicate that DEP testing and analysis, as presented here, is not able to distinguish stem-like cells 
from non stem-like cells from oral dysplastic lines.
4.4,2 Limitations of the Current Study
Whilst the study presented here used methods such as SEM and mice models to confirm the results 
found through DEP testing and analysis, the study, as it is presented here and in publication [21] has 
a number of limitations.
Firstly, during the collagen IV adherence protocol, cells deemed to be late adherent (LAC) cells were 
only trypsinised once (to remove them from their culture flask and apply them to a collagen IV- 
coated dish). However, cells deemed as rapidly or middle adherent (RAC and MAC, respectively) cells 
were trypsinised twice-once to remove them from their culture flasks and apply them to collagen IV- 
coated dishes and once more to remove them from these dishes. Therefore, if Trypsin damages 
membrane surface features or integrity, any surface features of LAC cells could be less damaged than 
those of MAC (or even RAC) cells because they have endured one less round of trypsinisation. This 
could potentially explain why cells from the MAC population achieved greater membrane 
conductance values than cells from the RAC and LAC populations, for the CaLH3, H357 and DOK lines 
(Figures 4.6 and 4.7)-due to increased membrane permeability caused by Trypsin-induced damage, 
though LAC cells still achieved lower membrane capacitance values than RAC and MAC cells (Figures 
4.4 and 4.5). One way to remove this as a possible source of error would be to subject cells from the 
LAC groups to trypsinisation twice, to match the conditions that RAC and MAC populations were
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subject to. Alternatively, different dissociation media, such as Accutase orTrypLE could be used in 
place of Tryspin, and the results of DEP testing following use of these dissociation media could be 
investigated.
Secondly, of the four lines examined in this study, the tumour-forming ability of only one line 
(OSCCl) was investigated and the membrane surface topographies of only two lines (CaLH3 and 
OSCCl) were investigated. It would have been of interest to study the tumour-forming ability of all 
three cancer lines examined in this study (CaLH3, H357 and OSCCl), and to be able to accept or 
reject the results of DEP testing and analysis, as they pertained to membrane properties, by 
examining SEM images of all four cell lines examined in this study, CaLH3, H357, OSCCl and DOK.
With regards to the DEP results achieved for the DOK line, a limitation of this study was that no 
significant differences were found, for cytoplasmic conductivity, membrane conductance or 
membrane capacitance for populations enriched for stem-like cells (RAC) compared with those likely 
to contain smaller populations of stem-like cells (MAC and LAC). This may therefore have implications 
regarding the use of the 3DEP DEP-Well testing and analysis system described here for early 
detection of oral cancer metastatic potential.
The number of experimental repeats used to generate the membrane capacitance results in this 
study, were few at times. The number of repeats used to generate mean membrane capacitance 
values for the CaLH3 cell line was four or five, and for the DOK line the number of repeats used was 
three or four. However, the mean membrane capacitance values for H357 and OSCCl were 
generated from two experimental repeats. Such small sample sizes limit the power of the statistical 
tests used in this study, and render the membrane capacitance results gained in this study as 
preliminary results, particularly in the case of those gained for H357 and OSCCl. Small sample sizes 
were less of an issue for mean membrane conductance and mean cytoplasmic conductivity, as three 
to five repeats were used to generate mean values.
Finally, one other area of inconsistency in this study, aside from SEM and mice models not being 
used to investigate DEP results for all cell lines tested, was the inclusion and exclusion criteria for 
data, particularly membrane capacitance data, but also membrane conductance data. The researcher 
cannot explain why data points which could be classed as outliers were removed from some data 
sets, but not all. With sample sizes of two to five there is a cause for arguing against removal of any 
data points, as it is extremely difficult to determine which points are true and which are erroneous. 
Exclusion of data points also extended to the relative values used in statistical tests, where actual
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values existed and were included, yet the corresponding relative value was, for an unknown reason, 
excluded.
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4.5 Conclusions
The aim of this study was to examine the dielectric properties of sub-populations of oral cancer and 
oral dysplasia cells which were defined as stem-like or non-stem-like depending on their rate of 
adherence to collagen IV, using dielectrophoresis, and therefore determine if dielectrophoretic 
testing and analysis could be used to differentiate between populations of oral cancer and dysplasia 
cells with different levels of tumour-forming potential.
The results of DEP testing and analysis and SEM, reported in the paper upon which this chapter is 
based, appeared to show that the dielectric variable, membrane capacitance, could be used to 
distinguish rapidly adherent (RAC) oral cancer cells from middle (MAC) and late adherent (LAC) oral 
cancer cells. As RAC cells were proved in this study (through testing on NOD/ SCID mice) to possess 
greater tumour-forming potential than MAC and LAC cells, DEP testing of cells divided into sub­
groups using rapidity of adherence to collagen IV as a marker for cancer cell stem-ness, appeared to 
be capable of distinguishing between cancer stem-like cells and cancer cells which were less or not 
stem-like.
If consistent rules were used for analysis of statistical results, particularly for membrane capacitance 
which showed promising results as to the role of DEP within cancer stem cell research, and further 
studies were conducted resulting in larger data sets for the H357 and OSCCl lines, and if the LAC sub­
group was subjected to the same experimental conditions as the RAC and MAC sub-groups, and SEM 
and mouse models were used to confirm the DEP results from all cell lines tested, this study would 
provide an in-depth investigation into dielectric properties of cancerous and dysplastic cells, whose 
stem-ness was determined through rate of adhesion to collagen IV.
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Chapter 5. Dielectrophoresis of Oral 
Cancer Stem-Like Cells with 
Epithelial-to-Mesenchymal 
Transition and Epithelial Phenotypes
5.1 Introduction
This experimental chapter focuses upon a small-scale study, conducted by the researcher and 
collaborators at Queen Mary University, London, in which the dielectric properties of stem-like cells 
within oral cancer cell lines were investigated, using dielectrophoresis (DEP).
Specifically, the dielectric properties of oral epithelial cancer stem-like cells which appeared to have 
undergone an epithelial-to-mesenchymal transition (EMT), to adopt a more mesenchymal 
phenotype, were compared with oral epithelial cancer stem-like cells which had a more 
differentiated (i.e. epithelial) phenotype.
The purpose of this study was to determine if oral cancer stem-like cells with an EMT phenotype 
could be distinguished from oral cancer stem-like cells with an epithelial phenotype, using DEP, as 
this would be the first stage towards possible future separation of cells with these phenotypes from 
mixed populations, using DEP.
The chapter begins with an introduction to the topic of the epithelial-to-mesenchymal transition 
(EMT) and its role within the theories of cancer stem cells and tumour development, followed by 
details of the methods and materials use within this study, the study results and a discussion of these 
results.
5,1.1 The Epithelial to Mesenchymal Transition (EMT) and 
Cancer Stem Cells
Kalluri and Weinberg define epithelial-to-mesenchymal transition (EMT) as "...a biological process 
that allows a polarized epithelial cell, which normally interacts with basement membrane via its basal 
surface, to undergo multiple biochemical changes that enable it to assume a mesenchymal cell 
phenotype, which includes enhanced migratory capacity, invasiveness, elevated resistance to
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apoptosis and greatly increased production of ECM components." [1], where ECM is an abbreviation 
for extra cellular matrix. Lee and colleagues stated that proteins such as vimentin, N—cadherin, 
Snaill and Snail2 (Slug), fibronectin. Twist, Goosecoid, FoxC2, ZEBl and ZEB2 are up-regulated, whilst 
proteins such as E-cadherin and cytokeratin are down-regulated in EMT [2].
Work by Green burg and Hay in 1982 [3] defined EMT as a formal process in epithelial tissues [4], and 
since then it has been proposed that EMTs could be categorised into three sub-types: those which 
give rise to primary mesenchyme from early, primitive epithelium during embryonic development 
(type 1), those which are associated with the production of cells to aid tissue regeneration and 
wound healing resulting from trauma, inflammation or the menstrual cycle (where EMT-like 
processes heal ovarian surface epithelium wounds [5]), as well as those which are associated with 
fibrosis (type 2), and those which occur in cancer cells, potentially leading to invasion and metastasis 
(type 3) [1]. Accordingly, type 3 EMTs were of most interest in this thesis. It would appear that EMT 
is another natural process designed to contribute to the restoration of homeostasis, which in the 
process of cancer development and progression, is hijacked and manipulated to destroy the balance 
it aims to restore.
It has been suggested that EMT is the mechanism responsible for adoption of a malignant phenotype 
by epithelial cancer cells [1, 4], one which allows them to invade through the basement membrane 
and into circulatory systems (be they blood or lymphatic) for transport to distant sites (at which point 
they could be deemed circulating tumour cells), whereupon they establish métastasés [4]. However, 
the EMT process is plastic, and epithelial cells which have undergone EMT can have the ability to 
switch back to an epithelial phenotype through mesenchymal-to-epithelial transitions (METs), which 
could explain why, if metastasis is driven by cells with a mesenchymal phenotype, cells constituting 
the bulk of metastatic tumours are of an epithelial rather than mesenchymal phenotype [1]. Lee and 
colleagues state that there has been scepticism, particularly amongst pathologists, as to the role of 
EMT in tumour development in vivo, as epithelial cells with mesenchymal-like phenotypes were 
apparently rarely observed in primary tumour sections [2], with some believing that EMT was an in 
vitro event. However, the plastic nature of the EMT process could also account for that, if the 
mesenchymal phenotype is adopted purely for invasion of the basement membrane and 
transportation to distant sites, then the majority of cells within a developing metastatic tumour 
which had yet to evade its primary site could be expected to have an epithelial phenotype. Thiery 
and colleagues also suggested that cells with mesenchymal phenotypes are very similar in 
appearance to stromal cells and tumour-associated fibroblasts [5], therefore it is possible that cells 
having undergone EMT were present, but were mistaken for these other cell types.
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However, Biddle and Mackenzie highlight that alternative models for metastatic spread have been 
suggested which do not involve the aforementioned EMT-MET process [6], including the theory that 
either cells which have undergone an irreversible EMT, or fibroblasts, carry epithelial cells with them 
when they evade the primary site and enter the circulatory system [7], and the theory that groups of 
non-EMT breast cancer cells are able to enter the lymphatic circulatory system but not the blood 
circulatory system, without the aid of EMT [8].
It has also been suggested that EMT is a marker for poor prognosis, as the markers SNAILl and SNAIL 
2 have been found to correlate with cancer relapse in breast, ovarian and colorectal cancers [5].
Other EMT markers associated with cancer progression are loss of E-cadherin [5], which in turn leads 
to de-regulation of the Wnt signalling pathway and results in selective degradation of the basement 
membrane [9] and Twist, Goosecoid and FoxC2 have been linked with metastatic potential [10]. E- 
cadherin has been identified as playing a key role in EMT, as Thiery and colleagues stated that most 
signalling pathways responsible for EMT induction come together at the induction of E-cadherin 
down-regulators [5]. However, the main inducer of EMTs is thought to be transforming growth 
factor-P (TGFP), though hypoxia and tumour-stromal interactions also act to trigger EMT [11].
Given the plasticity of the EMT process in converting epithelial cells from one phenotype to another 
(mesenchymal), and given that cancer cells having undergone EMT could be amongst those first to 
arrive at a distant site to develop a tumour, attention has turned to establishing if EMTs (and METs) 
are linked to cancer stem cells, and if so, in gaining a better understanding of how.
Gupta and colleagues discussed the contribution to CSC theory that the epithelial-to-mesenchymal 
transition (EMT) plays, and cite the work of Mani and colleagues [12] and Morel and colleagues [13], 
which showed that induction of EMT in transformed mammary epithelial cells resulted in enrichment 
of populations of cells judged to be CSCs by their ability to seed tumours and form mammospheres, 
and by the surface biomarkers they expressed (including mesenchymal proteins vimentin and 
fibronectin [12,14]. The authors stated that they thought it likely that other epithelial tumour types 
would follow this example [14], despite known issues of tissue heterogeneity [15] and inter-patient 
variability [16]. The authors also note that the apparent reversibility of EMT (i.e. when cells undergo 
a mesenchymal-to-epithelial transition) could indicate reversibility of non-CSCs to CSCs, i.e. that non- 
CSCs, upon receiving certain signals, could be transformed into CSCs. This would mean the 
hierarchical model for the CSC model is incorrect, as it states that CSCs can differentiate but that 
non-CSCs cannot de-differentiate. Based on this, and the findings that CSCs arising from EMT cells are 
more resistant to treatment and therapy than their non-CSC and non-mesenchymal (i.e. epithelial)
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counterparts, the authors propose that curative anti-cancer treatments, rather than adopting an 
"either" CSC "or" bulk tumour approach, should target both the CSC population and the tumour bulk 
[14]. This would be of particular importance if the CSC hierarchy was in fact reversible as remaining 
cells could, under certain circumstances, revert to CSCs.
Brabletz and colleagues found that invading cancer cells expressed P eaten in in their nuclei 
(suggesting that these cells had undergone EMT) and also expressed the stem cell markers hTert and 
survivin, suggesting that EMT could be involved in the maintenance of cancer stem cells (CSCs) [17].
A much-referenced paper on the potential link between EMT and cancer stem cells is the paper 
referenced by Gupta and associates, by Mani and colleagues [12]. In this work, the authors induced 
non-tumorigenic immortalised human mammary epithelial cells (HMLEs) to undergo EMT by ectopic 
expression of transcription factors Twist or Snail, and found that the HMLEs adopted a mesenchymal- 
like phenotype, up-regulated mesenchymal markers such as N-cadherin, vimentin and fibronectin 
and down-regulated the epithelial marker such as E-cadherin [12]. The group also found that almost 
all of the cells with a mesenchymal-like phenotype were CD44 '^®'^CD24''°'  ^[12], i.e. they obtained the 
same expression pattern as that found by Al-Hajj and colleagues for mammary cancer stem cells [18]. 
Upon inducing EMT in HMLEs using TGFpl, the group found that the HMLEs again adopted a 
mesenchymal-like phenotype and obtained the CD44^'®^CD24‘‘°'^  expression pattern [12]. When the 
group performed mammosphere-forming assays, HMLEs induced into EMT by ectopic expression of 
Twist or Snail produced greater than 30 times the number of mammospheres than the untreated 
control group, while HMLEs induced into EMT using TGF(31 formed greater than 40 times the number 
of mammospheres than the untreated control group [12]. These results again confirmed that HMLE 
cells induced into EMTs acquired characteristics of mammary stem cells [12]. To verify that the 
CD44”'®^CD24‘‘°'" expression pattern and mammosphere-forming ability of HMLEs resulted from EMT 
induction, the group treated HMLEs with tamoxifen, which activated Twist or Snail [12]. Following 12 
days of tamoxifen treatment, the HMLE cells again adopted a mesenchymal-like phenotype and 
Snail-activated HMLEs demonstrated a mesenchymal mRNA profile, through up-regulation of 
vimentin, N-cadherin and fibronectin, and down-regulation of E-cadherin, and Twist-activated HMLEs 
achieved similar results [12]. Both sets of tamoxifen-treated HMLEs also developed a CD44 '^ '^^CD24''°'  ^
expression profile, and Snail-activated HMLEs achieved 10 times more mammospheres than 
untreated controls and Twist-activated HMLEs achieved 81 times more mammospheres than 
untreated controls. The resulting mammospheres were also found to contain stem cells, which 
formed at least one generation of mammospheres in vitro after tamoxifen treatment had been
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ceased [12]. The group also found that when Snail was activated through tamoxifen treatment for 
primary human mammary epithelial cells, they too adopted a mesesnchymal-like phenotype, showed 
decreased E-cadherin expression, increased vimentin and fibronectin expression and formed 10 
times more mammospheres than un-treated cells [12]. This set of results suggested that EMT could 
bestow stem-like traits upon normal human mammary epithelial cells, as well as immortalised 
human mammary epithelial cells [12]. Other results achieved by the group suggested that 
mammosphere-forming CD44 '^®^CD24^°" cells were able to self-renew and both increase then 
maintain steady numbers of these self-renewing cells among a greater HMLE population, and that a 
single CD44 '^®'^CD24'’°'" mammosphere-forming cell could generate progeny of luminal and basal 
types, as well as CD44''°'"CD24”'®^ cells. However, whilst CD44’'°'^CD24 '^®*’ could proliferate well in 
vitro, they could not produce CD44 '^®'’CD24'’°'^  cells [12]. Another finding observed by the group was 
that maintenance of the EMT or stem cell state was dependent upon signals continually inducing 
EMT, and the authors also found that the number of tumour-initiating cells was increased by two 
orders of magnitude when Twist or Snail were expressed [12]. In summary, the results presented in 
this large body of work linked EMTs and the stem-ness properties of normal and cancer stem cells, 
for mammary cells.
Hennessey, Gonzalez-Angulo and colleagues also examined EMT and stem-like properties of breast 
cancers, choosing to focus specifically on metablastic breast cancers (MBCs), characterised as 
aggressive, chemo-resistant breast cancers [19]. The authors found that MBCs had elevated CD44V 
CD24’ expression compared with other breast cancers, except those which were claudin-low 
(receptor-negative, characterised by lack of cell to cell adhesion) [19], and expressed high levels of 
EMT markers, leading the authors to conclude that claudin-low features, such as EMT and stem-like 
properties, could account for the plasticity of MBCs, and their aggressive phenotype [19].
A study by Gupta, Onder and colleagues also focused upon the link between EMT and cancer stem 
cells (CSCs) within breast cancer, but with a view to trialling drugs which targeted specifically the CSC 
population [20]. The authors found that transformed breast cancer cells in which EMT was induced 
by inhibiting E-cadherin formed 100 times more tumourspheres than the control cells, using 100 
times less cells, but were found to proliferate at a slower rate than their associated controls [20]. 
Having established that transformed breast cancer cells which had undergone EMT contained a 
significantly greater population of CSCs than the control cells, the group treated both populations 
with two commonly employed chemotherapeutic agents, doxorubicin and paclitaxel, to test if EMT 
cancer cells share the CSC trait of anti-cancer drug resistance [20]. They found that transformed 
breast cancer cells in which EMT was induced were more resistant to both drugs than the control
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cells, just as breast cancer CSCs were [20]. The authors also induced EMT in non-tumorigenic 
immortalised human mammary epithelial cells [20]. They found that the number of CD44 '^^^CD24'°'  ^
cells was 80 times greater than the number found in the control cell population and that these cells 
also showed increased resistance to both chemotherapeutic agents. In fact, because the non- 
tumorigenic immortalised human mammary epithelial cells in which EMT was induced displayed 
increased resistance to three additional chemotherapeutic agents, the group concluded that drug 
resistance observed following induction of EMT was not due to cancer transformation [20]. The 
group also found that paclitaxel treatment led to growth in non-tumorigenic cells that had 
undergone EMT, i.e. it enriched the stem-like population rather than eradicating it [20]. The group 
then decided, on the basis of their results, to test eight more agents which specifically targeted 
mesenchymal-like cells from EMT and non EMT non-tumorigenic immortalised human mammary 
epithelial cells, from which four agents (etoposide, salinomycin, nigericin and abamectin) were 
observed to demonstrate moderate to high selectivity for EMT cells over non-EMT cells [20]. Of 
these, salinomycin was the only agent to be selectively toxic for EMT cells, across a range of 
concentrations, and treatment using salinomycin resulted in the loss of genes associated with poor 
prognosis, whilst treatment with paclitaxel failed to do so [20]. The authors concluded that as agents 
such as salinomycin (which were screened using non-tumorigenic immortalised human mammary 
epithelial cells) also targeted CSCs, this suggested a link between CSCs and EMT [20].
Verification that the body of work that exists on linking EMT and cancer stem cells has thus far 
focused upon breast cancers is also apparent upon evaluating Table 1 in Polyak and Weinberg's 
paper, which shows that the vast majority of EMT-associated genes listed have been studied for 
breast cancer [11]. However, research has been conducted into the linked roles of EMT and cancer 
stem cells, for head and neck cancers.
In their review paper, Chen and colleagues list markers and modulators associated with EMT in head 
and neck squamous cell carcinomas (HNSCCs) [21]. This list has many markers and modulators in 
common with e.g. those found for breast cancers, such as increased expression of vimentin [22], 
fibronectin [23], N-cadherin [24] and matrix metalloproteinases (MMPs) [25, 26], decreased 
expression of E-cadherin [22], p-catenin [27] and claudins [28] and associated modulators or 
mediators such as Twist [29], Snail [27], ZEBl [30], ZEB2 [31]and TGF- p [26]. Chen and colleagues 
also state that work has been conducted within head and neck cancer research to highlight possible 
targets for therapy, including targeting factors contributing to cell motility, such as MMPS [32]. 
However, the authors also state that research groups have encountered difficulties with MMP
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inhibitors in clinical trials [33, 34]. Many of the markers/ modulators listed were also identified for 
HNSCCs in a review by Smith and associates [35].
The association of EMT transcription factors ZEBl and ZEB2 with prognosis in head and neck cancers 
was the focus of research by Chu and colleagues [36]. In their study, this group looked at the effect 
that E-cadherin suppressors ZEBl and ZEB2 had on head and neck cancer cells which were either 
CD133^ or CD 133", with CD133 being cited as a haematopoietic stem cell marker and marker for 
malignant progression and poor prognosis [36]. Having established CD133^ and CD133" populations 
from resected head and neck cancers from two patient tissue samples, using magnetic activated cell 
sorting (MACS), the group found that the CD133^ population had a significantly greater ability to 
form tumour spheres than the CD133" population [36]. Using quantitative reverse transcriptase 
polymerase chain reaction (RT-PCR) and western blotting, the group found that the CD133^ 
population showed increased levels of ZEBl, ZEB2 and vimentin (i.e. mesenchymal markers) 
compared with the CD133" population and decreased levels of E-cadherin (i.e. an epithelial marker) 
compared with the CD133" population [36]. The group therefore concluded that ZEBl and ZEB2 were 
involved in mediating the stem-like properties of the CD133^ population [36]. Upon co-knockdown of 
ZEB 1 and ZEB2, the group found that self-renewal of CD133^ cells decreased, as did expression of 
stem-ness markers and resistance to the chemotherapeutic agent cisplatin, leading the group to 
conclude that ZEBl/ ZEB2 co-knockdown resulted in reduction in the stem-like properties and 
abilities of head and neck cancer stem-like cells [36]. The group also found that prognosis was poorer 
for ZEBl/ ZEB2 positive head and neck cancer patients, as ZEBl/ ZEB2 expression was correlated with 
pathologic stage of disease [36].
However, these reviews and studies focused on head and neck cancers, of which oral cancer is just 
one of a number of cancer types grouped under this heading. A research group at Queen Mary 
University, London conducted a number of studies on the association between EMT and cancer stem 
and stem-like cells, but focused specifically on skin and oral cancers in these studies.
In one such study, the group examined the cancer stem cell (CSC) properties of one oral cancer cell 
line and three cutaneous (skin) cancer cell lines [29]. They found, upon staining cells from the oral 
cancer cell line for CD44 (used as a marker for stem cells) and ESA (epithelial-specific antigen, i.e. an 
epithelial marker), that a population presented which had a CD44 '^®^ESA'°'" profile, suggesting that 
cells within this population were possibly EMT oral cancer stem cells [29]. These CD44 '^^^ESA'°" cells 
had fibroblast-like appearances and presented as single cells, outside of colonies, which also 
suggested that these cells had undergone EMT [29]. CD44 '^®'’ESA^ '^  ^cells formed holoclone colonies.
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which grew faster in adherent cell culture than cells which were CD44'”®^ ESA'°'", and CD44'°" cells 
formed small paraclones [29]. However, CD44 '^®^ESA'°'" cells were found to be highly motile and 
demonstrated much greater rates of migration in 3D in vitro conditions than CD44 '^®^ESA*’'®'^  and 
CD44'°" cells [29]. Cells from the CD44 '^ '^’ESA'°'" populations from the cell lines tested were also found 
to produce 10 times as many tumour spheres as CD44 '^ ’^’ESA'”®^ cells and 80 times more tumour 
spheres than CD44'°'^ cells [29]. To investigate if the CD44 '^®^ESA'°'  ^population had genetic as well as 
phenotypic traits of EMT cells, the group performed RT-PCR, and observed that the CD44 '^®'^ ESA'°'  ^
population showed increased levels of EMT associated genes vimentin (particularly for those cells at 
the edges of colonies). Snail, Twist and A xl and decreased expression of E-cadherin and Involucrin, 
genes found to be expressed less in EMT [29]. The group also found that addition of TGF-p resulted in 
a large increase in the CD44 '^®^ESA'°'" population, which was completely reversed upon introducing a 
TGF- P inhibitor. A point to note was that the group found that whilst TGF- P appeared to induce 
EMT, it was not required for maintenance of the resulting EMT phenotype [29]. The group also 
obtained similar results for CD44/ ESA staining, RT-PCR and sphere-forming assays for two cutaneous 
squamous cell carcinoma (SCC) lines, as they did for the OSCC line [29]. The group also sought to 
determine if these EMT CSC populations were apparent in vivo, and used three oral squamous cell 
carcinoma (OSCC) tissue samples, from which they removed fibroblasts, to do so. They found that 
CD44^‘^ ^ESA'°'" cells represented 5.1% -28.0% of the tumour populations [29], demonstrating a 
degree of heterogeneity, and that these CD44^®'’ESA'°" cells from each tumour expressed increased 
levels of vimentin and Twist, and decreased level of E-cadherin [29]. Both the EMT CSC cells 
(CD44 '^®^ESA'°'") and the epithelial-like CSCs (CD44^ '®'^ ESA^ '®'’) formed tumours consisting of 
hetereogenous populations upon implantation into NOD/ SCID (non-obese diabetic/ severe 
combined immunodeficient) mice, but only the EMT CSCs showed lymph node infiltration after 26 
days [29]. Of interest, tumours formed by the CD44'”^ E^SA^ '®^  population grew faster in the early 
stages of development than those formed by the CD44 '^®^ESA'°'" population [29]. Results of single cell 
clones also suggested that CSCs with an epithelial-like phenotype (CD44^ '®^ ESA^ '®^ ) were bipotent, i.e. 
they could produced both CD44 '^®^ESA'°'" and CD44^ '®^ ESA'^ '®^  cells, whilst only a portion of CSCs with 
an EMT phenotype (50% in the OSCC line and 29% in the cutaneous SCC line tested) were bipotent 
[29]. This tends to suggest that not all EMTs are reversible and that CSCs with an EMT phenotype are 
less able to produce a variety of cell types, unlike CSCs with an epithelial-like phenotype. The group 
also found that ALDHl was a marker for bipotency in EMT CSCs [29].
In another study Gammon and colleagues investigated the oxygen utilisation abilities of cancer stem 
cells (CSCs) with epithelial and EMT phenotypes [37]. The group found that when cells from three
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oral cancer cell lines were exposed to hypoxic conditions (approximately 2% O2 level), they showed 
increased expression of hypoxia inducible factor 1 alpha (HIF-la). Upon examining cells from these 
lines cultured in hypoxic conditions for 14-21 days, the authors found less cells forming tightly- 
packed colonies and more cells with a fibroblast-like appearance, and that the number of cells with a 
CD44' '^®V ESA'°'" EMT profile increased greatly under hypoxic conditions, increasing even more so 
when the 02  level was decreased from 2% to 0.2% [37]. Having returned cells from the oral cancer 
lines to normoxic conditions, the EMT population within the cell lines was found to decrease until at 
21 days, the size of the EMT fraction was of a similar size to that found in control samples [37], 
suggesting that the EMT state was reversible if hypoxic conditions were removed. The group also 
demonstrated that the ESA'°'" fraction from one of the oral cancer cell lines showed
increased expression of EMT-associated genes such as vimentin and Twist, and reduction of E- 
cadherin, when compared with the CD44^'®V ESA^ '®^  epithelial phenotype CSC population [37]. The 
sphere forming ability of unfractionated populations was also assessed, and it was found that cancer 
cells exposed to hypoxic conditions formed more spheres than cancer cells cultured in normoxic 
conditions [37]. In summary, in this study the group found that hypoxic conditions result in an 
increase in CSCs having undergone EMT, but upon restoring normoxic condtions, this EMT CSC 
population diminished to the level normally found in CSC populations. This finding was of interest 
given that hypoxia has been linked to failure of radiotherapy treatment [20], and the findings of this 
study could therefore suggest that the EMT population within oral cancers, induced into this EMT 
state by hypoxic conditions, are potentially linked to cancer treatment failure.
Members of the same group also found that dissociation of CSCs from their culture vessels, using 
Trypsin, was found to enrich for EMT CSC populations, because Trypsin was found to destroy variant 
CD44 isoforms (expressed by non-EMT CSCs), but not the standard CD44 isoforms (expressed by 
EMT CSCs) [38].
Having embarked upon a collaboration with the aforementioned group investigating cancer stem cell 
properties within oral squamous cell carcinomas (OSCCs), at Queen Mary University, London, the 
researcher decided to conduct a preliminary investigation into the dielectric properties of OSCC CSCs 
with EMT and epithelial phenotypes (demonstrated in Figure 5.1 from [29]), using dielectrophoresis, 
and decided to investigate also the effects of choice of dissociation media on these properties given 
the results found for Trypsin use [38].
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Figure 5.1: Illustration of the different characteristics of the epithelial-like ("non-EMT phenotype") and EMT CSCs to be 
studied in this experimental chapter. Image courtesy of [29].
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5.2 Methods
Cell culture and all fluorescence-activated cell sorting (FACS) preparation and sorts were performed 
at the Blizard Institute, Queen Mary University of London, UK. Dr Adrian Biddle was responsible for 
cell culture and preparation of cells for FACS sorting, and Drs Gary Warnes and Barry Wilbourn 
performed all FACS sorts.
5,2.1 Cell Cultures
Three cell lines were studied in the course of this investigation, CAl, LUC4 and LUC9. The CAl line, 
cited in numerous publications investigating oral cancer stem cells [29, 37-41], was derived from a 
tumour of the tongue. The LUC4 and LUC9 lines, both of which have featured in prior publications 
[29, 37], were established from tumours in two elderly male patients (79 and 87 years old, 
respectively), LUC4 originating from a moderately/ poorly differentiated tumour of the floor of the 
mouth and LUC9 from a moderately differentiated tumour of the mandibular gingivae.
All three cell lines were cultivated at 37“C and 5% CO2 in T-75 ventilated culture flasks using FAD 
medium [39], consisting of 3 parts Dulbecco's Modified Eagle's Medium (DMEM): 1 part Hams F12 
medium, and this was supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin (catalogue number P ll-0 1 0 ). All reagents and media were purchased from 
PAA.
5.2.2 Fluorescence-Activated Cell Sorting Protocol
FACS was performed when cell lines were approximately 80% confluent. Cells were detached from 
their culture vessels through brief incubation (for up to 10 minutes) in 5 ml IX  Trypsin-EDTA solution 
(PAA) at 37°C, which was then neutralised using 5 ml FAD culture medium (described above). These 
cell solutions were then passed through sterile 100 pm-pore size filters (VWR International, UK) to 
dissociate the contained cells and so create single cell solutions, prior to FACS, and were 
subsequently centrifuged at 360 times gravity (xg) for 5 minutes at 4°C. Upon completion of 
centrifugation, the resulting supernatant was aspirated from the cell pellets, which were then re­
suspended in 500 pi cold (approximately 4°C) phosphate buffered saline (PBS), to which 5 pi CD44-PE 
conjugated antibody (clone G44-26, catalogue number 555479, BD Biosciences, Oxford) and 5 pi ESA-
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APC conjugated antibody (clone HEA-125, catalogue number 130-091-254, Miltenyi Biotec, Surrey) 
were added. The solutions were rested in ice and shielded from light for 15 minutes, after which time 
the cell solutions were further diluted with 2 ml cold PBS and centrifuged again at 360g for 5 minutes 
at 4°C. The resulting supernatant was then aspirated and each of the cell pellets were re-suspended 
in 500 pi cold PBS and transferred to sterile polypropylene FACS tubes (Becton Dickinson, Oxford,
UK). Just prior to performing the sorts, 2.5 pi of Ipg/m l DAPI (Sigma Aldrich, Dorset, UK) was added 
to each of the cell solutions, to identify dead cells during the sorting process.
FACS for each of the three cell lines resulted in the collection of two sorted populations as shown in 
Figure 5.2. Sorted populations were collected in sterile polypropylene FACS tubes (Becton Dickinson, 
Oxford, UK) containing 1 ml cold FAD medium, then cultured (as described prior to FACS) for at least 
48 hours (to recuperate following FACS and prior to transportation) and until cell yield was great 
enough to successfully perform dielectrophoretic testing.
Mixed
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Figure 5.2: Hierarchical diagram illustrating the populations gained, for CAl, LUC4 and LUC9, as a result of FACS. The 
CD44^ESA  ^and CD44^ESA' populations from each of the three cell lines were then tested using DEP.
All DEP testing was conducted at the University of Surrey. All cell lines were transported in closed-cap 
T-75 culture flasks (Nunc™, Thermo Fisher Scientific, UK) containing 30 ml culture medium to ensure 
nutrient coverage of the cell monolayer, with Parafilm® sealing the flask necks to prevent 
contamination during transportation. Upon arrival at the University of Surrey, all closed caps were 
substituted for vented caps, to permit aerobic growth and maturation. Flasks were examined once or 
twice daily (depending on perceived growth rate) using a Nikon Eclipse TS 100 inverted microscope 
(Nikon, Surrey, UK) to determine when both the following conditions had been satisfied;
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i. There were enough cells present in the flask on which to perform DEP testing,
ii. The majority of cells in the flask were of the subtype of interest (i.e. either epithelial- 
mesenchymal transition-like or epithelial-like cancer stem cells).
Once these conditions were satisfied, cell populations were photographed using an AVT Dolphin 
F145B digital interface camera (Allied Vision Technologies, Germany) mounted to the 
aforementioned inverted microscope, shot and processed using SmartView for WDM (version
0.1.3.3), the software supplied with the aforementioned camera, and prepared for DEP testing.
5.2,3 Preparation for DEP Testing
In the course of each experimental repeat, both the CD44"^ESA’ (EMT) and the CD44^ESA^ (EPI) 
populations, for any of the three cell lines, deemed ready (i.e. the concentration of the population of 
interest was great enough to permit DEP testing), were tested using DEP. All culture medium was 
aspirated from the culture flasks containing each population, after which 10 ml PBS was used to wash 
the cell monolayers within each flask several times. Once all PBS had been removed from the flasks,
3 ml of the dissociation of choice, either IX  Trypsin-EDTA solution (catalogue number LM-T1705 from 
Biosera, East Sussex, UK) or 3 ml Accutase solution (catalogue number L15-007 from PAA, Yeovil, UK), 
was applied to the monolayers, and incubated for 10 minutes at 37°C. All flasks were then examined 
under the aforementioned inverted microscope. If the vast majority or all of the cells were detatched 
from their respective flasks, dissociation was ruled complete. If not, incubation at 37“C was 
continued in intervals of 5 minutes until maximum cell yield was achieved. Dissociation was 
neutralised by adding heated (to 37°C in waterbath) 4 ml High Glucose (4.5g/ L) Dulbecco's Modified 
Eagles Media with L-Glutamine (catalogue number LM-D1109 from Biosera , East Sussex, UK) 
supplemented with 10% FBS (catalogue number FB-1370 from Biosera , East Sussex, UK). The 
resulting cell solutions were then transferred into 15 ml Falcon tubes and centrifuged at 406 g for 5 
minutes at 5“C, following which, supernatant from each flask was aspirated.
Two subsequent centrifuge "spins" were performed (at 406 g for 5 minutes at 5°C), with cells 
suspended in 4 ml DEP testing medium, to ensure removal of traces of the highly conductive DMEM- 
based cell culture medium prior to DEP experiments being performed. This DEP testing medium 
consisted of a de-ionised (Dl) water-based solution containing 17 mM dextrose and 248 mM sucrose, 
and supplemented with 100 pM calcium chloride and 250 pM magnesium chloride. PBS was then
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added to achieve a final conductivity of 10 mS/m, verified using a Jenway 470 Conductivity M eter 
(VWR Jencons, Leicestershire, UK), and then sterile filtered.
Upon completion of the final wash in DEP testing medium, supernatant was aspirated from each 
Falcon tube, and the cell pellets (i.e. an EMT cell pellet from one Falcon tube and an EPI cell pellet 
from the second Falcon tube) were each re-suspended in 1ml fresh DEP testing medium and added 
to separate eppendorfs. In order to establish cell concentration and viability, 10 pL cell solution was 
extracted from each Eppendorf and added to a fresh Eppendorf containing 10 pLTrypan Blue 
(catalogue number T8154, Sigma Aldrich, Dorset, UK). From each of these 20 pi solutions, 10 pL was 
extracted and added to one counting area of a C-chip™ disposable haemocytometer (part number 
DHC-FOl, Labtech International, East Sussex, UK), i.e. one of the two haemocytometer counting areas 
contained a sample of the EMT population and the other a sample of the EPI population. The total 
cell yield and percentage viability of said yield, were recorded for both populations. Subsequent 
dilution using fresh DEP testing medium was performed, if necessary, to ensure both the EMT and 
EPI populations had the same approximate cell concentrations. Each counting area was then 
photographed using the same setup and software used to photograph each flask prior to DEP testing. 
Collection of photographic references for each population tested provided visual recorded evidence 
of cell yield, viability and sample quality and also permitted approximate mean cell radii to be 
indirectly measured for use during analysis of the results of DEP testing.
The Eppendorfs containing the EMT and EPI populations were marked as C l and C2 respectively, and 
this was kept consistent in each round of experiments. To reduce contamination and test result 
dubiety. C l and C2 from each cell line had separate; 20 Well chips, extraction syringes and needles, 
cover slides (to be placed on the superior surface of the Well apertures), fresh DEP test medium 
(used to flush through the Wells after each experiment run), fresh Dl water (to clean glass cover 
slides after each experiment run) and blue roll (used to dab the 20 Well chip dry, to avoid indirect 
dilution of the cell solutions over time). In short, anything that came directly into contact with the 
two different populations of cells was only used to aid testing of that cell type, from that cell line.
The DEP Well chips used in this study were the 805 model (3DEP-Chip-20, Labtech International, East 
Sussex, UK), containing 20 identical Well electrodes, each with an aperture diameter of 1mm and a 
Well depth of 1.54mm, sealed on the inferior surface by a glass cover-slip to allow both light 
transmission and simultaneous filling of all 20 Wells. Each Well was composed of seven insulator 
layers of 150 pm-thick FR4 (fibreglass reinforced epoxy) sandwiched between eight conductor layers
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of gold-plated copper (top and bottom layers were 35 pm in thickness, six remaining layers were 70 
pm in thickness).
5.2.4 DEP Testing Protocol
DEP tests were performed using the DEPtech 3DEP system (part code: 3DEP-reader-01, Labtech 
International, East Sussex, UK), connected to a PC and controlled using a MATLAB-based graphic user 
interface (GUI) created by Dr Kai Hoettges, a screenshot of which is shown (Figure 5.3). The 3DEP 
system functioned in a very similar manner to the DEP-Well technology outlined in previous 
chapters. However, the 3DEP system permitted simultaneous testing of the contents bounded by all 
20 Well electrodes, applying only a different frequency to each (within a range predefined by the 
researcher) whilst keeping the voltage (peak-to-peak voltage of lOV) and the application period of 
the alternating current (AC) signal constant for each Well.
For all experiments, the following experimental parameters that accepted user inputs (as can be seen 
in Figure 5.3) were applied and kept constant:
•  Time [sec] = 80
•  Interval [sec] = 0.5
•  Start Frequency [kHz] = 10
•  End Frequency [kHz] =60 000
The "Time [sec]" parameter in Figure 5.3 was the period of time in seconds that each experimental 
run lasted (i.e. the period for which AC signals were applied to the Well electrodes) and the "Interval 
[sec]" parameter dictated how frequently images were captured to determine the change in light 
intensity as a function of time (i.e. in this case, in steps of 0.5 seconds). Whilst the first three Trypsin 
experiments were only run for 40 seconds (compared with the period of 80 seconds for all other 
experiments), the spectra from each experiment were only modelled over the first 40 seconds for all 
runs. The details of parameters used to generate each model are given in the Analysis of Results 
section of this chapter.
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Figure 5.3: The MATLAB graphic user interface (GUI) used in this study to control the DEP test settings applied over the 
course of each DEP test repeat.
The protocol for all DEP experiments was as follows. Firstly, the contents of the Eppendorf to be 
tested (C l containing the EMT population, or C2 containing the EPI population) were vortex-mixed at 
low speed, to re-suspend cells throughout the testing medium. Next, 0.1 ml cell solution was 
extracted from the Eppendorf being tested, using a Im L syringe (BD Plastipak, UK) fitted with a 25G x 
5 / 8" needle. The sharpened point of the attached needle had previously been removed, to prevent 
penetration of the glass cover slide affixed to the underside of each 20 Well chip, and the tip was 
then bent, to allow more precise filling of the Wells. Cell solution was then applied to the edge of one 
Well electrode, at an angle conducive to the reduction in likelihood of introducing air bubbles into 
the Wells. This action simultaneously filled all 20 Wells and continued to the point at which there was 
an excess of cell solution over each Well aperture area. A glass cover slide (large enough to cover the 
area of the 20 Wells) was then laid slowly at an angle to this excess (to reduce the possibility of 
trapping air in any of the Wells). Any remaining excess was removed and added back to the 
Eppendorf from which it came.
The 20 Well chip was aligned inside the 3DEP reader and the "Preview" button (as shown in Figure 
5.3) was pressed. "Preview" allowed the researcher to view the contents of the 20 Wells in real-time, 
to check that all 20 Wells were in view, that no bubbles were present within any of the Wells and 
that no Well had contents much lighter or much darker upon visual inspection, than all other Wells 
(i.e. all Wells had a relatively similar light intensity profile at the commencement of each 
experimental repeat). Selecting the "Start experiment" button commenced the application of the AC 
signals of frequencies from 10 kHz to 60 MHz (increasing by a factor of 1.581 from one Well to the
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next) to the contents bounded by each Well electrode and the recording of the change in light 
intensity within each Well as a function of time and the DEP experiment conducted. For each 
experimental repeat, a graph of change in light intensity as a function of both DEP Well radius and 
time, was produced for each of the 20 Wells, indicating whether positive, negative or no DEP had 
taken place and in what region of each of the Wells i.e. across what bands. From MATLAB 
parameters produced for each frequency, a chart of the real part of the Clausius-Mossotti factor, 
Re[K(ca)] (otherwise known as relative polarisability) versus frequency, i.e. a DEP spectrum, was 
produced for each experimental run, for both the C l and C2 populations. The results of each 
experimental run were saved and at the end of each run, the chip was removed from the 3DEP 
reader, the glass cover slide removed, cleaned with Dl water and dried, and the Wells flushed 
through with fresh DEP test medium and dabbed dry. This procedure was undertaken five times each 
for both the EMT and EPI populations, starting with run 1 EMT, then run 1 EPI, run 2 EMT, run 2 EPI 
until run 5 was completed for each, as demonstrated in the Figure 5.4.
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Figure 5.4: Graphical representation of the procedure adopted for DEP testing, demonstrating the synchronous nature of 
the preparation for DEP testing, followed by the alternate nature of DEP testing.The procedure was designed such that 
during the post-experiment analysis, all 5 runs could be grouped together for their respective cell type (i.e. runs 1-5 for Cl, 
and runs 1-5 for C2).
5.2.5 Analysis of DEP Results
5.2.5.1 Modelling Raw Results from DEP Testing
5.2.5.1.1 Cellular Dielectric Characteristics by Fitting Single-Shell Model Cui^e
Cell radii for the EMT and EPI populations were approximated by loading images recorded during the 
cell count into the software program ImageJ (NIH, USA). ImageJ converted the number of pixels in 
the selected image into a length, selected to be a micrometer (pm) length for these experiments. 
This was achieved by selecting an image that showed part of the larger peripheral counting squares 
(4 of, arranged into smaller 4 x 4 squares) of the haemocytometer. Each side of each of these 16 
smaller squares was known to be 250 pm, and so this was used, along with the measurement gained
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by tracing a line across one of the sides of these squares (to provide the pixel value for the known 
distance), to convert pixel numbers into micrometer length within the selected image. Fifty cells 
were then selected, starting at the top left hand corner of the image and working to the top right 
hand corner, then moving vertically down the image slightly and counting from right to left. By doing 
so, cells were not selected due to size or appearance, instead a more objective procedure was used 
that could be repeated for all experiments. A line was drawn horizontally, straight through the centre 
of each cell, from left to right cell border and this distance measured. After 50 cells were counted, 
the measurements were summarised and a value for the mean cell diameter was produced in 
micrometers, from which the cell radius was then found by dividing the mean cell diameter by two.
Having gained an approximate mean radius for the cells examined in each experimental run, for the 
EMT and EPI populations from each cell line, the raw DEP spectra for each could be modelled using 
the single-shelled model [42-44] employed by the graphic user interface "DEP_well_plotter" ([45,46] 
introduced DEP Well fabrication and data acquisition, respectively), as was done in both experiment 
chapters preceding this. To summarise briefly, a curve governed by the parameters determining the 
Clausius-Mossotti Factor (see equations 3 and 4 of [46]) was fitted to each raw data DEP spectrum. 
This was achieved by entering values for cytoplasmic conductivity (S/m) and permittivity, and 
membrane conductivity (S/m) and permittivity, as well as inputting values for mean cell radius and 
constant values for medium conductivity and permittivity and membrane thickness (values shown in 
Figure 5.5), as per the single-shell model. This model was subsequently used to estimate values for 
the following cellular dielectric properties: cytoplasmic conductivity (S/m) and permittivity, and 
membrane conductivity (S/m) and permittivity.
Two more cellular dielectric properties, membrane conductance (Gmem, or "gspec" in Figure 5.5) and 
membrane capacitance (Cmem, or "cspec" in Figure 5.5), were then calculated, by applying the 
estimated values for membrane conductivity [(Tmem) permittivity (s^g^i ) to the following 
equations [47]:
^ m e m x ^0
~d
Where Eq is the permittivity of free space (8.854187817X 10'^  ^F/m) and d is the cell membrane 
thickness in meters.
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Figure 5.5: DEP_well_plotter GUI used to model raw results from DEP analysis. All fields with numerical values assigned 
were kept constant (i.e. radial bands, evaluation time, scale factors, number of shells considered, membrane thickness, 
medium conductivity and medium permittivity).
"Best-fit" was achieved when the highest value for the correlation coefficient (R) was found. DEP 
spectra from experimental runs 1-5 which achieved an R value > 0.9 between the raw experimental 
data and the "best-fit" curve representing the Clausius-Mossotti Factor (CMF) were deemed model- 
able and retained for further analyses whilst those spectra with an R value < 0.9 were disregarded for 
the purposes of further analyses.
5.2.5.2 Data Analysis
A number of different methods of results analysis were explored in order to uncover if any 
differences existed between the EMT and epithelial phenotypes of OCSCs, in terms of their dielectric 
properties.
5.2.5.2.1 Analysis of C e llu la r  Dielectric Properties
First, the values of the dielectric properties gained by modelling the DEP raw spectra using the "best 
fit" CMF curve were evaluated using two methods: by calculating a mean value for each OCSC 
subgroup from each cell line using mean values from each experiment (calculated mean values), and
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by producing and modelling average DEP spectra for each OCSC subgroup from each cell line using 
mean modelled DEP spectra from each experiment (modelled mean values).
Results from each experimental run, from each OCSC subgroup (EMT and EPI), from each cell line, 
using both dissociation media (Trypsin and Accutase), were entered into an SPSS database designed 
and managed by the researcher. Calculated mean values were produced by using model-able DEP 
spectra from experimental runs 1-5 to calculate a single, mean value for each cellular dielectric 
parameter, for each experiment. These mean experiment values were then averaged together in 
SPSS to give a single mean value, for cytoplasmic conductivity, membrane conductance and 
membrane capacitance, for each cell population (EMT and EPI), from each cell line (LUC4, CAl and 
LUC9). Cell membrane thickness, medium conductivity and permittivity were kept constant, for all 
experiment runs, for both the EMT and EPI populations, from each cell line.
Modelled mean values were produced by using model-able DEP spectra from experimental runs 1-5 
to create a single, mean DEP spectrum for each experiment. These experiment mean DEP spectra 
were then used to create a single, mean spectrum, for each cell population (EMT and EPI), from each 
cell line (LUC4, CAl and LUC9) and these spectra were modelled using "best fit" CMF curves to 
produce a mean value, for cytoplasmic conductivity, membrane conductance and membrane 
capacitance. Again, cell membrane thickness, medium conductivity and permittivity were kept 
constant, for all experiment runs, for both the EMT and EPI populations, from each cell line.
5.2.5.2.2 Low-Frequency Crossover Analyses of Model-able Experimental Runs
Then, having established values for the cellular dielectric parameters, for each OCSC subgroup, from 
each cell line, lower crossover frequencies were calculated for each experimental run. The crossover 
frequency is the frequency for which the CMF is equal to zero, i.e. the frequency at which no cell 
movement due to dielectrophoretic force occurs because the cells under testing are transitioning 
from undergoing negative DEP to positive DEP. This occurs when the effective polarisibility of the 
cells matches that of the medium they are suspended in [48]. Crossover frequencies were of 
particular interest in this study, as they can be indicative of the theoretical possibility of separation of 
differing cell types. Ideally, for two different types of cells to be separated on application of a single 
frequency, one cell type should undergo strong positive polarisability and the other cell type should 
undergo strong negative polarisability. This would result in the former cell type being attracted to the
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electrodes and the latter being repelled by the electrodes, maximising the chance of collecting two 
distinct cell types. If the different cell types under consideration have identical or very similar 
crossover frequencies and have similarly-shaped DEP spectra, then the likelihood of possible 
separation through application of a single frequency would be greatly diminished. As evidenced by 
Figure 2.7 of the DEP of Oral Brush Biopsies Methods section, there can be an upper crossover 
frequency present in a cellular DEP spectrum, and a lower crossover frequency (not shown in Figure 
2.7). In this study, only the lower crossover frequency, typically occurring in the kHz range [48] was 
calculated and analysed, as there was a greater volume of research pertaining to calculation of the 
lower crossover frequency than for the upper crossover frequency, at the time this chapter was 
written. Following reviews of published research on DEP and specifically its use within the field of 
stem cells, the researcher selected two formulae commonly used to calculate lower crossover 
frequency, one introduced by Jones and Kallio [49] and the latter by Pethig and colleagues [50]. From 
this point onwards, in this chapter, the former will be referred to as Jones' formula and the latter as 
Pethig's formula.
Jones' Formula [49] for lower crossover frequency (/c), also used by Huang and colleagues [47] is as 
follows:
(<7i -  <72)(<T2 +  20-i)
(^2 -  +  2 £ i )
Where subscript 1 denotes medium properties and subscript 2 denotes particle (in this case, cell) 
properties and o and e represent conductivity and permittivity, respectively.
Pethig's Formula [50, 51] for lower crossover frequency [fxo), used by Velugotia and colleagues [48] 
is as follows:
Where r denotes cell radius (meters), o^ denotes conductivity of the suspending medium (S/m) and 
Qm denotes cell membrane capacitance (F/m^). This formula was derived from the simplification of 
Jones' formula, presented by Huang and colleagues [47] (where faoss is lower crossover frequency, 
and Gm is medium conductivity):
V2
STtvCffiem
(4o-m -  rCm em Y ~  ( 5 )
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The steps required to produce Pethig's formula are as follows;
V2
V2
SjivCjjigjji
V2
2 n rC r
{ A a m -  ^rGmem)
However the value of rGmem is negligible, given that the crossover frequency values will be the 
thousands or tens of thousands, so the above equation can be simplified to equal Pethig's formula.
5.2.5.3 Statistical Analysis
Finally, the resulting dielectric properties and crossover frequencies achieved when Trypsin was the 
dissociation medium of choice were compared with those gained when Accutase was used, in order 
to establish which dissociation medium should be used in future to best ensure successful 
differentiation between the OCSC subgroups.
All statistical analysis was performed using SPSS Statistics 19.0 software (SPSS Inc., Chicago) and a p 
value of 0.05 was chosen, as the sample sizes in this study were relatively small. The Kolmogorov- 
Smirnov test for normality was performed on each data set. If all data sets were deemed normally 
distributed, the t-test was employed to determine if statistically significant differences were present. 
Otherwise, the Mann-Whitney U test for non-parametric data was employed.
The null hypotheses for this body of work, to be accepted or rejected depending on the results of the 
conducted statistical analysis were as follows (where cellular dielectric properties are inclusive of low 
frequency crossovers):
1. There was no statistically significant difference in cellular dielectric properties of the
CD44^ESA'(EMT-like) population compared with the CD44^ESA  ^(EPI-like) population, for cell 
line LUC4, using Trypsin EDTA as the dissociation fluid of choice.
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2. There was no statistically significant difference in cellular dielectric properties of the 
CD44^ESA’ (EMT-like) population compared with the CD44^ESA  ^(EPI-like) population, for cell 
line CAl, using Trypsin EDTA as the dissociation fluid of choice,
3. There was no statistically significant difference in cellular dielectric properties of the 
CD44^ESA' (EMT-like) population compared with the CD44^ESA  ^(EPI-like) population, for cell 
line LUC4, using Accutase as the dissociation fluid of choice.
4. There was no statistically significant difference in cellular dielectric properties of the 
CD44^ESA' (EMT-like) population compared with the CD44^ESA^ (EPI-like) population, for cell 
line CAl, using Accutase as the dissociation fluid of choice.
5. There was no statistically significant difference in cellular dielectric properties of the 
CD44^ESA" (EMT-like) population compared with the CD44^ESA"  ^(EPI-like) population, for cell 
line LUC9, using Accutase as the dissociation fluid of choice.
6. There was no statistically significant difference in cellular dielectric properties of the LUC4 
CD44^ESA' (EMT-like) population compared with the CAl CD44^ESA" (EMT-like) population, 
using Trypsin as the dissociation fluid of choice.
7. There was no statistically significant difference in cellular dielectric properties of the LUC4 
CD44^ESA  ^(EPI-like) population compared with the CAl CD44^ESA  ^(EPI-like) population, 
using Trypsin as the dissociation fluid of choice.
8. There was no statistically significant difference in cellular dielectric properties of the LUC4 
CD44^ESA' (EMT-like) population compared with the CAl CD44^ESA" (EMT-like) population, 
using Accutase as the dissociation fluid of choice.
9. There was no statistically significant difference in cellular dielectric properties of the CAl 
CD44"^ESA' (EMT-like) population compared with the LUC9 CD44^ESA' (EMT-like) population, 
using Accutase as the dissociation fluid of choice.
10. There was no statistically significant difference in cellular dielectric properties of the LUC4 
CD44^ESA‘ (EMT-like) population compared with the LUC9 CD44^ESA' (EMT-like) population, 
using Accutase as the dissociation fluid of choice.
11. There was no statistically significant difference in cellular dielectric properties of the LUC4 
CD44^ESA  ^(EPI-like) population compared with the CAl CD44^ESA  ^(EPI-like) population, 
using Accutase as the dissociation fluid of choice.
12. There was no statistically significant difference in cellular dielectric properties of the CAl 
CD44^ESA  ^(EPI-like) population compared with the LUC9 CD44^ESA  ^(EPI-like) population, 
using Accutase as the dissociation fluid of choice.
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13. There was no statistically significant difference in cellular dielectric properties of the LUC4 
CD44^ESA  ^(EPI-like) population compared with the LUC9 CD44^ESA  ^(EPI-like) population, 
using Accutase as the dissociation fluid of choice.
In short, the purpose of the statistical tests was threefold. Firstly, to determine if there were any 
significant differences in cellular dielectric properties between the EMT-like OCSC subgroup and the 
epithelial-like OCSC subgroup for each cell line examined. Secondly, to determine which of the two  
dissociation media used (Trypsin or Accutase) resulted in the highest number of or greatest degree of 
significant differences in terms of cellular dielectric properties. Finally, to determine if any significant 
differences in cellular dielectric properties existed between the same OCSC subgroup (EMT or 
epithelial) for the different cell lines examined (e.g. EMT from LUC4 versus EMT from CAl).
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5.3 Results
5.3.1 Cell Radii and Dielectric Properties
As alluded to in the Methods section, two approaches were used to produce mean values for cell 
radius, cytoplasmic conductivity, membrane conductance and membrane capacitance. The first was 
to calculate mean experiment values by averaging the cellular dielectric properties gained by 
modelling the raw DEP spectra from each of the experimental runs 1-5. The second method was to 
produce a mean DEP spectrum for each experiment, by averaging the raw DEP spectra from each 
experimental run, and to deduce the cellular dielectric properties of interest from each of the mean 
experiment models. Results gained using the former method are henceforth referred to as calculated 
properties and results gained using the latter method as modelled properties.
Bar charts with error bars representing the standard error of the mean (SE) were constructed to 
illustrate descriptive statistics for cell radius and each cellular dielectric property investigated: 
cytoplasmic conductivity, membrane conductance and membrane capacitance.
5.3.1.1 Comparison of EMT and Epithelial Oral Cancer Stem Cell Radii 
and Dielectric Properties Gained when the Dissociation Medium used 
was Trypsin
The cellular dielectric properties of oral cancer stem cells with EMT and epithelial phenotypes, when 
Trypsin was the dissociation medium of choice, were analysed for two cell lines: LUC4 and CAl. Three 
experimental repeats were performed for each OCSC sub-group from each cell line. For an 
experimental repeat to be considered valid, at least one of the five runs constituting each 
experimental repeat was required to have a correlation of the Clausius-Mossotti Factor (CMF) curve 
to DEP spectrum data points, of 0.9 or greater.
When Trypsin was the dissociation medium employed, the following number of experiments were 
considered valid (number of valid experiments (total number of experiments)):
•  LUC4 EMT = 3 (3)
•  LUC4 EPI = 3 (3)
•  CAl EMT = 3 (3)
•  CAl EPI = 2 (3 )
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Whilst cell radius was not determined by DEP testing (and therefore only had a calculated value), it 
constituted one of the cellular properties under investigation in this study because determination of 
its value was required for the calculation of both membrane conductance and membrane 
capacitance.
Upon studying Figure 5.6, it appears that whilst the values for mean cell radius of EMT-like cells were 
similar for both the LUC4 and CAl lines (8.6 and 8.4 pm, respectively), the epithelial-like cells of the 
CAl line were found to have smaller mean radii, 7.9 + 0.4 pm, than their EMT-like counterparts. This 
is the opposite of what was found when studying the LUC4 line, whose epithelial-like population had 
a mean cell radius of 9.8 + 1.2 pm, whilst the EMT-like population achieved a mean cell radius of 8.6 
± 0 .6  pm.
EMT Versus Epithelial Mean Cell Radius, using 
Trypsin
stem Cell
Sub-type
ct4T 
□  aithelial
10.00-
2 .00-
Cell Line
Error bars: +/- 2 SB
Figure 5.6: Mean + standard error (SE) bar chart for cell radius, when the dissociation medium used was Trypsin.
Regarding cytoplasmic conductivity (shown in Figure 5.7), the same opposing trend was found, for 
both the calculated and the modelled means, when comparing EMT versus epithelial results for CAl 
with those from LUC4. Again, the EMT-like cells from the CAl line achieved a greater value than their 
epithelial-like counterparts, whilst the EMT-like cells from the LUC4 line achieved a lower value for 
cytoplasmic conductivity than their epithelial-like counterparts, for both the calculated and modelled
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results. This suggested that the ionic content of EMT-like CAl cells was greater than that of epithelial 
-like CAl cells. However, this level was lower than the ionic content of LUC4 EMT-like cells, which 
had a lower ionic content than LUC4 epithelial-like cells. As was observed in Figure 5.6, the 
deviations from the mean results were greater in the epithelial-like cells than the EMT-like cells. 
Overall, when considering the results for cytoplasmic conductivity along with those for cytoplasmic 
permittivity (results not shown), only minor differences were observed when comparing the EMT-like 
LUC4 cells with the epithelial-like LUC4 cells. As can be seen in Table 5.1, no statistically significant 
differences were found for the CAl line or the LUC4 line, for cytoplasmic conductivity, as p »0 .05 .
Table 5.1 reports the results of statistical testing only for those results gained through calculation. 
These results were focused upon because either the modelled results showed less differences for 
EMT versus EPI (as seen for cytoplasmic conductivity in Figure 5.7 and membrane capacitance in 
Figure 5.9), or the standard errors found for one or both sub-groups (EMT or EPI) were large (as for 
membrane conductance in Figure 5.8).
EMT Versus Epithelial Mean Cytopiamic Conductivity, 
using Trypsin
LUC4 Ca1
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by:0.60-
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□  Model
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Error Bars: +/- 2 SE
Figure 5.7: Mean + SE bar chart for cytoplasmic conductivity, comparing the calculated and modelled results for EMT and 
EPI, for both LUC4 and CAl cell lines, when the dissociation medium used was Trypsin.
From the bar charts in Figures 5.6-5.9, it is clear that all parameters investigated, with the exception 
of mean cell radius, have large associated standard errors. A large difference in mean membrane
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conductance value, for the LUC4 line, is evident in Figure 5.8. However, the standard error of the 
mean is large for both the EMT-like and epithelial-like sub-groups, especially when the results were 
modelled. Therefore, whilst the ability of the LUC4 EMT-like cells' membranes to conduct charge is 
much greater than that of the epithelial-like LUC4 cells, this difference was not found to be 
significant upon examination of the results of t-tests in Table 5.1. The mean values for membrane 
conductance for the CAl line were found to be very similar in value, for both EMT-like and epithelial- 
like cells, confirmed by the p-value of 0.890 in Table 5.1.
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Figure 5.8: Mean + SE bar chart for membrane conductance, comparing the calculated and modelled results for EMT and 
EPI, for both LUC4 and CAl cell lines, when the dissociation medium used was Trypsin.
The results for membrane capacitance (Figure 5.9) show EMT-like LUC4 cells to have a greater ability 
to store charge than epithelial-like LUC4 cells whilst the CAl line results suggested little difference 
between the EMT-like and epithelial-like cells, confirmed by the high p-value (p = 0.951) gained in 
Table 5.1.
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EMT Versus Epithelial Mean Membrane Capacitance,
using Trypsin
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Figure 5.9: Mean + SE bar chart for membrane capacitance, comparing the calculated and modelled results for EMT and EPI, 
for both LUC4 and CAl cell lines, when the dissociation medium used was Trypsin.
As can be seen in Table 5.1 no statistically significant differences were found, for any of the 
electrophysiological characteristics investigated. Of note, none had a p value less than 0.1. These 
results suggest that no clear, marked difference (as would be evident after three repeats) was found 
between oral cancer stem-like cells with an EMT phenotype compared with those with an epithelial 
phenotype, when Trypsin is the dissociation medium of choice. However, the p values were lowest 
for CAl when considering cytoplasmic conductivity (p = 0.268), whilst the lowest p value for LUC4 
was found when considering membrane conductance (p = 0.155).
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Cell Radius p = 0.404 p • 0.441
Cytoplasmic
Conductivity
p = 0.653 p = 0.268
Membrane
Conductance
p = 0.155 p = 0.890
Membrane
Capacitance
p = 0.462 p = 0.951
Table 5.1: Summary of results of t-tests for statistical significance, for the calculated cellular dielectric properties 
investigated using DEP testing, using the dissociation medium Trypsin. The p value was set at p = 0.05. All data sets were 
found to be normally distributed, using the Kolmogorov-Smirnov test for normality, therefore the parametric t-test was 
employed to test for statistically significant differences.
5.3.1.2 Comparison of EMT and Epithelial Oral Cancer Stem Cell Radii 
and Dielectric Properties Gained when the Dissociation Medium used 
was Accutase
Cell radii results (Figure 5.10) show that there is a negligible difference between EMT-like and 
epithelial-like cells, for both the LUC4 and CAl lines, and that these results are very similar in 
magnitude to the results shown in Figure 5.6. Cells from the LUC9 line however, were found to have 
smaller cell radii than cells from both the LUC4 and CAl lines and unlike the results for both these 
lines, for Accutase, the EMT-like cells from the LUC9 line achieved a greater mean cell radius than 
their epithelial-like counterparts, 7.8 + 0.3 pm for the former and 6.7 + 0.4 pm for the latter.
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EMT Versus Epithelial Mean Cell Radius, using 
Accutase
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Figure 5.10: Mean + SE bar chart for cell radius, when the dissociation medium used was Accutase.
Upon examination of Figure 5.11, the cytoplasmic conductivity of EMT-like cells from all three cell 
lines was found to be almost identical, achieving a range of 0.2-0.3 S/m. However, whilst LUC4 
epithelial-like cells' cytoplasms achieved greater conductivity than their EMT-like counterparts, the 
epithelial-like cells from both the CAl and LUC9 lines had lower values for cytoplasmic conductivity 
than their EMT-like counterparts. This trend, for LUC4 and CAl, was also observed in Figure 5.7 when 
Trypsin was used as the dissociation medium of choice.
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EMT Versus Epithelial Mean Cytoplasmic Conductivity,
using Accutase
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Figure 5.11: Mean + SE bar chart for cytoplasmic conductivity, comparing the calculated and modelled results for EMT and 
EPI, for the LUC4, CAl and LUC9 cell lines, when the dissociation medium used was Accutase.
Whilst only marginal differences in membrane conductance (Figure 5.12) between EMT-like and 
epithelial-like cells were observed in all three cell lines (together with large values of associated 
standard error), notable differences were observed for membrane capacitance, for two of the three 
cell lines (Figure 5.13). This observation was supported by the results of t-tests, shown in Table 5.2, 
which confirmed that the differences between EMT-like and epithelial-like cells for both LUC4 and 
LUC9 achieved p-values of less than 0.1.
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EMT Versus Epithelial Mean Membrane Conductance,
using Accutase
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Figure 5.12: Mean + SE bar chart for membrane conductance, comparing the calculated and modelled results for EMT and 
EPI, for the LUC4, CAl and LUC9 cell lines, when the dissociation medium used was Accutase.
EMT Versus Epithelial Mean Membrane Capacitance, 
using Accutase
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Figure 5.13: Mean + SE bar chart for membrane capacitance, comparing the calculated and modelled results for EMT and 
EPI, for the LUC4, CAl and LUC9 cell lines, when the dissociation medium used was Accutase.
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Also shown in Table 5.2, the difference for the LUC9 line, in terms of membrane capacitance was 
statistically significantly different, with a p-value of 0.048, Therefore, the ability of the membranes of 
LUC9 EMT-like cells to store charge was found to be significantly greater than that of LUC9 epithelial- 
like cells. This trend was observed for the C M  line, though the difference was not statistically 
significant. The opposite trend was found for LUC4 cells, whose epithelial-like cells possessed greater 
ability to store charge than their EMT-like counterparts, the difference between which resulted in a p 
value of 0.094.
The results in Table 5.2 (for two EMT versus three EPI LUC4 experiements, three EMT versus two EPI 
CAl experiments and two EMT versus two EPI LUC9 experiments) suggest a difference of statistical 
significance (i.e. p <0.05) upon comparison of membrane capacitance (the ability of the cells' plasma 
membranes to store electrical charge) values for EMT-like oral cancer stem-like cells and those values 
for epithelial-like oral cancer stem-like cells, but only for the LUC9 cell line when Accutase was the 
dissociation medium of choice. No statistically significant differences were found for either the LUC4 
or CAl lines, for any of the cellular dielectric properties examined.
Again, as with Table 5.1, Table 5.2 reports the results for statistical testing for only calculated cellular 
dielectric parameters, for the same reasons as those stated previously for Table 5.1.
Cell Radius p = 0.635 p = 0.289 p = 0.165
Cytoplasmic
Conductivity
p = 0.183 p = 0.379 p = 0.192
Membrane
Conductance
p = 0.522 p = 0.524 p = 0.845
Membrane
Capacitance
p = 0.094 p = 0.656 p = 0.048
Table 5.2: Summary of results of t-tests for statistical significance, for calculated cellular dielectric properties investigated 
using DEP testing. All three cell lines (LUC4, CAl and LUC9) were detached using Accutase. The p value was set at p = 0.05.
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5.3.1.3 Summary: Trypsin versus Accutase
Tables 5.3 and 5.4 were constructed to enable comparison of mean + standard error of mean (SE) 
values gained using two different dissociation media (Trypsin and Accutase), with the former 
presenting results gained using calculated means and latter presenting mean values gained by 
modelling experiment mean DEP spectra.
The values presented in Tables 5.3 and 5.4 are those illustrated in the graphs constituting Figures 5.6- 
5.13. In both tables, the membrane capacitance column is of particular interest, when comparing 
Trypsin and Accutase, given the proteolytic action of both solutions.
LUC4 (Mean 
±SE)
OCSC Line, Sub-type and 
Dissociation Medium
EMT
Tiypsin
EMT
Accutase
EPI
Tr3fpsin
EPI
Accutase
EMT
Trypsin
EMT
Accutase
EPI
Trypsin
EPI
Accutase
CAl (Mean + 
SE)
LUC9 (Mean 
±SE)
EMT
Accutase
EPI
Accutase
Number of 
Model-able 
Experimental 
Repeats
8.6 + 0.6 0.2 ±0.1 1583.3 ±469.3 10.8 ±2.5
9.1 ±0.0 0.3 ±0.0 993.8 ±31.3 9.8 ±0.3
9.8 ±1.2 0.3 ±0.1 726.7 ±140.3 8.4 ±1.5
9.3 ±0.4 0.4 ±0.1 1315.0±343.6 15.0 ±1.6
8.4 ±0.1 0.3 ±0.0 963.0 ±521.4 10.7 ±3.2
8.4 ±0.2 0.3 ±0.1 1201.7± 186.0 10.3 ±2.6
7.9 ±0.4 0.2 ±0.1 1080.0 ±520.0 10.4 ±2.2
8.7 ±0.0 0.2 ±0.0 983.3 ±250.0 8.4 ±2.8
7.8 ±0.3 0.3 ±0.1 1350.3 ±402.3 11.0 ±0.0
6.7 ±0.4 0.2 ±0.0 1450,0 ±50.0 5.1 ±0.5
Table 5.3: Comparison of the calculated mean cellular dielectric properties gained using Trypsin with those gained using 
Accutase, when considering OCSC sub-type (i.e. EMT- or epithelial-like OCSCs) from each cell line separately. Coloured rows 
for LUC4 and CAl highlight the results gained when Trypsin was the dissociation medium used and these were compared 
with the non-coloured rows (indicating results gained when Accutase was used as the dissociation medium), for their 
specific cell line (i.e. either LUC4 or CAl). All results are shown as mean + standard error of the mean to one decimal place.
The calculated results in Table 5.3 show that whilst there is little difference in the ability of Trypsin 
treated LUC4 EMT cells' membranes to store charge compared with that of Accutase treated LUC4 
EMT cells. Trypsin treated LUC4 EPI cells' membranes have a lesser ability to store charge than the 
membranes of Accutase treated LUC4 EPI cells. As membrane capacitance is influenced by surface
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area, this could indicate that using Trypsin rendered LUC4 EPI cell membrane surfaces "smoother" 
than the membrane surfaces of LUC4 EPI cells treated with Accutase.
Comparison of CAl Trypsin and Accutase membrane capacitance results in Table 5.3 show that both 
are almost equal, as was found with the LUC4 line. However, unlike the results for the LUC4 line, 
Accutse treated CAl EPI cells attained a lesser value for membrane capacitance than Trypsin treated 
CAl EPI cells, suggesting that the membrane surfaces of CAl EPI cells treated with Accutase were 
smoother than those CAl EPI cells treated with Tryspin. This trend was also found when results were 
modelled rather than calculated, as can be seen in Table 5.4.
Also of note, from both Tables 5.3 and 5.4, is that cells from the LUC9 line follow the same trend as 
CAl cells and the opposite trend to LUC4 cells, in terms of EMT versus EPI membrane capacitance 
values, when Accutase was the dissociation medium of choice-the membrane capacitance of EMT 
cells is greater on average of that of the EPI cells.
Number of 
Model-able 
Experimental 
Repeats
Cytoplasmic
Conductivity
(S/m)
Membrane
Conductance
(S/m2)
Membrane
Capacitance
(mF/m2)
OCSC Line, Sub-type and 
Dissociation Medium
EMT 
Trypsin 
EMT 
Accutase 
EPI 
Trypsin 
EPI 
Accutase 
EMT 
Trypsin 
EMT 
Accutase 
EPI 
Trypsin 
EPI 
Accutase
0 .2 + 0.0 1200.0 + 700.0 
595.0 + 5.0
287.0 ±199.1
700.0 ± 6 5 0 .5
910.0 + 298.2
.7 + 1.7
0.2 + 0.0 8.4 + 0.4LUC4(Mean + 
SE)
0.2 +  0.0 6.5 + 1.0
0.3 + 0.1 12.1 + 2.4
0.3 + 0.0 12.0 + 1.4
0.3 + 0.1 863.3 + 334.2 9.3 + 1.1CAl(Mean + 
SE) 1630.0 + 
1070.00.2 + 0.0 13.3 + 0.9
0.2 + 0.0 940.0 + 0.0 6.5 + 2.5
EMT
Accutase 0.2 + 0.0 905.0 + 595.0 9 .4+  2.1LUC9 (Mean ±  
SE) EPI 
Accutase 0.2 + 0.0 1500.0 + 0.0 5.1 + 0.4
Table 5.4: Comparison of the modelled mean cellular dielectric properties gained using Trypsin with those gained using 
Accutase, when considering OCSC suh-type (i.e. EMT- or epithelial-like OCSCs) from each cell line separately. Coloured rows 
for LUC4 and CAl highlight the results gained when Trypsin was the dissociation medium used and these were compared 
with the non-coloured rows (indicating results gained when Accutase was used as the dissociation medium), for their 
specific cell line (i.e. either LUC4 or CAl). All results are shown as mean + standard error of the mean to one decimal place. 
Values for cell radius were determined prior to calculation or modelling of the other cellular dielectric properties, making 
the cell radii values independent of type of analysis used to establish mean properties.
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5.3.2 Results of Low Frequency Crossover Analysis for EMT 
and Epithelial Oral Cancer Stem Cells
The method used to achieve mean crossover frequency results differs from that used to achieve the 
previously mentioned cellular dielectric properties in that individual runs with correlation coefficients 
greater than 0.9 (i.e. model-able) were selected then averaged to give a mean for the overall OCSC 
line sub-type, rather than the model-able runs being averaged together to give an experiment mean, 
then being averaged again to give an overall OCSC line sub-type mean. This approach was adopted 
because there were few runs, from each OCSC sub-type that were valid (R > 0.9), from which to 
calculate mean values.
As this method for generating mean results differed to that employed to generate the results shown 
in Tables 5.3 and 5.4, Table 5.5 shows the values used to generate crossover frequencies using Jones' 
equation and Pethig's equation.
1 n
LUC4
_EMT
5 8.6 ±  
0.4
1.4E-5±
3.2E-6 0.2 ±0.1 12.4 ±2.9
79.6 ±  
17.2 1400 ±321 11.0 ±2.6
c
&
LUC4
_EPI
7 10.1 ±  
0.7
6.9E-6 + 
2.7E-6 0.3 ±0.1 9.0 ±1.4
64.0 ±  
14.2 687 ±  266 8.0 ±1.2
1-
CA1_
EMT
8 8.4 ±  
0.1
6.7E-6 + 
2.0E-6 0.3 ±0.0 15.1 ±1.7
44.9 ±  
11.3 674 ±204 13.4 ±1.5
CA1_
EPI
7 7.8 ±  
0.2
1.0E-5 + 
2.6E-6 0.2 ±0.0 12.1 ±1.0
50.1 ± 
16.6 1010±257 10.8 ±0.9
LUC4
_EMT
8 9.1 ±  
0.0
9.9E-6 +
1.2E-6 0.3 ±0.0 11.1 ±0.9
78.8 ±  
10.8 994 ±116 9.8 ±0.8
LUC4
_EPI
10 9.0 ±  
0.1
1.1E-5 + 
1.8E-6 0.4 ±0.0 15.9 ±1.5
80.1 ± 
16.0 1080 ±175 14.1 ±1.3
%
iS
CA1_
EMT
5 8.4 + 
0.2
1.2E-5±
2.8E-6 0.3 ±0.1 12.2 ±2.5
89.0 ±  
15.4 1160 ±284 10.8 ±2.2
3gCA1_EPI 6 8^ +0.0 9.8E-6±1.7E-6 0.2 ±0.0 9.5 ±2.1 61.7 ±7.0 983 ±172 8.4 ±1.8
LUC9
_EMT
9 7.8 ± 
0.1
1.3E-5±
3.1E-6 0.3 ±0.0 12.4 ±1.3 61.7 ±6.7 1310±312 11.0±1.1
LUC9
_EPI
5 7.0 ±  
0.2
1.4E-5 + 
1.5E-6 0.2 ±0.0 6.0 ±0.7 79.0 ±7.8 1420 ±146 5.4 ±0.6
Table 5.5: Summary of the cellular dielectric properties (mean + standard error of mean) used to generate the low 
frequency crossover results from TB Jones' equation and Pethig's equation.
By inputting the appropriate values from Table 5.5 into equations 3 and 4 (shown in the Methods 
section), with medium conductivity and permittivity constant at 10 mS/m and 78, respectively, mean
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+ standard error of mean results were produced. Those for EMT versus EPI, for LUC4 and CAl cell 
lines when Trypsin was employed, are shown in Figures 5.14 and 5.15, and Table 5.6.
Mean Low Frequency Crossover Results Achieved using Jones' Equation
(Trypsin)
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Figure 5.14: Mean + SE bar chart for low frequency crossovers results gained using Jones' equation, for EMT and EPI, for the 
LUC4 and CAl cell lines, when the dissociation medium used was Trypsin.
Figure 5.14 shows the crossover frequencies found using Jones' equation (equation 3) for the CAl 
EMT and EPI sub-groups to be almost identical, whereas there is no overlap in mean value, even 
when taking standard errors into consideration, for the LUC4 EMT and EPI sub-groups. However, as 
can be seen in Table 5.6, the mean value for LUC4 EMT is based upon one experimental run, unlike 
the other sub-groups in Figure 5.14 which have mean values generated by a minimum of five 
experimental runs.
The results from Figure 5.15 and Table 5.6 suggest only minor differences in mean low frequency 
crossover values gained by employing Pethig's equation (equation 4). However, there were many 
more experimental runs contributing to the mean and standard error values. Both Jones' and 
Pethig's equations were applied to all runs which achieved an R value > 0.9, and Pethig's equation 
produced a value for low frequency crossover for all such runs. However, Jones' equation could only 
yield an answer for low frequency crossover if:
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Membrane conductivity was greater than the conductivity of the surrounding medium and 
the membrane permittivity was less than the permittivity of the surrounding medium. 
Membrane conductivity was less than the conductivity of the surrounding medium and the 
membrane permittivity was greater than the permittivity of the surrounding medium.
Mean Low Frequency Crossover Results Achieved using Pethig's 
Equation (Trypsin)
LUC4 Ca1
5* 40000^
qjithelial B /T
Stem Celi Sub-type
q)ithelial
Error bars: +/- 2 SE
Figure 5.15: Mean + SE bar chart for low frequency crossovers results gained using Pethig's equation, for EMT and EPI, for 
the LUC4 and CAl cell lines, when the dissociation medium used was Trypsin.
l U J C 4 ^ ^ 26 019 + 4 090 (5)
15 859 + 3 855 (5)
Table 5.6: Low frequency crossover results (mean + standard error of mean), for both TB Jones' and Pethig's equations, 
with Trypsin as the dissociation medium of choice.
The low frequency crossover results for EMT versus EPI, for the LUC4, CAl and LUC9 cell lines when 
Accutase was employed, are shown in Figures 5.16 and 5.17, and Table 5.7.
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Mean Low Frequency Crossover Results Achieved using Jones' Equation 
(Accutase)
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37500- 
X  35000-
>  30000-
Hi 27500“
0) 20000“
li. 15000-
o 12500-
c 10000-
7500-
Bi4r ^ithelial
stem Cell Sub-type
Epithelial
Error bars: +/- 2 SE
Figure 5.16: Mean + SE bar chart for low frequency crossovers results gained using Jones' equation, for EMT and EPI, for the 
LUC4, CAl and LUC9 cell lines, when the dissociation medium used was Accutase.
Figure 5.16 shows the low frequency crossovers for EMT and EPI from the LUC4 cell line, using Jones' 
equation, to be almost identical. Despite there being a difference in mean crossover frequencies for 
CAl EMT and EPI, this difference was not significant. This is also true for the crossovers achieved by 
EMT and EPI for the LUC9 cell line.
The crossover frequencies for the EMT and EPI sub-groups from the LUC4 line, when Accutase was 
used in place of Trypsin (Figure 5.17 and Table 5.7) were again of a very similar value, as was found 
when Trypsin was used (Figure 5.16). Again, the differences in mean crossover frequency values for 
the OCSC sub-groups from the CAl line were not significant. Of note, however, upon comparison of 
Figures 5.16 and 5.17, is that the trend shifts from EMT CAl cells achieving a greater mean crossover 
frequency than their EPI counterparts when Trypsin was employed, to having a lesser mean 
crossover frequency than their EPI counterparts when Accutase was the dissociation medium of 
choice.
Upon viewing Table 5.7, it is evident that there were many more experimental runs contributing to 
the mean and standard error values when Pethig's equation was used compared to when Jones' 
equation was used. Again, all runs which achieved an R value > 0.9 produced crossover frequencies 
using Pethig's equation, but not all did using Jones' equation. Given that the crossover frequencies 
for EMT versus EPI, from the LUC4 and CAl cell lines, using Trypsin, were either very similar in
246
magnitude or had associated standard errors which were great in magnitude, the results of statistical 
testing (Table 5.8) showed no significant differences were present. This was again the case for the 
crossover frequencies from the LUC4 and CAl lines, when Accutase was the dissociation medium of 
choice.
The only statistically significant difference in mean crossover frequency for EMT versus EPI was found 
for the LUC9 cell line using Pethig's equation, when Accutase was the dissociation medium 
employed, with p = 0.001 (Table 5.8). In this case, the EPI sub-group achieved a mean value more 
than twice the value of that achieved by the EMT sub-group, and this difference was remained 
significant because standard error values failed to create an overlap in values between the two OCSC 
sub-groups (Figure 5.17 and Table 5.7).
Mean Low Frequency Crossover Results Achieved using Pethig's 
Equation (Accutase)
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100000-  
„  95000- 
X  90000- 
85000- 
W 80000-
LUC4 Cat LUC9
75000-
W 70000-
65000-
^  60000-
5* 55000-
50000-
45000-
£  40000-
35000-
30000-
25000-
«  20000-
15000-
10000-
5000-
qjithelial EMT qjithelial
Stem Cell Sub-type
B 4T  %)ithelial
Error bars: +/- 2 SE
Figure 5.17: Mean + SE bar chart for low frequency crossovers results gained using Pethig's equation, for EMT and EPI, for 
the LUC4, CAl and LUC9 cell lines, when the dissociation medium used was Accutase.
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LUC4_EMT 8 11 685 + 3 275 (5) 26 514 + 1955 (8)
LUC4_EPI 10 11011 + 1863 (6) 20 390 + 3 390(10)
CAl.EMT 5 24 582 + 6 128(2) 28 831 + 5 293 (5)
CA1_EPI 6 16 956 + 1 783(5 ) 51775 + 22 571(6)
LUC9_EMT 9 14 143 + 3 425 (5) 28 886 + 3 586 (9)
LUC9_EPI 5 18 342 + 4 851 (4) 64 616 + 8 283 (5)
Table 5.7: Low frequency crossover results (mean + standard error of mean), for both TB Jones' and Pethig's equations, 
with Accutase as the dissociation medium of choice.
LUC4_EMT vs. LUC4_EPI
N/A p = 0.797
Trypsin CA1_EMT vs. CA1_EPI
p = 0.983 p = 0.435
LUC4_EMT vs. LUC4_EPI
p = 0.856 p - 0.163
Accutase
CA1_EMT vs. CA1_EPI
N/A p = 0.390
LUC9_EMTvs. LUC9_EPI
p = 0.490 p = 0.001
Table 5.8: Summary of results of t-tests for statistical significance, for low frequency crossovers using both Jones' equation 
and Pethig's equation. The basis of the testing being to determine if any statistically significant differences were present for 
EMT versus EPI, for LUC4, CAl and LUC9. The p value was set at p = 0.05.
Statistical tests were also performed on the same OCSC sub-groups from different cell lines (e.g. EMT 
from LUC4 versus EMT from CAl and LUC9), the results of which are shown in Table 5.9.
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1 LUC4_EPI vs. CA1_EPI p = 0.108 p = 0.357
LUC4_EMT vs. CA1_EMT N/A p = 0.638
CA1_EMT vs. LUC9_EMT N/A p = 0.993
Accutase
LUC4_EMT vs. LUC9_EMT p = 0.618 p = 0.584
LUC4_EPI vs. CA1_EPI p = 0.049 p = 0.225
CA1_EPI vs. LUC9_EPI p = 0.777 p = 0.634
LUC4_EPI vs. LUC9_EPI p = 0.141 p = 0.000
Table 5.9: Summary of results of t-tests for statistical significance, for low frequency crossovers using both Jones' equation 
and Pethig's equation. The basis of the testing being to determine if any statistically significant differences were present for 
the same sub-groups from different cell lines (e.g. LUC4 EMT versus CAl EMT, or CAl EPI versus LUC9 EPI), for LUC4, CAl 
and LUC9. The p value was set at p = 0.05.
Entries marked with "N/A" in Table 5.9 indicate that one of the sub-groups was considered to contain 
too few experimental runs to justify statistical testing.
There were two tests which achieved a p value of less than 0.05: LUC4 EPI versus CAl EPI achieved a 
p value of 0.049 and LUC4 EPI versus LUC9 EPI achieved a value of 0.000. Both significant differences 
were found when Pethig's equation for low crossover frequency was used, and when Accutase was 
the dissociation medium employed prior to DEP testing. Of note, no significant differences were 
found for the EMT sub-group, for either Trypsin or Accutase.
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5.4 Discussion
In this study, it was the aim of the researcher to investigate the dielectric characteristics of two sub­
groups of self-renewing oral cancer stem-like cells, one comprising cells with an epithelial-to- 
mesenchymal phenotype and the other comprising cells with an epithelial phenotype (shown Figure
5.1 of the Introduction section for this chapter).
This section of the study will interpret, and seek to provide implications and supply context for, the 
results presented in the preceding section. The limitations of this study in its current form will be 
discussed, as will possible solutions for the removal of these limitations and ideas for future 
development of the study.
5.4.1 Cellular Dielectric Properties
5.4.1.1 Electrophysiological Characteristics
5 .4 .1 .1 .1  T ry p s in
Trypsin was trialled in this study, because a prior study by Biddle and colleagues [38] showed Tryspin 
to act as a selective marker for cells within the stem-like CD44* population that possessed an EMT- 
like phenotype, by destroying variants of the standard CD44 isoform. It was therefore considered 
possible that the differing surface protein expression of the EMT sub-group compared with the 
epithelial sub-group, resulting from dissociation via Trypsin, could result in significant differences 
between the sub-groups, in terms of their dielectric profiles.
However, no statistically significant differences were found between the EMT and epithelial sub­
groups, for either the LUC4 or the CAl cell lines when Trypsin was used to dissociate the cells from 
their culture vessels, prior to DEP testing (Table 5.1, Results section).
Of particular interest were the results for membrane capacitance, given the role of Tryspin in 
selectively destroying variant CD44 surface isoforms but retaining standard CD44 isoforms. The 
results shown in Figure 5.9 and Table 5.3 indicate that despite this destruction of selected membrane 
surface features, the mean capacitance (which is directly proportional to membrane surface area) of 
cells from the CAl line with an EMT phenotype was almost identical to the mean capacitance of cells 
from the same line with an epithelial phenotype (10.7 + 3.2 mF/m^ and 10.4 + 2.2 mF/m^ 
respectively). This result was unexpected, because cells undergoing or having undergone an
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epithelial-to-mesenchymal transition have greater motility than their epithelial counterparts [11], 
and this motility is achieved in some cells by cell membrane features and protrusions, such as 
filopodia and lamellipodia [52].
In contrast, the mean membrane capacitance achieved by the EMT sub-group from the LUC4 line 
was greater than that achieved by the LUC4 epithelial sub-group (10.8 + 2.5 mP/m^ and 8.4 + 1.5 
mF/m^ respectively).
It is notable however, that Huang and colleagues [47] estimated that a cell with a smooth, flat 
membrane surface would have a membrane capacitance of approximately 9 mF/m^. The results 
shown in Table 5.3 suggest that the membranes of cells from both the EMT and epithelial sub­
groups, from both the LUC4 and CAl lines are smooth and therefore lacking significant membrane 
protrusions. Upon comparison with membrane capacitance values reported in published literature, 
the values of membrane capacitance, from the EMT and epithelial sub-groups from both LUC4 and 
CAl (Table 5.3) are similar to the values recorded by Wang and colleagues for human myelogenous 
leukaemia cells after treatment with an apoptosis induction agent [53], and to the values presented 
in the previous chapter for oral stem-like cancer cells after treatment with hyaluronic acid synthesis 
inhibitor 4-MU (which resulted in loss of membrane protrusions and ruffling) [54].
Whilst no significant differences were found for membrane conductance (indicative of ionic 
transport across the plasma membrane), the difference in mean values achieved by the EMT and 
epithelial sub-groups from the LUC4 line produced a large percentage difference of 74.0%. The EMT 
sub-group achieved a value of 1583.3 + 469.3 S/m^ whilst the epithelial sub-group achieved a value 
of 726.7 + 140.3 S/m^. This particularly high value for EMT membrane conductance also coincided 
with a decreased cytoplasmic conductivity value for EMT compared with that of the epithelial group 
(0 .2+  0.0 S/m and 0.3 + 0.1 S/m respectively), which could suggest a net migration of ions out of the 
cell into the suspending medium.
The cells of CAl line did not show the same trend in membrane conductance as their LUC4 
counterparts. The percentage difference between the mean values obtained by the EMT and 
epithelial groups was only 11.5%. However, the percentage difference in cytoplasmic conductivity 
between the two stem-like sub-groups was 42.0% (see Table 5.3 for values), suggesting that the EMT 
CAl cells had much greater ionic content than their epithelial counterparts, not necessarily caused by 
a net migration of ions into the CAl EMT cytoplasms.
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5.4.1.1.2 Accutase
Accutase, like Trypsin, is a proteolytic dissociation agent. However, the manufacturers of Accutase 
maintain that it is a gentler, yet more efficient cell detachment solution than Trypsin [55].When 
Accutase was used in this study, in place of Trypsin, the results of DEP testing (Figures 5.10-5.13) 
again suggested there were no significant differences between the EMT and epithelial sub-groups, 
for the LUC4 and CAl cell lines (Table 5.2), though membrane capacitance for LUC4 EMT versus 
epithelial did achieve a p value of 0.094. However, a significant difference was found, for membrane 
capacitance, when cells from the LUC9 line were tested.
As shown in Table 5.2, the difference between the EMT and epithelial (EPI) LUC9 sub-groups, in 
terms of membrane capacitance, earned a p value of 0.048 and a percentage difference in mean 
values of 74.0%. Membrane capacitance is influenced by membrane permittivity and thickness, as 
shown in equation 2 in the Methods section, but is also influenced by cell membrane surface area. 
The surface area of a cell is increased when the membrane is ruffled or folded, or hosts protrusions 
such as blebs, filopodia or microvilli [56]. Ratanachoo and colleagues [56] stipulated that the changes 
in membrane capacitance seen in their studies, of up to 40.0%, were too great to be the product of 
differences in membrane composition (of e.g. pores, ion channels, membrane-bound and 
protruding proteins) but rather, were attributable to large-scale changes in membrane morphology 
resulting in significant changes in surface area. Using this theory therefore, the significantly increased 
membrane capacitance value for LUC9 EMT compared with LUC9 EPI was most likely the result of 
changes in membrane morphology and hence significantly (in this case) increased cell membrane 
surface area. The mean values for both LUC9 EMT and LUC9 epithelial membrane capacitance are 
still relatively low, especially that of LUC9 epithelial membrane capacitance (5.1 + 0.5 mF/m^), 
indicating smooth membrane surfaces.
This is the case for the mean membrane capacitance values from all other sub-groups, from LUC4 
and CAl, with the exception of LUC4 EPI Accutase (Table 5.3), which achieved a mean + standard 
error value of 15.0 + 1.6 mF/m^. Of note, this value is greater than the value obtained by the LUC4 
EMT Accutase sub-group (9.8 + 0.3 mF/m^), suggesting the epithelial cells from LUC4 had larger 
surface areas than their counterparts with mesenchymal phenotypes.
Of the two membrane-based cellular dielectric properties focused upon in this study, membrane 
conductance appears to be less widely used as a discriminating factor than membrane capacitance, 
with some research groups focusing on membrane capacitance and crossover frequencies [48, 57].
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5.4.1.1.3 Calculated versus Modelled Mean Results
At the time of writing, no established protocol for results analysis, following DEP testing using the 
DEPtech 3DEP system, existed in publication. The DEP Well system described and used in the two 
studies preceding this, in contrast, had a well-established, well-documented protocol. It however, 
was capable of producing far less raw experimental data than the 3DEP system, over the same period 
of time. Using the DEP Well system, the time taken to produce one full DEP spectrum (sweeping 
through frequencies of less than 10 kHz to 20 MHz, taking change in light intensity readings at 5 
frequency points per decade) was approximately 60-90 minutes, excluding sample preparation, 
photographing and counting. Due to its capacity to test the contents bounded by 20 Well electrodes 
simultaneously, the time required by the 3DEP system to produce a full spectrum, from kilohertz to 
megahertz, was equal to the time required by the DEP Well system to run one frequency, i.e. in the 
case of this study, 40-80 seconds. The consequence of this was that rather than producing one full 
spectrum, with a few data points repeated if they appeared to be obvious outliers, multiple full DEP 
spectra could be produced using the 3DEP system, for the same sample. This in turn required a mean 
value, for each experiment to be produced, as it was the number of times that different samples (i.e. 
with passage numbers) from the same sub-group and cell line were repeated that was of importance, 
not the number of full spectrum runs generated for each experimental repeat.
Two main methods for generating mean experiment values were identified, as described in the 
Methods section, one involving calculation of means from the original modelled experimental runs, 
and the other involving producing an average DEP spectrum for each experiment and modelling 
these spectra. Tables 5.3 and 5.4 in the Results section show the values gained, using both of 
calculation and modelling methods, for the cellular dielectric properties for the EMT and epithelial 
sub-groups for each cell line, using both Trypsin and Accutase.
Figures 5.7-5.13 illustrate these differences in mean and standard error of mean values, in the form 
of bar charts. It is clear, upon consulting these bar charts that a trend does not exist whereby one 
method consistently resulted in larger or smaller magnitudes of mean values. For example, the 
calculated mean cytoplasmic conductivity values for the LUC4 line when Trypsin was used were 
greater than the modelled values, but the opposite trend was found for the CAl line (Figure 5.7), and 
whilst the calculated mean cytoplasmic conductivity values for the LUC4 line were again greater than 
the modelled values, when Accutase was used in place of Tryspin, the same trend this time was seen 
for CAl as was seen for LUC4 (Figure 5.11).
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In an attempt to decide whether calculated or modelled means should be used to best highlight any 
differences between the EMT and epithelial values from each of the cell lines, the values presented 
in Tables 5.3 and 5.4 were scrutinised. As the only differences deemed statistically significant were 
found for the membrane capacitance variable, the researcher calculated the range of both mean 
values and standard error of mean values, for the membrane capacitance values in Tables 5.3 and 
5.4.
The results in Table 5.3 showed that the range of calculated Cmem mean values, when Trypsin was 
used, was 2.4 mP/m^ and the associated standard error range was 2.3 mP/m^. When Accutase was 
used in place of Trypsin, the range of calculated Cmem mean values was 9.9 mP/m^ and the associated 
standard error range was 1.31 mP/m^. Therefore, a greater range in calculated mean values was 
found when Accutase was used, but the range of standard errors was lesser for Accutase than 
Trypsin.
With regards to the modelled means and standard errors in Table 5.4, the range of Cmem mean values, 
when Trypsin was used, was 6.8 mP/m^ and the associated standard error range was 1.3 mP/m^. 
When Accutase was used in place of Trypsin, the range of modelled Cmem mean values was 7.1 
mP/m^ and the associated standard error range was 1.5 mP/m^. Therefore, whilst the mean values 
achieved a greater range when Accutase was used in place of Trypsin, the range of the associated 
standard errors was also greater.
Comparing the ranges for means and standard errors gained using the calculated and modelled 
methods, the calculated method produced the greatest range in Cmem mean values, when Accutase 
was the dissociation medium used, whilst producing the 2"  ^smallest range of standard error values. 
This result implies that dissociation using Accutase, and calculation rather than modelling of the 
mean cellular dielectric properties could result in greater differences in mean values between sub­
groups and lower error values.
S.4.1.2 Low Frequency Crossover Analysis
Low frequency crossovers were another dielectric characteristic evaluated in the course of this study, 
in an attempt to determine if DEP could distinguish between cancer stem-like cells with a 
mesenchymal (EMT) phenotype and those with an epithelial phenotype. Lower crossover 
frequencies, i.e. those crossovers which occur at frequencies below approximately 1 MHz [58] and
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are influenced by cellular membrane properties, have been used by a number of different groups 
using DEP to study stem cell characteristics [48, 57, 59]. In this study, two separate equations were 
used to calculate lower crossover frequencies, one postulated by Jones and Kallio (equation 3 in the 
Methods section) [49] and the other by Pethig and colleagues (equation 4 in the Methods section) 
[50].
Figures 5.14 and 5.15 in the Results section show the mean crossover frequencies achieved using 
Jones' and Pethig's equations respectively, by cells in the EMT and epithelial sub-groups, when 
Trypsin was used. As can be seen, and verified using the numerical results in Table 5.6, there was 
almost no difference in crossover frequencies for the EMT and epithelial cells from the CAl line 
(Figure 5.14), suggesting that these cells, post dissociation using Trypsin, would, most likely, not be 
separated using DEP. This result was in agreement with the results in Table 5.1 for CAl, in which the 
p values associated with membrane dielectric characteristics were greater than 0.8. There was a 
difference in mean crossover frequency values for the sub-groups from the LUC4 cell line however, 
the mean value for the EMT sub-group was based on one valid experimental run, and so this 
difference was not suitable to be submitted for statistical analysis, as shown in Table 5.8. The 
crossover results generated by Pethig's equation, when Trypsin was used (Figure 5.15), show the 
opposite trend to that seen in Figure 5.14. Using Pethig's equation, the crossover frequencies for the 
LUC4 sub-groups were very similar (with a difference of approximately 3 kHz) and the CAl EMT cells 
achieved a lower mean crossover frequency than their epithelial counterparts (Just as was observed 
for LUC4 in Figure 5.14). However, the difference between the CAl EMT and epithelial crossover 
frequencies was Just 4.3 kHz (Table 5.6). Given these results, and those shown in Figure 5.16, it was 
of no surprise that no significant differences were found in terms of crossover frequencies, using 
either Jones' equation or Pethig's equation, and regardless of the dissociation medium used, for EMT 
versus epithelial cells from the LUC4 and CAl lines.
However, using Pethig's equation for lower crossover frequency calculation, a statistically significant 
difference between EMT and epithelial cells was evident upon review of Figure 5.17, Table 5.7 and 
Table 5.8. Once again, as was found for membrane capacitance, cells from the sub-groups from the 
LUC9 line were significantly different, this time in terms of the mean crossover frequencies they 
achieved, which earned a p value equal to 0.001 (Table 5.8). This result was not unexpected, as 
membrane capacitance is used to calculate the lower crossover frequency in Pethig's equation 
(equation 4). The epithelial sub-group achieving a higher mean crossover frequency than EMT sub­
group, suggesting that the average DEP spectrum of the epithelial sub-group was shifted to the right 
of the mean DEP spectrum of the EMT sub-group, and that it may be possible to apply a single
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frequency that would cause negative DEP of the LUC9 epithelial cells whilst causing positive DEP of 
the LUC9 EMT cells, hence separating them.
Of note, upon examination of Table 5.9, was that statistically significant differences were found, 
using both Jones' equation and Pethig's equation, between epithelial cells from different lines, when 
Acutase was used in place of Trypsin. The difference in mean crossovervalues between the epithelial 
cells of the LUC4 and CAl lines gained a p value of 0.049, when Jones' equation was used for 
crossover calculation. Also, a p value of 0.000 was gained for the difference in mean crossover 
frequencies between the LUC4 and LUC9 lines, when Pethig's equation was used for crossover 
calculation. This could indicate that DEP could be used to distinguish between or, in future, separate 
epithelial cells from specific different cell lines. Interestingly, no significant differences were found 
for EMT cells from different lines, and where one equation produced a significant difference, the 
other did not.
It is noticeable upon evaluation of the results shown in Tables 5.6 and 5.7 that the low frequency 
crossovers gained using Pethig's equation are consistently higher than those gained using Jones' 
equation. The percentage differences between the mean crossovers gained using the two equations 
range from 19.8% to 90.4% for Trypsin, and 15.9% to 111.6% using Accutase. Given the disparity 
between the mean crossover frequency values gained using Jones' equation compared with those 
gained using Pethig's equation, a decision over which of these equations to use in any expansion of 
this study could only be made based upon experimental evidence of cell trapping and separation 
efficiency, using an electrode setup with cell collection capabilities.
Discrepancies were not just isolated to the results achieved in this study using the two equations for 
low frequency crossovers, but were also encountered in terms of the format of these equations, 
found in published literature. Within published literature, there appear to be six different equations 
to generate low frequency crossover results. Four of these equations appear to be variations of two 
different equations, that presented by Jones and Kallio in 1979 [49], and that presented by Pethig 
and colleagues in 2005 [50] as a re-working of an equation originally presented by Huang and 
colleagues in 1996 [47]. Huang and colleagues also cite Jones' equation in their 1996 paper, but this 
equation is in agreement with the original and differs only in the notation used.
Broche et al [60] referenced the Jones' equation presented in the paper by Huang and colleagues, 
and presented the following equation:
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A^e\  -  A£2£z -  2 eI
Where A =  (r2 = cell radius and ra -  ri = membrane thickness), a is conductivity, e is
V 2 ~  f ' l )
permittivity and the subscripts 2 and 3 refer to cell membrane and suspending medium properties, 
respectively. However, upon substituting Sp for EzA and Op for 0 2 A, and comparing with Jones' 
equation (equation 3), it becomes evident that the sign preceding the middle term of the 
denominator is negative in Broche's equation and positive in Jones' equation. Given that this is the 
only difference, this tends suggest the presence of a typing error, rather than a disagreement over 
theory.
Another version of Jones' equation was presented, by Pethig and Talary in a paper in 2007 [61], 
which read:
(0"c -
( f c  -
Where the subscripts c and s represent cell and surrounding medium properties, respectively. Upon 
substituting 1 for s and 2 for c, in keeping with the notation in Jones' equation, there appears to be a 
discrepancy in the numerator. In Jones' equation, the 1^ ‘ bracketed term of the numerator reads (o i-  
0 2 ), not ( 0 2  - Oi) as is stated in equation 10. Again, as this is the only difference between the two  
equations, this too suggests the presence of a typing error in equation 10, rather than a 
disagreement over theory, and therefore equation 3 should be used rather than equation 10.
Salmanzadeh and colleagues appear to have quoted equation 10 in their paper [57], substituting p 
and m for subscript notations c and s respectively, but also quoted the Pethig equation (equation 4), 
which is agreement with the original and appear to have used Pethig's equation to generate all 
crossover results in their work, rather than the equation 10.
A paper by Prieto and colleagues [62] also presents a different equation for low frequency crossover, 
which seems to be based on Pethig's equation (equation 4), rather than Jones' equation (equation 3). 
Prieto and colleagues reference the following equation as a simplification of the equation presented 
by Huang and colleagues [47] (the equation which was re-worked to become Pethig's equation):
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Where the subscripts m and mem refer to medium and membrane properties, respectively. This 
equation is almost identical to that presented and commonly used by Pethig (equation 4), except 
that equation 11 omits V2 from the numerator and equation 4 does not.
It would appear that equations 9-11 are only different to the equations for low frequency crossover 
postulated by Jones (equation 3) and Pethig (equation 4) by virtue of typing errors. This suggests, 
therefore, that for calculation of low frequency crossover, only equations 3 (Jones' equation) and 4 
(Pethig's equation) should be used.
5.4.3 Limitations and Options for Future Development of 
Current Study
The study presented here was a preliminary investigation into the use of DEP for studying cancer 
stem-like cells with differing phenotypes. As such, there are a number of different aspects of the 
study that could be expanded upon in future, or improved.
Production of conclusive, meaningful results from the current study is fully dependent upon the 
successful, efficient separation of the highly plastic EMT and epithelial cancer stem-like cell sub­
groups, using FACS. FACS was required to precede the label-free DEP testing stage in order to 
determine the dielectric profiles of the cells within both sub-groups separately, and sort efficiency 
was assumed to be satisfactory in this study. However, if the sorting efficiency was poor, the 
populations assumed to contain largely EMT or largely epithelial populations would actually be a 
mixed population of both, where the cell sub-type of interest was not in the majority, thus giving rise 
to misleading, erroneous results.
This issue of having mixed rather than distinct populations could potentially be resolved if the time 
taken to restore sample heterogeneity post FACS was known and if the cell concentration needed to 
perform a successful DEP test (i.e. one were the signal-to-noise ratio was great in magnitude) was 
low. The lower the cell concentration needed, the less time would be required to reach this lower 
percentage of confluence. This in turn would mean less likelihood of cells switching from one 
phenotype to the other (in the case of EMT cells), or cells with an epithelial phenotype (with a faster
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rate of proliferation) establishing themselves as the majority cell type within a previously EMT 
population.
In order to verify that the results presented in this study are true results, and not the product of 
outlier data, more experimental runs would have to be conducted, particularly for LUC4 EMT using 
Accutase, CAl EPI using both Trypsin and Accutase and LUC9 EMT and EPI using Accutase. To gain a 
better understanding of the effects of dissociation media on DEP results, the LUC9 line would have to 
be tested using DEP following cell detachment using Trypsin, just as cells from the LUC4 line and CAl 
line were. Investigating the effects of Trypsin and Accutase using three cell lines should ensure that in 
the case of conflicting results between two cell lines, those results from the third line should provide 
a consensus of theory. In fact, this could be achieved using any number of cell lines, as long as the 
number was odd and greater than one, and performing DEP testing on more cell lines in future, 
should render the investigation more rigorous.
Another method of verifying the results of DEP testing, aside from performing more DEP tests, would 
be to introduce parallel testing of the cell sub-groups studied, that would in turn aid interpretation of 
DEP results. For example, scanning electron microscopy could be employed to capture images of the 
membrane surface topographies of the EMT and epithelial cells, and the results gained when Trypsin 
and when Accutase were used, could be compared to better understand the membrane capacitance 
results gained via DEP. Patch clamping could also be considered, to gain a better understanding of 
the membrane conductance and cytoplasmic conductivity results gained using DEP.
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5.5 Conclusions
This study was undertaken having used DEP to examine the dielectric properties of stem-like (RAC) 
versus non stem-like (LAC) oral cancer cells, in the study preceding this. Having gained results 
suggesting DEP could be used to distinguish between these groups of cells at either end of a scale of 
stem-ness, the researcher decided to study specific sub-groups within the cancer stem-like cells 
group, specifically those stem-like cells with a migratory (mesenchymal) phenotype linking them to 
establishment of distant metastasis, and those with an epithelial phenotype which are highly 
proliferative and capable of populating in colonies (as seen in tumours).
Within this general aim, there were several specific aims of this study, outlined in as null hypotheses 
in the Methods section of this chapter. To summarise, these aims were to investigate if DEP could be 
used to differentiate between cells from different phenotype sub-groups (i.e. EMT or epithelial) from 
the same cell line, and cells from the same phenotype sub-group (i.e. EMT or epithelial) from 
different cell lines. Additional aims were to attempt to identify whether Trypsin or Accutase was best 
suited to be used as the dissociation medium of choice, prior to DEP testing and to evaluate which 
method for generating mean results from DEP testing best distinguished cells with mesenchymal 
phenotypes from those with epithelial phenotypes; calculating mean results or modelling mean 
results.
Using the Methods outlined earlier in this chapter, DEP testing and subsequent results analysis 
generated several points of note. The first was that the only significant differences found in this 
study occurred when Accutase was the dissociation medium used, and this would suggest that any 
future work following-on from this study should use Accutase to better highlight key differences 
between cells from the EMT and epithelial sub-groups.
Secondly, of the three cell lines examined in this study, the only significant differences found 
between cells with mesenchymal phenotypes versus those with epithelial phenotypes, were seen in 
the LUC9 line.
However, more repeats, particularly using the LUC9 line, must be conducted in order to achieve 
conclusive results, and methods should be employed to further examine the cellular properties that 
DEP testing focuses upon, i.e. the ionic content of the cytoplasm, ionic transport across the plasma 
membrane and the surface topography of the plasma membrane of the EMT and epithelial sub­
groups.
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Also of note was that mean values that are calculated rather than modelled had a greater range, but 
their associated standard errors had a smaller range.
Finally, the differences between cancer stem-like cells with mesenchymal and epithelial phenotypes 
appear to be subtle for the LUC4 and CAl cell lines, but that it may be possible to use DEP to 
distinguish between cancer stem-like cells with mesenchymal and epithelial phenotypes, from the 
LUC9 line, using membrane capacitance or low frequency crossovers. The 3DEP system used here for 
DEP testing was also able to distinguish between epithelial cells from the LUC4 line and the CAl line, 
and from the LUC4 line and the LUC9 line, when low frequency crossovers were used as the 
discriminatory dielectric characteristic.
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Appendix 1: Study Participant 
Inclusion and Exclusion Criteria- 
Dielectrophoresis of Oral Ex Vivo Cells 
Collected using Brush Biopsies
astnan ^  §ürî^
Oral Brush Biopsy Studv-Patient Inclusion and Exclusion Information
The oral brush biopsy human specimens are not obtained from any individuals belonging to high risk groups. High 
risk groups are defined in Appendix 1 of the Safety Policy: SP/03/98 document. Thus, the oral brush biopsy human 
specimens can be considered as human specimens from low risk groups.
In all cases, prospective study patients will be approached by the attending clinician to see if they are willing to 
participate in the study. In cases, the clinician will inform the
subject of the research, will invite him/her to participate in the study and, on agreement, the subject will sign a 
consent form. A copy of the consent form will be placed in the patient's NHS records and the patient's GP will be 
informed of their participation in the study.
The principle inclusion criteria are:
•  Individuals aged over 16 years
•  The presentation of an oral mucosal lesion with clinical features suggestive of potentially malignant or 
malignant disease of the oral mucosa (mouth lining)
•  Subjects of the control group must have normal healthy mucosa and no exposure to tobacco (smoking or 
chewed), areca nut, or excessive alcohol intake (>21 units/week for men and >14 units/week for women)
•  Subjects must be able to understand and communicate in written and spoken English
The principle exclusion criteria are:
•  Individuals unable to understand spoken and written English
•  Individuals under 16 years of age
•  In the control group, exposure to tobacco (smoking or chewed), areca nut, or excessive alcohol intake (>21
units/week for men and >14 units/week for women)
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Appendix 2: Video Clip Showing 
Positive and Negative Dielectrophoresis 
of Oral Ex Vivo Cells from One Oral 
Brush Biopsy Sample
WMVl
Positive and Negative DER of OBB Sample_KA Graham.wmv (Command Line)
Click on the video file above to launch a Windows Media Player file showing 
positive and negative DEP occurring, at separate frequencies, for one oral 
brush biopsy sample (OBB_96) tested using the DEPtech 3DEP DEP-Well 
system. Sample collected by Dr S Fedele (UCL Eastman Dental Institute, London 
UK) and tested by K.A. Graham.
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Human oral cancer cells with increasing 
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O bjective: A lthough cells w ith  tu m orige n ic /s tem  ce ll- like  properties have been iden tified in many 
cancers, inc lud ing oral squam ous ce ll carc inom a (OSCC), the ir iso lation and characte risation is still at 
early stages. The aim o f th is study is to  characterise the  e lec trophys io log ica l properties o f OSCC cells 
w ith  d iffe ren t tum orige n ic  properties in o rde r to  establish if a co rre la tion  exists be tw een tum orige n ic ity  
and ce llu la r e lectrica l characteristics. Materials and m ethods: Rapid adherence to  co llagen IV was used 
as a non-invasive, functiona l m e thod  to  isolate subsets o f cells w ith  d iffe ren t tum o rig e n ic  abilities fro m  
one oral dysplastic and three  O SCC-derived cell lines. The ce ll subsets iden tified and isolated using this 
m e thod  w ere  fu rthe r investigated using d ie lectrophoresis, a labe l-free  m e thod to  de term ine  the ir 
e lectrophysio log ica l parameters. Cell m em brane m orpho logy  was investigated using scanning e lec tron  
m icroscopy (SEM) and m odula ted by use o f 4 -m e th y lu m b e llife ro n e  (4-MU). Results: Rapid adherent cells 
(RAC) to  co llagen IV, enriched fo r increased tum orige n ic  ability, had s ign ificantly  h igher e ffective 
m em brane capacitance than m idd le  (MAC) and late (LAC) adherent cells. SEM show ed that, in con tras t 
to  MAC and LAC, RAC displayed a rough surface, extrem e ly rich in ce llu la r protrusions. T rea tm en t w ith  
4 - MU dram atica lly altered RAC m em brane m o rpho logy  by causing loss o f filopod ia , and s ign ificantly 
decreased the ir m em brane capacitance, ind ica ting tha t the h ighest m em brane capacitance found 
in RAC was due to  the ir ce ll m em brane m orpho logy. C onclusion: This is the  first study show ing  tha t 
OSCC cells w ith  h igher tu m o u r fo rm a tio n  ab ility  exh ib it h igher e ffec tive  m em brane capacitance than 
cells tha t are less tum origen ic . OSSC cells w ith  d iffe ren t tum orige n ic  ab ility  possessed d iffe ren t 
e lectrophysio log ica l properties m ostly  due to  the ir d iffe rences in the  ce ll m em brane m orpho logy . These 
results suggest tha t d ie lectrophoresis  cou ld  po ten tia lly  used in the  fu tu re  fo r reliable, labe l-fre e  isolation 
o f putative tum orige n ic  cells.
Introduction
Oral cancer ranks as the sixth most eommon type of cancer 
world-wide/ w ith 90% of oral eancers being oral squamous cell 
carcinomas (OSCC). It has a 5 year survival rate o f approxi­
mately 50%, which has not improved during recent decades,^ 
due in part to tumour recurrence following therapy. There is 
growing awareness that such recurrences may be related to 
patterns of cellular heterogeneity and tumour stemness w ith in 
tumours. The presence o f a subpopulation of caneer cells with 
stem cell-like properties (CSCs), including increased tumorigenesis 
has been shown in haematological cancers,^ as well as many
“  The Gade Laboratory f o r  Pathology, Departm ent o f  C lin ica l M edicine,
Faculty o f  M edicine a nd  Dentistry, University o f  Bergen, 5021, Bergen, N orw ay  
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‘’ Departm ent o f  Pathology, H aukeland  University H ospita l, 5021, Bergen, Norw ay
solid cancers,'* ineluding OSCC.^ These cells were also shown to 
have the ability to resist various apoptosis-inducing drugs, thus 
making therapeutic eradication o f tumours very d ifficu lt and 
allowing tumour recurrence.® Nevertheless, there are s till many 
controversies about the presence and behaviour o f cancer cells 
w ith stem cell-like properties/increased tumorigenic ability,^ 
and more information is needed on their charaeteristies and 
behaviour in order to learn how to target and eradicate them. 
The aim o f this study was to eharacterise OSCC cells with 
various tumorigenic abilities in terms of their electrophysio­
logical properties and investigate whether CSCs possess unique 
dielectrical features that can be putatively used in the future for 
their isolation.
The most common way o f isolating tumorigenic/CSCs is 
fluorescence-activated cell sorting. For an expanding range 
of human epithelial tumours, including OSCC, differential 
expression o f eertain cell surfaee markers, prim arily CD44,®*’“^ 
enzymatic activities (ALDHl)^ or exclusion o f DNA dyes^ has
This journal is ©The Royal Society of Chemistry 2014 Integr. Biol., 2014, 6, 545-554 1 545
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enabled prospective identification and isolation o f tumorigenic/ 
CSCs. However, great debate surrounds the existence o f specific 
phenotypic markers for tumorigenic cells in  OSCC and in  cancer 
in  general,*” since cancer cells are veiy versatile cells and have 
been shown to rapidly switch phenotypes, such that no specific 
markers are commonly accepted. There are, however, alternative 
ways to isolate tumorigenic/CSCs based on functional stem cell­
like characteristics such as self-renewal (serial sphere forma­
tion), tumorigenicity {in vivo serial tum our engraftment), drug 
resistance, or the presence o f a certain niche (adhesiveness to 
specific substrates). For normal epithelium, the localization 
o f self-renewing stem cells (label-retaining cells) near basal 
membranes (BM) that are rich in  collagen IV indicates that 
collagen IV m ight be a component o f the stem cell niche and 
suggests that adherence to collagen IV can be used for enriching 
in  tumorigenic/CSCs. Previous studies on normal epithelium 
showed that the population o f cells rapidly adhering to BM 
proteins contained the self-renewing population, and this 
method was shown to enrich stem cells in  both human, murine 
and rabbit normal epithelium.** Adherence to BM components 
(collagen IV) was found to be crucial not only for normal cell 
growth, but also for tumour cell adhesion, growth, invasion and 
metastasis. The rapid adherence to collagen IV was also tested 
and proven to enrich for stem cells in  epithelial malignancies 
such as hepatic carcinoma,*^ due to their differential expres­
sion o f specific integrins.*^ We have chosen this method to 
identify and isolate cells w ith  different tumorigenic/CSCs pro­
perties since i t  is a non-invasive, functional method that can 
sort cells w ith a non-altered phenotype.
To determine the electrophysiologal properties o f the sub­
sets o f cells w ith different tumorigenic properties we have used 
dielectrophoresis. Dielectrophoresis (DEP) is an electrostatic 
phenomenon whose firs t in-depth study is attributed to Herbert 
Pohl in  1951, and is the name given to the movement of 
particles due to polarisation forces produced when the particles 
are subjected to an inhomogeneous electric field.*^ Cells can 
polarise in an electric field because unequal concentrations o f 
charges at the interfaces between the cell and suspending 
medium causes the formation o f a dipole across the cell 
membrane (between the intracellular contents and the sur­
rounding medium) along the direction o f the electric field 
lines. Interaction o f the two dipole charge centres w ith  a field 
gradient creates non-equal opposing Coulombic forces, resulting 
in a net force and driving cellular movement in  the direction of 
the field gradient. The force acting on the cells (fcEp) is defined 
in  eqn (l), where r  is the radius o f the spherical body, £ „ the 
relative perm ittivity o f the surrounding medium, Cq is the 
perm ittivity o f free space and is the square o f the gradient
146of the strength o f the applied electric field 
Edep = 2neoBmt^ Re[K{o))]'7E^ (1)
Re indicates “ the real part o f  and E(ca) refers to the 
Clausius-Mossotti factor, a complex term dependent on the 
dielectric properties o f the medium and cellular components, 
and on the frequency o f the energising electric field. I t  is this 
parameter which, when analysed as a function o f frequency,
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allows the cellular dielectric characteristics to be elucidated. 
The resultant “ DEP spectrum” *® can be directly related via a 
scaling factor to the value o f Re[E(cü)] at that frequency and 
from this, certain electrophysiological parameters can be found, 
namely the cytoplasmic conductivity, effective membrane conduc­
tance (Geff) and effective membrane capacitance (Cgff). Cytoplasmic 
conductivity reflects the electrical charge contained w ithin the 
cytoplasm, and therefore is indicative o f ionic strength. Effective 
membrane conductance (Ggff) relates to ionic transport across the 
cellular membrane, and effective membrane capacitance (Cgff) 
is indicative o f the morphology or phenotype o f the cellular 
membrane. DEP testing can be used to measure these properties, 
allowing i t  to be used as a characterisation tool.
DEP was firs t used on liv ing cells by Pohl and Hawk in  
1966,*® but has since been used to both characterise and 
separate different populations o f cells, for a variety o f different 
purposes w ith in  biology and medicine, such as to study 
links between m ultidrug resistance and cancer, and to study 
apoptosis.*^ DEP has been employed in  a micro-fluidic chip to 
separate colorectal cancer cells from E. coli bacteria and 
Human Embtyonic Kidney 293 cells.*® Dielectric methods have 
also been used to separate breast cancer cells from  blood,*” and 
to distinguish stem cells from their progeny.^” Recently, DEP 
has been used to study the electrical effects o f sphingosine on 
mouse ovarian cancer progression models^* and discriminate 
normal oral cells from pre-cancerous and neoplastic oral cell 
lines.^^ DEP offers many advantages over other methods o f 
measuring cell electrophysiology; i t  requires no markers and 
is not confounded by cell-marker interactions (unlike flow 
cytometry*^), and can examine many cells (typically 1000+) 
simultaneously, unlike patch clamp (where costly systems have 
much lower throughput).
This study is the firs t to examine primary human tum our 
in itia ting  cells using dielectrophoresis. Our analysis showed 
that there are marked electrophysiological differences between 
oral cancer cells w ith  different tumorigenic properties. The 
differences appear to culminate around the membrane effective 
capacitance which appears to (through SEM verification) be 
related to a cell membrane very rich in  cellular protrusions. 
In  this study, the method o f separation o f OSCC cells relied on 
their differential adhesiveness to collagen IV, hence highlighting 
this as a simple and robust method to sort rapid adherent cells 
(RAC) enriched w ith  tumorigenic properties, m iddle (MAC) 
and late (LAC) adherent cells that show gradual loss o f the 
tumorigenic abilities.
Further, the overall results suggest that DEP could potentially 
be used as a reliable, label-free tool for the isolation o f putative 
oral cancer tumorigenic cells.
Materials and methods
Cell culture
Oral dysplastic/premalignant cell lines DOK^® and human cell 
lines H357,^* CaLH3,®‘^  OSCCl,®’^ ® derived from patients w ith  
OSCC were used in  this study. CaLH3 and OSCCl cell lines were
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obtained in-house from  patients w ith  OSCC after informed 
consent, and grown as previously described.® DOK, H357 and 
CaLH3 were grown routinely in  the so called ‘FAD’ medium,^® a 
3 :1  mixture o f Dulbecco’s Modified Eagle’s Medium (DMEM) 
and Ham’s F12 supplemented w ith  10% Foetal Bovine Serum 
(FES), 25 pg m l“  ^ Bovine Pituitary Extract (InVitrogen, USA), 
0.4 pg m l“  ^ hydrocortisone, 5 pg m l“  ^ insu lin  (Novo Nordisk, 
Bagsværd, Denmark), 20 pg m l“  ^ transferrin, 50 pg ml~^ 
L-ascorbic acid, 20 pg m l“  ^ L-glutamine. OSCCl were grown 
routinely in  keratinocyte serum free medium (KSFM, 
InVitrogen) supplemented w ith 1 ng m l“  ^EGF, 25 pg m l“  ^BPE, 
100 U ml~^ penicillin, 100 pg m l“  ^streptomycin and 0.25 pg m l“  ^
amphotericin B (all from  GibcoBRL, Grand Island, NY, USA). 
A ll cells were grown under standard cell culture conditions: a 
hum idified incubator at 37 °C and 5% C02/95% air. At 60-70% 
confluence, the cells were released using 0.25% tiypsin-EDTA. 
A ll reagents were supplied by Sigma Aldrich, (St. Louis, MO, 
USA) unless otherwise indicated.
Adherence to collagen IV
Tissue culture dishes (100 mm) were coated evenly w ith 
10 pg m l“  ^human collagen IV (BD Biosciences, Franklin Lakes, 
USA) diluted in  10 mM acetic acid. After incubation at room 
temperature for 1 hour, the remaining collagen IV solution was 
aspirated and the dishes were twice rinsed carefully w ith 
phosphate-buffered saline (PBS), to remove any remaining 
acetic acid. The coated dishes were sterilised overnight using 
UV radiation. Single-cell suspensions in  medium were allowed 
to attach to the tissue culture dishes coated w ith  collagen IV in 
the incubator. Cells that attached to the dishes w ith in  10 m in 
were collected after tiypsinisation and referred to as rapid 
adherent cells (RAC). The cells that remained unattached 
w ith in  the firs t 10 m in were then transferred to a new, sterile 
collagen IV-coated dish for an additional 30 m in in  the incu­
bator. Cells that adhered w ith in  this period were referred to as 
middle adherent cells (MAC). A ll remaining unattached cells 
were collected as late adherent cells (LAC). The sorted cells 
using this method were further tested for their tissue regenera­
tion and tum our in itia ting  properties.
Three-dimensional organotypic assay
Three-dimensional (3D) organotypic co-cultures were obtained 
by seeding dysplastic (DOK) and neoplastic oral kératinocytes 
on top o f collagen type I biomatrices populated w ith  carcinoma 
associated fibroblasts, using a protocol established in  our 
laboratoiy.^^ The organotypic cultures were grown in  serum 
free culture medium: 3 vol Dulbeceo’s Modified eagle’s medium 
(Sigma)/! vol Ham’s F 12 (Sigma), supplemented w ith 0.4 pg m l“  ^
hydrocortisone (Sigma), 5 pg mP^ Insulin (Novo Nordisk, 
Bagsværd, Denmark), 20 pg m l“  ^ transferrin (Sigma), 50 pg m l"^ 
L-ascorbic acid (Sigma), 1 mg m l“  ^ linoleic acid-albumin (Sigma), 
200 pg m l“  ^ penicillin, 200 pg m l“  ^ streptomycin, 0.5 pg mP^ 
amphotericin B, 6 pg mP^ fluconazole, 20 pg m l“  ^ L-glutamine. 
The cultures were lifted at a ir-liqu id  interface and harvested 
after 10 days, formalin fixed and paraffin embedded or fresh- 
frozen, as previously described.^^
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Tongue xenotransplantation assay in  NOD/SCID mice
NOD/SCID mice w ith the age o f 6-8 weeks were used and kept 
in  an isolation facility under pathogen-free conditions and a 
12 hour day/night cycle. A ll animal procedures were approved 
by the Norwegian Animal Research Authority. Cells suspended 
in 50 pi of matrigel (BD Biosciences) were injected into the tongues 
o f mice. Tumour formation was visualized and assessed at the 
onset o f symptoms.
DEP experiments
Homogeneous cell suspensions were prepared and centrifuged 
at room temperature at 190 x g for 5 minutes. To ensure 
complete removal o f highly conductive culture medium, cell 
suspensions were washed twice and re-suspended in  fresh iso­
tonic medium for DEP experimentation, consisting of 8.5% (w/v) 
sucrose and 0.3% (w/v) dextrose.^® The medium conductivity 
was adjusted to 10 mS m “  ^using PBS and the final conductivity 
was verified by a Jenway 470 eonductivity meter (VWR Jencons, 
Leicestershire, UK). Cells were used immediately after 
re-suspension to minim ise the effects o f suspension in  low- 
conductivity medium. A small sample o f the fina l cell suspen­
sion was stained w ith  Ttypan blue and counted using a Bürker 
haemocytometer chamber and adjusted to 1.2 x 10® cells per 
m l for all DEP measurements. The “ DEP Well chip”  3D well 
electrode (DEPtech, Uckfield, UK) and associated MATLAB (The 
MathWorks Inc, Nantick, MA) control and analysis software 
used in  this study are described in  detail elsewhere.^^’^  ^ The 
chip was analysed using a prototype 3 DEP reader (Labtech, 
Uckfield, UK) with measurements taken using 10 Vp_p sinusoidal 
signals applied for 60 seconds, with measurements eveiy 3 seconds. 
The change in light intensity across the well was measured for each 
frequency; a “ best-fit” o f the real part o f the Clausius-Mossotti 
factor (Re[K(co)]) versus frequency was then found for the corre­
sponding spectrum using the “ single shell model” approach^® and 
the following variables: cytoplasmic conductivity (S m“ )^, effective 
membrane conductance (S m“ )^ and effective membrane capa­
citance (F m~^). Each experiment was repeated three times for 
CaLH3 cell line and twice for H357 and OSCCl cell lines. Cell 
diameters were measured using Image J software and the micro­
scope images of at least 50 cells were analysed, for each cell type, to 
determine cell radii for subsequent DEP modelling.
Scanning electronic microscopy (SEM)
RAC, MAC and LAC were obtained from CaLH3 and H357 cell 
lines. They were detached from  the collagen coated surfaces, 
counted and resuspended in  a single cell suspension; 500 cells 
o f the RAC, MAC and LAC subset o f cells were allowed to attach 
for 1.5 h to the poly-lysine-coated coverslips in  24 wells plates 
(VWR International AS, Oslo, Norway), at 37°. Samples were 
then fixed w ith 2% (v/v) glutaraldehyde in  0.1 M  phosphate 
buffer (pH = 7.2) for 2 h at 4 °C. Fixed samples were then 
subjected to graded ethanol dehydration and critical point 
dried, mounted on aluminium stubs, and coated w ith evaporated 
carbon, for the visual analysis performed using a Jeol JSM-7400 
field emission-scanning electron microscope.
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Treatment with 4-methylumbeIliferone (4-MU)
The sodium salt 4-MU (Sigma), a hyaluronic acid (HA) synthesis 
inhibitor, was dissolved in distilled water at a concentration of 
0.3 mM. This stock solution was appropriately diluted in the 
respective cell culture medium. CaLH3 and OSCCl cells were 
grown routinely un til approximately 50% confluent, and then 
incubated in the presence o f 4-MU for 48 h. The experiment was 
repeated three times.
Statistics
Data are expressed as mean ±  standard error of the mean 
(StEM) or standard deviation (SD) using GraphPad Prism 
software version 5.00 for Windows (GraphPad Software, 
San Diego, California, USA, www.graphpad.com) and SPSS 
programme (PASW Statistics 18, IBM, New York, USA). The 
differences in  Qm Ggff, cytoplasmic conductivity, and cell 
diameter between different cell subpopulations were analysed 
using ANOVA and the paired student t-test after relative data 
transformation to fu lfil the assumption o f normality. Paired 
student t-test was also used to analyse the Ceff, Geff and 
cytoplasmic conductivity values before and after 4-MU treat­
ment in CaLH3 cell line.
RAC isolated from OSCC-derived cells showed great tumour 
formation efficiency and shorter lag time of tumour formation 
than LAC in NOD/SCID mice
To test the tum our-initiating potential o f RAC, MAC and LAC 
isolated from OSCCl cell line, serial dilutions o f these three 
subpopulations were xenotransplanted in  the tongues of NOD/ 
SCID mice (n = 35). RAC (82%) showed higher tum our incidence 
than MAC (58%) and LAC (42%) (Fig. 2A(a)). When as few as 
100 cells were injected, RAC formed the tongue tumour at the 
earliest lag time (20.33 ±  3.5), 5 days before tum our formation 
in  LAC (25.33 ±  9.90), but w ith  a lag time sim ilar to MAC 
(20.00 ±  2.83) (Fig. 2A(b) and B). When 1000 cells were xeno­
transplanted, RAC and MAC formed primary tumours 7 days 
earlier compared to LAC (Fig. 2A and C). This indicates that cells 
sorted based on adherence to collagen IV showed decrease 
tumour formation ability from RAC to MAC to LAC.
RAC showed the highest effective membrane capacitance (Ceff), 
but no consistent trend was found between RAC, MAC and LAC in 
terms of effective membrane conductance (Geff) or cytoplasmic 
conductivity for both oral dysplastic and neoplastic cell lines
RAC, MAC and LAC displayed significant differences in terms of Ceff 
when all oral cancer cell lines were analysed together (p < 0.001).
Results
RAC isolated from the oral dysplastic cell line DOK gave rise to 
a dysplastic epithelium that had the greatest thickness in 3D 
organotypic cultures
To test the regenerative potential o f RAC, MAC and LAC, 3D 
organotypic culture were constructed separately by growing 
each of these cell sub-populations isolated from the oral 
dysplastic cells DOK on top o f a fibroblast-populated collagen 
biomatrix for 10 days. All subpopulations gave rise to a dysplastic 
epithelium, but RAC formed a thicker epithelium (33.78 ±  19.60) 
when compared to MAC (20.02 ±  16.48) and LAC (27.00 ±  16.16) 
for (Fig. lA  and B).
Organotypic cultures in oral 
dysplastic cell line DOK
I a  LAC
Fig. 1 (A) RAC displays the thickest epithelium among three different sub­
populations. (B) Quantification o f thickness in organotypic cultures by RAC, 
MAC and LAC.
Tumour initiating ability for NOD/SCID  
mice in oral cancer cell line 0SCC1
I h1 lîmm
RAC MAC LAC 100 1 (»0 
OSCCl OSCCl
a  MAC 
O  LAC
□  LAC
Day of tumour initiating 
injected with OSCC1 (100 cells)
□  MAC
□  LAC
Day of tumour initiating 
injected with O SCCl (1000 cells)
Fig. 2 Tum our initiating ability of RAC, MAC and LAC subpopulations o f 
cells isolated from  OSCCl cell lines in NOD/SCID mice: (A) (a) RAC showed 
highest tum our incidence than MAC and LAC. (b) RAC had earlier tum our 
initiating time than LAC, but similar time point to  MAC. (B) Individual tum our 
initiating time formed by 100 cells of RAC MAC and LAC. (C) Individual 
tum our initiating time formed by 1000 cells o f RAC MAC and LAC.
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Electrophysiological properties 
in various oral cancer cell lines
Electrophysiological properties 
in oral dysplastic cell line
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Fig. 3 Quantification o f the electrophysiological parameters for RAC, 
MAC and LAC subpopulations o f cells isolated from  CaLH3, H357 and 
QSCCl cell lines: (A) RAC displays the highest effective membrane 
capacitance (Ceff). (B) No consistent trend could be observed from  RAC 
to  MAC to  LAC in terms o f effective membrane conductance (Geff) or (C) 
cytoplasmic conductivity. Data are presented as mean StEM o f three 
CaLH3 and tw o H357 and QSCCl experiments. Star indicates statistically 
significant differences w ith a p value <  0.05.
Paired student’s t test showed that RAC had the highest effective 
membrane capacitance (Qm mF m“ )^ (18.10 ±  3.28 mF m “ )^, 
20.26% higher when compared to MAC (15.05 ±  2.74 mF m “ ,^ 
p = 0.026) and 79.65% higher than LAC (10.08 ±  1.65 mF m “ ,^ 
p <  0.001). MAC had also a significantly higher Ceff than 
LAC [p  = 0.018). There were some variations in the extent 
of differences between RAC, MAC and LAC w ith the type of 
cancer cell line analysed, and although the differences 
between RAC, MAC and LAC were only statistically significant 
for the CaLH3 cell line (p  = 0.011), the other two cell lines 
analysed showed the same trend o f decreased Cgff w ith a 
decrease in stem cell-like properties (Fig. 3A). The same 
trend for effective membrane capacitance was present for 
DOK (Fig. 4A).
The effective membrane conductance of oral cancer cell lines 
no consistent trend (Fig. 3B) from RAC (454.03 ±  63.66 S m~^) to 
MAC (585.72 ±  113.64 S m“ )^ to LAC (243.76 ±  28.61 S m '^). 
M inim al differences were detected between RAC, MAC and 
LAC for cytoplasmic conductivity (0.40 ±  0.07 S m " \  
0.36 ±  0.05 S m " \  and 0.44 ±  0.08 S m “ \  respectively), but 
no consistent trend could be observed from cells enriched in 
stem cell-like properties (RAC) towards cells that lost stem cell­
like properties (LAC) (Fig. 3C). A sim ilar trend was found in 
dysplastic cell line DOK (Fig. 4B and C).
Fig. 4 Quantification o f the electrophysiological parameters for RAC, MAC and 
LAC subpopulations of cells isolated from oral dysplastic cell line DQK: (A) RAC 
displays the highest effective membrane capacitance (Ceff). (B) No consistent 
trend could be observed from RAC to MAC to LAC in terms of effective mem­
brane conductance (Geff) or (C) cytoplasmic conductivity. Data are presented as 
mean StEM of three CaLH3 and two H357 and OSCCl experiments.
RAC were smaller and displayed a more folded and ruffled cell 
membrane tban MAC and LAC for botb oral dysplastic and 
neoplastic cell lines
Since the differences detected in  this study were mostly at the 
effective membrane capacitance level, known to be influenced by 
the morphology o f the cellular membrane, we further investi­
gated morphology-related aspects o f the three subsets of cells we 
have used in  the study. For oral cancer cell lines, RAC were found 
to have a significantly smaller diameter (13.46 ±  0.23 pm) than 
MAC (13.80 ±  0.21 pm, p = 0.004) and LAC (14.98 ±  0.23 pm, 
p = 0.000) (Fig. 5B). MAC had also a significantly smaller 
diameter than LAC [p  = 0.000) (Fig. 5B). This appearance was 
consistent w ith all oral dysplastic cell line DOK (Fig. 5C).
SEM revealed that RAC had a more regular spherical shape 
but displayed a more folded and ruffled cell membrane surface, 
rich in  both filopodia and lamellipodia membrane protrusions, 
but predominantly the former (Fig. 5A). In contrast, MAC and 
LAC were more heterogeneous and had a flat appearance, w ith 
smoother cell borders and less cellular protrusions on the 
surface (Fig. 5A). This appearance was consistent for all oral 
dysplastic and cancer cell lines examined in the study.
Treatment w ith 4-MU induced loss o f filopodia and decreased 
Ceff o f RAC in  CaLH3 cell line
In order to determine whether the cell membrane morphology 
was the key parameter for the difference in the Ceff observed 
between the three subsets o f cells, we altered this parameter
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Cell morphology in oral cancer 
and dysplastic cell lines
Comparison of non-treated and 
4MU-treated oral cancer cell lines
m
m  mac
□  LAC
H357 OSCCl 
Cell lines
□  LAC
Fig. 5 (A) SEM images o f RAC, MAC and LAC from oral cancer cell line 
CaLH3 and oral dysplastic cell line DOK: (a, d) RAC exhibited a regular, 
round shape and a ruffled cell surface, densely covered w ith cellular 
protrusions and extremely rich in cell protrusions, (b, e) MAC displayed 
a regular, round shape as well, but showed a surface less densely 
covered w ith cellular protrusions, (c, f) LAC cells showed an irregular 
shape and a flatten surface, w ith less cellular protrusions. (B, C) Quanti­
fication o f the cell diameter o f RAC, MAC and LAC subpopulations o f cells 
isolated from oral cancer cell lines CaLH3, H357 and QSCCl cell lines 
and oral dysplastic cell line DQK (C) RAC are the smallest cells. Data 
are presented as mean StEM of m inim um 50 cells in three different 
experiments. Star indicates statistically significant differences w ith a 
p value <  0.05. Double star indicates statistically significant differences 
w ith a p value <  0.01.
□  LAC
treated 4MU-treated
m  RAC 
a  LAC
non^reated dMU-treated
Fig. 6 Comparison o f non-treated and 4MU-treated CaLH3. RAC exhib­
ited a regular, round shape (a) and a ruffled cell surface, densely covered 
w ith cellular protrusions and extremely rich in filopodia (d). MAC displayed 
a regular, round shape as well (b), but showed a surface less densely 
covered w ith cellular protrusions and not so rich in filopodia (e). LAC cells 
showed an irregular shape (c) and a flattened surface, w ith fewer and 
shorter filopodia (f). Treatment w ith 4-MU induced a flatter surface on all 
cell subsets and a loss o f filopodia, especially in RAC and MAC (g-l).
through treating cells w ith the small molecule inh ib ito r of HA 
synthesis, 4-MU. 4-MU was previously shown to induce changes 
of the membrane morphology o f OSCC cells through inhibition 
of hyaluronic acid chain elongation.®^ Treatment w ith 4-MU and 
subsequent SEM showed a loss o f filopodia and smoothening of 
the cell membrane o f RAC cells compared to non-treated RAC, 
and similar to the cell surface o f LAC (Fig. 6A). DEP analysis of 
cells treated with 4-MU for 48 h showed a significant decrease 
in Ceff in RAC from 23.39 ±  4.04 mF m“  ^to 10.41 ±  0.76 mF m“  ^
{p = 0.031) in the CaLH3 cell line. No difference was detected in 
the Ceff of RAC, MAC and LAC cells after treatment w ith 4-MU in 
CaLH3 cell line (Fig. 6B). In another cell line OSCCl, showed a 
slight decrease in RAC but not in MAC and LAC (Fig. 6C). 4-MU 
did not significantly alter the other electrophysiological para­
meters investigated in the study.
Discussion
This study produces the first evidence of a link  between 
differing electrophysiological properties of oral cancer cell 
subsets w ith differing tumorigenic/stem cell-like properties.
The results highlighted a correlation between tum our regenera­
tion (tumorigenicity) and electrophysiological properties. The 
greater the tumorigenesis or greater the tumorigenic capacity of 
the OSCC cells, the higher the effective membrane capacitance. 
To separate subsets o f OSCC cells w ith different tumorigenic/ 
stem cell-like properties we have chosen here a functional 
method based on the cellular adherence to collagen IV. This 
method has been reported to successfully enrich for cells w ith 
stem cell-like properties in various epithelial tissues, such as 
normal human skin.^®’®° This method has been shown to 
robustly sort cell populations w ith different self-renewing capa­
cities^® and different potential for regenerating normal skin®° 
and OSCC.®“ We have chosen to use this method for CSC 
enrichment since it avoids possible cell surface modifications 
that m ight occur due to antibody binding, and thus prevents 
any alterations of their original electrophysiological properties 
that would occur after marker-based cell sorting. In this way, we 
are confident that we have preserved, in as much as possible, 
the original characteristics o f the cells for a valid DEP o f the 
subsets o f cells w ith different tumorigenic/stem cell-like pro­
perties (RAC, MAC and LAC). However, this method has lim ita ­
tions. The enrichment in tumorigenic/CSCs through increased 
adherence to collagen FV is related to increased expression of
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p i integrin on the surface o f stem cell-like cells/® and although 
i t  does not directly use antibody binding for cell sorting, i t  is 
still related to a specific phenotype that can vary w ith  the 
epithelium type (squamous or simple versus transitional),®^ or 
culture conditions. Nevertheless, our results indicate that 
the RAC subset o f cells, although not exclusively containing 
tumorigenic/CSCs, is enriched for cells w ith  increased self- 
renewal and increased tumorigenicity, two essential attributes 
o f CSCs.
We further show here that the subset o f OSCC cells enriched 
for cells w ith  tumorigenic abilities/stem cell-like properties 
(RAC) possess different electrophysiological properties than 
the rest o f the cancer cells (MAC and LAC) due to their unique 
membrane characteristics. RAC displayed the highest Cgff 
when compared to the other sub-populations o f oral cancer 
cells tested (MAC and LAC). W hilst Cgff may be affected by 
membrane composition (including lip id  type and protein com­
position),®® it  is most strongly influenced by the membrane 
surface area, which is in  turn  related to the morphology o f the 
cell membrane. When the cellular morphologies o f our three 
subsets o f cells were analysed further, SEM showed marked 
differences between their cell membrane morphology, w ith 
RAC showing a cellular membrane morphology abundant 
in  cellular protrusions. We report here for the firs t time 
that cancer-stem cell like cells have a unique cell membrane 
morphology, enriched in  filopodia. The biological significance 
o f this ruffled cell membrane morphology is not yet elucidated, 
and especially not in  pathological conditions such as cancer. 
In  the normal state, the shape o f cellular membrane is o f major 
importance for the control o f cell signalling and cellular 
processes: invaginations o f the plasma membrane allow forma­
tion o f endocytic vesicles that remove signalling molecules 
from the cell surface; conversely, plasma protrusions in to the 
extracellular space allow a cell to probe its environment. Our 
results are in  line w ith  the few studies on the ultrastructure o f 
adult stem cells that show, for example, that undifferentiated 
mesenchymal stem cells have a cell surface covered by filopodia 
and undulipodia. During differentiation, the mesenchymal 
stem cells changed their shape from a round to a fibroblastic- 
like shape and lose their protrusions.®® Also in  neurogenesis, 
the abundance o f other cellular protrusions, such as apical 
m icrovilli, also decrease w ith the onset o f differentiation,®^ and 
two signaling pathways known to regulate the proliferation 
versus differentiation o f neural progenitors (Sonic Hedgehog 
and W nt signaling) have been linked w ith the regulation o f 
these cellular protrusions.®® Other observations pointing to a 
more ruffled cell membrane surface in  epithelial stem-like cells 
also come from studies on the localization o f prominin-1 
(CD133), a marker for both hematopoietic and epithelial stem 
cells that was selectively found on plasma membrane protru­
sions. In  addition, this seemed to be a general characteristic 
independent o f cell type since i t  showed in  both epithelial and 
transfeeted non-epithelial cells a selective association w ith 
apical m icrovilli and plasma membrane protrusions, respec­
tively.®® Of interest, the embryonic stem cells seem to be, in 
contrast, characterised by a smoother cell surface and many
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investigators relate the presence o f cellular protrusions to the 
cellular process o f invasion. Using anchor cell invasion into the 
vulvar epithelium in  C. elegans as an in vivo model o f invasive 
behaviour that allows for genetic and single-cell visual analysis 
o f invasion, investigators have shown that generation o f robust 
protrusions that breach the BM is responsible for their invasion 
and that this is due to a particular cell signalling and molecular 
mechanism.®® Although we did not aim to identify the mole­
cular mechanisms that are responsible for the generation o f the 
cellular protrusions in  RAC, the fact that 4-MU smoothens their 
surface indicates a role for hyaluronic acid and its complex 
biology in  the formation o f these cellular protrusions. This also 
indicate that the presence o f these numerous filopodia m ight 
be related to increased m igration and invasion o f RAC cells, 
as suggested by the fact that treatment o f OSCC-derived cell 
lines w ith  4-MU induced a decrease in  its migration through 
transwells (data not shown). The association between a cell 
membrane morphology rich in  cellular protrusions and 
increased m igration in  cancer stem cells fits also very well w ith 
the relatively recent theory o f CSCs as the more migratory, 
cancer cell population.®®
Of importance for our study is that the presence o f a cell 
membrane morphology rich in  cellular protrusions could 
explain the highest Cgff detected in  RAC. Our hypothesis that 
the ruffled membrane morphology o f RAC cells was the main 
determinant o f their high Cgff was proven by the find ing 
that treatment w ith  4-MU dramatically altered the membrane 
morphology o f all RAC cells by loss o f filopodia and produced a 
significant decrease o f Cgff, abolishing the difference observed 
in itia lly  between the three subsets o f cells. The change in  
capacitance could also be related to changes in  the perm ittivity 
o f the membrane due to the action o f 4-MU in  shortening the 
HA chains; however, we suggest that o f the two mechanisms, 
the effects o f morphology change are likely to significantly 
outweigh those o f perm ittivity change. The unique differences 
in  the membrane electrophysiological properties o f stem-like 
cells is in  line w ith a recent find ing from our group showing 
that cell membrane dielectric properties could potentially be 
used as a marker for stem cells in  neural tissues.®^ W ith  a lack 
o f d istinct stem cell markers, isolation o f tissue-specific stem 
cells for tissue engineering and gene therapy is a great 
challenge. More functional and non-invasive methods for 
tumorigenic/stem cell isolation are sought. The results o f this 
study suggest that DEP m ight be used in  the future as a reliable, 
label-free and non-invasive method for putative isolation o f 
tumorigenic cell in  oral caneer.
Conclusions
To our knowledge, this is the firs t study to show that OSCC cells 
w ith higher tum our formation (tumorigenicity) exhibit higher 
effective membrane capacitance than cells w ith  less tum ori­
genicity. OSCC w ith different stem cell-like properties possessed 
different electrophysiological properties, mostly due to differ­
ences in  cell membrane morphology resulting from  varying
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levels o f abundance o f cellular protrusions. The study shows 
the potential use o f effective membrane capacitance as a 
potential tumorigenic/stem cell-like marker. The results sug­
gest that dielectrophoresis may potentially be o f use in  the 
future for reliable, label-free isolation o f putative tumorigenic/ 
cancer stem cells.
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